matchedPattern,context,lineNumber,columnNumber,publicationName
1.10.3.2,"... Laccases (benzenediol:oxygen oxidoreductase, E.C.1.10.3.2) are copper-containing oxidoreductases pr...",17,882,3_Biotech_2015_Dec_10_5(6)_911-924.txt
EC 3.2.1.26,Invertases [β-d-fructofuranoside fructohydrolase (EC 3.2.1.26)] are disaccharidases which belong to ...,10,51,PMC4909026.txt
EC 3.2.1.78,"...tion of β-mannanase (1,4-β-mannan mannohydrolases EC 3.2.1.78), which releases manno-oligosaccharide...",18,120,PMC4912962.txt
1.2.2.213,"...droxy­methyl-10-meth­oxy-17,22-dioxapenta­cyclo­[21.2.2.213,16.13,7.011,30]triaconta-1(25),3,5,7(30)...",3,325,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jul_28_68(Pt_8)_o2598-o2599.txt
3.2.8.1,"...ed in CHO-K1 cells with 1.5 mM NB-DNJ (a), CHO Lec3.2.8.1 cells with 0.5 mM NB-DNJ (b), CHO-K1 cells...",69,151,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2011_Jun_30_67(Pt_7)_785-789.txt
2.1.2.2,2.1.2.2 GNP technolog,43,1,Acta_Pharm_Sin_B_2015_Jan_12_5(1)_38-46.txt
1.3.1.8,1.3.1.8	PF11_0370	—	—,165,1,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
2.3.1.181,2.3.1.181	MAL8P1.37	Lipoyl(octanoyl) transferase	—...,169,1,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
1.11.1.7,"...roxidases (PODs) (donor: H2O2 oxidoreductase, EC: 1.11.1.7) belong to a large family of enzymes whic...",18,53,Adv_Biomed_Res_2015_Jul_27_4_159.txt
6.2.4.317,...ns Pharmacogenomics 2001 2 317 327 10.1517/14622416.2.4.317 11722282,381,148,Adv_Ther_2016_Jul_12_33(9)_1461-1480.txt
2.24.6.574,... AIDS Educ Prev 2012 24 6 574 581 10.1521/aeap.2012.24.6.574 23206205,2186,245,AIDS_Behav_2016_Nov_13_20_880-918.txt
4.51.6.117,...nd Social Psychology  6 1173 1182 10.1037/0022-3514.51.6.1173 3806354,142,241,AIDS_Care_2016_May_26_28(sup2)_16120-167.txt
3.39.6.799,...Drugs Today (Barc) 2003 39 451 468 10.1358/dot.2003.39.6.799450 12944997,378,277,Allergo_J_Int_2014_May_9_23(3)_87-95.txt
4.6.1.95,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.1.95Case ReportA Case of Codeine Induced Anaph...,3,255,Allergy_Asthma_Immunol_Res_2014_Jan_3_6(1)_95-97.txt
4.6.2.156,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.2.156Original ArticleCross-reactivity to Aceta...,3,255,Allergy_Asthma_Immunol_Res_2014_Mar_13_6(2)_156-162.txt
EC 3.4.99.11,...nus Bacillus (Gobinath et al. 2014). Keratinases (EC 3.4.99.11) are serine- or metalloproteases (Gup...,12,976,AMB_Express_2016_Jun_30_6_42.txt
4.88.7.688,...ium wilt Plant Dis 2004 3 688 694 10.1094/PDIS.2004.88.7.688,160,164,AMB_Express_2013_Aug_17_3_46.txt
2.62.2.10,...Concord BioScience 2012 62 170 181 10.1525/bio.2012.62.2.10,168,212,Ambio_2015_Jan_9_44(Suppl_1)_69-77.txt
2.37.7.151,... and Oceanography 1992 37 1512 1526 10.4319/lo.1992.37.7.1512,217,193,Ambio_2015_Mar_15_44(Suppl_2)_228-240.txt
2.6.1.2,"...ed plants. Upon waterlogging, AlaAT activity (E.C.2.6.1.2) in roots of both nodulated and non-nodula...",72,171,Amino_Acids_2010_Oct_23_39(4)_1043-1053.txt
2.6.1.2,"... rather than being alanine aminotransferases (E.C.2.6.1.2). However, this prediction of enzyme funct...",90,845,Amino_Acids_2010_Oct_23_39(4)_1043-1053.txt
6.16.4.445,...pert Opin Ther Pat 2006 16 445 458 10.1517/13543776.16.4.445,108,128,Amino_Acids_2011_Feb_4_40(2)_731-740.txt
EC 2.1.1.13,"...l-l-glutamate:l-homocysteine-S-methyltransferase; EC 2.1.1.13), present in the cytoplasm, converts h...",29,398,Am_J_Clin_Nutr_2011_Jul_94(1)_359S-365S.txt
3.46.4.291,...73Korean Association of Anatomists 10.5115/acb.2013.46.4.291Case ReportApplied AnatomyRadiological a...,3,120,Anat_Cell_Biol_2013_Dec_24_46(4)_291-295.txt
6.49.2.99,...73Korean Association of Anatomists 10.5115/acb.2016.49.2.99Original ArticleCell BiologyChanges in ex...,3,120,Anat_Cell_Biol_2016_Jun_24_49(2)_99-106.txt
6.49.4.249,...73Korean Association of Anatomists 10.5115/acb.2016.49.4.249Original ArticleApplied AnatomyAn osteol...,3,120,PMC5266103.txt
1.2.7.2,...oducts; GO enrichment analysis. R package version 1.2.7.2. Available at: http://CRAN.R-project.org/p...,171,158,Andrology_2013_Nov_28_1(6)_822-829.txt
2.42.8.521,...ry. Korean Circ J. 2012 42 8 521 7 10.4070/kcj.2012.42.8.521 2297744,119,228,Anesth_Pain_Med_2015_Apr_20_5(2)_e19707.txt
1.35.6.833,... Ann Rehabil Med. 2011 35 6 833 43 10.5535/arm.2011.35.6.833 22506212,336,197,Anesth_Pain_Med_2015_Aug_22_5(4)_e29716.txt
2.31.2.199,...ject Rangifer. Spec. Issue 2011 19 97 102 10.7557/2.31.2.1994,114,139,PMC5295152.txt
3.29.2.83,...he Korean Society of Coloproctology 10.3393/ac.2013.29.2.83Case ReportAdenosquamous Carcinoma of the...,3,126,Ann_Coloproctol_2013_Apr_30_29(2)_83-86.txt
3.29.3.89,...he Korean Society of Coloproctology 10.3393/ac.2013.29.3.89EditorialClinical Significance of the Met...,3,126,Ann_Coloproctol_2013_Jun_30_29(3)_89-90.txt
4.30.5.237,...he Korean Society of Coloproctology 10.3393/ac.2014.30.5.237Case ReportIntramedullary Spinal Cord Me...,3,126,Ann_Coloproctol_2014_Oct_28_30(5)_237-240.txt
5.31.4.163,"...he Korean Society of Coloproctology 10.3393/ac.2015.31.4.163Letter to the EditorCommentary on \"Inser...",3,126,Ann_Coloproctol_2015_Aug_31_31(4)_163-164.txt
6.32.2.83,...he Korean Society of Coloproctology 10.3393/ac.2016.32.2.83Case ReportXanthogranulomatous Appendicit...,3,126,Ann_Coloproctol_2016_Apr_30_32(2)_83-86.txt
3.25.3.321,...ciety for Investigative Dermatology 10.5021/ad.2013.25.3.321Original ArticleAltered Levels of Sphing...,3,164,Ann_Dermatol_2013_Aug_13_25(3)_321-326.txt
4.26.2.256,...ciety for Investigative Dermatology 10.5021/ad.2014.26.2.256Letter to the EditorExpression of Cold-I...,3,164,Ann_Dermatol_2014_Apr_30_26(2)_256-258.txt
4.26.5.570,...ciety for Investigative Dermatology 10.5021/ad.2014.26.5.570Original ArticleDietary Pattern and Nutr...,3,164,Ann_Dermatol_2014_Oct_26_26(5)_570-575.txt
5.27.6.738,...ciety for Investigative Dermatology 10.5021/ad.2015.27.6.738Original ArticleTissue and Serum Inflamm...,3,164,Ann_Dermatol_2015_Dec_7_27(6)_738-743.txt
6.28.2.210,...ciety for Investigative Dermatology 10.5021/ad.2016.28.2.210Original ArticleThe Importance of Collag...,3,164,Ann_Dermatol_2016_Apr_31_28(2)_210-215.txt
5.9.1.109,...s Exp Rev Neurother 2009 9 109 136 10.1586/14737175.9.1.109,344,174,Ann_Gen_Psychiatry_2011_Jan_18_10_1.txt
2.32.1.79,...an Society for Laboratory Medicine 10.3343/alm.2012.32.1.79Brief CommunicationClinical MicrobiologyE...,3,120,Ann_Lab_Med_2012_Jan_20_32(1)_79-81.txt
2.32.5.339,...an Society for Laboratory Medicine 10.3343/alm.2012.32.5.339Original ArticleDiagnostic ImmunologyCha...,3,131,Ann_Lab_Med_2012_Sep_13_32(5)_339-344.txt
2.32.6.413,...an Society for Laboratory Medicine 10.3343/alm.2012.32.6.413Original ArticleClinical MicrobiologyClo...,3,131,Ann_Lab_Med_2012_Nov_17_32(6)_413-419.txt
3.33.3.217,...an Society for Laboratory Medicine 10.3343/alm.2013.33.3.217Case ReportDiagnostic GeneticsIdentifica...,3,131,Ann_Lab_Med_2013_May_17_33(3)_217-220.txt
4.34.4.325,...an Society for Laboratory Medicine 10.3343/alm.2014.34.4.325Letter to the EditorClinical Microbiolog...,3,131,Ann_Lab_Med_2014_Jul_19_34(4)_325-327.txt
5.35.2.269,...an Society for Laboratory Medicine 10.3343/alm.2015.35.2.269Letter to the EditorDiagnostic GeneticsT...,3,131,Ann_Lab_Med_2015_Mar_12_35(2)_269-271.txt
5.35.5.535,...an Society for Laboratory Medicine 10.3343/alm.2015.35.5.535Brief CommunicationDiagnostic GeneticsCY...,3,131,Ann_Lab_Med_2015_Sep_15_35(5)_535-539.txt
5.35.6.635,...ty for Laboratory Medicine 2635435310.3343/alm.2015.35.6.635Brief CommunicationClinical Microbiology...,3,139,Ann_Lab_Med_2015_Nov_1_35(6)_635-638.txt
3.33.3.196,...an Society for Laboratory Medicine 10.3343/alm.2013.33.3.196Case ReportDiagnostic HematologyA Case o...,3,131,Ann_Lab_Med_2013_May_17_33(3)_196-199.txt
2.3.4.243,...Saf Health Work 2012 26 4 243 256 10.5491/SHAW.2012.3.4.243 23251840,129,85,Ann_Occup_Environ_Med_2014_Feb_10_26_3.txt
6.21.4.235,...ociety of Pediatric Endocrinology 10.6065/apem.2016.21.4.235Case ReportAn 11-month-old girl with cen...,3,187,PMC5290180.txt
6.21.4.219,...ociety of Pediatric Endocrinology 10.6065/apem.2016.21.4.219Original ArticleThe impact of obesity on...,3,187,PMC5290177.txt
1.35.6.939,...of Rehabilitation Medicine 2250622510.5535/arm.2011.35.6.939Case ReportLance-Adams Syndrome Lee Ha L...,3,150,Ann_Rehabil_Med_2011_Dec_30_35(6)_939-943.txt
3.37.4.505,...Academy of Rehabilitation Medicine 10.5535/arm.2013.37.4.505Original ArticleTherapeutic Effect of Wh...,3,142,Ann_Rehabil_Med_2013_Aug_26_37(4)_505-515.txt
4.38.1.122,...Academy of Rehabilitation Medicine 10.5535/arm.2014.38.1.122Case ReportVideofluoroscopy-Guided Ballo...,3,142,Ann_Rehabil_Med_2014_Feb_25_38(1)_122-126.txt
4.38.1.77,...Academy of Rehabilitation Medicine 10.5535/arm.2014.38.1.77Original ArticleThe Relationships Between...,3,142,Ann_Rehabil_Med_2014_Feb_25_38(1)_77-83.txt
4.38.5.620,...Academy of Rehabilitation Medicine 10.5535/arm.2014.38.5.620Original ArticleWhite Matter Hyperintens...,3,142,Ann_Rehabil_Med_2014_Oct_30_38(5)_620-627.txt
6.40.2.294,...Academy of Rehabilitation Medicine 10.5535/arm.2016.40.2.294Original ArticleComparison of Therapeuti...,3,142,Ann_Rehabil_Med_2016_Apr_25_40(2)_294-300.txt
5.10.11.11,"Tests to assess bactericidal activity , p 5.10.11.11 –15.10.13.16 . I",216,43,PMC5278754.txt
EC 1.15.1.1,Superoxide dismutase (SOD: EC 1.15.1.1) belongs to a class of metalloproteins...,29,28,Antioxidants_(Basel)_2013_Nov_26_2(4)_340-369.txt
3.1.2.6,...orded at 240 nm. The determination of Gly II (EC: 3.1.2.6) activity was done by monitoring the decre...,32,387,AoB_Plants_2015_Jan_21_7_plv009.txt
EC 1.15.1.1,...25 °C. The activity of superoxide dismutase (SOD; EC 1.15.1.1) was measured by the method of Beaucha...,42,536,AoB_Plants_2015_Jan_19_7_plv004.txt
4.2.5.649,...Expert Rev Vaccines 2003 2 649 660 10.1586/14760584.2.5.649 14711326,151,187,Appl_Health_Econ_Health_Policy_2016_Jan_30_14_245-252.txt
EC 3.2.1.99,"...sidase/α-l-arabinofuranosidase, endo-arabinanase (EC 3.2.1.99), β-xylanase (EC 3.2.1.8), and exo-β-1...",15,231,Appl_Microbiol_Biotechnol_2008_Sep_30_80(3)_399-408.txt
EC 3.2.1.55,"...abinofuranosidases (ABF, α-N-arabinofuranosidase, EC 3.2.1.55) release terminal non-reducing α-l-ara...",12,566,Appl_Microbiol_Biotechnol_2011_Mar_7_89(6)_1665-1673.txt
2.1.3.2,Aspartate carbamoyltransferase	2.1.3.2	735 ± 134	43 ± 11	0.06	<0.001,218,32,Appl_Microbiol_Biotechnol_2016_Jul_27_100(24)_10307-10319.txt
2.2.2.1,2.2.2.1. Production of [18F]fluorid,36,1,Appl_Sci_(Basel)_2014_Mar_17_4(1)_66-78.txt
6.51.5.226,...a Limnol Oceanogr 2006 51 2262 2277 10.4319/lo.2006.51.5.2262,264,184,Aquat_Biosyst_2012_Mar_16_8_6.txt
EC 1.5.1.20,"...N-5-methyl-THF by N-5,10-methylene-THF reductase (EC 1.5.1.20, MTHFR) at the expense of NADPH (Fig. ...",32,473,Arch_Biochem_Biophys_2013_Jul_15_535(2)_150-162.txt
1.1.99.1,5	1.1.99.1	Choline dehydrogenase	FAD	GMC_ oxred	CHDH...,132,3,Arch_Biochem_Biophys_2013_Jul_15_535(2)_150-162.txt
2.5.1.26,66	2.5.1.26	Alkyldihydroxyacetone phosphate synthase	...,215,4,Arch_Biochem_Biophys_2013_Jul_15_535(2)_150-162.txt
3.2.1.1,According to Part I Module 3 (3.2.1.1) of the Medicinal Product Directive 2001/8...,212,31,Arch_Immunol_Ther_Exp_(Warsz)_2014_Feb_6_62(2)_117-129.txt
2.39.4.412,...lastic and Reconstructive Surgeons 10.5999/aps.2012.39.4.412Original ArticleA Retrospective Review o...,3,152,Arch_Plast_Surg_2012_Jul_13_39(4)_412-416.txt
2.39.4.431,...lastic and Reconstructive Surgeons 10.5999/aps.2012.39.4.431ImageSebaceous Carcinoma Arising from th...,3,152,Arch_Plast_Surg_2012_Jul_13_39(4)_431-433.txt
3.40.4.461,...lastic and Reconstructive Surgeons 10.5999/aps.2013.40.4.461ImagesGiant Proliferating Trichilemmal T...,3,152,Arch_Plast_Surg_2013_Jul_17_40(4)_461-463.txt
3.40.5.510,...lastic and Reconstructive Surgeons 10.5999/aps.2013.40.5.510Original ArticleProposed Treatment Proto...,3,152,Arch_Plast_Surg_2013_Sep_13_40(5)_510-516.txt
4.41.1.85,...lastic and Reconstructive Surgeons 10.5999/aps.2014.41.1.85Idea and InnovationMinimally Invasive Exc...,3,152,Arch_Plast_Surg_2014_Jan_13_41(1)_85-88.txt
6.43.1.110,...lastic and Reconstructive Surgeons 10.5999/aps.2016.43.1.110ImagesLow-Grade Fibromyxoid Sarcoma of t...,3,152,Arch_Plast_Surg_2016_Jan_15_43(1)_110-112.txt
6.43.1.102,...lastic and Reconstructive Surgeons 10.5999/aps.2016.43.1.102ImagesExcision of a Lower Eyelid Inflamm...,3,152,Arch_Plast_Surg_2016_Jan_15_43(1)_102-104.txt
6.43.2.210,...lastic and Reconstructive Surgeons 10.5999/aps.2016.43.2.210ImageRobotic Harvest of a Right Gastroep...,3,152,Arch_Plast_Surg_2016_Mar_18_43(2)_210-212.txt
2.39.3.227,...lastic and Reconstructive Surgeons 10.5999/aps.2012.39.3.227Original ArticleUtility of Toe-brachial ...,3,152,Arch_Plast_Surg_2012_May_10_39(3)_227-231.txt
6.43.6.586,...lastic and Reconstructive Surgeons 10.5999/aps.2016.43.6.586Case ReportMultidisciplinary Approach to...,3,152,Arch_Plast_Surg_2016_Nov_18_43(6)_586-589.txt
6.43.6.619,...lastic and Reconstructive Surgeons 10.5999/aps.2016.43.6.619ImageCongenital Multiple Metatarsal Syno...,3,152,Arch_Plast_Surg_2016_Nov_18_43(6)_619-621.txt
4.17.3.322,... Microbe Interact 2004 17 322 329 10.1094/MPMI.2004.17.3.322 15000399,57,308,Arch_Virol_2015_Nov_23_160_517-521.txt
2.17.11.198,...in Res 2002 17 1988 1996 12412806 10.1359/jbmr.2002.17.11.1988,323,356,Arthritis_Res_Ther_2009_Oct_14_11(5)_251.txt
4.19.6.938,... J Bone Miner Res 2004 19 938 946 10.1359/jbmr.2004.19.6.938 15190886,226,247,Arthritis_Res_Ther_2010_May_24_12(3)_R101.txt
2.6.4.274,...846Korean Society of Spine Surgery 10.4184/asj.2012.6.4.274Case ReportA Case of Pyogenic Spondylodis...,3,114,Asian_Spine_J_2012_Dec_14_6(4)_274-278.txt
3.7.1.14,...846Korean Society of Spine Surgery 10.4184/asj.2013.7.1.14Clinical StudyInterference of Detection Ra...,3,114,Asian_Spine_J_2013_Mar_6_7(1)_14-19.txt
3.7.4.282,...846Korean Society of Spine Surgery 10.4184/asj.2013.7.4.282Clinical StudyAdolescent Idiopathic Scoli...,3,114,Asian_Spine_J_2013_Dec_28_7(4)_282-288.txt
4.8.1.84,...846Korean Society of Spine Surgery 10.4184/asj.2014.8.1.84Case ReportSymptomatic Solitary Osteochond...,3,114,Asian_Spine_J_2014_Feb_6_8(1)_84-88.txt
5.9.3.423,...846Korean Society of Spine Surgery 10.4184/asj.2015.9.3.423Clinical StudyOptimal Timing of Preoperat...,3,114,Asian_Spine_J_2015_Jun_8_9(3)_423-426.txt
5.9.3.416,...846Korean Society of Spine Surgery 10.4184/asj.2015.9.3.416Clinical StudyEvaluating Kyphosis and Lor...,3,114,Asian_Spine_J_2015_Jun_8_9(3)_416-422.txt
5.9.6.978,...846Korean Society of Spine Surgery 10.4184/asj.2015.9.6.978Review ArticleLateral Lumbar Interbody Fu...,3,114,Asian_Spine_J_2015_Dec_8_9(6)_978-983.txt
6.10.4.776,...846Korean Society of Spine Surgery 10.4184/asj.2016.10.4.776Review ArticlePseudarthrosis of the Cerv...,3,114,Asian_Spine_J_2016_Aug_16_10(4)_776-786.txt
1.1.3.123,...thma and Clinical Immunology 10.5415/apallergy.2011.1.3.123Current ReviewSublingual immunotherapy in...,3,147,Asia_Pac_Allergy_2011_Oct_11_1(3)_123-129.txt
2.2.2.109,... Clinical Immunology 2270186010.5415/apallergy.2012.2.2.109Current ReviewThe role of tiotropium in t...,3,171,Asia_Pac_Allergy_2012_Apr_30_2(2)_109-114.txt
2.2.3.167,...thma and Clinical Immunology 10.5415/apallergy.2012.2.3.167Current ReviewHealth care utilization and...,3,163,Asia_Pac_Allergy_2012_Jul_25_2(3)_167-171.txt
2.2.4.256,http://dx.doi.org/10.5415/apallergy.2012.2.4.25,5,40,Asia_Pac_Allergy_2013_Jan_30_3(1)_75.txt
5.5.2.98,...thma and Clinical Immunology 10.5415/apallergy.2015.5.2.98Original ArticleThe association of forced ...,3,163,Asia_Pac_Allergy_2015_Apr_29_5(2)_98-102.txt
5.5.4.193,...thma and Clinical Immunology 10.5415/apallergy.2015.5.4.193Current ReviewMaking allergic and hyperse...,3,163,Asia_Pac_Allergy_2015_Oct_28_5(4)_193-196.txt
4.19.3.506,...chology and Aging 2004 19 506 514 10.1037/0882-7974.19.3.506 15383000,136,167,Atten_Percept_Psychophys_2011_Apr_16_73(3)_908-918.txt
4.19.1.327,...l and Motor Skills 1964 19 327 334 10.2466/pms.1964.19.1.327 14198856,220,147,Atten_Percept_Psychophys_2016_Nov_18_78_647-662.txt
2.9.2.4,...es). Feature Extraction 12.0.1.1 and Cytogenomics 2.9.2.4 (Agilent Technologies) software was used f...,13,2722,PMC5343336.txt
3.1.9.2,"... using the statistical software, G*Power (version 3.1.9.2) [8], [9] to determine the appropriate num...",62,81,BBA_Clin_2015_Jan_15_3_135-140.txt
5.19.5.641,...ropsychology 2005 19 641 16187882 10.1037/0894-4105.19.5.641,276,157,Behav_Brain_Funct_2006_May_30_2_20.txt
3.22.5.541,... Psychol 2003 22 541 548 14570538 10.1037/0278-6133.22.5.541,254,271,Behav_Brain_Funct_2007_Apr_28_3_22.txt
3.31.6.147,... Learn Mem Cogn 2005 31 1477 1491 10.1037/0278-7393.31.6.1477,332,156,Behav_Brain_Funct_2007_Aug_20_3_42.txt
4.14.2.295,...ol Aging 1999 14 295 303 10403716 10.1037/0882-7974.14.2.295,207,214,Behav_Brain_Funct_2007_Oct_31_3_57.txt
5.15.3.351,...ychology 2001 15 351 360 11499990 10.1037/0894-4105.15.3.351,298,182,Behav_Brain_Funct_2008_Feb_8_4_7.txt
2.4.2.189,...s Emotion 2004 4 189 200 15222855 10.1037/1528-3542.4.2.189,161,176,Behav_Brain_Funct_2009_Mar_12_5_16.txt
4.19.3.523,...ol Aging 2004 19 523 535 15383002 10.1037/0882-7974.19.3.523,181,209,Behav_Brain_Funct_2009_Mar_2_5_14.txt
5.7.10.135,...Neurotherapeutics 2007 7 1357 1374 10.1586/14737175.7.10.1357,335,136,Behav_Brain_Funct_2010_May_28_6_29.txt
2.1.3.1,2.1.3.1 Apparatus pre-exposur,56,1,Behav_Brain_Res_2015_Mar_15_281_250-257.txt
4.10.3.437,...ta. Psychol Aging 10:437–446. doi:10.1037/0882-7974.10.3.437 8527064,464,373,Behav_Genet_2009_Jul_15_39(4)_380-392.txt
4.64.4.678,... Pers Soc Psychol 1993 64 678 691 10.1037/0022-3514.64.4.678,831,168,Behav_Genet_2015_Feb_26_45(2)_137-156.txt
3.22.6.135,...nd Cognition  1996 22 6 1354 1363 10.1037/0278-7393.22.6.1354 2-s2.0-0030491452,129,203,Behav_Neurol_2015_Oct_5_2015_707625.txt
5.60.2.599,...nd Motor Skills  1985 60 2 599 602 10.2466/pms.1985.60.2.599 2-s2.0-0022051781 4000880,215,172,Behav_Neurol_2015_Oct_26_2015_519801.txt
2.1.1.2,2.1.1.2. Target Setting,75,1,Behav_Sci_(Basel)_2014_Oct_13_4(4)_371-393.txt
2.3.1.2,2.3.1.2. Participant,199,1,Behav_Sci_(Basel)_2014_Oct_13_4(4)_371-393.txt
1.3.1.2,1.3.1.2. Resilience Prevention in the Armed Force,108,1,Behav_Sci_(Basel)_2015_Jun_1_5(2)_264-304.txt
EC 3.2.1.91,...endoglucanases ([EC 3.2.1.4]) and exoglucanases ([EC 3.2.1.91]). This initial degradation is accompa...,106,448,Biochem_Eng_J_2016_Jan_15_105(Pt_B)_455-472.txt
EC 2.7.7.49,"... glutamine synthetase adenylyltransferase (ATase, EC 2.7.7.49) of Escherichia coli . Biochemistry  4...",95,130,Biochemistry_2009_Dec_8_48(48)_11514-11521.txt
4.5.5.32,4.5.5.32 The system comprises the enzyme’,170,1,Biochemistry_2014_Jul_15_53(27)_4467-4475.txt
EC 5.4.99.5,"...(a)). The bifunctional enzyme, chorismate mutase (EC 5.4.99.5)/prephenate dehydratase (EC 4.2.1.51) ...",14,202,Biochem_Res_Int_2010_Aug_4_2010_549572.txt
5.1.4.2,5.1.4.2 MtDNA mutatio,148,1,Biochim_Biophys_Acta_2010_Jan_1802(1)_111-121.txt
5.2.1.2,5.2.1.2 MtDNA mutatio,163,1,Biochim_Biophys_Acta_2010_Jan_1802(1)_111-121.txt
3.3.2.5,...alkenylglycerophosphoethanolamine hydrolase (E.C. 3.3.2.5) (N),32,2473,Biochimie_2013_Jan_95(1)_59-65.txt
2.12.3.291,"... Opin Ther Targets 2008 12 291 299 10.1517/14728222.12.3.291 Gupta S, Singh RK, Dastidar S, Ray A (2...",241,170,Biogerontology_2009_Dec_3_10(6)_721-734.txt
1.5.5.421,...rats Nutr Res Pract 2011 5 421 428 10.4162/nrp.2011.5.5.421 22125679,118,202,Biogerontology_2016_Apr_4_17_737-747.txt
2.4.1.2,2.4.1.2 Auto-encode,129,1,Bioinformatics_2016_Nov_15_32(22)_3444-3453.txt
2.4.2.3,2.4.2.3 Traditional feature generatio,179,1,Bioinformatics_2016_Nov_15_32(22)_3444-3453.txt
4.1.2.13,Fructose-bisphosphate aldolase (EC: 4.1.2.13),172,37,Bioinformation_2012_Jul_21_8(14)_664-672.txt
EC 3.2.1.2,"(EC 3.2.1.9.1) and β- gucosidase (EC 3.2.1.2.1), which have bee",27,35,Bioinformation_2012_Nov_13_8(22)_1105-1110.txt
EC 1.1.1.41,NAD-IDH (EC 1.1.1.41) but most of the bacteria have NADPdep...,48,10,Bioinformation_2014_Feb_19_10(2)_81-86.txt
2.7.-.-,...sphate hydrolases SCOP superfamily. The EC number 2.7.-.- and the GO identifiers 0016301 and 0016772...,83,919,Bioinform_Biol_Insights_2009_Nov_24_1_77-90.txt
5.3.99.2,ec:3.1.1.4 phospholipase A2	ec:5.3.99.2 prostaglandin-D synthase,450,32,Bioinform_Biol_Insights_2012_Apr_23_6_69-96.txt
EC 3.1.3.1,"...ormate, zinc-dust, and alkaline phosphatase (ALP, EC 3.1.3.1) were obtained from E. Merck and Aldric...",32,245,Bioinorg_Chem_Appl_2015_Oct_8_2015_386587.txt
4.1.1.3,4.1.1.3 Consequences for network stabilit,704,1,Biol_Cybern_2008_Jun_20_98(6)_459-478.txt
1.4.2.324,... were performed using PQStat for Windows (version 1.4.2.324). Serum concentrations of bone metabolic...,41,71,Biol_Sport_2016_Mar_8_33(1)_83-87.txt
2.42.4.127,...dontal Implant Sci 2012 42 127 35 10.5051/jpis.2012.42.4.127 22977742,154,211,Biomatter_2012_Oct_1_2(4)_271-277.txt
5.20.6.104,... J Korean Med Sci 2005 20 1046 52 10.3346/jkms.2005.20.6.1046 16361820,117,186,Biomatter_2013_Jan_1_3(1)_e24278.txt
1.44.11.735,...ells BMB Rep 2011 44 11 735 740 10.5483/BMBRep.2011.44.11.735 22118540,154,183,Biomed_Eng_Online_2012_Oct_25_11_80.txt
3.1.1.8,... 3.1.1.7) and butyrylcholinesterase (BuChE) (E.C. 3.1.1.8) [12]. The zebrafish (Danio rerio) has lon...,46,485,Biomed_Res_Int_2013_Jun_20_2013_623789.txt
1.6.5.4,MDHAR (EC: 1.6.5.4) activity was determined by the method of ...,78,12,Biomed_Res_Int_2014_Jun_3_2014_757219.txt
4.66.1.184,...ial Psychology  1994 66 1 184 195 10.1037/0022-3514.66.1.184 2-s2.0-0027929212 8126648,113,184,Biomed_Res_Int_2014_Aug_13_2014_678169.txt
3.2.2.35,"...re transferred to the HT planning system (Version 3.2.2.35 Tomotherapy Inc., Madison, WI). A prescri...",45,100,Biomed_Res_Int_2015_Feb_12_2015_959504.txt
4.34.2.98,...oratory Medicine  2014 34 2 98 103 10.3343/alm.2014.34.2.98 2-s2.0-84897847160 24624344,204,172,Biomed_Res_Int_2015_Apr_27_2015_109275.txt
3.14.7.403,... Prevention  2013 14 7 4033 4039 10.7314/APJCP.2013.14.7.4033 2-s2.0-84885456615 23991948,437,196,Biomed_Res_Int_2015_May_3_2015_621324.txt
3.1.4.167,...h plasma Joints  2013 1 4 167 170 10.11138/jts/2013.1.4.167 25606529,438,177,Biomed_Res_Int_2015_May_5_2015_542502.txt
3.26.3.219,...Journal of Pain  2013 26 3 219 222 10.3344/kjp.2013.26.3.219 2-s2.0-84880441064 23861995,400,113,Biomed_Res_Int_2015_Jun_7_2015_546497.txt
4.23.1.104,...8 23 1 104 118 2-s2.0-43049105789 10.1037/0882-7974.23.1.104 18361660,134,197,Biomed_Res_Int_2015_Jun_9_2015_129180.txt
EC 3.2.1.1,"... 12]. α-Amylase (1,4-α-D-glucan glucanohydrolase, EC 3.2.1.1) is a class of important industrial enz...",28,999,Biomed_Res_Int_2015_Jun_9_2015_245649.txt
3.27.1.68,... of Ophthalmology  2013 27 1 68 71 10.3341/kjo.2013.27.1.68 2-s2.0-84891462190 23372386,327,238,Biomed_Res_Int_2015_Jul_6_2015_782420.txt
2.24.2.181,...s of Dermatology  2012 24 2 181 188 10.5021/ad.2012.24.2.181 2-s2.0-84860625144 22577269,254,227,Biomed_Res_Int_2015_Jul_12_2015_846062.txt
3.25.3.649,...nd Performance  1999 25 3 649 660 10.1037/0096-1523.25.3.649 2-s2.0-0033143428 10385982,323,200,Biomed_Res_Int_2015_Oct_18_2015_683279.txt
5.76.11.195,...riodontology  2005 76 11 1950 1959 10.1902/jop.2005.76.11.1950 2-s2.0-28644452355 16274315,190,252,Biomed_Res_Int_2016_Jun_20_2016_2581876.txt
EC 3.2.1.21,"...hydrolases (EC 3.2.1.91), and β-glucosidase (BGL; EC 3.2.1.21), which act synergistically to hydroly...",12,372,PMC5223008.txt
4.23.4.292,...nes Exp. Neurobiol. 2014 23 292 313 10.5607/en.2014.23.4.292 25548530,188,133,Biomolecules_2015_May_13_5(2)_865-892.txt
5.1.1.3,  5.1.1.3. Thioredoxin………………………………………………………………………………...,31,3,Biomolecules_2015_Sep_30_5(4)_2247-2337.txt
2.20.4.380,...d Pharmacology ooomb4-20-38010.4062/biomolther.2012.20.4.380ArticleSuppression of Transglutaminase-2...,3,165,Biomol_Ther_(Seoul)_2012_Jul_20(4)_380-385.txt
2.20.3.256,...cology 24130921ooomb4-20-25610.4062/biomolther.2012.20.3.256ArticlesTamoxifen Resistance in Breast C...,3,173,Biomol_Ther_(Seoul)_2012_May_20(3)_256-267.txt
5.18.10.959,... News Perspect.  (2005) 18 623 629 10.1358/dnp.2005.18.10.959576 16491164,112,105,Biomol_Ther_(Seoul)_2013_Sep_30_21(5)_381-390.txt
2.92.6.654,...s Phytopathology 2002 92 654 658 10.1094/PHYTO.2002.92.6.654 18944263,241,201,Biosensors_(Basel)_2015_Aug_6_5(3)_537-561.txt
EC 3.2.1.55,"...osidases (EC 3.2.1.37), α-L-arabinofuranosidases (EC 3.2.1.55), α-glucuronidases (EC 3.2.1.139), ace...",13,772,Biotechnol_Biofuels_2011_May_18_4_12.txt
EC 6.2.1.12,...sferase EC 2.1.1.146; 4CL: 4-coumarate-CoA ligase EC 6.2.1.12; F5H: Ferulate-5-hydroxylase EC 1.14.-...,156,280,Biotechnol_Biofuels_2012_Sep_21_5_71.txt
2.4.1.18,"...2.4.1.21); BE, α-1,4-glucan branching enzyme (EC: 2.4.1.18); and HXK, hexokinase (2.7.1.1). Starch c...",112,1660,Biotechnol_Biofuels_2012_Sep_24_5_74.txt
1.1.1.44,"...uconate dehydrogenase (decarboxylating) (PGD, EC: 1.1.1.44)	−1.13",117,60,Biotechnol_Biofuels_2012_Sep_24_5_74.txt
EC 1.2.1.2,"...pressing an NAD+-dependent formate dehydrogenase (EC 1.2.1.2; FDH), an NADH oxidase (EC 1.6.99.3; NO...",15,1540,Biotechnol_Biofuels_2013_Jan_25_6_7.txt
6.2.1.1,"... In this pathway, acetyl-CoA synthetase (acs, EC: 6.2.1.1) plays a key role in the synthesis of acet...",169,1272,Biotechnol_Biofuels_2013_Jan_15_6_3.txt
EC 6.3.1.2,"...ipts of glutamine synthase (GS, Phatrdraft_22357, EC 6.3.1.2), a key enzyme in ammonia assimilation ...",84,799,Biotechnol_Biofuels_2013_May_4_6_67.txt
3.1.3.4,"...ermediate [37]. Phosphatidate phosphatase (PAP, EC3.1.3.4, Phatrdraft_40261) mRNA levels increased b...",115,797,Biotechnol_Biofuels_2013_May_4_6_67.txt
EC 3.2.1.91,"...H I, EC 3.2.1.176) and non-reducing ends (CBH II, EC 3.2.1.91), while EGs (and LPMOs) introduce new ...",17,477,Biotechnol_Biofuels_2014_Feb_21_7_27.txt
EC 3.2.1.8,"....1.99.18), β-glucosidase (EC 3.2.1.21), xylanase (EC 3.2.1.8), polygalacturonase (EC 3.2.1.15), xyla...",39,343,Biotechnol_Biofuels_2014_Nov_29_7_161.txt
EC 2.7.7.27,...way which requires ADP-glucose pyrophosphorylase (EC 2.7.7.27) and granulose synthase (EC 2.4.1.21) ...,75,418,Biotechnol_Biofuels_2016_Jan_4_9_4.txt
3.2.1.21,"...lobiohydrolase, EC3.2.1.91), and β-glucosidase (EC3.2.1.21) [5]. Endoglucanases randomly hydrolyze i...",20,613,Biotechnol_Biofuels_2016_Feb_13_9_36.txt
5.53.2.216,...rean Chem Eng Res 2015 53 216 223 10.9713/kcer.2015.53.2.216,368,200,PMC5331700.txt
1.7.1.6,...ogical researches showed that the azoreductase (EC1.7.1.6) activity increased in the late phase with...,107,353,Biotechnol_Biotechnol_Equip_2014_Jul_4_28(4)_6358-642.txt
EC 3.2.1.4,"...doglucanases (β-1, 4-D-glucan-4-glucanohydrolase, EC 3.2.1.4, carboxymethyl cellulase, EC), exogluca...",8,855,Biotechnol_Res_Int_2011_Jan_23_2011_810425.txt
EC 3.4.22.32,"...alities of pineapple are attributed to bromelain (EC 3.4.22.32), which is a crude extract from pinea...",8,452,Biotechnol_Res_Int_2012_Dec_10_2012_976203.txt
3.48.2.145,...ociety on Thrombosis and Hemostasis 10.5045/br.2013.48.2.145Case ReportAcute colonic pseudo-obstruct...,3,242,Blood_Res_2013_Jun_25_48(2)_145-148.txt
6.51.2.133,...ociety on Thrombosis and Hemostasis 10.5045/br.2016.51.2.133Letter to the EditorAcute myeloid leukem...,3,242,Blood_Res_2016_Jun_23_51(2)_133-137.txt
3.46.4.160,...cular Biology 23615261BMB-46-20110.5483/BMBRep.2013.46.4.160Research ArticlesSulforaphane controls T...,3,139,BMB_Rep_2013_Apr_46(4)_201-206.txt
4.4.5.677,...rt Rev. Vaccines  (2005) 4 677 685 10.1586/14760584.4.5.677 16221069,123,199,BMB_Rep_2013_Jan_46(1)_17-24.txt
3.46.8.237,...cular Biology 23977987BMB-46-39810.5483/BMBRep.2013.46.8.237Research ArticlesFloridoside suppresses ...,3,139,BMB_Rep_2013_Aug_46(8)_398-403.txt
2.45.4.207,...rapy. BMB Rep (2012) 45 207 212 10.5483/BMBRep.2012.45.4.207 22531129,132,144,BMB_Rep_2015_Jan_48(1)_6-12.txt
5.48.6.20,Biology 25541055BMB-48-33610.5483/BMBRep.2015.48.6.20Research-ArticlesAnti-septic activity of ...,4,45,BMB_Rep_2015_Jun_30_48(6)_336-341.txt
4.47.7.195,...vivo. BMB Rep (2014) 47 376 381 10.5483/BMBRep.2014.47.7.195 24286332,167,147,BMB_Rep_2015_Oct_48(10)_577-582.txt
3.46.2.272,...odel. BMB Rep (2013) 46 124 129 10.5483/BMBRep.2013.46.2.272 23433117,85,180,BMB_Rep_2015_Nov_48(11)_618-623.txt
1.44.1.11,...ystems biology BMB Rep 44 11 21 10.5483/BMBRep.2011.44.1.11 21266101,167,113,PMC5319659.txt
2.38.2.820,...Drugs Today (Barc) 2002 38 2 75 89 10.1358/dot.2002.38.2.820104 12532186,212,148,BMC_Anesthesiol_2016_Aug_3_16_56.txt
EC 3.4.11.6,Aminopeptidase B (Ap-B; EC 3.4.11.6) catalyzes the cleavage of basic resid...,6,25,BMC_Biochem_2007_Oct_31_8_21.txt
3.2.8.1,...culture supernatants of stably transfected CHO Lec3.2.8.1 as described before [33]. The protein solu...,202,136,BMC_Biochem_2011_Jul_30_12_39.txt
EC 1.2.3.3,"...f and was described as a conserved motif of POXs (EC 1.2.3.3), PDCs (EC 4.1.1.1), AHASs (EC 2.2.1.6)...",119,359,BMC_Biochem_2012_Nov_17_13_24.txt
3.16.6.829,...ug News Perspect 2003 16 6 355 362 10.1358/dnp.2003.16.6.829307 12973446,191,98,BMC_Biochem_2014_Apr_3_15_9.txt
2.6.1.29,2.6.1.29	ygjG	2.6.1.29	2.6.1.13	2.6.1.13	2.6.1.13	...,177,1,BMC_Bioinformatics_2006_Mar_23_7_168.txt
3.1.3.8,"3.1.3.8	agp	3.1.3.8, 3.1.3.10	3.1.3.10	3.1.3.10	3....",179,1,BMC_Bioinformatics_2006_Mar_23_7_168.txt
6.3.2.15,6.3.2.15	murF	6.3.2.15	6.3.2.10	6.3.2.10	6.3.2.15	inconsistency of EC (6.3.2.15 is changed ...,207,42,BMC_Bioinformatics_2006_Mar_23_7_168.txt
2.6.1.32,1.8.1.5	artifact	2.6.1.32	difficult	4.2.1.5	difficult,193,18,BMC_Bioinformatics_2007_Jul_10_8_244.txt
1.14.13.58,1.14.13.58	excellent	2.8.1.3	excellent	5.1.3.17	di...,209,1,BMC_Bioinformatics_2007_Jul_10_8_244.txt
1.14.15.2,1.14.15.2	difficult	3.1.1.40	poor	5.5.1.11	good,213,1,BMC_Bioinformatics_2007_Jul_10_8_244.txt
1.4.1.11,1.1.1.226	excellent	1.4.1.11	Good,272,21,BMC_Bioinformatics_2007_Jul_10_8_244.txt
2.6.1.75,3.2.1.112	excellent	2.6.1.75	Good,277,21,BMC_Bioinformatics_2007_Jul_10_8_244.txt
3.5.1.30,3.5.1.30	Good	None	5-amino-penta-namidase	Pseudomo...,307,1,BMC_Bioinformatics_2007_Jul_10_8_244.txt
3.11.1.7,....1.10	0.067	g.3.11.1.10	0.028	g.3.11.1.10	9.390	g.3.11.1.7	0.4665	g.3.11.1.9	96.05,390,57,BMC_Bioinformatics_2005_Nov_29_6_282.txt
4.3.1.19,"...our are part of the group and the fifth (reaction 4.3.1.19 which appears first) is part of the \"Thre...",206,264,BMC_Bioinformatics_2005_Aug_31_6_217.txt
1.2.3.4,"...-Hit score = 150 to the enzyme with the EC number 1.2.3.4 and the cutoff values = 100, 120, 180, 200...",27,760,BMC_Bioinformatics_2006_Feb_6_7_53.txt
2.7.1.39,2.7.1.39	260	260(54)	*	*,217,1,BMC_Bioinformatics_2007_Mar_27_8_104.txt
1.1.1.38,"...an bypass the above TCA gap via malic enzyme (EC: 1.1.1.38), phosphoenolpyruvate-protein phosphotran...",124,1183,BMC_Bioinformatics_2007_Aug_28_8_313.txt
EC 4.2.1.1,"...EC 2.7.1.2, EC 2.7.4.2, EC 3.5.1.14, EC 3.6.1.23, EC 4.2.1.1, EC 4.2.1.2 (Figure 2), EC 5.3.1.6 and ...",103,265,BMC_Bioinformatics_2008_Dec_17_9_544.txt
5.1.1.18,Serine racemase	5.1.1.18	NP_068766	8 e-243		SRR	17,134,17,BMC_Bioinformatics_2009_Sep_1_10_273.txt
2.7.2.1,PF00871	Acetate_kinase	12	405	2.7.2.,122,31,BMC_Bioinformatics_2009_Jun_9_10_174.txt
2.7.2.1,2.7.2.1	173	942	44	236	85%	15%	46%	4%	1	1,48,1,BMC_Bioinformatics_2009_Jul_24_10_231.txt
5.1.1.3,5.1.1.3	163	400	41	99	88%	17%	30%	17%	2	2,55,1,BMC_Bioinformatics_2009_Jul_24_10_231.txt
2.7.2.1,"2.7.2.1	100%	100%	100%	1,00	100%	100%	100%	1.00",76,1,BMC_Bioinformatics_2009_Jul_24_10_231.txt
2.1.2.10,2.1.2.10	100%	100%	98%	0.99,142,1,BMC_Bioinformatics_2009_Jul_24_10_231.txt
EC 1.11.1.7,...family. For the heme-dependent peroxidase family (EC 1.11.1.7) and the xylose isomerases (EC 5.3.1.5...,27,158,BMC_Bioinformatics_2010_May_11_11_242.txt
EC 3.2.1.-,(EC 3.2.1.-),248,2,BMC_Bioinformatics_2011_Apr_27_12_122.txt
6.4.1.4,"The MCC protein complex (E.C. 6.4.1.4) is a mitochondrial, biotin-dependent hete...",39,31,BMC_Bioinformatics_2011_Sep_19_12_371.txt
EC 1.2.3.4,"...s labels: [EC 1.-.-.-, EC 1.2.-.-, EC 1.2.3.- and EC 1.2.3.4], and it is assigned as prediction only...",70,719,BMC_Bioinformatics_2012_Apr_25_13_61.txt
4.2.1.17,...2-pentenoyl-CoA + H2O ↔ (3 S)-3-hydroxyadipyl-CoA	4.2.1.17,104,69,BMC_Bioinformatics_2012_May_11_13_93.txt
5.1.93.151,...Journal on Computing 2003 15 93 113 10.1287/ijoc.15.1.93.15155,256,97,BMC_Bioinformatics_2012_Dec_19_13(Suppl_19)_S11.txt
EC 1.1.1.103,"... orange: EC 1.1.1.95, brown: EC 1.1.1.47, yellow: EC 1.1.1.103, lavender: EC 1.1.1.90). The network ...",74,346,BMC_Bioinformatics_2013_Feb_28_14(Suppl_3)_S6.txt
4.6.3.357,...pert Rev Vaccines 2007 6 3 357 368 10.1586/14760584.6.3.357 17542751,176,241,BMC_Bioinformatics_2013_Feb_14_14_52.txt
3.42.1.8,17	3.42.1.8	34	3761	5	552	44	7.39.1.3	13	2083	14	2242...,202,4,BMC_Bioinformatics_2010_Jan_18_11(Suppl_1)_S16.txt
1.6.47.1,... base-calling filtering (Illumina CASAVA pipeline 1.6.47.1) and mapped using TopHat v1.4.,322,99,BMC_Bioinformatics_2013_Nov_9_14_320.txt
EC 1.7.2.1,...uloplasmins (EC 1.16.3.1) and nitrate reductases (EC 1.7.2.1). Laccases were first discovered in the...,15,193,BMC_Bioinformatics_2014_Oct_21_15(Suppl_11)_S15.txt
1.1.1.37,"...o oxaloacetate by cytosolic malate dehydrogenase (1.1.1.37) which then results, via gluconeogenesis,...",69,774,BMC_Biol_2010_Feb_10_8_14.txt
3.2.1.28,...uced by the metabolism of trehalose by trehalase (3.2.1.28). Several trehalase genes are downregulat...,69,1384,BMC_Biol_2010_Feb_10_8_14.txt
2.2.1.6,BU225	EG10499	2.2.1.6	acetolactate synthase (ALS),43,16,BMC_Biol_2014_Dec_20_12_110.txt
EC 3.5.1.9,...xylic acid and ammonia [34]. Formamidase (KFase) (EC 3.5.1.9) is a key enzyme in the metabolic seque...,203,487,BMC_Biotechnol_2015_Mar_14_15_17.txt
1.14.13.90,...sed 1.58-fold at 240 h. Zeaxanthin epoxidase (EC: 1.14.13.90; ZEP) and xanthoxin dehydrogenase (EC: ...,59,744,BMC_Biotechnol_2015_Sep_15_15_81.txt
1.14.13.78,...osphate synthase; 4.2.3.19: ent-kaurene synthase; 1.14.13.78: ent-kaurene oxidase; 1.14.13.79: ent-k...,59,2213,BMC_Biotechnol_2015_Sep_15_15_81.txt
EC 3.1.1.3,"Microbial lipase (triacylglycerol lipase, EC 3.1.1.3) catalyze hydrolysis of the long chain ...",20,43,BMC_Biotechnol_2016_May_3_16_38.txt
EC 2.3.2.13,"Transglutaminase (TGase, EC 2.3.2.13) is an enzyme that exhibits several ca...",17,26,BMC_Biotechnol_2016_Oct_28_16_75.txt
EC 4.2.2.8,"... from Sigma-Aldrich (Oslo, Norway). Heparitinase (EC 4.2.2.8) and chondroitinase ABC (EC 4.2.2.4) we...",28,560,BMC_Cancer_2009_Jun_15_9_183.txt
4.17.4.469,...n Investig Drugs 2008 17 4 469 479 10.1517/13543784.17.4.469 18363513,122,185,BMC_Cancer_2011_May_27_11_207.txt
5.4.3.3,"...putational approach (FrameWoker software, release 5.4.3.3) that has been shown to identify conserved...",30,229,BMC_Cancer_2014_Jan_13_14_16.txt
2.13.7.347,... J Cancer Prev 2012 13 3471 3476 10.7314/APJCP.2012.13.7.3471 22994780,360,209,BMC_Cancer_2014_Apr_28_14_297.txt
2.13.5.190,...c J Cancer Prev 2012 13 5 1901 6 10.7314/APJCP.2012.13.5.1901 2290114,993,217,BMC_Cancer_2014_Sep_15_14_672.txt
1.14.2.79,...l of breast cancer 2011 14 2 79 87 10.4048/jbc.2011.14.2.79 21847401,185,192,BMC_Cancer_2016_Jan_6_16_5.txt
2.13.4.138,... J Cancer Prev 2012 13 4 1389 93 10.7314/APJCP.2012.13.4.1389 22799337,210,200,BMC_Cancer_2016_Feb_11_16_87.txt
4.56.2.267,...Pers Soc Psychol 1989 56 2 267 83 10.1037/0022-3514.56.2.267 2926629,232,155,BMC_Cancer_2016_Apr_8_16_264.txt
3.1.9.2,...ed logistic regression analysis using the G*Power 3.1.9.2 tool [25]. Two-tailed analysis for predict...,75,130,BMC_Cancer_2016_May_27_16_337.txt
5.16.6.239,...J Cancer Prev 2015 16 6 2397 402 10.7314/APJCP.2015.16.6.2397 25824771,335,211,BMC_Cancer_2016_Jul_4_16_382.txt
1.26.4.513,...J Korean Med Sci 2011 26 4 513 20 10.3346/jkms.2011.26.4.513 21468258,256,258,BMC_Cancer_2016_Jul_13_16_468.txt
2.2.1.-,2.2.1.- Office or clinical blood pressur,31,1,BMC_Cardiovasc_Disord_2012_Jan_27_12_1.txt
2.27.2.180,...rean J Intern Med 2012 27 2 180 8 10.3904/kjim.2012.27.2.180 22707890,343,302,PMC5217339.txt
2.27.2.180,...rean J Intern Med 2012 27 2 180 8 10.3904/kjim.2012.27.2.180 22707890,343,302,PMC5217339.txt
5.3.6.805,...ab Toxicol 2007 3 805 817 18028026 10.1517/17425255.3.6.805,157,212,BMC_Cell_Biol_2009_Mar_26_10_21.txt
4.21.1.8,... prospects J Bone Metab 2014 21 8 10.11005/jbm.2014.21.1.8 24707463,256,137,BMC_Cell_Biol_2015_Mar_18_16_10.txt
2.35.4.420,... Biochem Mol Biol 2002 35 4 420 10.5483/BMBRep.2002.35.4.420 12297003,148,246,BMC_Complement_Altern_Med_2016_Jul_13_16_212.txt
EC 3.2.1.20,...d the in vitro inhibition of yeast α-glucosidase (EC 3.2.1.20) and porcine pancreatic α-amylase (EC ...,26,77,BMC_Complement_Altern_Med_2013_Feb_20_13_39.txt
2.10.2.383,...design Psychol Rep 1962 10 383 392 10.2466/pr0.1962.10.2.383,285,125,BMC_Complement_Altern_Med_2016_Jul_18_16_227.txt
3.46.12.248,...nesis BMB Rep 2013 46 12 567 74 10.5483/BMBRep.2013.46.12.248 24238363,205,169,PMC5336672.txt
4.48.2.197,...n Israel Mammalia 1984 48 197 206 10.1515/mamm.1984.48.2.197,232,113,BMC_Ecol_2010_Jun_2_10_15.txt
2.7.1.1,"...o peptidase (LAP, 3.4.11.1) and hexokinase-1 (HK, 2.7.1.1); and (3) Tris-citrate pH 6.7/6.3 (TC 6.7)...",28,741,BMC_Evol_Biol_2010_Jul_22_10_220.txt
EC 3.5.1.54,...and allophanate hydrolase (also known as amidase; EC 3.5.1.54) activity. Two adjacent genes (DUR1 an...,13,1179,BMC_Evol_Biol_2011_Mar_29_11_80.txt
EC 3.2.1.73,... there are also examples of licheninase activity (EC 3.2.1.73,309,264,BMC_Evol_Biol_2012_Sep_20_12_186.txt
6.4.15.68,BMNH 1896.4.15.68	Penelopides	panini	panini	Guimaras	28 De...,56,9,BMC_Evol_Biol_2012_Oct_12_12_203.txt
EC 3.1.1.4,Phospholipase A2 (PLA2; EC 3.1.1.4) enzymes are esterolytic enzymes which ...,58,25,BMC_Evol_Biol_2008_Feb_28_8_70.txt
2.3.4.5,"...lii exhibit phalangeal complements for the pes of 2.3.4.5.4 and 2.3.4.5.3, respectively). This contr...",38,883,BMC_Evol_Biol_2008_Nov_11_8_310.txt
4.1.1.20,"...ne into proteins. Moreover, DAP-decarboxylase (EC:4.1.1.20), the enzyme that converts DAP into lysin...",34,308,BMC_Evol_Biol_2013_Sep_9_13_190.txt
2.3.1.117,...ynthase; 1.3.1.26: dihydrodipicolinate reductase; 2.3.1.117: tetrahydrodipicolinate succinyltransfer...,36,627,BMC_Evol_Biol_2013_Sep_9_13_190.txt
2.5.1.48,"The genes for EC:2.5.1.48, EC:2.5.1.49, and EC:4.4.1.8 (two version...",131,18,BMC_Evol_Biol_2013_Sep_9_13_190.txt
3.5.1.2,...en sampled populations were performed in ARLEQUIN 3.5.1.2 [71]. Only sampling localities with more t...,1149,1223,BMC_Evol_Biol_2015_Jun_10_15_105.txt
EC 3.2.1.80,"...EC 3.2.1.26), inulinase (EC 3.2.1.7, EC 3.2.1.64, EC 3.2.1.80), levanase (EC 3.2.1.65), fructosyltra...",20,884,BMC_Evol_Biol_2015_Dec_7_15_273.txt
2.9.3.2,...pgen/softwares/fstat.htm]  The current version is 2.9.3.2 (Feb. 2002).,256,196,BMC_Evol_Biol_2015_Dec_21_15_289.txt
3.5.2.2,...ckage [36]. An AMOVA was conducted with ARLEQUIN v3.5.2.2 [33] following the grouping scheme describ...,50,1256,BMC_Evol_Biol_2016_Nov_7_16_237.txt
4.6.1.2,...itochondrial ND4 locus were created with NETWORK v4.6.1.2 (www.fluxus-engineering.com; [40–42]) as i...,78,795,PMC5237248.txt
4.6.1.2,...itochondrial ND4 locus were created with NETWORK v4.6.1.2 (www.fluxus-engineering.com; [40–42]) as i...,78,795,PMC5237248.txt
2.18.1.48,...Korean J Hepatol 2012 18 1 48 55 10.3350/kjhep.2012.18.1.48 22511903,243,307,BMC_Gastroenterol_2014_Nov_25_14_198.txt
4.12.4.281,...infliximab Intest Res 2014 12 281 6 10.5217/ir.2014.12.4.281 25374493,185,197,BMC_Gastroenterol_2015_Mar_18_15_31.txt
2.13.4.136,...c J Cancer Prev 2012 13 4 1361 4 10.7314/APJCP.2012.13.4.1361 22799332,223,229,BMC_Gastroenterol_2016_Aug_23_16(1)_101.txt
1.1.1.8,"8. Glycerol-3-phosphate dehydrogenase	GPD-1 to -4	1.1.1.8	RW	M, L",34,51,BMC_Genet_2001_Sep_21_2_15.txt
6.3.3.349,...cogenomics 2002 3 349 366 12052143 10.1517/14622416.3.3.349,225,116,BMC_Genet_2005_Jun_2_6_30.txt
2.9.3.2,...sing four statistical indices calculated by Fstat 2.9.3.2 [19]. This analysis was done excluding the...,296,114,BMC_Genet_2010_Jan_28_11_9.txt
EC 2.4.1.13,"...genic plants [2,43]. In plants, sucrose synthase (EC 2.4.1.13, SuSy) catalyzes the decomposition of ...",100,494,BMC_Genet_2014_Jun_20_15(Suppl_1)_S7.txt
EC 1.4.7.1,... Ferredoxin-dependent glutamate synthase (GOGAT) (EC 1.4.7.1) is a flavoprotein catalyzing the forma...,21,703,BMC_Genet_2013_Sep_4_14_77.txt
1.16.7.122,...er Res 2001 16 1220 1227 11450697 10.1359/jbmr.2001.16.7.1220,322,275,BMC_Genomics_2006_Apr_27_7_95.txt
2.7.1.-,Uni45384254	2.7.1.-	Probable serine/threonine-protein kinase,190,13,BMC_Genomics_2006_Jun_15_7_152.txt
2.3.1.41,Eukarya	hsa	54995	16261191	2.3.1.41	2.3.1.41	4,183,37,BMC_Genomics_2006_Dec_13_7_315.txt
5.4.99.5,Bacteria	mtu	Rv1885c	15654876	5.4.99.5	5.4.99.5	4,194,31,BMC_Genomics_2006_Dec_13_7_315.txt
2.5.1.17,Bacteria	spt	SPA0821	15547259	2.5.1.17	2.5.1.17	4,198,31,BMC_Genomics_2006_Dec_13_7_315.txt
3.5.1.11,Bacteria	pae	PA1032	16461666	3.5.1.-	3.5.1.11	≤ 3,226,38,BMC_Genomics_2006_Dec_13_7_315.txt
6.1.1.101,...cogenomics 2000 1 101 108 11258592 10.1517/14622416.1.1.101,142,180,BMC_Genomics_2005_Jun_14_6_91.txt
EC 1.5.1.3,"...hich is reduced by dihydrofolate reductase (DHFR, EC 1.5.1.3) to tetrahydrofolate (THF). Folylpolygl...",31,301,BMC_Genomics_2007_Jul_23_8_245.txt
EC 1.2.4.1,"...03.2), which are associated to a single reaction (EC 1.2.4.1). On the other hand, two isoenzymes of ...",315,482,BMC_Genomics_2008_Apr_11_9_163.txt
3.1.1.61,3.1.1.61	Protein-glutamate methylesterase	Yes,36,1,BMC_Genomics_2009_Jul_15_10_315.txt
EC 4.2.1.3,"...o a final concentration of 0.5 mM. The aconitase (EC 4.2.1.3) assay mixture contained 1.2 mM MnCl2, ...",206,1185,BMC_Genomics_2009_Oct_5_10_461.txt
1.1.1.86,1.1.1.86	ketolacid reductoisomerase	KARI	At3g58610...,150,1,BMC_Genomics_2010_Mar_22_11_190.txt
1.15.1.1,...ression showed a superoxide dismutase activity (EC1.15.1.1) of the encoded protein [31]. Silencing o...,19,1196,BMC_Genomics_2010_Nov_8_11_620.txt
EC 4.1.3.27,...nsferase (EC 2.4.2.18) and anthranilate synthase (EC 4.1.3.27) homologous ESTs were found to be diff...,234,287,BMC_Genomics_2011_Jan_18_12_41.txt
2.5.1.21,"..., 2.7.4.2 (Pmvk), 4.1.1.83 (Mvd), 5.3.3.2 (Idi1), 2.5.1.21 (Fdft1), and 1.14.99.7 (Sqle), 5.4.99.7 (...",531,380,BMC_Genomics_2011_Feb_3_12_95.txt
2.7.1.36,"...ol biosynthetic pathway include 1.1.1.34 (Hmgcr), 2.7.1.36 (Mvk), 2.7.4.2 (Pmvk), 4.1.1.83 (Mvd), 5....",536,313,BMC_Genomics_2011_Feb_3_12_95.txt
2.7.1.30,"...spectively, and include: GK, glycerol kinase (EC: 2.7.1.30); GPAT, glycerol-3-phosphate O-acyltransf...",207,264,BMC_Genomics_2011_Mar_14_12_148.txt
2.4.1.21,"...horylase (EC: 2.7.7.27); SS, starch synthase (EC: 2.4.1.21); BE, α-1,4-glucan branching enzyme (EC: ...",216,471,BMC_Genomics_2011_Mar_14_12_148.txt
6.7.1.25,...mics Pharmacogenomics 2006 7 25 29 10.2217/14622416.7.1.25 16354122,224,115,BMC_Genomics_2010_Oct_22_11_593.txt
2.3.3.10,2.3.3.10	HMGS	HMG-CoA synthase	2	6,51,1,BMC_Genomics_2011_Nov_2_12_539.txt
1.17.1.2,1.17.1.2	4-hydroxy-3-methylbut-2-enyl-diphosphate ...,66,1,BMC_Genomics_2011_Oct_30_12_533.txt
EC 2.7.7.27,"...viations are: AGP: ADP glucose pyrophosphorylase (EC 2.7.7.27), GS: Glycogen synthase (EC 2.4.1.21),...",166,394,BMC_Genomics_2012_Feb_2_13_56.txt
1.14.13.21,F3'H	Flavanone 3'-hydroxylase	K05280 (1.14.13.21)	5	3	3	0,79,40,BMC_Genomics_2012_Jan_13_13_19.txt
4.1.1.15,& citrate	GAD	Glutamate decarboxylase	K01580 (4.1.1.15)	3	2	2	0,98,47,BMC_Genomics_2012_Jan_13_13_19.txt
1.1.1.2,psbD	1.1.1.2	psbD	1.3	+/- 1.2	15	244.8	+/- 72.3,81,6,BMC_Genomics_2012_May_31_13_215.txt
5.2.4.465,...Future Lipidology 2007 2 4 465 476 10.2217/17460875.2.4.465 20354580,489,136,BMC_Genomics_2012_Oct_16_13_558.txt
EC 6.3.2.17,"T. equi encodes dihydrofolate synthase (EC 6.3.2.17, BEWA_029790) and a bifunctional dihyd...",100,41,BMC_Genomics_2012_Nov_9_13_603.txt
2.5.1.-,"...dehydrodolichyl diphosphate synthase (DHDDS, E.C. 2.5.1.-) also uses 16 as its substrate to generate...",91,620,BMC_Genomics_2012_Oct_30_13_576.txt
2.5.1.10,"EC: 2.5.1.10	(2E,6E)-farnesyl diphosphate synthase.	KE...",86,5,BMC_Genomics_2012_Sep_17_13_487.txt
1.6.99.3,NF_0313_0956	13	11	1.6.5.3 1.6.99.3	NDUFA7: NADH dehydrogenase (ubiquinone) 1...,134,28,BMC_Genomics_2009_Mar_18_10_114.txt
3.93.10.127,...topathology 2003 93 10 1274 1284 10.1094/PHYTO.2003.93.10.1274 18944327,235,195,BMC_Genomics_2013_Feb_11_14_91.txt
EC 1.1.1.274,"...ncoding a 2,5-diketo-D-gluconic acid reductase B (EC 1.1.1.274)",34,876,BMC_Genomics_2013_May_31_14_365.txt
1.12.4.2,"...0 base reads). Raw reads were processed using RTA 1.12.4.2 and Casava 1.6 (Illumina, USA) and all se...",148,2536,BMC_Genomics_2014_Feb_6_15_90.txt
4.17.10.105,...icrobe Interact 2004 15 1051 1062 10.1094/MPMI.2004.17.10.1051 15497398,447,151,BMC_Genomics_2014_Jan_24_15_66.txt
EC 2.3.3.10,"...2.3.1.9.) and hydroxymethylglutaryl-CoA synthase (EC 2.3.3.10), are known to be involved in several ...",167,703,BMC_Genomics_2013_Oct_28_14_737.txt
EC 3.2.1.37,"...thase, EC 2.7.7.9: UDP glucose pyrophosphorylase, EC 3.2.1.37: xylan 1,4-beta-xylosidase, EC 3.1.1.1...",75,1023,BMC_Genomics_2014_Jun_30_15(1)_540.txt
4.2.3.-,Terpene synthase (TPS)	4.2.3.-	2	13.13	13	6.83,233,24,BMC_Genomics_2014_Jul_12_15(1)_588.txt
1.14.13.21,Flavonoid-3′-Hydroxylase	K05280	EC.1.14.13.21,102,37,BMC_Genomics_2014_Aug_23_15(1)_706.txt
4.2.1.22,"...ME49_059180	cystathionine beta-synthase, putative	4.2.1.22	amino acid metabolism	n.a.	n.a.	n.a.	8.37...",79,53,BMC_Genomics_2013_Mar_15_14_183.txt
EC 2.5.1.29,"... and geranyl-geranyl diphosphate synthase (GGPPS, EC 2.5.1.29) in a step-by-step manner to generate ...",111,420,BMC_Genomics_2013_Jun_13_14_396.txt
1.2.1.3,...oline metabolism	aldehyde dehydrogenase (NAD+)	EC:1.2.1.3	FL638461	Host,217,68,BMC_Genomics_2013_Jul_19_14_491.txt
1.6.5.3,70 bp	NADH dehydrogenase subunit f	1.6.5.3	1.54	2.450,47,36,BMC_Genomics_2013_Sep_11_14_614.txt
5.4.2.7,...hoglucomutase (EC 5.4.2.2) or phosphopentomutase (5.4.2.7) and the second step is associated with ri...,36,338,BMC_Genomics_2014_Sep_17_15(1)_800.txt
2.7.1.48,"... in two steps, involving uridine-cytidine kinase (2.7.1.48) and pyrimidine-nucleoside phosphorylase ...",127,135,BMC_Genomics_2014_Sep_17_15(1)_800.txt
3.5.3.11,3.5.3.11	Agmatinase	agmatine + H2O = putrescine + ...,249,1,BMC_Genomics_2014_Sep_24_15(1)_810.txt
3.2.1.55,"GH54	pectin (RGI)	α-L-arabinofuranosidase	3.2.1.55	1	97, 117, 118",107,43,BMC_Genomics_2014_Sep_11_15(1)_785.txt
3.1.1.72,"CE4	hemicellulose	acetyl xylan esterase	3.1.1.72	2	100, 104, 105",165,41,BMC_Genomics_2014_Sep_11_15(1)_785.txt
EC 1.2.1.9,"..., 40) and glyceraldehyde dehydrogenase phosphate, EC 1.2.1.9 (GAPC) (sp 212,505,509) were found to s...",95,1030,BMC_Genomics_2014_Nov_3_15(1)_949.txt
EC 3.4.23.-,...serine (EC 3.4.21.-) and aspartic endopeptidases (EC 3.4.23.-). Although it has more genes coding fo...,97,871,BMC_Genomics_2014_Sep_29_15(1)_822.txt
EC 1.15.1.1,"...inst this oxidative stress, superoxide dismutase (EC 1.15.1.1) expression was up-regulated for the c...",139,352,BMC_Genomics_2014_Sep_29_15(1)_822.txt
2.1.1.104,caffeoyl-CoA O-methyltransferase	-	2.1.1.104	Transferase	2	1	0,350,36,BMC_Genomics_2014_Nov_18_15(1)_984.txt
4.1.3.18,"...icide that inhibits acetolactate synthase (ALS, EC4.1.3.18, also known as acetohydroxyacid synthase,...",21,229,BMC_Genomics_2015_Mar_17_16(1)_206.txt
1.3.1.9,HSD11B2	P80365	1.1.1.-	1.3.1.9**	Enoyl-[acyl-carrier-protein] reductase (...,156,24,BMC_Genomics_2015_Jun_11_16(Suppl_7)_S16.txt
4.2.1.17,...main-containing protein 3	enoyl-CoA hydratase [EC:4.2.1.17],147,109,BMC_Genomics_2015_Sep_18_16(1)_711.txt
4.3.2.1,"...nate synthase (6.3.4.5), argininosuccinate lyase (4.3.2.1), arginase (3.5.3.1), ornithine aminotrans...",300,3235,BMC_Genomics_2015_Nov_16_16_946.txt
2.6.1.13,"..., arginase (3.5.3.1), ornithine aminotransferase (2.6.1.13), pyrroline-5-carboxylate reductase (1.5....",300,3293,BMC_Genomics_2015_Nov_16_16_946.txt
EC 1.14.15.3,"...omplex II protein family, and Glyma05g09080 is an EC 1.14.15.3 alkane 1-monooxygenase. The p-values ...",345,2417,BMC_Genomics_2015_Nov_25_16_1011.txt
1.1.1.1,...al acetaldehyde/alcohol dehydrogenase [EC1.2.1.10 1.1.1.1] was characterized as Leuconostoc-specific...,216,200,BMC_Genomics_2015_Dec_29_16_1117.txt
3.2.1.49,...nked oligosaccharides	α-N-acetylgalactosaminidase	3.2.1.49	7	43,120,55,BMC_Genomics_2014_Sep_11_15_785.txt
3.1.3.11,"...e kinase; EC:2.7.2.3, phosphoglycerate kinase; EC:3.1.3.11, fructose-1,6-bisphosphatase I; EC:4.2.1....",182,2310,BMC_Genomics_2016_Mar_15_17_234.txt
4.1.2.13,"...se-1,6-bisphosphatase I; EC:4.2.1.11, enolase; EC:4.1.2.13, fructose-bisphosphate aldolase, class I)...",182,2376,BMC_Genomics_2016_Mar_15_17_234.txt
EC 4.2.1.2,"....1.54), malate to fumarate by fumarate hydratase (EC 4.2.1.2) and SucCoA to succinate by succinyl-Co...",220,1105,BMC_Genomics_2016_May_13_17_353.txt
EC 2.7.1.86,"... found, two reactions were added (EC 2.7.1.23 and EC 2.7.1.86) to allow the presence of NADP and NAD...",234,1165,BMC_Genomics_2016_May_13_17_353.txt
1.3.1.76,...helatase / Uroporphyrinogen-III methyltransferase	1.3.1.76/4.99.1.4/2.1.1.107	fig|644335.4.peg.2909	...,232,125,BMC_Genomics_2016_Jun_24_17_473.txt
2.7.1.11,"...omerase [EC: 5.3.1.9], 6-phosphofructokinase [EC: 2.7.1.11], fructose-bisphosphate aldolase [EC: 4.1...",144,323,BMC_Genomics_2016_Aug_11_17_616.txt
1.4.3.2,L-amino-acid oxidase	ec:1.4.3.2,129,25,BMC_Genomics_2016_Aug_19_17_657.txt
EC 4.2.1.92,"... for the formation of allene oxide synthase (AOS, EC 4.2.1.92), which further catalyses the synthesi...",98,437,PMC5220608.txt
1.14.3.336,...t Microbe Interact 2001 14 336 48 10.1094/MPMI.2001.14.3.336 11277431,318,296,PMC5249006.txt
4.10.3.478,...hol Aging 1995 10 478 491 8527068 10.1037/0882-7974.10.3.478,242,176,BMC_Geriatr_2009_Jul_13_9_27.txt
4.15.7.330,...ac J Cancer Prev 2014 15 3305 10 10.7314/APJCP.2014.15.7.3305 24815487,261,269,BMC_Geriatr_2015_Apr_10_15_43.txt
2.41.1.111,...udy Contemp Nurse 2012 41 111 119 10.5172/conu.2012.41.1.111 22724912,332,174,BMC_Geriatr_2016_Dec_2_16_207.txt
3.23.6.564,... Psychol 2004 23 564 573 15546224 10.1037/0278-6133.23.6.564,185,245,BMC_Health_Serv_Res_2006_Feb_13_6_9.txt
3.18.2.183,... Psychol 1999 18 183 188 10194054 10.1037/0278-6133.18.2.183,170,222,BMC_Health_Serv_Res_2008_May_8_8_100.txt
3.29.1.3,...ept Perform 2003 29 3 18 12669744 10.1037/0096-1523.29.1.3,311,152,BMC_Health_Serv_Res_2009_Jun_29_9_110.txt
2.2.1.3,2.2.1.3 Sample and procedur,102,1,BMC_Health_Serv_Res_2011_May_27_11_130.txt
6.19.1.3,...liability Psychol Rep 1966 14 3 11 10.2466/pr0.1966.19.1.3 5942109,279,118,BMC_Health_Serv_Res_2014_Mar_1_14_97.txt
4.51.6.117,...s Soc Psychol 1986 51 6 1173 1182 10.1037/0022-3514.51.6.1173 3806354,258,222,BMC_Health_Serv_Res_2015_Mar_22_15_115.txt
2.24.6.549,... AIDS Educ Prev 2012 24 6 549 563 10.1521/aeap.2012.24.6.549 23206203,252,167,BMC_Health_Serv_Res_2015_Dec_8_15_542.txt
2.4.7.378,...J Paramed Pract 2012 4 7 378 381 10.12968/jpar.2012.4.7.378,245,141,BMC_Health_Serv_Res_2016_Feb_2_16_39.txt
2.2.2.183,"... study was imported to EpiData analysis software v2.2.2.183 (EpiData Association, Odense, Denmark) f...",64,229,BMC_Health_Serv_Res_2016_Jul_15_16_266.txt
4.51.6.117,...s Soc Psychol 1986 51 6 1173 1182 10.1037/0022-3514.51.6.1173 3806354,451,210,BMC_Health_Serv_Res_2016_Oct_18_16_582.txt
EC 3.2.1.17,"...0 rabbit polyclonal anti-human lysozyme antibody (EC 3.2.1.17) (DAKO, Carpinteria, CA) overnight at ...",34,774,BMC_Infect_Dis_2008_Oct_8_8_134.txt
3.26.2.136,...n Health Psychol 2007 26 2 136 45 10.1037/0278-6133.26.2.136 17385964,312,220,BMC_Infect_Dis_2010_May_12_10_114.txt
6.31.1.48,...cutive cases Vasa 2002 14 1 48 55 10.1024/0301-1526.31.1.48 11951699,245,228,BMC_Infect_Dis_2014_Apr_28_14_228.txt
4.8.3.293,...Expert Rev Vaccines 2009 8 293 298 10.1586/14760584.8.3.293 19249971,944,155,BMC_Infect_Dis_2014_Jul_30_14_425.txt
1.52.10.117,...Ophthalmol Soc 2011 52 10 1173 81 10.3341/jkos.2011.52.10.1173,176,173,BMC_Infect_Dis_2015_Apr_9_15_177.txt
2.30.2.83,...y Korean J Parasitol 1992 30 83 90 10.3347/kjp.1992.30.2.83,206,259,BMC_Infect_Dis_2015_Nov_14_15_519.txt
3.16.73.289,...study Pan Afr Med J 2013 16 1 10 10.11604/pamj.2013.16.73.2891 24570772,324,271,BMC_Infect_Dis_2016_Apr_26_16_183.txt
1.54.1.11,...e 71 Korean J Pediatr 2011 54 11 6 10.3345/kjp.2011.54.1.11 21359055,252,176,BMC_Infect_Dis_2016_Oct_19_16_585.txt
5.1.33.238,...Faso AIDS Educ Prev 2003 15 1 33 48 10.1521/aeap.15.1.33.23847 12627742,309,168,BMC_Int_Health_Hum_Rights_2013_Jan_23_13_6.txt
2.13.2.411,...ac J Cancer Prev. 2012 13 411 20 10.7314/APJCP.2012.13.2.411 2252479,368,209,BMC_Med_2015_Aug_18_13_190.txt
2.1.1.2,...alent Examination or accreditation systems (Theme 2.1.1.2) coupled with at least 12 months of clinic...,141,95,BMC_Med_Educ_2012_Sep_29_12_91.txt
3.97.2.268,...Educ Psychol. 2005;97:268–74. doi:10.1037/0022-0663.97.2.268,228,214,BMC_Med_Educ_2015_Oct_24_15_182.txt
2.30.8.821,...ess Soc Behav Pers 2002 30 821 836 10.2224/sbp.2002.30.8.821,363,169,BMC_Med_Educ_2015_Nov_12_15_203.txt
1.18.2.52,...pproach Nurse Res 2011 18 2 52 62 10.7748/nr2011.01.18.2.52.c8284 21319484,141,116,BMC_Med_Educ_2016_Feb_16_16_63.txt
4.42.2.303,...est (all items). http://dx.doi.org/10.2224/sbp.2014.42.2.303. (DOCX 15 kb,342,161,BMC_Med_Educ_2016_Sep_2_16(1)_234.txt
2.24.1.3,...n Korean J Med Educ 2012 24 1 3 6 10.3946/kjme.2012.24.1.3 25812785,296,131,PMC5331658.txt
3.18.2.195,...iner Res 2003 18 195 203 12568396 10.1359/jbmr.2003.18.2.195,281,261,BMC_Med_Genet_2007_Nov_26_8_70.txt
1.4.2.157,...Americans Per Med 2007 4 2 157 169 10.2217/17410541.4.2.157 19802360,251,192,BMC_Med_Genet_2011_Jun_6_12_80.txt
6.49.11.112,...ean J Pediatr 2006 49 11 1125 1139 10.3345/kjp.2006.49.11.1125,199,119,BMC_Med_Genet_2014_Aug_15_15_94.txt
EC 6.4.1.2,"...oxylase (EC 6.4.1.1), and acetyl-CoA carboxylase (EC 6.4.1.2) [1],[2]. Treatment, which consists of ...",18,388,BMC_Med_Genet_2014_Sep_1_15_96.txt
EC 1.2.1.3,"....38, 1.1.1.39, 1.1.1.40). Aldehyde dehydrogenase (EC 1.2.1.3) was down-regulated to prevent degradat...",69,337,BMC_Med_Genomics_2010_Sep_10_3_39.txt
EC 4.1.2.13,"... mainly involved in the conversion of D-fructose (EC 4.1.2.13), D-fructose-1P (ECs 2.7.1.1, 2.7.1.11...",69,749,BMC_Med_Genomics_2010_Sep_10_3_39.txt
2.6.1.51,...tem J Comput Sci Eng 2012 6 51 59 10.5626/JCSE.2012.6.1.5,226,174,BMC_Med_Inform_Decis_Mak_2013_Jan_10_13_9.txt
1.20.3.33,...lations Nurse Res 2013 20 3 33 37 10.7748/nr2013.01.20.3.33.c9495 23346777,571,112,BMC_Med_Res_Methodol_2014_Mar_25_14_42.txt
1.3.3.22,"...nd incubated for 1 h at 4°C with anti-human CD81 (1.3.3.22), anti-murine CD81 (MT81, MT81w) or anti-...",129,113,BMC_Microbiol_2009_May_28_9_111.txt
3.2.1.74,"(xylan, xyloglucan)		3.2.1.74",53,22,BMC_Microbiol_2016_Jul_12_16_147.txt
6.41.6.116,...y Limnol Oceanogr 1996 41 1169 1179 10.4319/lo.1996.41.6.1169,333,245,BMC_Microbiol_2011_Apr_29_11_88.txt
EC 2.7.1.69,"...stem, N-acetylglucosamine-specific IIB component (EC 2.7.1.69)	7	0	0	0	0	0	0",121,57,BMC_Microbiol_2011_May_15_11_103.txt
3.2.1.15,"...kbone of pectin are polygalacturonases (PGA, E.C. 3.2.1.15 and XPG, E.C. 3.2.1.67), pectate lyases (...",15,1195,BMC_Microbiol_2011_Dec_9_11_260.txt
4.17.5.456,...-Microbe Interact 2004 17 456 466 10.1094/MPMI.2004.17.5.456 15141949,203,209,BMC_Microbiol_2012_Jul_3_12_131.txt
1.31.1.30,... Korean J Lab Med 2011 31 1 30 36 10.3343/kjlm.2011.31.1.30 21239868,163,233,BMC_Microbiol_2015_Oct_13_15_210.txt
3.74.2.196,...riodontol 2003 74 196 201 12666708 10.1902/jop.2003.74.2.196,133,209,BMC_Mol_Biol_2007_Feb_23_8_12.txt
3.18.8.154,... J Bone Miner Res 2003 18 1547 53 10.1359/jbmr.2003.18.8.1547 12929946,346,181,BMC_Musculoskelet_Disord_2009_Dec_24_10_165.txt
1.9.2.3,"... was performed using CTAnalyser software, version 1.9.2.3 (SkyScan). A global grey value threshold r...",56,597,BMC_Musculoskelet_Disord_2010_May_28_11_105.txt
6.5.6.556,...e J Neurosurg Spine 2006 5 556 561 10.3171/spi.2006.5.6.556 17176025,117,182,BMC_Musculoskelet_Disord_2011_Apr_14_12_76.txt
2.17.7.123,... Bone Miner Res 2002 17 1237 1244 10.1359/jbmr.2002.17.7.1237 12096837,355,198,BMC_Musculoskelet_Disord_2012_Oct_22_13_204.txt
1.16.10.173,... Bone Miner Res 2001 14 1739 1746 10.1359/jbmr.2001.16.10.1739 11585335,181,322,BMC_Musculoskelet_Disord_2013_Dec_9_14_344.txt
EC 1.15.1.1,"...sti IE Manuel SJ Buckley RA Superoxide dismutase (EC 1.15.1.1), manganese and the effect of ethanol ...",236,55,BMC_Nephrol_2013_Nov_17_14_254.txt
EC 3.2.1.22,"... the acid hydrolase enzyme alpha-galactosidase A (EC 3.2.1.22), which catalyses removal of a galacto...",8,167,BMC_Nephrol_2014_May_6_15_72.txt
4.29.7.957,...J Korean Med Sci 2014 29 7 957 64 10.3346/jkms.2014.29.7.957 25045228,329,221,BMC_Nephrol_2015_Jun_18_16_84.txt
2.4.3.232,...ry J Cogn Neurosci 1992 4 232 243 10.1162/jocn.1992.4.3.232 2396488,114,148,BMC_Neurol_2014_Mar_7_14_44.txt
5.18.5.4,...ation Neurosurg Focus 2005 18 5 E3 10.3171/foc.2005.18.5.4 15913279,142,135,BMC_Neurol_2016_Jul_16_16_106.txt
4.9.1.9,...Neurointervention 2014 9 9 20 10.5469/neuroint.2014.9.1.9 24644529,154,150,PMC5223551.txt
3.27.4.895,...Percept Perform 2001 27 4 895 918 10.1037/0096-1523.27.4.895 11518152,210,125,BMC_Neurosci_2011_Jan_26_12_14.txt
1.14.5.858,...ug News Perspect 2001 14 5 261 267 10.1358/dnp.2001.14.5.858392 12813589,365,166,BMC_Neurosci_2011_Oct_27_12_107.txt
5.11.1.52,...c Work Soc Sci Rev 2004 11 1 52 69 10.1921/17466105.11.1.52,302,182,BMC_Nurs_2014_Mar_25_13_8.txt
1.48.2.669,...weight Psychol Rep 1981 48 669 670 10.2466/pr0.1981.48.2.669 7291403,322,114,PMC5219768.txt
4.41.4.362,...tion Arch Plast Surg 2014 41 362 5 10.5999/aps.2014.41.4.362 25075358,77,143,BMC_Ophthalmol_2016_Jan_7_16_4.txt
4.15.18.773,... J Cancer Prev 2014 15 18 7731 5 10.7314/APJCP.2014.15.18.7731 2529205,342,233,BMC_Ophthalmol_2016_Sep_1_16(1)_156.txt
3.14.1.469,...Pac J Cancer Prev 2013 14 469 73 10.7314/APJCP.2013.14.1.469 23534775,286,247,BMC_Pharmacol_Toxicol_2015_Mar_28_16_5.txt
4.12.3.367,...rt Opin Emerg Drugs 2007 12 367 88 10.1517/14728214.12.3.367 17874967,199,138,BMC_Pharmacol_Toxicol_2016_May_23_17_23.txt
EC 1.14.11.-,"Plant ODDs (EC 1.14.11.-) constitute a class of non-heme, iron...",17,13,BMC_Plant_Biol_2004_Dec_13_4_20.txt
4.1.1.50,...xylase and adenosylmethionine decarboxylase (E.C. 4.1.1.50) as well as adenosyl methionine decarboxy...,53,772,BMC_Plant_Biol_2008_Feb_25_8_19.txt
3.3.12.5,SGN-U313179	1-1-3.3.12.5	EB138262	Photosystem I reaction center su...,398,17,BMC_Plant_Biol_2008_Feb_17_8_16.txt
4.2.20.9,SGN-U312527	1-1-4.2.20.9	EB137890	S-adenosylmethionine synthetase ...,416,17,BMC_Plant_Biol_2008_Feb_17_8_16.txt
EC 3.2.1.26,...490		0.2	0.2	Beta-fructofuranosidase 1 precursor (EC 3.2.1.26) {Zea mays;}	sp|P49175	1E-46,66,58,BMC_Plant_Biol_2008_Apr_3_8_32.txt
EC 2.7.7.9,5	UDP-glucose pyrophosphorylase (EC 2.7.7.9)	FG343121	-	110	3.2,152,34,BMC_Plant_Biol_2008_Dec_1_8_122.txt
2.7.1.40,2.2.1.1	2.7.1.40	4.1.2.13,243,10,BMC_Plant_Biol_2009_Jan_28_9_14.txt
EC 2.4.1.82,...henotypes. Our targets were a raffinose synthase (EC 2.4.1.82) and an omega-6 fatty acid desaturase ...,23,346,BMC_Plant_Biol_2009_Jul_14_9_89.txt
3.2.1.21,Beta-glucosidase	ec:3.2.1.21	B						X,106,21,BMC_Plant_Biol_2009_Oct_24_9_128.txt
EC 1.2.1.12,"...ceraldehyde-3-phosphate dehydrogenase (NAD-GAPDH, EC 1.2.1.12), 5 units of 3-phosphoglyceric phospok...",138,1269,BMC_Plant_Biol_2010_Mar_7_10_42.txt
5.4.2.1,...sphoglycerate-independent phosphoglycerate mutase	5.4.2.1	PGAM1-b	60.0/5.6	53.4/5.4d	20d,40,86,BMC_Plant_Biol_2010_Dec_1_10_268.txt
1.14.11.9,"...015842001	Naringenin,2-oxoglutarate 3-dioxygenase	1.14.11.9	Flavonoid",156,75,BMC_Plant_Biol_2011_Jan_10_11_7.txt
3.2.1.20,"....3, glucan 1,4-α-glucosidase; 3.2.1.4, cellulase; 3.2.1.20, α-glucosidase; 3.2.1.21, β-glucosidase; ...",126,663,BMC_Plant_Biol_2010_Jul_17_10_150.txt
2.15.6.529,... Microbe Interact 2002 15 529 539 10.1094/MPMI.2002.15.6.529 12059101,272,205,BMC_Plant_Biol_2012_Mar_23_12_42.txt
2.15.6.529,... Microbe Interact 2002 15 529 539 10.1094/MPMI.2002.15.6.529 12059101,272,205,BMC_Plant_Biol_2012_Mar_23_12_42.txt
2.7.1.31,"...minotransferase), 2.7.1.19 (phosphoribulokinase), 2.7.1.31 (glycerate kinase), 2.7.2.3 (phosphoglyce...",62,913,BMC_Plant_Biol_2013_Mar_21_13_49.txt
1.3.5.1,"...ruvate dehydrogenase E1 component subunit alpha), 1.3.5.1 (succinate dehydrogenase), 1.4.1.2 (glutam...",66,724,BMC_Plant_Biol_2013_Mar_21_13_49.txt
6.3.2.3,"...epimerase), 6.3.2.2 (glutamate--cysteine ligase), 6.3.2.3 (glutathione synthase)",68,894,BMC_Plant_Biol_2013_Mar_21_13_49.txt
1.11.1.6,"...rx-f), superoxide dismutase (1.15.1.1), catalase (1.11.1.6), and peroxiredoxin (1.11.1.15). Glyceral...",73,884,BMC_Plant_Biol_2013_Mar_21_13_49.txt
1.14.7.905,... Microbe Interact 2001 14 905 909 10.1094/MPMI.2001.14.7.905 11437264,188,163,BMC_Plant_Biol_2009_Aug_18_9_108.txt
1.1.1.2,D7UA58	0.59	1.176	1.1.1.2	Gossypium hirsutum	PsbP precursor,78,19,BMC_Plant_Biol_2014_Apr_28_14_110.txt
4.17.12.136,...icrobe Interact 2004 17 1366 1375 10.1094/MPMI.2004.17.12.1366 15597742,239,223,BMC_Plant_Biol_2014_May_8_14_126.txt
3.5.1.2,values using Arlequin v3.5.1.2. Genbank accession numbers of sequences ge...,441,25,BMC_Plant_Biol_2014_Jan_10_14_17.txt
1.1.1.22,Alcohol dehydrogenase	EC:1.1.1.22	C	 	*	*	*	*	 	 	 	 ,82,26,BMC_Plant_Biol_2014_Aug_2_14_205.txt
2.4.1.29,Cellulose synthase catalytic subunit	EC:2.4.1.29	C	 	 	 	*	 	 	 	 	 ,92,41,BMC_Plant_Biol_2014_Aug_2_14_205.txt
2.1.1.10,Homocysteine S-methyltransferase	2.1.1.10	5	2.6-20.1,172,34,BMC_Plant_Biol_2014_Aug_15_14_215.txt
4.6.1.1,...n Bandelt et al. [49] and implemented in Network v4.6.1.1. [50]. A Star Contraction was run before r...,156,533,BMC_Plant_Biol_2014_Sep_3_14_229.txt
4.4.1.5,"...lyoxalase I (GLY I; lactoylglutathione lyase, EC: 4.4.1.5) was also induced throughout the resistant...",113,52,BMC_Plant_Biol_2014_Nov_25_14_300.txt
1.1.1.49,"Pentose phosphate pathway	ec:1.1.1.49, ec:2.7.1.11, ec:4.1.2.13, ec:5.4.2.2",522,31,BMC_Plant_Biol_2015_Mar_6_15_76.txt
2.5.1.15,"...C:2.7.6.3, HPPK) and dihydropteroate synthase (EC:2.5.1.15, DHPS), which is a bifunctional enzyme in...",17,1413,BMC_Plant_Biol_2015_Aug_19_15_204.txt
1.3.3.6,"...ynthase, ACS; EC4.4.1.14) and ACC oxidase (ACO; EC1.3.3.6) are responsible for ethylene biosynthesis...",20,427,BMC_Plant_Biol_2016_Jan_9_16_13.txt
EC 1.15.1.1,...t the chemical reactions they catalyze.SOD assay (EC 1.15.1.1,166,295,BMC_Plant_Biol_2016_Jun_10_16_131.txt
EC 1.12.99.6,"...l-ACP, catalysed by stearoyl-ACP desaturase (SAD, EC 1.12.99.6) [6, 7]. Oleoyl-ACP is a precursor fo...",22,365,BMC_Plant_Biol_2016_Jun_14_16_137.txt
4.54.6.106,... Pers Soc Psychol 1988 54 1063 70 10.1037/0022-3514.54.6.1063 3397865,289,184,BMC_Pregnancy_Childbirth_2015_Feb_13_15_25.txt
4.1.2.13,"Fructose-1,6-bisphosphate aldolase	4.1.2.13	23.62	±	3.32		20.74	±	8.41",25,37,BMC_Proc_2011_Nov_22_5(Suppl_8)_P129.txt
5.15.1.128,...chology 2001 15 128 135 11216883 10.1037//0894-4105.15.1.128,130,187,BMC_Psychiatry_2003_Jul_30_3_9.txt
4.76.6.103,...hology 1999 76 1035 1049 10402685 10.1037/0022-3514.76.6.1035,302,219,BMC_Psychiatry_2008_Aug_18_8_70.txt
2.77.3.489,...Orthopsychiatry 2007 77 3 489 496 10.1037/0002-9432.77.3.489 17696677,181,162,BMC_Psychiatry_2009_Dec_22_9_81.txt
5.55.3.335,...p Psychotherapy 2005 55 3 335 354 10.1521/ijgp.2005.55.3.335 16175990,200,193,BMC_Psychiatry_2011_Aug_25_11_142.txt
3.17.4.210,...und Entwicklung 2008 17 4 210 218 10.1026/0942-5403.17.4.210,270,164,BMC_Psychiatry_2013_Jan_3_13_3.txt
4.85.2.348,...t J Per 2004 72 Suppl 6 1301 1334 10.1037/0022-3514.85.2.348,203,181,BMC_Psychiatry_2013_Jan_9_13_16.txt
5.7.5.889,...ne Neural Comput 1995 7 5 889 904 10.1162/neco.1995.7.5.889 7584891,219,105,BMC_Psychiatry_2014_Apr_27_14_122.txt
3.34.3.176,...sychol Psychother 2005 34 176 187 10.1026/1616-3443.34.3.176,303,145,BMC_Psychiatry_2013_Nov_15_13_306.txt
6.4.3.359,...J Soc Clin Psych 1986 4 3 359 373 10.1521/jscp.1986.4.3.359,301,128,BMC_Psychiatry_2014_Sep_26_14_272.txt
2.10.3.799,... Scale Psychol Rep 2011 10 799 812 10.2466/pr0.1962.10.3.799,294,107,BMC_Psychiatry_2015_Oct_21_15_257.txt
6.57.8.119,...a Psychiatr Serv 2006 57 8 1199 202 10.1176/ps.2006.57.8.1199 16870973,286,231,BMC_Psychiatry_2016_Jan_6_16_1.txt
6.57.11.163,...y process Psychiatr Serv 2006 57 11 10.1176/ps.2006.57.11.1636,291,139,BMC_Psychiatry_2015_Dec_15_15_313.txt
3.34.4.228,...Korean J Fam Med 2013 34 4 228 40 10.4082/kjfm.2013.34.4.228 2390495,431,153,BMC_Psychiatry_2016_Jan_27_16_17.txt
5.33.1.125,...ural Nepal Ethos 2005 33 1 125 147 10.1525/eth.2005.33.1.125,373,194,BMC_Psychiatry_2016_Mar_8_16_58.txt
4.67.2.319,...Pers Soc Psychol 1994 67 2 319 33 10.1037/0022-3514.67.2.319,303,205,BMC_Psychiatry_2016_Sep_21_16_329.txt
4.54.6.106,... Pers Soc Psychol 1988 54 1063 70 10.1037/0022-3514.54.6.1063 3397865,315,184,BMC_Psychiatry_2016_Dec_8_16_439.txt
5.13.2.150,...pharmacol Neurosci 2015 13 2 150 6 10.9758/cpn.2015.13.2.150 26243841,115,193,PMC5299682.txt
4.81.5.774,... Pers Soc Psychol 2001 81 774 778 10.1037/0022-3514.81.5.774 11708556,227,125,BMC_Psychol_2016_Jan_30_4_4.txt
4.54.6.106,...ers Soc Psychol 1988 54 1063 1070 10.1037/0022-3514.54.6.1063 3397865,393,182,BMC_Psychol_2016_Nov_29_4_60.txt
5.76.8.137,...odontol 2005 76 1374 1385 16101372 10.1902/jop.2005.76.8.1374,212,230,BMC_Public_Health_2008_Jan_29_8_39.txt
3.19.3.223,... Psychol 2000 19 223 231 10868766 10.1037/0278-6133.19.3.223,270,260,BMC_Public_Health_2008_Sep_26_8_337.txt
1.73.3.193,... J Vitam Nutr Res 2003 73 193 200 10.1024/0300-9831.73.3.193 12847996,204,177,BMC_Public_Health_2009_Nov_23_9_426.txt
3.23.1.58,...ment Health Psychol 2004 23 58 66 10.1037/0278-6133.23.1.58 14756604,165,214,BMC_Public_Health_2010_May_24_10_271.txt
3.26.4.401,...DE Health Psychol 2007 26 401 409 10.1037/0278-6133.26.4.401 17605559,431,298,BMC_Public_Health_2010_Aug_3_10_452.txt
4.5.5.641,...Expert Rev Vaccines 2006 5 641 649 10.1586/14760584.5.5.641 17181438,172,134,BMC_Public_Health_2010_Aug_31_10_523.txt
4.70.3.491,... Pers Soc Psychol 1996 70 491 512 10.1037/0022-3514.70.3.491,326,148,BMC_Public_Health_2010_Nov_19_10_712.txt
6.31.4.241,... Vascular Disease 2002 11 241 248 10.1024/0301-1526.31.4.241,315,263,BMC_Public_Health_2011_Jul_13_11_559.txt
5.19.3.247,...J Cogn Psychother 2005 19 247 260 10.1891/jcop.2005.19.3.247,237,148,BMC_Public_Health_2014_Apr_7_14_322.txt
3.14.12.750,...Cancer Prev 2013 14 12 7509 7515 10.7314/APJCP.2013.14.12.7509 24460326,385,208,BMC_Public_Health_2015_Dec_1_15_1200.txt
4.8.2.213,...ents Nutr Res Pract 2014 8 2 213 9 10.4162/nrp.2014.8.2.213 24741407,351,208,BMC_Public_Health_2015_Dec_24_15_1292.txt
4.8.2.213,...ents Nutr Res Pract 2014 8 2 213 9 10.4162/nrp.2014.8.2.213 24741407,320,208,BMC_Public_Health_2016_Jan_7_16_18.txt
1.54.10.401,... Korean J Pediatr 2011 54 10 401 4 10.3345/kjp.2011.54.10.401 22232621,355,94,BMC_Public_Health_2016_Jan_28_16_89.txt
6.15.22.225,... use Br J Nurs 2006 15 22 1212 6 10.12968/bjon.2006.15.22.22557 17346018,278,157,BMC_Public_Health_2016_Feb_19_16_173.txt
2.6.2.235,...of Ghana Gut Liver 2012 6 2 235 40 10.5009/gnl.2012.6.2.235 22570754,274,230,BMC_Public_Health_2016_Jul_11_16_537.txt
3.28.1.83,...ndex Health Psychol 2009 28 83 90 10.1037/0278-6133.28.1.83 19210021,237,147,BMC_Public_Health_2016_Aug_17_16_805.txt
5.20.25.211,...Euro Surveill 2015 20 7 13 10.2807/1560-7917.ES2015.20.25.21163 26132767,157,195,BMC_Public_Health_2016_Nov_29_16_1203.txt
3.18.1.89,...on Health Psychol 1999 18 1 89 94 10.1037/0278-6133.18.1.89 9925050,339,134,BMC_Public_Health_2016_Dec_13_16_1246.txt
5.4.9.114,... Toxicol 2008 4 1143 1152 18721109 10.1517/17425255.4.9.1143,82,212,BMC_Res_Notes_2009_Aug_5_2_158.txt
2.6.6.883,...v Cardiovasc Ther 2008 6 6 883 895 10.1586/14779072.6.6.883 18570625,207,152,BMC_Res_Notes_2012_Jan_4_5_2.txt
2.77.4.534,... J Orthopsyciatr. 2007 77 534 542 10.1037/0002-9432.77.4.534,197,210,BMC_Res_Notes_2016_Nov_8_9_485.txt
5.76.1.129,...ents J Periodontol 2005 76 129 133 10.1902/jop.2005.76.1.129 15830647,259,299,PMC5316180.txt
5.35.8.487,...orts Phys Ther 2005 35 8 487 494 10.2519/jospt.2005.35.8.487 1618750,206,169,BMC_Sports_Sci_Med_Rehabil_2014_Mar_27_6_13.txt
5.35.6.377,...ture review JOSPT 2005 35 377 87 10.2519/jospt.2005.35.6.377 16001909,317,177,PMC5326499.txt
EC 2.7.2.1,"...]. Sequential activities of acetate kinase (AckA, EC 2.7.2.1) and phosphotransacetylase (Pta, EC 2.3...",15,331,BMC_Struct_Biol_2012_Oct_2_12_24.txt
EC 1.4.1.2,"...F15.1010 to EC 1.4.1.3 was kept, and removed from EC 1.4.1.2 and E.C. 1.4.1.4",72,280,BMC_Syst_Biol_2009_Jun_5_3_57.txt
1.1.1.-,"1.1.1.-	0.663257	limonene-1,2-diol dehydrogenase",276,1,BMC_Syst_Biol_2009_Oct_29_3_103.txt
2.7.1.40,2.7.1.40	pyruvate kinase	Cthe_1955	RNA binding S1	...,92,1,BMC_Syst_Biol_2010_Mar_22_4_31.txt
2.5.1.29,2.5.1.29	farnesyltranstransferase	Cthe_0831	Polypr...,106,1,BMC_Syst_Biol_2010_Mar_22_4_31.txt
1.1.1.1,"...KDC, ec4.1.1.1) and alcohol dehydrogenase (ADH, ec1.1.1.1), which is based on the reaction mechanism...",21,379,BMC_Syst_Biol_2010_Mar_28_4_35.txt
1.1.1.61,ec4.1.1.1 → ec1.1.1.61,51,16,BMC_Syst_Biol_2010_Mar_28_4_35.txt
6.1.1.1,...coplast/mitochondrion	Aminoacyl-tRNA biosynthesis	6.1.1.1/6.1.1.2/6.1.1.5/6.1.1.6/6.1.1.10	x	2,222,100,BMC_Syst_Biol_2010_Aug_31_4_120.txt
4.2.1.2,4.2.1.2	12.67	12.667	+∞	14.67	14.657	+∞	0.905	0.88...,158,1,BMC_Syst_Biol_2010_Nov_17_4_156.txt
6.4.1.2,EC-6.4.1.2	AccB*	Acetyl-CoA carboxylase biotin carbox...,186,5,BMC_Syst_Biol_2011_May_25_5_83.txt
5.4.99.7,LmjF06.0650	lanosterol synthase	5.4.99.7	steroid biosynthesis	ER	0.6	100% (L)	3,36,33,BMC_Syst_Biol_2012_Apr_27_6_27.txt
2.1.1.-,2.1.1.-	4.4.1.14	2.8.1.9	1.14.11.-	1.13.11.51	4.4....,77,1,BMC_Syst_Biol_2016_Sep_2_10(1)_87.txt
6.2.1.-,1.14.11.13	1.1.1.-	6.2.1.-	2.5.1.18	1.14.11.-	2.8.1.9	1.14.11.13	1.14...,84,20,BMC_Syst_Biol_2016_Sep_2_10(1)_87.txt
1.13.11.-,....-	2.4.1.263	1.13.11.-	2.4.1.195	1.11.1.9	2.8.1.9	1.13.11.-	1.13.11.-	1.14.11.23	2.4.1.-,90,75,BMC_Syst_Biol_2016_Sep_2_10(1)_87.txt
EC 2.4.1.203,"...bolic route. A trans-zeatin-glucosyl-transferase (EC 2.4.1.203), which catalyzes the conjugation of ...",153,840,BMC_Syst_Biol_2016_Sep_2_10(1)_87.txt
EC 1.14.13.-,"... experimental analysis. Such as, oxidoreductases (EC 1.14.13.-) and their enzyme-coding genes DWF4 (...",394,2072,BMC_Syst_Biol_2016_Sep_2_10(1)_87.txt
2.53.1.111,...cer Yonsei Med J 2012 13 1 111 117 10.3349/ymj.2012.53.1.111 22187240,119,159,BMC_Urol_2013_Oct_22_13_53.txt
3.16.1.17,...r 2013 16 1 17 21 Epub 2013/09/07 10.5223/pghn.2013.16.1.17 24010101,241,137,BMC_Womens_Health_2014_Jan_23_14_16.txt
2.25.4.487,...bolic Interaction 2002 25 4 487 513 10.1525/si.2002.25.4.487,421,167,BMC_Womens_Health_2015_Sep_16_15_75.txt
2.9.1.28,"...as implemented in the “mix” package in R, version 2.9.1.28 29 To evaluate its imputation, we used a ...",60,381,BMJ_2011_Apr_7_342_d1875.txt
4.8.2.117,2014 ;8 :117 –30 . doi:10.5009/gnl.2014.8.2.11724672652,312,39,BMJ_Open_2015_Sep_9_5(9)_e008266.txt
3.19.7.347,2013 ;19 :347 –54 . doi:10.12968/ijpn.2013.19.7.34724273812,273,42,BMJ_Open_2015_Nov_19_5(11)_e008527.txt
5.20.5.28,2013 ;20 :28 –32 . doi:10.7748/nr2013.05.20.5.28.e32723687846,381,40,BMJ_Open_2016_Apr_25_6(4)_e009379.txt
3.27.3.379,doi:10.1037/0278-6133.27.3.37918624603,242,21,BMJ_Open_2016_Jun_27_6(6)_e011982.txt
3.93.1.491,2003 ;93 :49 –58 . doi:10.2466/pr0.2003.93.1.4914563026,334,39,BMJ_Open_2016_Oct_6_6(10)_e012207.txt
5.28.2.752,2015 ;28 :75 –87 . doi:10.3344/kjp.2015.28.2.7525852828,297,39,BMJ_Open_2016_Dec_12_6(12)_e013042.txt
2.21.4.224,doi:10.12968/bjon.2012.21.4.22422398936,440,22,BMJ_Open_Diabetes_Res_Care_2016_Jun_1_4(1)_e000165.txt
1.31.11.645,doi:10.2519/jospt.2001.31.11.64511720297,462,22,BMJ_Open_Sport_Exerc_Med_2016_Jan_19_2(1)_e000043.txt
1.31.9.511,2001 ;31 :511 –17 . doi:10.2519/jospt.2001.31.9.51111570735,487,42,BMJ_Open_Sport_Exerc_Med_2016_Jan_19_2(1)_e000043.txt
5.19.4.509,"...Neuropsychology, 19, 509–519. doi:10.1037/0894-4105.19.4.509. 16060826",178,511,Brain_Imaging_Behav_2009_Sep_5_3(3)_262-276.txt
3.19.3.165,... Psychophysiology 2005 19 165 181 10.1027/0269-8803.19.3.16,274,176,PMC5319948.txt
4.2.1.3,4.2.1.3 Procedur,128,1,Brain_Res_2013_Feb_16_1496_70-83.txt
2.2.1.2,2.2.1.2. Locomotor Activity: SHR,34,1,Brain_Sci_2012_Sep_12_2(3)_375-404.txt
5.8.4.535,...memory Neuropsychology 1994 8 535 10.1037/0894-4105.8.4.535,240,93,Brain_Sci_2013_Aug_19_3(3)_1261-1281.txt
3.17.2.625,...rcept. Mot. Skills 1963 17 625 626 10.2466/pms.1963.17.2.625 14057288,152,147,Brain_Sci_2016_Mar_22_6(1)_10.txt
3.18.6.579,...Health Psychology 1999 18 579 590 10.1037/0278-6133.18.6.579 10619531,192,136,Brain_Sci_2016_Jul_19_6(3)_22.txt
5.11.2.122,...e J. Clin. Neurol. 2015 11 122 131 10.3988/jcn.2015.11.2.122 25851890,256,280,Brain_Sci_2016_Aug_19_6(3)_35.txt
4.78.3.963,...Percept Mot Skills 1994 78 963 967 10.2466/pms.1994.78.3.963 8084719,357,58,Braz_J_Med_Biol_Res_2014_Mar_21_47(4)_321-327.txt
2.2.78.88,...ern Fetal Neonatal Med 2002 12 78 88 10.1080/jmf.12.2.78.88 12420836,374,89,Braz_J_Med_Biol_Res_2014_Apr_11_47(5)_419-425.txt
1.1.1.42,1.1.1.42.	Isocitrate dehydrogenase	IDH	1M Isocitri...,45,1,Braz_J_Microbiol_2011_Sep_1_Jul-Sep_42(3)_1030-1046.txt
EC 3.1.1.3,"The amylase (E.C 3.2.1.1), lipase (EC 3.1.1.3) and protease (EC 3.4.21–24 and 99) are...",8,36,Braz_J_Microbiol_2014_Oct_9_45(3)_903-910.txt
EC 2.7.1.40,"2.7.1.11), pyruvate kinase (PK, EC 2.7.1.40), lactate dehydrogenase (LDH, EC 1.1.1...",59,33,Braz_J_Microbiol_2015_Dec_1_46(4)_1193-1199.txt
3.33.11.647,... 33 11 647 660 http://dx.doi.org/10.2519/jospt.2003.33.11.647 14669960,906,113,Braz_J_Phys_Ther_2015_May_29_May-Jun_19(3)_167-176.txt
2.15.4.373,... J Breast Cancer 2012 15 4 373 380 10.4048/jbc.2012.15.4.373 23346164,116,179,Breast_Cancer_2016_Feb_10_23_486-490.txt
2.5.3.531,...Rev Cardiovasc Ther 2007 5 531 552 10.1586/14779072.5.3.531 17489676,193,162,Breast_Cancer_Res_2009_Nov_10_11(6)_R81.txt
3.18.5.844,... J Bone Miner Res 2003 18 844 851 10.1359/jbmr.2003.18.5.844 12733723,155,262,Breast_Cancer_Res_2011_Oct_27_13(5)_R105.txt
4.16.5.569,...pin Investig Drugs 2007 16 569 571 10.1517/13543784.16.5.569,179,205,Breast_Cancer_Res_2012_May_21_14(3)_R79.txt
EC 1.4.3.13,"Lysyl oxidase (LOX; ExPASy ENZYME entry: EC 1.4.3.13) and members of the LOX-like family, L...",5,42,Breast_Cancer_Res_2015_Aug_13_17(1)_107.txt
3.23.1.3,...nge Health Psychol 2004 23 1 3 15 10.1037/0278-6133.23.1.3 14756598,288,198,Breast_Cancer_Res_Treat_2016_Jul_14_158_563-572.txt
1.14.18.1,"1.14.18.1) (Pawelek et al., 1973), the rate limiti...",159,1,Br_J_Cancer_1990_Dec_62(6)_919-922.txt
3.5.4.17,3.5.4.1,575,1,Br_J_Cancer_1991_Sep_64(3)_428-436.txt
EC 2.1.1.45,Thymidylate synthetase (EC 2.1.1.45) from L121,605,25,Br_J_Cancer_1983_Mar_47(3)_393-398.txt
3.5.4.6,3.5.4.6). The relationship of these enzymes in the...,101,1,Br_J_Cancer_1994_Aug_70(2)_212-218.txt
EC 2.5.1.18,"...-S-transferase (GSTs), namely the subclass GSTpi (EC 2.5.1.18), have been extensively reported to be...",11,1600,Br_J_Cancer_2006_Feb_27_94(4)_473-480.txt
4.1.1.19,Arginine decarboxylase	4.1.1.19	Arginine	Pyridoxal phosphate	Agmatine and...,9,24,Br_J_Cancer_2003_Feb_24_88(4)_613-623.txt
EC 3.4.24.11,fold more EC 3.4.24.11 activity on the H345 SCLC cell lin,412,11,Br_J_Cancer_1999_Jan_79(2)_214-220.txt
1.14.16.2,"L-Tyrosine hydroxylase	TH	TH, P07101	1.14.16.2: L-tyrosine + O2 -> L-DOPA	Protein kinas...",224,38,Br_J_Pharmacol_2013_Dec_17_170(8)_1797-1867.txt
3.1.4.37,"...',3'-cyclic nucleotide 3'-phosphodiesterase (E.C. 3.1.4.37 CNPase) activity is associated with myeli...",392,364,Br_J_Pharmacol_2013_Dec_17_170(8)_1797-1867.txt
1.14.13.30,"CYP4F3	CYP4F3, Q08477	1.14.13.30	Responsible for ω-hydroxylation of LTB4...",484,23,Br_J_Pharmacol_2013_Dec_17_170(8)_1797-1867.txt
2.7.1.127,"Inositol 1,4,5-trisphosphate 3-kinases (E.C. 2.7.1.127, ENSFM00250000001260) catalyse the gener...",796,46,Br_J_Pharmacol_2013_Dec_17_170(8)_1797-1867.txt
2.5.1.21,"EC number	2.5.1.21: 2 trans,trans-farnesyl diphosphate -> pr...",860,11,Br_J_Pharmacol_2013_Dec_17_170(8)_1797-1867.txt
2.5.1.21,"EC number	2.5.1.21: 2 trans,trans-farnesyl diphosphate -> pr...",860,11,Br_J_Pharmacol_2013_Dec_17_170(8)_1797-1867.txt
3.4.24.34,EC number	3.4.24.7	3.4.24.24	3.4.24.17	3.4.24.23	3.4.24.34	3.4.24.35,943,50,Br_J_Pharmacol_2013_Dec_17_170(8)_1797-1867.txt
2.3.1.48,‐ 2.3.1.48 Histone acetyltransferases (HATs,1215,3,Br_J_Pharmacol_2015_Dec_9_172(24)_6024-6109.txt
1.14.13.100,1.14.13.10,4378,1,Br_J_Pharmacol_2015_Dec_9_172(24)_6024-6109.txt
4.1.1.15,4.1.1.15: L‐glutamic acid + H+ ‐>GABA + CO,5009,1,Br_J_Pharmacol_2015_Dec_9_172(24)_6024-6109.txt
2.8.1.2,2.8.1.,5821,1,Br_J_Pharmacol_2015_Dec_9_172(24)_6024-6109.txt
1.1.1.205,1.1.1.20,6202,1,Br_J_Pharmacol_2015_Dec_9_172(24)_6024-6109.txt
2.7.10.1,2.7.10.,2821,1,Br_J_Pharmacol_2015_Dec_9_172(24)_5979-6023.txt
3.18.6.960,"... J Bone Miner Res 2003 18 960 974 10.1359/jbmr.2003.18.6.960 Babij P, Zhao W, Small C, Kharode Y, Ya...",193,228,Calcif_Tissue_Int_2007_Dec_4_81(6)_421-429.txt
3.18.7.123,... Bone Miner Res 2003 18 1235 1246 10.1359/jbmr.2003.18.7.1235 12854833,154,242,Calcif_Tissue_Int_2011_Jul_28_89(1)_10-20.txt
EC 1.3.99.3,"...n specific acyl-CoA dehydrogenase, mitochondrial (EC 1.3.99.3) OS=Homo sapiens PE=2 SV=1 - [B4DJE7_H...",2010,102,Cancer_Biol_Med_2015_Sep_12(3)_246-254.txt
3.14.6.344,... Cancer Prev 2013 14 6 3449 3453 10.7314/APJCP.2013.14.6.3449 23886126,155,268,Cancer_Cell_Int_2014_Dec_23_14_66.txt
6.7.1.57,...s Korean J Radiol 2006 7 57 69 doi:10.3348/kjr.2006.7.1.57 . PMid:16549957 16549957,43,156,Cancer_Imaging_2010_Jul_29_10(1)_169-172.txt
3.4.2.2,...ective function of p38α/β as described in Section 3.4.2.2 Prolonged downstream effects of ASK1 activ...,302,1182,Cancer_Metastasis_Rev_2015_Oct_29_34(4)_643-690.txt
2.4.5.609,... Emerg Ther Targets 2000 4 609 633 10.1517/14728222.4.5.609,285,171,Cancer_Microenviron_2016_Mar_9_9(1)_45-61.txt
2.44.4.262,...2005-9256Korean Cancer Association 10.4143/crt.2012.44.4.262Original ArticleCD10 Is Again Expressed ...,3,172,Cancer_Res_Treat_2012_Dec_31_44(4)_262-266.txt
3.4.1.1,3.4.1.1. Backgroun,60,1,Cancers_(Basel)_2011_May_13_3(2)_2382-2401.txt
4.12.6.933,...n. Investig. Drugs 2003 12 933 941 10.1517/13543784.12.6.933,172,156,Cancers_(Basel)_2013_Sep_6_5(3)_1140-1162.txt
3.3.1.1,3.3.1.1. Substrate-Competitive Inhibitors of CDK,364,1,Cancers_(Basel)_2015_Jan_23_7(1)_179-237.txt
2.36.5.371,...tabolism journal 2012 36 5 371 378 10.4093/dmj.2012.36.5.371 23130322,197,189,Cardiovasc_Diabetol_2013_May_2_12_71.txt
6.9.3.343,...t Opin Pharmacother 2008 9 343 349 10.1517/14656566.9.3.343 18220486,314,280,Cardiovasc_Diabetol_2011_Feb_11_10_18.txt
2.96.6.104,...sion J Neurosurg 2002 96 1046 1051 10.3171/jns.2002.96.6.1046 12066905,130,208,PMC5336536.txt
4.2.5.1,4.2.5.1 Myocardial infarct siz,116,1,Cardiovasc_Res_2014_Dec_1_104(3)_399-411.txt
1.19.4.169,...iovasc Ultrasound 2011 19 4 169 73 10.4250/jcu.2011.19.4.169 22259658,214,174,Cardiovasc_Ultrasound_2016_Feb_4_14_7.txt
1.60.5.362,...Anesthesiology  2011 60 5 362 364 10.4097/kjae.2011.60.5.362 2-s2.0-79958734416 21716566,101,265,Case_Rep_Anesthesiol_2015_May_13_2015_567925.txt
3.44.4.710,...Medical Journal  2003 44 4 710 714 10.3349/ymj.2003.44.4.710 2-s2.0-0042381181 12950129,49,272,Case_Rep_Cardiol_2015_Nov_11_2015_819839.txt
3.74.8.110,...eriodontology  2003 74 8 1104 1109 10.1902/jop.2003.74.8.1104 2-s2.0-0141630610 14514223,83,255,Case_Rep_Dent_2015_Sep_3_2015_374850.txt
4.15.2.267,...al of Radiology  2014 15 2 267 276 10.3348/kjr.2014.15.2.267 2-s2.0-84896301226 24642650,50,161,Case_Rep_Endocrinol_2016_Feb_28_2016_3601508.txt
3.43.12.785,...lation Journal  2013 43 12 785 792 10.4070/kcj.2013.43.12.785 2-s2.0-84892592258 24385988,132,141,Case_Rep_Genet_2015_May_5_2015_259627.txt
5.20.1.75,...Mineral Research  2005 20 1 75 80 10.1359/jbmr.2005.20.1.75 2-s2.0-14844326069 15619672,95,189,Case_Rep_Genet_2016_Jan_19_2016_9814928.txt
4.18.1.34,...rnal of Audiology  2014 18 1 34 37 10.7874/kja.2014.18.1.34 2-s2.0-84898945299 24782949,194,213,Case_Rep_Otolaryngol_2015_Jul_30_2015_250312.txt
2.62.8.8,...ct available: www.jstor.org/stable/10.1525/bio.2012.62.8.8,11,58,CBE_Life_Sci_Educ_2013_Spring_12(1)_9-11.txt
2.2.1.2,"...atrix Science, London, UK) and Distiller (version 2.2.1.2) (Matrix Science, London, UK). Briefly, pe...",138,211,Cell_Biosci_2013_Sep_19_3_37.txt
2.9.6.121,...Opin Ther Targets 2005 9 1217 1233 10.1517/14728222.9.6.1217 16300472,142,168,Cell_Commun_Signal_2010_Jun_10_8_10.txt
4.19.7.112,... J Bone Miner Res 2004 19 1128 36 10.1359/jbmr.2004.19.7.1128 15176996,134,270,Cell_Cycle_2014_Jan_1_13(1)_62-71.txt
3.1.2.2,3.1.2.2.a Experimental Techniqu,128,1,Cell_Mol_Life_Sci_2006_Jan_28_63(1)_36-51.txt
3.1.2.2,3.1.2.2.c Resolutio,134,1,Cell_Mol_Life_Sci_2006_Jan_28_63(1)_36-51.txt
1.3.4.355,...m J Cogn Neurosci 1991 3 4 355 66 10.1162/jocn.1991.3.4.355 23967816,92,146,Cerebellum_Ataxias_2016_Mar_2_3_6.txt
4.4.1.2,4.4.1.2.3. Frying and Deep Frying. In frying a muc...,810,1,Chem_Rev_2010_Apr_14_110(4)_2313-2365.txt
4.4.2.2,4.4.2.2. High Pressure. Some useful processes in c...,857,1,Chem_Rev_2010_Apr_14_110(4)_2313-2365.txt
2.3.4.5,2.3.4.5 Involvemen,770,1,Chem_Rev_2014_Apr_23_114(8)_4366-4469.txt
3.3.1.1,3.3.1.1.4 Asymmetric Synthesi,2269,1,Chem_Rev_2014_Sep_24_114(18)_9154-9218.txt
3.4.1.5,"3.4.1.5 1,3-Dioxin-4-one",2447,1,Chem_Rev_2016_Sep_14_116(17)_9748-9815.txt
2.74.1.5,...opsychiatry 2004 74 5 13 14769104 10.1037/0002-9432.74.1.5,342,249,Child_Adolesc_Psychiatry_Ment_Health_2009_Jan_30_3_4.txt
6.20.6.618,...der J Pers Disord 2006 20 618 644 10.1521/pedi.2006.20.6.618 17192141,174,123,Child_Adolesc_Psychiatry_Ment_Health_2013_Jul_31_7_29.txt
6.36.2.129,...Life Threat Behav 2006 36 129 135 10.1521/suli.2006.36.2.129 16704319,300,153,Child_Adolesc_Psychiatry_Ment_Health_2015_Sep_28_9_33.txt
6.57.8.121,...nts Psychiatric Serv 2006 57 8 1211 10.1176/ps.2006.57.8.1211,432,145,Child_Adolesc_Psychiatry_Ment_Health_2015_Dec_23_9_55.txt
5.39.2.285,...Ann. Rehabil. Med. 2015 39 285 293 10.5535/arm.2015.39.2.285 25932426,325,178,PMC5184809.txt
4.15.1.281,...ac J Cancer Prev 2014 15 281 286 10.7314/APJCP.2014.15.1.281 24528040,241,142,Chin_J_Cancer_2015_Jul_31_34_33.txt
5.51.2.66,...National University Medical School 10.4068/cmj.2015.51.2.66Review ArticleOptimizing the Use of Aripi...,3,129,Chonnam_Med_J_2015_Aug_17_51(2)_66-80.txt
4.63.6.932,"...ocial Psychology,63, 932–944. doi:10.1037/0022-3514.63.6.932. 1460561",205,405,Clin_Child_Fam_Psychol_Rev_2009_Sep_2_12(3)_255-270.txt
2.45.1.44,...ciety of Gastrointestinal Endoscopy 10.5946/ce.2012.45.1.44ReviewKorean Guidelines for Postpolypecto...,3,124,Clin_Endosc_2012_Mar_31_45(1)_44-61.txt
2.45.4.379,... Gastrointestinal Endoscopy 2325188510.5946/ce.2012.45.4.379Focused Review Series: Globalization and...,3,132,Clin_Endosc_2012_Nov_30_45(4)_379-385.txt
3.46.2.116,...ciety of Gastrointestinal Endoscopy 10.5946/ce.2013.46.2.116CommentaryEndoscopic Ultrasound Elastogr...,3,124,Clin_Endosc_2013_Mar_31_46(2)_116-117.txt
3.46.3.248,...ciety of Gastrointestinal Endoscopy 10.5946/ce.2013.46.3.248ReviewIs Image-Enhanced Endoscopy Useful...,3,124,Clin_Endosc_2013_May_31_46(3)_248-250.txt
3.46.4.313,...ciety of Gastrointestinal Endoscopy 10.5946/ce.2013.46.4.313CommentaryDiagnosis of Subepithelial Les...,3,124,Clin_Endosc_2013_Jul_31_46(4)_313-314.txt
3.46.4.390,...ciety of Gastrointestinal Endoscopy 10.5946/ce.2013.46.4.390Original ArticlePhotodynamic Therapy in ...,3,124,Clin_Endosc_2013_Jul_31_46(4)_390-394.txt
4.47.1.115,...ciety of Gastrointestinal Endoscopy 10.5946/ce.2014.47.1.115Case ReportExtramedullary Plasmacytoma o...,3,124,Clin_Endosc_2014_Jan_24_47(1)_115-118.txt
4.47.1.31,...ciety of Gastrointestinal Endoscopy 10.5946/ce.2014.47.1.31Focused Review Series: Endoscopic and Mol...,3,124,Clin_Endosc_2014_Jan_24_47(1)_31-39.txt
4.47.5.447,...ciety of Gastrointestinal Endoscopy 10.5946/ce.2014.47.5.447Case ReportVarious Upper Endoscopic Find...,3,124,Clin_Endosc_2014_Sep_30_47(5)_447-451.txt
1.4.3.118,...olaryngology-Head and Neck Surgery 10.3342/ceo.2011.4.3.118Original ArticleDoes the Kyphotic Change ...,3,167,Clin_Exp_Otorhinolaryngol_2011_Sep_6_4(3)_118-121.txt
1.4.4.177,...olaryngology-Head and Neck Surgery 10.3342/ceo.2011.4.4.177Original ArticleThe Effect of Doxycycline...,3,167,Clin_Exp_Otorhinolaryngol_2011_Dec_15_4(4)_177-183.txt
3.6.3.184,...olaryngology-Head and Neck Surgery 10.3342/ceo.2013.6.3.184Case ReportPrimary Burkitt's Lymphoma in ...,3,192,Clin_Exp_Otorhinolaryngol_2013_Sep_4_6(3)_184-186.txt
3.6.4.243,...olaryngology-Head and Neck Surgery 10.3342/ceo.2013.6.4.243Original ArticleRelationships between Tum...,3,192,Clin_Exp_Otorhinolaryngol_2013_Dec_29_6(4)_243-248.txt
6.9.1.75,...laryngology-Head and Neck Surgery 10.21053/ceo.2016.9.1.75ceo-2016-9-1-75Original ArticleMetastatic ...,3,193,Clin_Exp_Otorhinolaryngol_2016_Mar_7_9(1)_75-79.txt
3.40.3.126,...Society for Reproductive Medicine 10.5653/cerm.2013.40.3.126Original ArticleEffectiveness of emergen...,3,169,Clin_Exp_Reprod_Med_2013_Sep_30_40(3)_126-130.txt
6.43.2.90,...Society for Reproductive Medicine 10.5653/cerm.2016.43.2.90Original ArticleDietary supplementation w...,3,169,Clin_Exp_Reprod_Med_2016_Jun_23_43(2)_90-96.txt
6.43.4.185,...Society for Reproductive Medicine 10.5653/cerm.2016.43.4.185ReviewChronic endometritis and infertili...,3,169,PMC5234283.txt
3.2.1.26,...87-366XThe Korean Vaccine Society 10.7774/cevr.2013.2.1.26Review ArticleH9N2 avian influenza virus i...,3,148,Clin_Exp_Vaccine_Res_2013_Jan_15_2(1)_26-33.txt
3.2.1.1,...87-366XThe Korean Vaccine Society 10.7774/cevr.2013.2.1.1EditorialVaccine industrialization in Korea...,3,148,Clin_Exp_Vaccine_Res_2013_Jan_15_2(1)_1-3.txt
2.3.4.4,"...rth order subclades of 2.3.4.1, 2.3.4.2, 2.3.4.3, 2.3.4.4, 2.3.4.5, 2.3.4.6 over China [50] of which...",35,190,Clin_Exp_Vaccine_Res_2014_Jul_20_3(2)_117-127.txt
2.3.2.1,...of a H5N1 highly pathogenic influenza virus clade 2.3.2.1b circulating in Vietnam in 2011 Vet Microb...,175,139,Clin_Exp_Vaccine_Res_2014_Jul_20_3(2)_117-127.txt
5.4.1.46,...87-366XThe Korean Vaccine Society 10.7774/cevr.2015.4.1.46Review ArticleClinical vaccine development...,3,148,Clin_Exp_Vaccine_Res_2015_Jan_30_4(1)_46-53.txt
2.24.1.1,...012 24(1) 1 6 1 http://dx.doi.org/10.5792/ksrr.2012.24.1.1 22570845,118,141,Clinics_(Sao_Paulo)_2015_Mar_70(3)_202-206.txt
EC 1.4.1.1, 29	P30234	Alanine dehydrogenase (EC 1.4.1.1) (40 kDa antigen) (TB43)	Rv2780,90,35,Clin_Infect_Dis_2015_Oct_15_61(Suppl_3)_S225-S234.txt
EC 1.4.1.1, 29	P30234	Alanine dehydrogenase (EC 1.4.1.1) (40 kDa antigen) (TB43)	Rv2780,90,35,Clin_Infect_Dis_2015_Oct_15_61(Suppl_3)_S225-S234.txt
EC 1.1.1.42,"...te dehydrogenase, NADP-dependent, monomeric type (EC 1.1.1.42)	Rv0066c",104,70,Clin_Infect_Dis_2015_Oct_15_61(Suppl_3)_S225-S234.txt
2.18.4.420,...ciation for the Study of the Liver 10.3350/cmh.2012.18.4.420Liver ImagingHepatic metastases from hep...,3,152,Clin_Mol_Hepatol_2012_Dec_21_18(4)_420-423.txt
3.19.1.29,...ciation for the Study of the Liver 10.3350/cmh.2013.19.1.29Original ArticleAntiviral efficacies of c...,3,152,Clin_Mol_Hepatol_2013_Mar_25_19(1)_29-35.txt
3.19.2.131,...ciation for the Study of the Liver 10.3350/cmh.2013.19.2.131Original ArticlePredictive factors that ...,3,152,Clin_Mol_Hepatol_2013_Jun_27_19(2)_131-139.txt
3.19.3.216,...ciation for the Study of the Liver 10.3350/cmh.2013.19.3.216ReviewKASL Clinical Practice Guidelines:...,3,152,Clin_Mol_Hepatol_2013_Sep_30_19(3)_216-254.txt
6.5.2.79,...rean Society of Clinical Nutrition 10.7762/cnr.2016.5.2.79Original ArticleRice Cakes Containing Diet...,3,131,Clin_Nutr_Res_2016_Apr_30_5(2)_79-88.txt
3.1.2.4,"...using a Heidelberg retina tomograph II (HRT-II, v 3.1.2.4; Heidelberg Engineering GmbH, Heidelberg, ...",29,474,Clin_Ophthalmol_2011_Aug_26_5_1211-1216.txt
3.28.4.303,...d Conserv Dent 2003 28 4 303 313 10.5395/JKACD.2003.28.4.303,323,167,Clin_Oral_Investig_2016_Feb_9_20(8)_2149-2160.txt
1.3.2.157,...he Korean Orthopaedic Association 10.4055/cios.2011.3.2.157Brief CommunicationThe Natural History of...,3,119,Clin_Orthop_Surg_2011_Jun_12_3(2)_157-159.txt
4.6.1.80,...he Korean Orthopaedic Association 10.4055/cios.2014.6.1.80Original ArticleAlveolar Soft Part Sarcoma...,3,135,Clin_Orthop_Surg_2014_Mar_14_6(1)_80-86.txt
6.8.4.367,...he Korean Orthopaedic Association 10.4055/cios.2016.8.4.367Original ArticleMeasurement of Clavicle F...,3,135,Clin_Orthop_Surg_2016_Dec_4_8(4)_367-372.txt
6.19.5.757,doi: 10.1515/JPEM.2006.19.5.757 1678964,186,22,Clin_Pediatr_Endocrinol_2008_Aug_8_17(3)_61-64.txt
3.6.1.21,doi: 10.1515/JPEM.1993.6.1.21 8374685,326,22,Clin_Pediatr_Endocrinol_2014_Oct_6_23(4)_107-114.txt
4.1.1.277,...cide Life Threat Behav 2004 34 1 11 10.1521/suli.34.1.1.27772 15106883,308,136,Clin_Pract_Epidemiol_Ment_Health_2007_Oct_10_3_20.txt
5.2.3.2,5.2.3.2.2 Scannin,192,1,Clin_Psychol_Rev_2007_Apr_27(3)_287-306.txt
2.10.2.94,...College of Neuropsychopharmacology 10.9758/cpn.2012.10.2.94Original ArticleEffects of the Antioxidan...,3,181,Clin_Psychopharmacol_Neurosci_2012_Aug_31_10(2)_94-98.txt
3.11.2.96,"...College of Neuropsychopharmacology 10.9758/cpn.2013.11.2.96Original ArticleLow-frequency, Repetitive...",3,181,Clin_Psychopharmacol_Neurosci_2013_Aug_26_11(2)_96-102.txt
4.48.2.140,...J Pathol 2014 48 140 145 10.4132/KoreanJPathol.2014.48.2.140 24868227,40,209,Clin_Sarcoma_Res_2014_Jun_28_4_6.txt
4.7.1.25,7 :25 –31 . doi:10.1586/14760584.7.1.25 .18251691,257,32,Clin_Vaccine_Immunol_2015_Nov_26_22(11)_1166-1175.txt
6.18.6.102,...ve Neuroscience 2006 18 1029 1043 10.1162/jocn.2006.18.6.1029 16839308,185,206,Cogn_Affect_Behav_Neurosci_2012_Jun_23_12(2)_361-372.txt
4.56.6.922,...Social Psychology 1989 56 922 933 10.1037/0022-3514.56.6.922,295,224,Cogn_Affect_Behav_Neurosci_2016_Apr_28_16_672-688.txt
3.25.1.210,...Percept Perform 1999 25 1 210 228 10.1037/0096-1523.25.1.210,645,183,Cognit_Comput_2011_Mar_15_3(1)_264-278.txt
5.1.2.2,5.1.2.2 Altruistic donatio,224,1,Cognition_2015_Jan_134_193-209.txt
2.5.4.489,...ationship? Emotion 2005 5 489 497 10.1037/1528-3542.5.4.489 16366752,267,115,Cognit_Ther_Res_2014_Feb_7_38(2)_132-145.txt
3.29.6.114,... Learn Mem Cogn 2003 29 1141 1159 10.1037/0278-7393.29.6.1141 14622052,215,144,Cogn_Process_2010_May_27_11(2)_143-158.txt
4.54.4.687,...Social Psychology 1988 54 687 696 10.1037/0022-3514.54.4.687 3367285,205,193,PMC5281665.txt
4.6.4.559,...ing? Neural Comput 1994 6 559 601 10.1162/neco.1994.6.4.559,129,96,Commun_Integr_Biol_2012_Jan_1_5(1)_3-11.txt
2.8.3.352,...cessing Emotion  2008 8 3 352 363 10.1037/1528-3542.8.3.352 2-s2.0-44949109146 18540751,160,165,Comput_Intell_Neurosci_2015_Jun_15_2015_695921.txt
3.2.2.1,"...e 7 K. The bdea2− bonds with the previously known 3.2.2.1 mode, being centred on CoIII. Compared to ...",86,141,Coord_Chem_Rev_2014_Feb_1_260(100)_1-20.txt
2.6.2.197,...nic cough Gut Liver 2012 6 197 202 10.5009/gnl.2012.6.2.197 22570748,123,195,Cough_2013_Apr_16_9_12.txt
2.1.19.101,...development Organ Sci 2001 12 19 36 10.1287/orsc.12.1.19.10119,189,179,Daru_2014_Apr_3_22(1)_35.txt
2.1.2.7,2.1.2.7. Hybrid PET-M,83,1,PMC4807716.txt
EC 3.11.1.1,... phosphonoacetaldehyde hydrolase (phosphonatase) [EC 3.11.1.1] that has been purified from Bacillus ...,11,766,Curr_Microbiol_2014_Oct_27_68(3)_330-335.txt
3.29.4.229,...013 29 4 229 234 [http://dx.doi.org/10.5487/TR.2013.29.4.229]. [PMID: 24578792]. 24578792,350,233,PMC4981742.txt
1.5.3.-,...e	Pyridine of nifedipine	CYP3A4	5.3.3.- + 1.5.1.-|1.5.3.-,409,62,Curr_Pharm_Des_2015_Feb_21(6)_806-822.txt
3.1.1.-, 	 	Carboxylic acid of nifedipine	CYP3A4	3.1.1.-,410,42,Curr_Pharm_Des_2015_Feb_21(6)_806-822.txt
1.14.13.-,...ipine	Hydroxylation of the isobutyl moiety	CYP3A4	1.14.13.-,415,59,Curr_Pharm_Des_2015_Feb_21(6)_806-822.txt
1.14.13.-, 	 	6b-Hydroxy elpererone	CYP3A4	1.14.13.-,433,34,Curr_Pharm_Des_2015_Feb_21(6)_806-822.txt
1.5.3.5,...roved by our institutional ethical committee (UKM 1.5.3.5/244/02-01-02-SF1052). Isolation of periphe...,20,317,Cytotechnology_2016_Aug_1_68(4)_675-686.txt
2.5.1.32, Phytoene synthase	GO:0016117		70.26.03	2.5.1.32,99,41,Database_(Oxford)_2013_May_9_2013_bat014.txt
2.2.2.5,2.2.2.5 Placenes,77,1,Data_Brief_2015_Nov_6_5_846-851.txt
2.1.6.3,"2.1.6.3 Tetraethyl 3,4-dichlorophenethoxymethylene...",139,1,Data_Brief_2016_Jul_26_8_1157-1167.txt
1.5.1.6,...le from MaxQuant was loaded into Perseus (version 1.5.1.6). The matrix was reduced following a stand...,53,71,PMC5344218.txt
5.51.2.179,"...J Kor Soc Fish Technol 51 179 187 10.3796/ksft.2015.51.2.179 Shin HO, Hoe MA, Heo G (2015) The effec...",111,162,Dev_Reprod_2016_Mar_20(1)_23-29.txt
3.17.3.199,...nalysis Dev Reprod 2013 17 199 205 10.12717/DR.2013.17.3.199 25949134,326,70,PMC5270612.txt
2.4.1.45,"...EC:2.7.1.91); UGT8, UDP glycosyltransferase 8 (EC:2.4.1.45); EC 3.1.4.41, SM phosphodiesterase D",82,2052,Diabetes_2012_Aug_17_61(8)_2166-2175.txt
1.35.4.364,...33-6087Korean Diabetes Association 10.4093/dmj.2011.35.4.364Original ArticleEffects of Aerobic Exerc...,3,110,Diabetes_Metab_J_2011_Aug_31_35(4)_364-373.txt
1.35.6.567,...33-6087Korean Diabetes Association 10.4093/dmj.2011.35.6.567ReviewCosts of Diabetes Mellitus in Kore...,3,110,Diabetes_Metab_J_2011_Dec_26_35(6)_567-570.txt
2.36.2.116,...33-6087Korean Diabetes Association 10.4093/dmj.2012.36.2.116EditorialLatent Autoimmune Diabetes in A...,3,126,Diabetes_Metab_J_2012_Apr_17_36(2)_116-119.txt
4.38.1.25,...33-6087Korean Diabetes Association 10.4093/dmj.2014.38.1.25ReviewComplicationsCurrent Status of Diab...,3,126,Diabetes_Metab_J_2014_Feb_19_38(1)_25-31.txt
5.39.3.240,...33-6087Korean Diabetes Association 10.4093/dmj.2015.39.3.240Original ArticleComplicationsThe Relatio...,3,126,Diabetes_Metab_J_2015_Jun_22_39(3)_240-246.txt
5.2.1.1,...lesterol Future Lipidol 2007 2 1 4 10.2217/17460875.2.1.1,139,171,Diabetol_Metab_Syndr_2010_Mar_17_2_15.txt
1.16.2.250,... J Korean Med Sci 2001 16 2 250 2 10.3346/jkms.2001.16.2.250 11306758,114,143,Diagn_Pathol_2016_Feb_9_11_22.txt
2.9.1.20,...gnosis Ann Surg Oncol 2002 9 20 26 10.1245/aso.2002.9.1.20 11829426,170,200,Dig_Dis_Sci_2011_Jun_28_56(6)_1811-1817.txt
2.76.1.103,... 76 :103  - 8 ; http://dx.doi.org/10.1037/0002-9432.76.1.103 ; PMID: 16569133 16569133,187,57,PMC5314885.txt
3.7.6.629,...er Gut and Liver  2013 7 6 629 641 10.5009/gnl.2013.7.6.629 2-s2.0-84888586398 24312702,165,208,Dis_Markers_2015_Nov_18_2015_761908.txt
4.15.12.496,...Prevention  2014 15 12 4969 4976 10.7314/apjcp.2014.15.12.4969 2-s2.0-84904621299 24998573,244,276,Dis_Markers_2016_Jun_15_2016_1427849.txt
2.6.3.1,...ness using Philips Achieva Extended MR Workspace R2.6.3.1. The measurements were performed by two ev...,42,1136,Dis_Markers_2016_Nov_15_2016_5923243.txt
EC 3.2.1.33,"...nsferase (EC 2.4.1.25) and amylo-1,6-glucosidase (EC 3.2.1.33) (Taylor et al., 1975; Nakayama et al....",9,446,Dis_Model_Mech_2012_Nov_26_5(6)_804-811.txt
3.6.1.63,"...ceA) [EC:4.1.3.1] (K01637)	NP_540023.1 (phnM) [EC:3.6.1.63] (K06162)	NP_540859.1 (DPO3B, dnaN) (K023...",166,125,Drug_Des_Devel_Ther_2015_Mar_19_9_1691-1706.txt
2.31.6.357,... Neonatal Netw. 2012 31 6 357 368 10.1891/0730-0832.31.6.357 23134643,243,224,Drugs_Ther_Perspect_2016_Jan_26_32_119-130.txt
3.3.2.2,"...ecies are named as different nominal taxa” (ICZN 23.3.2.2). If strictly applied in the current case,...",92,372,Ecol_Evol_2012_Oct_24_2(10)_2367-2373.txt
2.9.3.2,...est gene diversities and fixation indices Version 2.9.3.2. Available via http://www2.unil.ch/popgen/...,226,101,Ecol_Evol_2013_Jan_10_3(1)_1a-17.txt
4.6.1.3,"...d be delimitated into two groups, NETWORK version 4.6.1.3 was used to determine genealogical relatio...",97,204,Ecol_Evol_2016_Jun_7_6(13)_4435-4444.txt
EC 3.2.1.17,"Lysozymes (EC 3.2.1.17) hydrolyze β(1,4) linkages between N-a...",46,12,eLife_2014_Jun_23_3_e01990.txt
6.18.7.155,...s Neural Computation 18 1555 1576 10.1162/neco.2006.18.7.1555 16764514,456,146,eLife_4_e05979.txt
6.18.7.155,...s Neural Computation 18 1555 1576 10.1162/neco.2006.18.7.1555 16764514,456,146,eLife_4_e05979.txt
6.18.7.155,...s Neural Computation 18 1555 1576 10.1162/neco.2006.18.7.1555 16764514,456,146,eLife_4_e05979.txt
1.17.21.3,"...q 2500, and Illumina Primary Analysis version RTA 1.17.21.3 and Secondary Analysis version CASAVA-1....",580,1074,PMC5293490.txt
3.1.4.513,... cancer Biomark Med 2007 1 513 523 10.2217/17520363.1.4.513 20477371,231,92,EJNMMI_Res_2014_Nov_12_4_60.txt
1.9.2.50,... Society of Electrolyte Metabolism 10.5049/EBP.2011.9.2.50ReviewV2 Receptor Antagonist; Tolvaptan Yi...,3,143,Electrolyte_Blood_Press_2011_Dec_31_9(2)_50-54.txt
6.4.2.66,...rolyte and Blood Pressure Research 10.5049/EBP.2006.4.2.66Review ArticleHypernatemia : Successful Tr...,3,183,Electrolyte_Blood_Press_2006_Nov_30_4(2)_66-71.txt
1.9.2.45,... Society of Electrolyte Metabolism 10.5049/EBP.2011.9.2.45ReviewMechanisms of the Effects of Acidosi...,3,143,Electrolyte_Blood_Press_2011_Dec_31_9(2)_45-49.txt
4.19.13.207,...rveill . 2014 ;19 :20758 . 10.2807/1560-7917.ES2014.19.13.20758 24721540,90,58,PMC5189127.txt
4.7.1.75,10.1586/14760584.7.1.75 18251695,31,16,Emerg_Infect_Dis_2010_Sep_16(9)_1500-1501.txt
2.2.1.1,"...noted, viruses belonging to a subset of the clade 2.2.1.1 group collected during 2009–2011 lacked a ...",49,421,Emerg_Infect_Dis_2013_Jan_19(1)_43-50.txt
2.3.2.1,"...009–2011 were assigned to 3 clades: 1.1 (n = 25), 2.3.2.1 (n = 70), and 2.3.4 (n = 30) (Figure 1; Te...",54,345,Emerg_Infect_Dis_2013_Dec_19(12)_1963-1971.txt
2.2.1.1,...ft progeny of the initially introduced virus) and 2.2.1.1 viruses (which might have emerged because ...,8,366,Emerg_Infect_Dis_2014_Apr_20(4)_542-551.txt
2.3.4.3,"...ubclades, resulting thus far in 2.3.4.1, 2.3.4.2, 2.3.4.3, 2.3.4.4, 2.3.4.5, and 2.3.4.6 (21). In ad...",122,130,Emerg_Infect_Dis_2015_Feb_21(2)_298-304.txt
2.3.2.1,CH/1 RG30	2.3.2.1	40	80	20	20	640	40	160	640	160,59,12,Emerg_Infect_Dis_2014_Apr_20(4)_671-674.txt
2.3.4.4,"...A virus genotypes have generated a range of clade 2.3.4.4 viruses containing different NA subtypes, ...",130,161,PMC5324792.txt
2.3.2.1," 	[2.3.2.1]	[2.3.2.1]	[2.3.4.1, 2.3.4.2]	[1.1]	[unknown]	[2.2.1...",110,14,Emerg_Microbes_Infect_2012_Sep_19_1(9)_e25.txt
2.3.2.1,".... In addition to these glycosylation sites, clade 2.3.2.1 isolates also had another glycosylation si...",70,235,Emerg_Microbes_Infect_2014_Feb_12_3(2)_e11.txt
2.3.2.1,...re similar to and clustered with those of a clade 2.3.2.1 H5N1 virus isolated from a tiger (A/tiger/...,13,92,PMC5180371.txt
4.29.2.202,...X2093-5978Korean Endocrine Society 10.3803/EnM.2014.29.2.202Case ReportRecurrent Hypoglycemia Trigge...,3,138,Endocrinol_Metab_(Seoul)_2014_Jun_26_29(2)_202-205.txt
4.29.2.146,...X2093-5978Korean Endocrine Society 10.3803/EnM.2014.29.2.146Original ArticleGenetic Analysis of Mult...,3,138,Endocrinol_Metab_(Seoul)_2014_Jun_26_29(2)_146-153.txt
5.30.1.110,...78Korean Endocrine Society 2549178110.3803/EnM.2015.30.1.110Case ReportMultiple Myeloma in a Patient...,3,146,Endocrinol_Metab_(Seoul)_2015_Mar_27_30(1)_110-115.txt
6.31.2.245,...X2093-5978Korean Endocrine Society 10.3803/EnM.2016.31.2.245Review ArticleCurrent Challenges in Diab...,3,138,Endocrinol_Metab_(Seoul)_2016_Jun_27_31(2)_245-253.txt
EC 1.14.13.8,genase (EC 1.14.13.8) in the metabolism and mode of action...,1407,9,Environ_Health_Perspect_1996_Mar_104(Suppl_1)_97-106.txt
1.1.1.11,"; I     i:?f.-?  11.1.1.11..1.111.1 'A ,14,",1670,19,Environ_Health_Perspect_1997_Sep_105(9)_928-939.txt
6.6.16.5,"Nily intake (pg/kg/day), 11.0 10.4 3.5 6.6.16.",750,40,Environ_Health_Perspect_1997_Dec_105(12)_1334-1342.txt
EC 2.6.1.2,sured plasma enzymes ALT (EC 2.6.1.2,226,27,Environ_Health_Perspect_1998_Sep_106(9)_597-606.txt
2.4.99.-,..._14	13001	13753	lgt	Prolipoprotein diacylglyceryl	2.4.99.-	Protein fate transferase,170,59,Environ_Microbiol_2008_Aug_10(8)_2111-2123.txt
3.1.1.1,Fluorescent esterase	FEST	3.1.1.1	1,60,27,Environ_Sci_Pollut_Res_Int_2014_Sep_17_21(3)_2165-2177.txt
4.19.4.333,...ev Nutr Food Sci 2014 19 4 333 342 10.3746/pnf.2014.19.4.333 25580399,184,267,PMC5219028.txt
1.44.5.218,... Public Health 2011 44 5 218 225 10.3961/jpmph.2011.44.5.218 22020187,216,244,PMC5219028.txt
4.2.1.-,"...[14], PLP-dependent phenylserine dehydratase [EC  4.2.1.-] [15], and inducible NADP+-dependent d-phe...",8,897,Enzyme_Res_2010_Mar_25_2010_597010.txt
EC 1.15.1.1,"Superoxide dismutases (SOD, EC 1.15.1.1) are a class of enzymes that catalyze ...",8,29,Enzyme_Res_2011_May_29_2011_307464.txt
EC 1.10.3.2,Laccases (benzenediol : oxygen oxidoreductases [EC 1.10.3.2]) are copper-containing enzymes cataly...,8,49,Enzyme_Res_2011_May_31_2011_368525.txt
EC 3.4.22.2,"...commercial crude papain (Vetec Química Fina LTDA, EC 3.4.22.2) with 6000 U·mg−1 of proteolytic activ...",36,196,Enzyme_Res_2015_Jan_1_2015_573721.txt
1.1.1.27,Thus lactate dehydrogenase with the EC number 1.1.1.27 is an oxidoreductase (indicated by the fi...,62,47,Essays_Biochem_2015_Nov_15_59_1-41.txt
4.79.6.100,...ers Soc Psychol 2000 79 1007 1021 10.1037/0022-3514.79.6.1007 Twenge JM (2000) The age of anxiety? B...,228,147,Eur_Child_Adolesc_Psychiatry_2009_Oct_5_18(10)_625-634.txt
4.72.2.467,... Pers Soc Psychol 1997 72 467 475 10.1037/0022-3514.72.2.467 9107012,197,165,Eur_Child_Adolesc_Psychiatry_2012_Nov_13_21(11)_623-633.txt
4.67.1.56,... J Pers Soc Psychol 1994 67 56 68 10.1037/0022-3514.67.1.56 8046584,162,200,Eur_J_Ageing_2011_Mar_11_8(1)_21-30.txt
4.68.5.926,... Pers Soc Psychol 1995 68 926 935 10.1037/0022-3514.68.5.926 7776188,308,167,Eur_J_Ageing_2012_Jun_5_9(2)_155-167.txt
EC 2.7.6.1,"....3 DPG (allosteric inhibitors of PRPP synthetase, EC 2.7.6.1) with a concomitant increase in intrace...",19,232,Eur_J_Appl_Physiol_2010_Dec_17_110(6)_1155-1162.txt
4.53.6.114,"...d Social Psychology  , 1146 1158 10.1037//0022-3514.53.6.1146 3694454",215,208,Eur_J_Dev_Psychol_2016_Jul_3_13(4)_4393-451.txt
4.1.4.7,4.1.4.7 N5-(4-fluorophenyl)-N4-(4-methyl-2-(thioph...,148,1,Eur_J_Med_Chem_2014_Nov_24_87_529-539.txt
4.2.2.3,4.2.2.3 N-2-Propenyl isatoic acid anhydride (12,82,1,Eur_J_Med_Chem_2011_Jun_46(6)_2091-2101.txt
5.1.1.29,"5.1.1.29 3-((6,7-Dimethoxyquinazolin-4-yl)oxy)phen...",187,1,Eur_J_Med_Chem_2016_Apr_13_112_20-32.txt
1.6.1.99,...e Ann Periodontol 2001 6 99 112 10.1902/annals.2001.6.1.99 11887478,132,164,Eur_J_Med_Res_2011_Nov_10_16(11)_514-518.txt
2.10.25.10,...ing of the German Trauma Society (DGU) in Berlin 22.10.25.10.2008,295,106,Eur_J_Med_Res_2010_May_18_15(5)_185-195.txt
2.38.9.696,...f COPD Drugs Today 2002 38 585 600 10.1358/dot.2002.38.9.696535 12582447,91,160,Eur_J_Med_Res_2010_Nov_4_15(Suppl_2)_64-67.txt
4.63.6.101,"...al Psychology , 63 , 1011 –1025 . 10.1037/0022-3514.63.6.1011 1460554",325,82,Eur_J_Psychol_2016_Feb_29_12(1)_49-67.txt
4.88.5.736,"...Psychology , 88 , 736 –748 . doi:.10.1037/0022-3514.88.5.736 15898872",152,85,Eur_J_Psychol_2015_May_29_11(2)_323-334.txt
4.42.4.682,"...Psychology , 42 , 682 –689 . doi:.10.1037/0022-3514.42.4.682 7077525",185,85,Eur_J_Psychol_2015_May_29_11(2)_323-334.txt
3.31.5.431,"...Personality , 31 , 431 –451 . doi:.10.2224/sbp.2003.31.5.431",240,71,Eur_J_Psychol_2015_May_29_11(2)_323-334.txt
6.21.45.303,...ol (ECDC) 2791825716-0069410.2807/1560-7917.ES.2016.21.45.3039130391Rapid CommunicationWidespread Us...,3,161,Euro_Surveill_2016_Nov_10_21(45)_30391.txt
6.21.47.304,...nd Control (ECDC) 161124-110.2807/1560-7917.ES.2016.21.47.304043040422653Author's CorrectionAuthors’...,3,153,PMC5291143.txt
2.8.1.21,...al cancer Swiss Surg 2002 8 21 24 10.1024/1023-9332.8.1.21,338,145,Eur_Radiol_2010_May_21_20(5)_1031-1046.txt
3.18.11.194,... Bone Miner Res 2003 18 1947 1954 10.1359/jbmr.2003.18.11.1947 14606506,175,207,Eur_Radiol_2016_Jan_22_26_3046-3053.txt
3.14.4.662,... Korean J Radiol 2013 14 4 662 672 10.3348/kjr.2013.14.4.662 23901325,296,296,Eur_Radiol_2017_Mar_22_27(1)_345-353.txt
1.10.2.3,...erience Neurosurg Focus 2001 10 E2 10.3171/foc.2001.10.2.3 16749749,169,190,Eur_Spine_J_2010_May_5_19(5)_821-827.txt
EC 3.4.21.4,"...ned from Seromed (Munich, Germany). Trypsin/EDTA (EC 3.4.21.4) was purchased from Sigma (Munich, Ger...",33,302,Evid_Based_Complement_Alternat_Med_2012_Mar_14_2012_509383.txt
3.40.2.55,...ductive Medicine  2013 40 2 55 59 10.5653/cerm.2013.40.2.55 2-s2.0-84882570525 23875160,242,172,Evid_Based_Complement_Alternat_Med_2014_Oct_28_2014_781684.txt
2.17.2.240,...neral Research  2002 17 2 240 248 10.1359/jbmr.2002.17.2.240 2-s2.0-0036155344 11811554,213,286,Evid_Based_Complement_Alternat_Med_2016_Jan_4_2016_2109204.txt
4.23.8.394,...of Wound Care  2014 23 8 394 399 10.12968/jowc.2014.23.8.394 2-s2.0-84907865266 25139597,515,160,PMC5296609.txt
3.6.1.5,... as a model the natural variation of apyrase (E.C.3.6.1.5) in Phlebotomus (Larroussius) ariasi Tonno...,18,492,Evol_Appl_2012_Apr_26_5(3)_293-305.txt
4.78.4.708,... Pers Soc Psychol 2000 78 708 724 10.1037/0022-3514.78.4.708 10794375,87,183,Exp_Brain_Res_2011_Jun_5_211(3-4)_423-428.txt
6.8.6.497,... J Cognit Neurosci 1996 8 497 506 10.1162/jocn.1996.8.6.497,178,180,Exp_Brain_Res_2011_Sep_4_213(2-3)_193-201.txt
3.32.6.150,...um Percept Perf 2006 32 1501 1504 10.1037/0096-1523.32.6.1501,98,109,Exp_Brain_Res_2012_Apr_26_218(1)_91-98.txt
4.36.11.125,...l Psychology 1978 36 11 1251 1258 10.1037/0022-3514.36.11.1251 745035,203,201,Exp_Brain_Res_2013_Aug_5_228(4)_399-410.txt
1.20.1.54,...ociety for Brain and Neural Science 10.5607/en.2011.20.1.54Original ArticleDifferences between Physo...,3,121,Exp_Neurobiol_2011_Mar_31_20(1)_54-65.txt
3.22.4.308,...ociety for Brain and Neural Science 10.5607/en.2013.22.4.308Original ArticleAbsence of Delayed Neuro...,3,134,Exp_Neurobiol_2013_Dec_31_22(4)_308-314.txt
3.22.4.268,...ociety for Brain and Neural Science 10.5607/en.2013.22.4.268Original ArticleThe Effect of Agmatine o...,3,134,Exp_Neurobiol_2013_Dec_31_22(4)_268-276.txt
4.23.1.65,...ociety for Brain and Neural Science 10.5607/en.2014.23.1.65Original ArticleTumor Necrosis Factor-Ass...,3,134,Exp_Neurobiol_2014_Mar_27_23(1)_65-76.txt
5.24.4.325,...ociety for Brain and Neural Science 10.5607/en.2015.24.4.325Review ArticleThe Role of Oxidative Stre...,3,134,Exp_Neurobiol_2015_Dec_12_24(4)_325-340.txt
6.25.3.139,...ociety for Brain and Neural Science 10.5607/en.2016.25.3.139Case ReportToxocara canis-Associated Mye...,3,134,Exp_Neurobiol_2016_Jun_8_25(3)_139-142.txt
4.56.5.441,...ean Neurosurg Soc 56 441 443 2014 10.3340/jkns.2014.56.5.441 25535525,124,207,PMC5228199.txt
3.31.1.76,10.1037/0278-7393.31.1.76 15641906,440,17,F1000Res_2014_Jul_4_3_154.txt
2.6.1.52,"2.6.1.52	0% (0/221,280)	10	0.19",181,2,F1000Res_2016_Feb_23_5_F1000_Faculty_Rev-207.txt
6.21.6.301,10.2807/1560-7917.ES.2016.21.6.30131,809,25,F1000Res_2016_Apr_5_5_568.txt
3.1.1.2,11 and the Epicalc package (version 3.1.1.2,52,37,F1000Res_2016_Jun_16_5_1397.txt
EC 1.1.1.255,"...). The production of mannitol dehydrogenase (MTD, EC 1.1.1.255) was hypothesized to increase the eff...",331,384,FEMS_Microbiol_Rev_2011_Mar_26_35(2)_299-323.txt
4.12.1.87,...stigational drugs 2003 12 1 87 100 10.1517/13543784.12.1.87 12517256,136,187,Fibrogenesis_Tissue_Repair_2016_Feb_13_9_1.txt
2.2.5.5,"... value “before.” CMH, 1-hydroxy-3-methoxycarbonyl-2.2.5.5-tetramethylpyrrolidine; EPR, electron para...",140,903,Food_Sci_Nutr_2014_Nov_17_2(6)_828-839.txt
EC 3.2.1.17,...e glycoside hydrolases which is a type of enzyme (EC 3.2.1.17) that damages bacterial cell walls by ...,14,89,Food_Sci_Nutr_2015_Sep_28_3(5)_453-465.txt
1.30.4.220,".... Individ. Differ.  30 , 220 –237 10.1027/1614-0001.30.4.220",280,188,Front_Aging_Neurosci_2011_Nov_15_3_17.txt
4.9.4.491,"...on . Psychol. Aging  9 , 491 –512 10.1037/0882-7974.9.4.491 7893421",287,209,Front_Aging_Neurosci_2011_Nov_15_3_17.txt
4.17.1.85,10.1037/0882-7974.17.1.85 11931290,241,17,Front_Aging_Neurosci_2013_Sep_12_5_46.txt
4.23.2.461,10.1037/0882-7974.23.2.461 18573020,191,17,Front_Aging_Neurosci_2014_Jan_16_5_101.txt
3.16.2.71,10.5223/pghn.2013.16.2.71 24010110,115,17,Front_Aging_Neurosci_2014_Jun_16_6_127.txt
4.20.4.542,10.1037/0882-7974.20.4.542 16420130,493,17,Front_Aging_Neurosci_2014_Jun_24_6_120.txt
4.7.2.290,"7 , 290 –298 .10.1037/0882-7974.7.2.290 1610518",384,31,Front_Aging_Neurosci_2014_Dec_17_6_338.txt
4.6.3.371,"6 , 371 –383 . 10.1037/0882-7974.6.3.371 1930754",333,32,Front_Aging_Neurosci_2015_Feb_18_7_11.txt
2.8.2.250,250 –255 . 10.1037/1528-3542.8.2.250 18410198,250,28,Front_Aging_Neurosci_2015_Aug_6_7_143.txt
5.25.4.30,"25 , 30 –37 . 10.7748/nop2013.05.25.4.30.e429 23789241",191,32,Front_Aging_Neurosci_2016_Apr_21_8_87.txt
4.17.2.299,"17 , 299 –320 . 10.1037/0882-7974.17.2.299 12061414",222,33,Front_Aging_Neurosci_2016_Apr_26_8_89.txt
3.25.6.157,"25 , 1579 –1594 . 10.1037/0096-1523.25.6.1579",490,35,Front_Aging_Neurosci_2016_Jun_30_8_164.txt
4.17.4.677,677 –689 . 10.1037/0882-7974.17.4.677 12507363,342,28,Front_Aging_Neurosci_2016_Aug_29_8_204.txt
4.20.4.695,"20 , 695 –709 . 10.1037/0882-7974.20.4.695 16420143",347,33,Front_Aging_Neurosci_2016_Nov_23_8_278.txt
3.22.1.14,"22 , 14 –19 . 10.1027/0269-8803.22.1.14",321,31,PMC5303733.txt
4.4.3.339,"4 , 339 –345 . 10.1037/0882-7974.4.3.339 2803627",474,32,PMC5306139.txt
4.99.3.546,"... . Behav. Neurosci. 99 , 546 –554 10.1037/0735-7044.99.3.546 2956971",199,261,Front_Behav_Neurosci_2010_Apr_5_4_9.txt
4.21.3.483,10.1037/0882-7974.21.3.483 16953711,161,17,Front_Behav_Neurosci_2013_Dec_18_7_203.txt
5.22.2.235,10.1037/0894-4105.22.2.235 18331166,232,17,Front_Behav_Neurosci_2014_Sep_2_8_272.txt
3.29.1.78,"...m. Behav. Process . 29 , 78 –83 . 10.1037/0097-7403.29.1.78 12561135",81,236,Front_Behav_Neurosci_2015_Mar_12_9_60.txt
3.1.3.1,"Cysteamine-S-phosphate	3.1.3.1	JLM_162926b,c,d,e",66,24,Front_Bioeng_Biotechnol_2014_Dec_10_2_68.txt
2.3.2.14,2.3.2.14		Insignificant E-value,74,2,Front_Bioeng_Biotechnol_2014_Dec_10_2_68.txt
1.4.3.3,1.4.3.3	Cre02.g096350.t1.3f,113,2,Front_Bioeng_Biotechnol_2014_Dec_10_2_68.txt
1.4.2.85,"4 , 85 –87 . 10.15283/ijsc.2011.4.2.85 24298339",103,31,Front_Cell_Dev_Biol_2014_Aug_13_2_36.txt
3.15.4.369,10.1179/joc.2003.15.4.369 12962365,137,16,Front_Cell_Infect_Microbiol_2014_Jul_29_4_101.txt
EC 2.4.1.17,"...us compounds, such as UDP-glucuronyltransferases (EC 2.4.1.17), are expressed in microsomes of the b...",104,241,Front_Cell_Neurosci_2014_Oct_27_8_340.txt
1.14.7.858,"...ug News Perspect . 14 , 412 –420 . 10.1358/dnp.2001.14.7.858424 12813584",423,117,Front_Cell_Neurosci_2015_Apr_8_9_108.txt
5.8.1.99,"8 , 99 –105 . 10.15283/ijsc.2015.8.1.99 26019759",206,32,Front_Cell_Neurosci_2016_Jan_6_9_497.txt
EC 3.1.1.3,"...ipozyme® CALB L, lipase B of C. antarctica (CALB, EC 3.1.1.3, 19.1 U/mg protein; 7.50 mg protein/ml)...",41,52,Front_Chem_2014_Aug_26_2_72.txt
2.9.4.27,"...ed) mode (20 and 200 mm Hg) of iox2 software (iox 2.9.4.27, emka TECHNOLOGIES USA) before data colle...",35,250,Front_Chem_2014_Oct_13_2_90.txt
6.18.6.131,".... Neural Comput.  18 , 1318 –1348 10.1162/neco.2006.18.6.1318 16764506",255,209,Front_Comput_Neurosci_2010_Dec_31_4_156.txt
3.19.6.126,"...ercept. Perform.  19 , 1266 –1277 10.1037/0096-1523.19.6.1266 8294891",187,201,Front_Comput_Neurosci_2011_Jul_13_5_33.txt
6.8.5.979,"8 , 979 –1001 10.1162/neco.1996.8.5.979 8697231",491,31,Front_Comput_Neurosci_2012_Feb_16_6_4.txt
3.21.5.117,10.1037/0096-1523.21.5.1174 7595246,196,17,Front_Comput_Neurosci_2013_Sep_3_7_120.txt
3.31.1.145,10.1037/0096-1523.31.1.145 15709869,239,17,Front_Comput_Neurosci_2013_Sep_18_7_127.txt
5.7.2.307,10.1162/neco.1995.7.2.307 8974733,401,17,Front_Comput_Neurosci_2014_Feb_4_8_8.txt
3.30.1.98,10.1037/0278-7393.30.1.98 14736299,74,17,Front_Comput_Neurosci_2014_Oct_14_8_129.txt
2.4.4.352,".... Cogn. Neurosci . 4 , 352 –374 . 10.1162/jocn.1992.4.4.352 23968129",261,247,Front_Comput_Neurosci_2015_Feb_10_9_5.txt
2.2.1.1,2.2.1.1. Location of coincident input,58,1,Front_Comput_Neurosci_2016_Jul_22_10_76.txt
EC 3.4.24.25,"... is metabolized by the zinc metalloendopeptidase, EC 3.4.24.25 (EP24.15) (Figure 2). EP24.15, also c...",41,84,Front_Endocrinol_(Lausanne)_2013_Jul_8_4_83.txt
5.7.4.464,"...y . Neuropsychology  7 , 464 –475 10.1037/0894-4105.7.4.464",202,155,Front_Evol_Neurosci_2010_Dec_30_2_110.txt
4.99.1.151,".... Behav. Neurosci.  99 , 151 –161 10.1037/0735-7044.99.1.151 4041227",142,226,Front_Evol_Neurosci_2011_Dec_22_3_10.txt
3.23.1.31,"23 , 31 –43 10.1037/0097-7403.23.1.31 9008861",373,29,Front_Evol_Neurosci_2012_Apr_9_4_6.txt
5.16.2.132,10.1037/0894-4105.16.2.132 11949704,599,17,Front_Genet_2014_Apr_23_5_88.txt
2.14.11.702,10.7314/APJCP.2012.14.11.7029 24377644,331,18,Front_Genet_2014_Dec_23_5_444.txt
1.2.6.7,1.2.6.7	Mad-like factors,200,1,Front_Genet_2016_Apr_5_7_42.txt
6.8.6.551,".... J. Cogn. Neurosci. 8 , 551 –565 10.1162/jocn.1996.8.6.551",143,170,Front_Hum_Neurosci_2009_Nov_30_3_56.txt
3.32.1.89,"...ol. Learn Mem. Cogn. 32 , 89 –100 10.1037/0278-7393.32.1.89 16478343",340,209,Front_Hum_Neurosci_2010_Jan_8_3_68.txt
4.35.12.847,"...Pers. Soc. Psychol. 35 , 847 –862 10.1037/0022-3514.35.12.847",258,136,Front_Hum_Neurosci_2010_Oct_1_4_168.txt
3.1.4.442,"... Hum. Learn. Mem.  104 , 442 –452 10.1037/0278-7393.1.4.442",165,166,Front_Hum_Neurosci_2011_Aug_22_5_86.txt
3.23.2.259,"23 , 259 –278 10.1037/0278-7393.23.2.259",258,31,Front_Hum_Neurosci_2012_Feb_14_6_17.txt
2.7.4.838,10.1037/1528-3542.7.4.838 18039053,648,17,Front_Hum_Neurosci_2012_Mar_19_6_52.txt
4.4.2.217,10.1037/0882-7974.4.2.217 2789749,140,17,Front_Hum_Neurosci_2012_Mar_27_6_63.txt
4.16.2.240,10.1037/0882-7974.16.2.240 11405312,226,17,Front_Hum_Neurosci_2012_Apr_17_6_90.txt
2.8.2.232,10.1037/1528-3542.8.2.232 18410197,247,17,Front_Hum_Neurosci_2012_May_4_6_122.txt
3.31.1.62,10.1037/0096-1523.31.1.62 15709863,276,17,Front_Hum_Neurosci_2012_Jun_7_6_164.txt
3.34.2.376,10.1037/0096-1523.34.2.376 18377177,196,17,Front_Hum_Neurosci_2012_Apr_18_6_86.txt
4.76.1.72,10.1037/0022-3514.76.1.72 9972554,159,17,Front_Hum_Neurosci_2012_Aug_8_6_218.txt
6.18.7.111,10.1162/jocn.2006.18.7.1112 16839285,516,17,Front_Hum_Neurosci_2012_Nov_7_6_304.txt
4.54.6.106,10.1037/0022-3514.54.6.1063 3397865,348,17,Front_Hum_Neurosci_2013_Apr_11_7_133.txt
5.16.1.69,"16 , 69 –83 10.1515/REVNEURO.2005.16.1.69 15810655",148,33,Front_Hum_Neurosci_2013_Jun_6_7_264.txt
4.51.6.117,10.1037/0022-3514.51.6.1173 3806354,160,17,Front_Hum_Neurosci_2013_Jun_19_7_274.txt
4.85.3.499,10.1037/0022-3514.85.3.499 14498785,183,17,Front_Hum_Neurosci_2013_Jul_8_7_330.txt
3.21.4.719,10.1037/0096-1523.21.4.719 7643045,420,17,Front_Hum_Neurosci_2013_Jul_29_7_397.txt
2.1.1.25,"1 , 25 –37 10.1037/1528-3542.1.1.25 12894809",569,28,Front_Hum_Neurosci_2013_Jul_30_7_428.txt
2.36.5.585,10.5535/arm.2012.36.5.585 23185722,254,16,Front_Hum_Neurosci_2013_Aug_14_7_449.txt
3.29.3.713,10.1037/0096-1523.29.3.713 12848335,306,17,Front_Hum_Neurosci_2013_Sep_25_7_597.txt
5.1.79.136,10.1076/jcen.25.1.79.13630 12607174,318,15,Front_Hum_Neurosci_2013_Oct_7_7_643.txt
3.34.2.399,399 –407 10.1037/0278-7393.34.2.399 18315414,572,26,Front_Hum_Neurosci_2013_Oct_24_7_668.txt
3.22.3.696,10.1037/0278-7393.22.3.696 8656152,257,17,Front_Hum_Neurosci_2013_Nov_11_7_763.txt
2.55.3.795,10.2466/pms.1982.55.3.795 7162915,242,16,Front_Hum_Neurosci_2013_Dec_10_7_836.txt
2.1.47.239,10.1076/iceh.52.1.47.23922 14768969,231,15,Front_Hum_Neurosci_2014_Jan_6_7_929.txt
6.18.9.157,10.1162/jocn.2006.18.9.1570 16989556,182,17,Front_Hum_Neurosci_2014_Jan_30_8_21.txt
4.83.6.128,10.1037/0022-3514.83.6.1281 1250081,258,17,Front_Hum_Neurosci_2014_May_21_8_330.txt
3.22.2.278,10.1037//0096-1523.22.2.278 8934844,95,18,Front_Hum_Neurosci_2014_Aug_1_8_576.txt
4.86.1.162,10.1037/0022-3514.86.1.162 14717634,181,17,Front_Hum_Neurosci_2014_Oct_10_8_769.txt
3.18.5.915,"...earn. Mem. Cogn . 18 , 915 –930 . 10.1037/0278-7393.18.5.915 1402716",268,178,Front_Hum_Neurosci_2014_Oct_31_8_878.txt
3.17.2.520,"17 , 520 –538 . 10.1037//0096-1523.17.2.520 1830090",232,34,Front_Hum_Neurosci_2014_Nov_14_8_920.txt
4.93.6.927,"93 , 927 –939 . 10.1037/0022-3514.93.6.927 1807284",429,33,Front_Hum_Neurosci_2014_Dec_11_8_967.txt
2.2.2.1,2.2.2.1. Working memory measures. Two sub-scales f...,45,1,Front_Hum_Neurosci_2015_Feb_5_9_37.txt
3.76.1.255,"76 , 255 –258 . 10.2466/pms.1993.76.1.255 8451135",187,32,Front_Hum_Neurosci_2015_Feb_18_9_77.txt
5.14.3.341,"14 , 341 –352 . 10.1037/0894-4105.14.3.341 10928737",295,33,Front_Hum_Neurosci_2015_Apr_7_9_175.txt
4.6.2.99,"6 , 99 –116 . 10.1162/jocn.1994.6.2.99 23962364",322,31,Front_Hum_Neurosci_2015_Apr_10_9_185.txt
3.70.4.589,".... Educ. Psychol . 70 , 589 –594 . 10.1037/0022-0663.70.4.589 701597",260,220,Front_Hum_Neurosci_2015_Apr_21_9_202.txt
3.28.6.127,10.1037/0096-1523.28.6.1275 12542127,432,17,Front_Hum_Neurosci_2015_May_12_9_269.txt
4.76.2.284,284 –304 . 10.1037/0022-3514.76.2.284 10074710,785,28,Front_Hum_Neurosci_2015_May_21_9_266.txt
6.18.6.911,911 –922 . 10.1162/jocn.2006.18.6.911 16839299,298,28,Front_Hum_Neurosci_2015_Jul_22_9_423.txt
4.76.6.893,"76 , 893 –910 . 10.1037/0022-3514.76.6.893 10402679",93,33,Front_Hum_Neurosci_2015_Aug_5_9_446.txt
3.27.3.600,"27 , 600 –621 . 10.1037//0096-1523.27.3.600 11424648",132,34,Front_Hum_Neurosci_2014_Sep_11_8_724.txt
1.28.3.279,"28 , 279 –296 . 10.1525/mp.2011.28.3.279",199,31,Front_Hum_Neurosci_2015_Aug_26_9_466.txt
4.56.5.815,"56 , 815 –822 . 10.1037/0022-3514.56.5.815 2724069",172,33,Front_Hum_Neurosci_2015_Sep_23_9_518.txt
3.12.4.549,"12 , 549 –563 . 10.1037/0096-1523.12.4.549",199,33,Front_Hum_Neurosci_2015_Oct_6_9_529.txt
6.18.8.138,"18 , 1380 –1393 . 10.1162/jocn.2006.18.8.1380 16859422",273,35,Front_Hum_Neurosci_2015_Oct_28_9_596.txt
6.18.9.158,"18 , 1586 –1594 . 10.1162/jocn.2006.18.9.1586 16989558",237,35,Front_Hum_Neurosci_2015_Nov_18_9_618.txt
3.27.3.595,595 –613 . 10.1037/0278-7393.27.3.595 1139466,425,28,Front_Hum_Neurosci_2015_Nov_24_9_642.txt
4.95.1.197,197 –211 . 10.1037/0022-3514.95.1.197 18605860,445,28,Front_Hum_Neurosci_2016_Feb_16_10_44.txt
6.83.1.143,"83 , 143 –152 . 10.2466/pms.1996.83.1.143 8873187",402,32,Front_Hum_Neurosci_2015_Sep_30_9_525.txt
4.54.6.106,"54 , 1063 –1070 . 10.1037/0022-3514.54.6.1063 339786",197,35,Front_Hum_Neurosci_2016_Jul_12_10_352.txt
3.9.1.82,10.1037/0278-7393.9.1.82,455,17,Front_Hum_Neurosci_2016_Jul_15_10_346.txt
3.30.5.110,1106 –1118 . 10.1037/0278-7393.30.5.1106 15355139,134,30,Front_Hum_Neurosci_2016_Oct_25_10_538.txt
1.41.4.225,"41 , 225 –235 10.4167/jbv.2011.41.4.225",224,30,Front_Immunol_2013_May_6_4_97.txt
6.9.13.230,10.1517/14656566.9.13.2305 18710355,174,16,Front_Immunol_2013_Jul_23_4_175.txt
4.5.6.851,...ev Vaccines  (2006 ) 5 (6 ):851 –7 10.1586/14760584.5.6.851 17184222,163,154,Front_Immunol_2013_Dec_2_4_407.txt
6.67.10.110,...Periodontol  (1996 ) 67 :1103 –13 .10.1902/jop.1996.67.10.1103 8910829,386,132,Front_Immunol_2014_Nov_19_5_584.txt
5.76.11.184,...dontol  (2005 ) 76 (11 ):1849 –55 .10.1902/jop.2005.76.11.1849 16274303,215,217,Front_Immunol_2015_May_5_6_214.txt
5.15.3.351,"... . Neuropsychology  15 , 351 –360 10.1037/0894-4105.15.3.351 11499990",20,191,Front_Integr_Neurosci_2011_Jun_13_5_26.txt
3.32.3.329,10.1037/0097-7403.32.3.329 16834500,153,17,Front_Integr_Neurosci_2012_Dec_3_6_111.txt
3.15.1.54,10.1037/0097-7403.15.1.54 2926335,191,17,Front_Integr_Neurosci_2014_Jan_9_7_103.txt
3.21.34.214,10.1027/0269-8803.21.34.214,468,17,Front_Integr_Neurosci_2014_Jan_16_8_1.txt
3.20.3.555,10.1037//0096-1523.20.3.555,205,18,Front_Integr_Neurosci_2015_Jan_6_8_96.txt
5.13.1.19,...stinal Res  (2015 ) 13 (1 ):19 –26 .10.5217/ir.2015.13.1.19 25691840,231,151,Front_Med_(Lausanne)_2016_May_30_3_24.txt
EC 4.1.2.13,"...yzed by fructose 1,6-bisphosphate (FBP) aldolase (EC 4.1.2.13) and 2-keto-3-deoxy-6-phosphogluconate...",149,86,Front_Microbiol_2011_Aug_1_2_165.txt
6.41.8.173,"41 , 1733 –1748 10.4319/lo.1996.41.8.1733",430,31,Front_Microbiol_2012_Feb_28_3_72.txt
1.36.8.185,"36 , 1851 –1864 10.4319/lo.1991.36.8.1851",280,31,Front_Microbiol_2012_Jun_7_3_204.txt
6.5.4.433,10.1517/14622416.5.4.433 15165179,248,16,Front_Microbiol_2013_Sep_12_4_254.txt
1.2.2.3,0.1.2.2.3	gp23		1	AF264137	Upland soils,85,3,Front_Microbiol_2014_Feb_18_5_34.txt
4.94.6.561,10.1094/PHYTO.2004.94.6.561 18943480,206,18,Front_Microbiol_2014_Jul_18_5_360.txt
6.41.8.161,10.4319/lo.1996.41.8.1610,311,15,Front_Microbiol_2014_Sep_5_5_453.txt
1.56.5.157,"...imnol. Oceanogr . 56 , 1577 –1586 . 10.4319/lo.2011.56.5.1577",183,179,Front_Microbiol_2014_Oct_17_5_532.txt
2.7.1.159,...80314	0.31	Inositol-tetrakisphosphate 1-kinase	EC:2.7.1.159; EC:2.7.1; EC:2.7.1.134; EC:3.1.3	2112	X...,111,67,Front_Microbiol_2015_Jul_14_6_526.txt
2.15.11.111,"15 , 1119 –1127 . 10.1094/MPMI.2002.15.11.1119 12423017",180,35,Front_Microbiol_2015_Oct_8_6_1096.txt
EC 1.2.7.7,... also showed that ketoisovalerate oxidoreductase (EC 1.2.7.7) was enriched in the 50FeS condition co...,250,437,Front_Microbiol_2016_Jan_6_6_1481.txt
4.11.8.109,1099 –1115 . 10.1517/13543784.11.8.1099,603,29,Front_Microbiol_2016_Jan_12_6_1444.txt
3.74.6.844,844 –848 . 10.1902/jop.2003.74.6.844 12886995,327,27,Front_Microbiol_2016_Feb_9_7_53.txt
2.14.2.113,"14 , 65 –78 . 10.7557/2.14.2.1136",194,23,Front_Microbiol_2016_Feb_23_7_170.txt
2.3.2.1,"...rculating in Guangdong province belonged to clade 2.3.2.1, including G3, so we wanted to estimate th...",161,89,Front_Microbiol_2016_May_6_7_635.txt
4.14.6.277,277 –288 . 10.4110/in.2014.14.6.277,191,26,Front_Microbiol_2016_May_24_7_776.txt
5.25.8.111,1116 –1125 . 10.1592/phco.2005.25.8.1116 16207103,276,30,Front_Microbiol_2016_Jun_7_7_855.txt
5.20.48.300,20 :30078 . 10.2807/1560-7917.ES.2015.20.48.30078 26675545,204,37,Front_Microbiol_2016_Jun_22_7_974.txt
EC 4.2.2.11,"...ties, the first type is specific toward G blocks (EC 4.2.2.11), the second type specific toward M bl...",18,628,Front_Microbiol_2016_Jul_19_7_1120.txt
2.7.1.23,NADP+ → NAD+ Kinase (nadK)	2.7.1.23	nadK	+	+	+	+	+	+	+,175,28,Front_Microbiol_2016_Aug_2_7_1166.txt
4.17.4.404,404 –413 . 10.1094/MPMI.2004.17.4.404 15077673,232,28,Front_Microbiol_2016_Sep_21_7_1495.txt
EC 1.3.1.9,"...enes, enoyl-acyl carrier-protein reductase (fabK, EC 1.3.1.9) was identified as being dispensable du...",104,350,Front_Microbiol_2016_Sep_28_7_1531.txt
EC 3.2.1.20,"GH31	α-glucosidases (EC 3.2.1.20), simple sugar using	Kellner et al., 2...",51,22,Front_Microbiol_2016_Nov_29_7_1897.txt
1.7.99.4,"...nitrite oxidoreductase, beta subunit [EC 1.7.5.1; 1.7.99.4]; narJ, nitrate reductase delta subunit; ...",137,404,Front_Microbiol_2016_Nov_30_7_1902.txt
4.1.3.24,165 –173 . 10.14719/pst.2014.1.3.24,347,28,PMC5239798.txt
5.31.3.840,1427 –1433 . 10.3305/nh.2015.31.3.8400 2572624,237,28,PMC5288333.txt
EC 1.1.1.366,".../NADPH dependent. In plants, an NAD+/NADH enzyme (EC 1.1.1.366) oxidizing L-idonate to 5-keto-D-gluc...",118,372,PMC5306355.txt
4.19.43.209,10.2807/1560-7917.ES2014.19.43.20941,260,24,PMC5309255.txt
2.3.4.4,"...rtantly, H5N6 is the only subtype among the clade 2.3.4.4 viruses that has caused human infections (...",16,716,PMC5329059.txt
2.1.3.2,"...e evolution of avian influenza A(H5) virus clades 2.1.3.2a, 2.2.1, and 2.3.4 during 2013-2014 . Infl...",215,258,PMC5329059.txt
3.39.1.740,".... Drugs Today (Barc.)  39 , 75 –83 10.1358/dot.2003.39.1.740206 12669110",154,162,Front_Mol_Neurosci_2011_Sep_13_4_22.txt
6.18.4.508,"...J. Cogn. Neurosci.  18 , 508 –521 10.1162/jocn.2006.18.4.508 16768357",113,223,Front_Mol_Neurosci_2011_Nov_9_4_41.txt
1.2.1.20,...pression Console” provided by Affymetrix (version 1.2.1.20). The data were evaluated using the progr...,43,162,PMC5253383.txt
2.6.29.4,...r (2.66 GHz) and 4 GB or RAM running Ubuntu Linux 2.6.29.4-rtai with RTXI version 1.1.2 and a Nation...,23,90,Front_Neural_Circuits_2013_Jan_7_6_111.txt
3.27.3.686,10.1037/0278-7393.27.3.686 11394674,350,17,Front_Neuroinform_2013_Nov_7_7_25.txt
2.1.2.1,"2.1.2.1. Implementation. In (Wang et al., 2011), w...",96,1,Front_Neuroinform_2013_Nov_22_7_27.txt
3.34.4.791,"34 , 791 –808 10.1037/0278-7393.34.4.791 18605869",148,31,Front_Neurol_2012_Jul_26_3_118.txt
2.8.2.89,... J Clin Neurol  (2012 ) 8 :89 –99 .10.3988/jcn.2012.8.2.89 22787491,128,186,Front_Neurol_2015_Feb_6_6_12.txt
3.54.5.129,...Yonsei Med J  (2013 ) 54 :1293 –6 .10.3349/ymj.2013.54.5.1293 23918585,435,155,Front_Neurol_2015_Jul_20_6_155.txt
3.21.5.111,10.1037/0096-1523.21.5.1117,305,17,Front_Neurorobot_2013_Oct_11_7_18.txt
2.5.3.1,2.5.3.1. Experiment 1: random exploration without ...,122,1,Front_Neurorobot_2015_Apr_7_9_1.txt
2.2.1.5,2.2.1.5.3 HRI Categor,318,1,Front_Neurorobot_2016_Oct_3_10_10.txt
3.18.23.121,".... J. Psychophysiol. 18 , 121 –129 10.1027/0269-8803.18.23.121",339,170,Front_Neurosci_2010_Jul_21_4_55.txt
3.18.23.121,".... J. Psychophysiol. 18 , 121 –129 10.1027/0269-8803.18.23.121",275,170,Front_Neurosci_2010_Nov_22_4_182.txt
6.3.5.475,"3 , 475 –483 10.2217/17460816.3.5.475 19890437",120,29,Front_Neurosci_2012_Aug_10_6_114.txt
4.61.3.380,"61 , 380 –391 10.1037/0022-3514.61.3.380 1941510",175,31,Front_Neurosci_2012_Jul_19_6_107.txt
3.20.3.307,10.1525/mp.2003.20.3.307,352,15,Front_Neurosci_2014_Jan_20_7_279.txt
2.20.2.151,10.1525/mp.2002.20.2.151,117,15,Front_Neurosci_2014_Jul_3_8_190.txt
4.84.2.296,10.1037/0022-3514.84.2.296 12585805,237,17,Front_Neurosci_2014_Sep_30_8_308.txt
4.15.2.131,"...v. Neurosci . 15 , 131 –156 . 10.1515/REVNEURO.2004.15.2.131 15202685",358,236,Front_Neurosci_2014_Oct_31_8_327.txt
4.48.5.121,"48 , 1218 –1226 . 10.1037/0022-3514.48.5.1218 3998988",326,35,Front_Neurosci_2015_Jul_14_9_240.txt
3.17.4.105,"17 , 1057 –1074 . 10.1037/0096-1523.17.4.1057 1837297",317,35,Front_Neurosci_2015_Sep_29_9_341.txt
4.67.2.319,"67 , 319 –333 . 10.1037/0022-3514.67.2.319 16487598",234,33,Front_Neurosci_2015_Oct_6_9_346.txt
3.21.1.109,"21 , 109 –127 . 10.1037/0096-1523.21.1.109 7707027",179,33,Front_Neurosci_2015_Aug_5_9_270.txt
5.16.2.595,"16 , 595 –600 . 10.7314/APJCP.2015.16.2.595 25684493",144,34,Front_Neurosci_2015_Nov_23_9_442.txt
3.19.3.165,"19 , 165 –181 . 10.1027/0269-8803.19.3.165",469,33,Front_Neurosci_2016_Mar_1_10_50.txt
3.37.5.603,"37 , 603 –610 . 10.5535/arm.2013.37.5.603 24233579",343,32,Front_Neurosci_2016_Apr_18_10_157.txt
5.11.2.122,"11 , 122 –131 . 10.3988/jcn.2015.11.2.122 25851890",59,32,Front_Neurosci_2016_Jun_7_10_246.txt
4.57.4.249,"57 , 249 –259 . 10.5468/ogs.2014.57.4.249 25105097",189,32,Front_Neurosci_2016_Sep_30_10_435.txt
1.20.1.1,"20 , 1 –17 . 10.5607/en.2011.20.1.1 22110357",896,28,Front_Neurosci_2016_Nov_24_10_541.txt
5.48.4.272,"48 , 229 –233 . 10.5483/BMBRep.2015.48.4.272 25560696",1062,35,Front_Neurosci_2016_Nov_29_10_540.txt
6.18.8.130,"18 , 1304 –1313 . 10.1162/jocn.2006.18.8.1304 1685941",323,35,PMC5300991.txt
5.12.1.3,"12 , 3 –12 . 10.1037/0894-4105.12.1.3 9460730",185,30,PMC5322262.txt
3.11.2.97,...lth Psychol  (1992 ) 11 :97 –100 .10.1037/0278-6133.11.2.97 1582385,131,154,Front_Nutr_2014_Jul_16_1_10.txt
EC 3.1.4.4,"...ospholipase C (EC 3.1.4.3); PLD, phospholipase D (EC 3.1.4.4). Metabolites: AA, arachidonic acid; CD...",33,622,Front_Oncol_2016_Aug_2_6_171.txt
4.46.3.489,...oc Psychol  (1984 ) 46 :489 –502 .10.1037/0022-3514.46.3.489 6707865,327,166,Front_Oncol_2015_Mar_26_5_71.txt
1.7.7.901,...Palliat Nurs  (2001 ) 7 :331 –7 .10.12968/ijpn.2001.7.7.9017 11951401,132,164,Front_Oncol_2015_Apr_27_5_96.txt
4.1.6.779,...ure Oncol  (2005 ) 1 (6 ):779 –86 .10.2217/14796694.1.6.779 16556057,158,139,Front_Oncol_2016_Jun_28_6_164.txt
6.8.6.122,10.1162/neco.1996.8.6.1227 8768393,612,17,Front_Pharmacol_2013_Jun_19_4_77.txt
4.16.12.192,10.1517/13543784.16.12.1921,529,16,Front_Pharmacol_2014_Jun_10_5_120.txt
3.22.2.59,10.5607/en.2013.22.2.59 23833554,112,15,Front_Pharmacol_2014_Sep_2_5_204.txt
2.73.4.210,"...ir. Dis. (Seoul) . 73 , 210 –218 . 10.4046/trd.2012.73.4.210 23166556",100,282,Front_Pharmacol_2015_Jun_3_6_117.txt
EC 2.4.1.-,"...a large glycosyltransferase (GT) 1 family of GTs (EC 2.4.1.-; GT), is a family of membrane-bound pro...",24,116,Front_Pharmacol_2016_Oct_24_7_388.txt
5.9.1.111,53 –57 . 10.5829/idosi.abr.2015.9.1.1114,247,31,PMC5174135.txt
2.6.6.619,10.1517/14728222.6.6.619 12472375,200,16,Front_Physiol_2013_Dec_17_4_361.txt
3.18.11.205,10.1359/jbmr.2003.18.11.2052 14606519,201,17,Front_Physiol_2014_Sep_17_5_313.txt
2.4.2.4,"...ifiable if the system is specified, as in Section 2.4.2.4. We also demonstrated three examples for n...",389,890,Front_Physiol_2016_Mar_24_7_89.txt
3.46.2.141,"46 , 107 –112 . 10.5483/BMBRep.2013.46.2.141 2343311",502,35,Front_Physiol_2016_Sep_29_7_439.txt
1.21.81.1,e_gw1.21.81.1	Sm99301,851,5,Front_Plant_Sci_2012_Feb_7_3_17.txt
EC 3.2.1.15,...ade the host cell wall. Polygalacturonases (PGs) (EC 3.2.1.15) are often the first enzymes secreted ...,101,582,Front_Plant_Sci_2012_Mar_2_3_39.txt
4.17.6.583,"17 , 583 –592 10.1094/MPMI.2004.17.6.583 15195941",48,31,Front_Plant_Sci_2012_Jul_6_3_136.txt
4.17.8.909,10.1094/MPMI.2004.17.8.909 15305612,433,17,Front_Plant_Sci_2012_Sep_28_3_222.txt
1.14.10.114,10.1094/MPMI.2001.14.10.1140 11605953,598,17,Front_Plant_Sci_2012_Oct_5_3_223.txt
EC 4.1.1.17,"...s exhibited homologies to Orn decarboxylase (ODC, EC 4.1.1.17), CuAO, and AT, representing potential...",34,689,Front_Plant_Sci_2012_Oct_26_3_239.txt
EC 3.1.1.-,"...; EC 3.1.1.6); AGME, acetyl glucomannan esterase (EC 3.1.1.- ); AXE, acetyl xylan esterase (EC 3.1.1...",89,77,Front_Plant_Sci_2013_May_21_4_118.txt
3.93.8.976,976 –981 10.1094/PHYTO.2003.93.8.976 18943864,331,27,Front_Plant_Sci_2013_Jun_4_4_171.txt
EC 6.2.1.1,"...l-CoA by PDC, mALDH and acetyl-CoA synthase (ACS, EC 6.2.1.1). When oxygen levels decrease NADH accu...",133,816,Front_Plant_Sci_2013_Jul_23_4_269.txt
EC 4.1.1.1,"...enase (EC 1.1.1.27); PDC, pyruvate decarboxylase (EC 4.1.1.1); ADH, alcohol dehydrogenase (EC 1.1.1....",137,234,Front_Plant_Sci_2013_Jul_23_4_269.txt
EC 4.1.1.19,"...ginine by the enzyme arginine decarboxylase (ADC, EC 4.1.1.19), located mainly in the chloroplast in...",28,221,Front_Plant_Sci_2014_Mar_18_5_95.txt
2.15.12.122,10.1094/MPMI.2002.15.12.1228 12481995,278,17,Front_Plant_Sci_2014_Mar_27_5_114.txt
EC 4.1.1.50,...SAM by S-adenosylmethionine decarboxylase (SAMDC; EC 4.1.1.50). Spd synthase (SPD; EC 2.5.1.16) and ...,26,549,Front_Plant_Sci_2014_May_8_5_182.txt
2.7.7.27,...9: UTP–glucose-1-phosphate uridylyltransferase; EC2.7.7.27: ADP-glucose pyrophosphorylase; EC3.2.1.2...,123,638,Front_Plant_Sci_2014_May_15_5_197.txt
3.40.50.200,"...213 (PANTHER); G3DSA:2.60.120.260 (GENE3D), G3DSA:3.40.50.2000 (GENE3D), PTHR11926:SF15 (PANTHER), S...",112,108,Front_Plant_Sci_2014_Dec_2_5_680.txt
3.80.10.10,"...5810.1	−7.82	−3.16	f-box lrr-repeat protein	G3DSA:3.80.10.10 (GENE3D), PTHR23125 (PANTHER), SSF52047...",182,60,Front_Plant_Sci_2014_Dec_2_5_680.txt
EC 3.2.1.80,"...is accomplished by fructan 1-exohydrolase (1-FEH; EC 3.2.1.80), releasing terminal fructosyl units a...",20,871,Front_Plant_Sci_2015_Sep_17_6_721.txt
3.87.6.752,10.1094/PDIS.2003.87.6.752A,308,17,Front_Plant_Sci_2015_Sep_25_6_772.txt
2.2.1.7,2.2.1.7: comp27284_c0 (0-0-0-4.28),124,1,Front_Plant_Sci_2015_Oct_6_6_819.txt
4.42.2.158,"42 , 158 –166 . 10.5941/MYCO.2014.42.2.158 2507138",392,33,Front_Plant_Sci_2015_Oct_6_6_805.txt
2.45.2.96,96 –101 . 10.5483/BMBRep.2012.45.2.96 22360887,253,29,Front_Plant_Sci_2015_Nov_19_6_1007.txt
5.5.1.6,"...nction and regulatory relationship with Enzyme EC:5.5.1.6 and with flavonoids, a significant downstr...",11,1238,Front_Plant_Sci_2015_Nov_27_6_1027.txt
5.5.1.6,Flavonoid—osa00941	EC:5.5.1.6	sf0315305925	mr1585	Lupulin A	Terpene,102,23,Front_Plant_Sci_2015_Nov_27_6_1027.txt
2.1.1.76,"... were focused on flavonol 3-O-methyltransferase (E2.1.1.76, up-regulated expression, comp37084_c6_se...",70,1034,Front_Plant_Sci_2016_Jan_5_6_1179.txt
4.1.1.28,...ino-acid decarboxylase/DOPA decarboxylase	K01593 (4.1.1.28)	17	0	8,93,69,Front_Plant_Sci_2016_Jan_5_6_1179.txt
EC 2.7.4.6,"...l chaperonin-60, nucleoside diphosphate kinase I (EC 2.7.4.6) (NDPK I), wound responsive protein, an...",99,960,Front_Plant_Sci_2016_Jan_28_7_11.txt
EC 4.1.1.15,"...dase (EC 1.4.3.22); GAD, glutamate decarboxylase (EC 4.1.1.15); NAGK, N-acetylglutamate kinase (EC 2...",20,468,Front_Plant_Sci_2016_Feb_16_7_78.txt
2.4.1.13,...0122.2540.r2.m	2.11	5.00E−05	Sucrose synthase [EC:2.4.1.13]	K00695,132,60,Front_Plant_Sci_2016_Mar_30_7_374.txt
1.1.1.343,"...and 6-phosphogluconate dehydrogenase (EC 1.1.1.44/1.1.1.343; reaction 24, 25). Previously, Williams ...",123,2299,Front_Plant_Sci_2016_Apr_26_7_537.txt
EC 1.11.1.11,"...e (GR, EC 1.6.4.2) and ascorbate peroxidase (APX, EC 1.11.1.11) increased markedly in SbSLSP–overexp...",97,1016,Front_Plant_Sci_2016_Jun_2_7_737.txt
EC 2.5.1.21,"...te synthase (EC 2.5.1.10); SS, squalene synthase (EC 2.5.1.21); SE, squalene epoxidase (EC 1.14.99.7...",25,895,Front_Plant_Sci_2016_Jul_25_7_1094.txt
1.1.1.40,...tolase (EC: 2.2.1.1) and NADP-malic enzyme 4 (EC: 1.1.1.40) showed decreased transcript abundance in...,73,314,Front_Plant_Sci_2016_Jul_26_7_1080.txt
EC 6.3.1.2,"...an be assimilated by glutamine synthetase 2 (GS2; EC 6.3.1.2), with the formed glutamine being furth...",30,824,Front_Plant_Sci_2016_Aug_3_7_1151.txt
2.7.2.3,"... carboxylase (EC: 4.1.1.39, spot 14), kinase (EC: 2.7.2.3, spots 2 and 34), hexose diphosphatase (EC...",169,430,Front_Plant_Sci_2016_Aug_17_7_1211.txt
1.36.8.155,1555 –1577 . 10.4319/lo.1991.36.8.1555,223,28,Front_Plant_Sci_2016_Aug_18_7_1223.txt
EC 6.2.1.12,"...ted to p-coumaroyl-CoA by 4-coumaroyl CoA ligase (EC 6.2.1.12, 5 unigenes). Further, Chalcone syntha...",83,569,Front_Plant_Sci_2016_Oct_27_7_1610.txt
4.99.1.1,"...ep. By contrast, we found that ferrochelatase (EC:4.99.1.1; Pp1s38_333V6), catalyzing protoheme (hem...",164,644,Front_Plant_Sci_2016_Nov_4_7_1661.txt
EC 2.1.1.41,"...); (5) Cycloartenol C-24 methyltransferase (SMT1, EC 2.1.1.41); (6) Sterol-4a-methyl oxidase (SMO, E...",22,1119,PMC5167740.txt
1.14.13.-,1.14.13.-	K00492	4	2	2,224,1,PMC5292412.txt
4.4.1.5,Glyoxalase I (EC: 4.4.1.5): The assay mixture contained 100 mM K-P b...,54,19,PMC5300965.txt
EC 2.5.1.19,"...rgely described. By inhibiting the EPSP synthase (EC 2.5.1.19), glyphosate-based herbicides prevent ...",16,206,PMC5314154.txt
5.17.3.402,...ropsychology  (2003 ) 17 :402 –9 .10.1037/0894-4105.17.3.402 12959506,359,201,Front_Psychiatry_2015_Apr_21_6_53.txt
6.18.2.141,... Neurosci  (2006 ) 18 (2 ):141 –5 .10.1176/jnp.2006.18.2.141 16720789,69,73,Front_Psychiatry_2016_May_13_7_85.txt
5.12.3.349,... Investig  (2015 ) 12 (3 ):349 –55 .10.4306/pi.2015.12.3.349 26207128,329,151,Front_Psychiatry_2016_Aug_26_7_149.txt
5.22.1.100,...ychology  (2008 ) 22 (1 ):100 –9 .10.1037/0894-4105.22.1.100 18211159,322,166,PMC5256117.txt
3.27.1.178,.... Percept. Perform.  27  178 –194 10.1037/0096-1523.27.1.178 11248932,216,194,Front_Psychol_2011_Jul_15_2_169.txt
3.10.2.276,"... Percept. Perform.  10 , 276 –291 10.1037/0096-1523.10.2.276 6232345",200,211,Front_Psychol_2010_Sep_29_1_145.txt
3.31.6.147,"...ercept. Perform.  31 , 1476 –1492 10.1037/0096-1523.31.6.1476 16366803",215,180,Front_Psychol_2010_Dec_20_1_217.txt
4.18.3.443,"...s . Psychol. Aging  18 , 443 –460 10.1037/0882-7974.18.3.443 14518807",237,163,Front_Psychol_2011_Sep_15_2_228.txt
4.85.4.756,"...ers. Soc. Psychol.  85 , 756 –767 10.1037/0022-3514.85.4.756 14561128",306,220,Front_Psychol_2012_Jan_2_2_393.txt
6.18.11.185,"... Cogn. Neurosci.  18 , 1850 –1862 10.1162/jocn.2006.18.11.1850 17069476",255,237,Front_Psychol_2012_Jan_9_2_397.txt
5.7.5.889,"...e . Neural. Comput.  7 , 889 –904 10.1162/neco.1995.7.5.889 7584891",210,127,Front_Psychol_2012_Jan_10_2_395.txt
4.61.1.115,"61 , 115 –121 10.1037/0022-3514.61.1.115 1890582",174,31,Front_Psychol_2012_Feb_13_3_20.txt
3.27.1.92,"27 , 92 –114 10.1037/0096-1523.27.1.92 11248943",182,30,Front_Psychol_2012_Feb_28_3_42.txt
2.6.2.215,"6 , 215 –223 10.1037/1528-3542.6.2.215 16768554",108,30,Front_Psychol_2012_Apr_17_3_107.txt
3.21.1.109,"21 , 109 –127 10.1037/0096-1523.21.1.109 7707027",208,31,Front_Psychol_2012_Apr_27_3_113.txt
3.10.4.680,"10 , 680 –698 10.1037/0278-7393.10.4.680",227,31,Front_Psychol_2012_Apr_27_3_113.txt
3.24.2.397,"24 , 397 –412 10.1037/0096-1523.24.2.397 9606108",310,31,Front_Psychol_2012_May_9_3_136.txt
3.16.2.415,"16 , 415 –428 10.1037/0096-1523.16.2.415 2142209",282,31,Front_Psychol_2012_May_17_3_142.txt
3.27.2.387,"27 , 387 –394 10.1037/0096-1523.27.2.387 11318054",224,31,Front_Psychol_2012_Jun_11_3_192.txt
3.4.4.335,"4 , 335 –370 10.1515/cogl.1993.4.4.335",136,30,Front_Psychol_2012_Aug_28_3_300.txt
4.80.1.136,"80 , 136 –151 10.1037/0022-3514.80.1.136 11195886",227,31,Front_Psychol_2012_Aug_31_3_311.txt
5.20.2.133,"20 , 133 –143 10.1037/0894-4105.20.2.133 16594774",253,31,Front_Psychol_2012_Aug_31_3_311.txt
6.18.10.163,"18 , 1631 –1643 10.1162/jocn.2006.18.10.1631 17014368",179,33,Front_Psychol_2012_Sep_18_3_333.txt
4.80.6.101,"80 , 1011 –1027 10.1037/0022-3514.80.6.1011 11414368",228,33,Front_Psychol_2012_Oct_8_3_394.txt
3.33.3.327,"33 , 327 –338 10.1037/0097-7403.33.3.327 17620030",85,31,Front_Psychol_2012_Jul_16_3_242.txt
3.31.6.147,"31 , 1477 –1491 10.1037/0278-7393.31.6.1477 16393058",480,33,Front_Psychol_2012_Oct_25_3_436.txt
3.14.1.36,"14 , 36 –42 10.1037/0097-7403.14.1.36",241,29,Front_Psychol_2012_Nov_7_3_473.txt
3.33.1.21,"33 , 21 –31 10.1037/0097-7403.33.1.21 17227192",230,29,Front_Psychol_2012_Nov_8_3_483.txt
2.5.4.379,"5 , 379 –395 10.1037/1528-3542.5.4.379 16366743",189,30,Front_Psychol_2012_Nov_30_3_520.txt
5.17.3.439,"17 , 439 –450 10.1037/0894-4105.17.3.439 12959510",192,31,Front_Psychol_2012_Dec_21_3_572.txt
5.7.4.433,"7 , 433 –445 10.1162/jocn.1995.7.4.433",319,30,Front_Psychol_2013_Jan_18_3_561.txt
3.7.1.1,"7 , 150 –164 10.1037/0097-7403.7.1.1",285,30,Front_Psychol_2013_Jan_25_4_5.txt
4.76.6.988,"76 , 988 –1007 10.1037/0022-3514.76.6.988 10402682",240,32,Front_Psychol_2013_Feb_7_4_41.txt
1.27.4.218,"27 , 218 –228 10.1027/1614-0001.27.4.218",496,31,Front_Psychol_2013_Feb_4_4_1.txt
3.14.4.218,"14 , 218 –225 10.1027//0269-8803.14.4.218",282,32,Front_Psychol_2013_Feb_12_4_47.txt
4.75.2.420,"75 , 420 –435 10.1037/0022-3514.75.2.420 9731317",254,31,Front_Psychol_2012_Sep_28_3_352.txt
4.90.2.288,10.1037/0022-3514.90.2.288 16536652,530,17,Front_Psychol_2013_Feb_28_4_52.txt
4.84.4.822,"84 , 822 –848 10.1037/0022-3514.84.4.822 12703651",84,31,Front_Psychol_2013_Mar_1_4_99.txt
3.29.3.347,"29 , 347 –361 10.1037/0278-7393.29.3.347 12776746",399,31,Front_Psychol_2013_Mar_22_4_130.txt
4.70.3.614,"70 , 614 –636 10.1037/0022-3514.70.3.614 8851745",151,31,Front_Psychol_2013_Apr_24_4_184.txt
2.4.4.354,"4 , 354 –363 10.1037/1528-3542.4.4.354 15571434",341,30,Front_Psychol_2013_Apr_26_4_211.txt
4.50.2.229,"50 , 229 –238 10.1037/0022-3514.50.2.229 3701576",122,31,Front_Psychol_2013_May_10_4_212.txt
4.50.5.103,"50 , 1031 –1038 10.1037/0022-3514.50.5.1031",298,33,Front_Psychol_2013_May_13_4_261.txt
4.59.5.899,"59 , 899 –915 10.1037/0022-3514.59.5.899",449,31,Front_Psychol_2013_May_13_4_261.txt
4.76.5.820,"76 , 820 –838 10.1037/0022-3514.76.5.820",560,31,Front_Psychol_2013_May_13_4_261.txt
4.70.6.125,"70 , 1256 –1269 10.1037/0022-3514.70.6.1256 8667166",440,33,Front_Psychol_2013_Jun_3_4_310.txt
4.49.1.95,10.1037/0022-3514.49.1.95,297,17,Front_Psychol_2013_Jun_27_4_378.txt
3.33.5.108,10.1037/0096-1523.33.5.1089 17924809,171,17,Front_Psychol_2013_Jul_22_4_449.txt
3.18.4.891,10.1037/0096-1523.18.4.891 1431753,151,17,Front_Psychol_2013_Oct_1_4_657.txt
4.17.1.85,10.1037/0882-7974.17.1.85 11931290,261,17,Front_Psychol_2013_Nov_1_4_810.txt
3.26.2.441,441 –455 10.1037//0278-7393.26.2.441 10764105,192,27,Front_Psychol_2013_Nov_8_4_822.txt
4.38.1.17,"... . Z. Sozialpsychol.  38 , 17 –31 10.1024/0044-3514.38.1.17",261,166,Front_Psychol_2011_Jan_4_1_235.txt
5.19.5.641,10.1037/0894-4105.19.5.641 16187882,121,17,Front_Psychol_2013_Nov_13_4_851.txt
4.21.3.373,10.1525/mp.2004.21.3.373,511,15,Front_Psychol_2013_Dec_17_4_837.txt
4.51.4.803,10.1037/0022-3514.51.4.803 16673624,235,17,Front_Psychol_2013_Dec_24_4_960.txt
3.33.3.615,615 10.1037/0278-7393.33.3.615,567,21,Front_Psychol_2014_Jan_7_4_1010.txt
4.15.4.684,10.1037/0882-7974.15.4.684 11144327,334,17,Front_Psychol_2014_Feb_4_5_30.txt
5.19.4.532,10.1037/0894-4105.19.4.532 16060828,362,17,Front_Psychol_2014_Feb_17_5_107.txt
2.4.1.23,10.1037/1528-3542.4.1.23 15053724,316,17,Front_Psychol_2014_Feb_21_5_143.txt
4.91.3.369,10.1037/0022-3514.91.3.369 16938025,228,17,Front_Psychol_2014_Mar_5_5_135.txt
3.34.1.80,10.1037/0278-7393.34.1.80 18194056,310,17,Front_Psychol_2014_Mar_6_5_175.txt
3.12.2.169,10.1037/0096-1523.12.2.169 2940321,306,17,Front_Psychol_2014_Mar_12_5_146.txt
3.12.2.169,10.1037/0096-1523.12.2.169 2940321,306,17,Front_Psychol_2014_Mar_12_5_146.txt
3.91.2.273,10.1037/0022-0663.91.2.273 10503647,551,17,Front_Psychol_2014_Mar_13_5_168.txt
3.18.2.394,10.1037/0096-1523.18.2.394 1593226,840,17,Front_Psychol_2014_Mar_17_5_72.txt
4.72.1.105,"...ers. Soc. Psychol . 71 , 105 –118 10.1037/0022-3514.72.1.105",105,288,Front_Psychol_2011_May_23_2_108.txt
3.28.1.233,"...earn. Mem. Cognit.  28 , 233 –243 10.1037/0278-7393.28.1.233 11827083",163,170,Front_Psychol_2011_May_2_2_81.txt
3.18.2.562,10.1037/0096-1523.18.2.562 1593235,195,17,Front_Psychol_2014_Mar_20_5_229.txt
3.23.5.126,10.1037/0278-7393.23.5.1261,376,17,Front_Psychol_2014_May_12_5_412.txt
6.18.5.803,10.1162/jocn.2006.18.5.803 16768379,209,17,Front_Psychol_2014_May_20_5_451.txt
1.3.4.345,10.1162/jocn.1991.3.4.345 23967814,185,17,Front_Psychol_2014_May_20_5_441.txt
3.21.6.132,10.1037/0096-1523.21.6.1323 8975684,107,17,Front_Psychol_2014_May_27_5_481.txt
4.55.3.144,10.1026/0012-1924.55.3.144,210,17,Front_Psychol_2014_May_30_5_517.txt
3.11.3.356,10.1037/0097-7403.11.3.356 4009124,1041,17,Front_Psychol_2014_Jun_2_5_504.txt
1.93.2.333,10.2466/pms.2001.93.2.333 11769885,264,16,Front_Psychol_2014_Jun_3_5_505.txt
3.16.4.717,10.1037/0278-7393.16.4.717 2142956,155,17,Front_Psychol_2014_Jun_26_5_657.txt
4.93.6.108,10.1037/0022-3514.93.6.1080 18072856,540,17,Front_Psychol_2014_Jul_8_5_701.txt
2.7.4.802,10.1037/1528-3542.7.4.802 18039049,204,17,Front_Psychol_2014_Jul_8_5_689.txt
3.22.2.318,10.1037/0096-1523.22.2.318 8934846,65,17,Front_Psychol_2014_Jul_10_5_725.txt
3.27.5.123,10.1037/0278-7393.27.5.1238 1155075,456,17,Front_Psychol_2014_Jul_29_5_818.txt
4.36.6.635,10.1037/0022-3514.36.6.635,298,17,Front_Psychol_2014_Aug_7_5_829.txt
3.30.3.714,10.1037/0278-7393.30.3.714 15099138,234,17,Front_Psychol_2014_Sep_25_5_1084.txt
3.27.1.229,10.1037/0096-1523.27.1.229 11248937,190,17,Front_Psychol_2014_Sep_25_5_1030.txt
3.27.3.547,10.1037/0096-1523.27.3.547 11424645,367,17,Front_Psychol_2014_Oct_9_5_1129.txt
6.18.4.562,10.1162/jocn.2006.18.4.562 16768360,314,17,Front_Psychol_2014_Sep_10_5_972.txt
4.71.2.262,10.1037//0022-3514.71.2.262,245,18,Front_Psychol_2014_Oct_14_5_1170.txt
3.6.2.174,174 –215 . 10.1037/0278-7393.6.2.174,214,28,Front_Psychol_2014_Oct_21_5_1187.txt
3.31.5.108,10.1037/0096-1523.31.5.1083 16262500,491,17,Front_Psychol_2014_Nov_12_5_1302.txt
4.84.3.619,10.1037/0022-3514.84.3.619 12635921,383,17,Front_Psychol_2014_Nov_18_5_1320.txt
4.59.6.111,10.1037/0022-3514.59.6.1111,274,17,Front_Psychol_2014_Nov_18_5_1336.txt
4.70.4.820,10.1037/0022-3514.70.4.820,350,17,Front_Psychol_2014_Nov_24_5_1323.txt
4.70.4.820,10.1037/0022-3514.70.4.820,350,17,Front_Psychol_2014_Nov_24_5_1323.txt
4.19.3.452,10.1037/0882-7974.19.3.452 15382996,372,17,Front_Psychol_2014_Nov_28_5_1388.txt
4.51.6.117,"... Soc. Psychol . 51 , 1173 –1182 . 10.1037/0022-3514.51.6.1173 3806354",250,228,Front_Psychol_2014_Dec_3_5_1386.txt
4.81.2.305,"...s. Soc. Psychol . 81 , 305 –321 . 10.1037/0022-3514.81.2.305 11519934",151,236,Front_Psychol_2015_Jan_6_5_1523.txt
6.3.4.39,10.1525/srsp.2006.3.4.39,349,17,Front_Psychol_2015_Jan_6_5_1504.txt
3.9.1.86,"... Percept. Perform . 9 , 86 –102 . 10.1037/0096-1523.9.1.86 6220126",42,173,Front_Psychol_2015_Jan_8_5_1554.txt
4.13.1.88,10.1037/0882-7974.13.1.88 9533193,250,17,Front_Psychol_2015_Jan_12_5_1567.txt
3.19.2.260,"...earn. Mem. Cogn . 19 , 260 –271 . 10.1037/0278-7393.19.2.260 1590311",263,194,Front_Psychol_2015_Jan_12_5_1544.txt
3.26.5.157,10.1037/0096-1523.26.5.1570,453,17,Front_Psychol_2015_Jan_13_5_1543.txt
4.85.6.107,10.1037/0022-3514.85.6.107 14674817,391,17,Front_Psychol_2015_Feb_2_6_42.txt
4.67.6.104,"... Soc. Psychol . 67 , 1049 –1062 . 10.1037/0022-3514.67.6.1049 7815301",187,156,Front_Psychol_2015_Feb_5_5_1550.txt
4.76.6.893,10.1037/0022-3514.76.6.893 10402679,233,17,Front_Psychol_2015_Feb_6_6_91.txt
5.22.4.523,"22 , 523 –530 . 10.1037/0894-4105.22.4.523 18590363",99,33,Front_Psychol_2015_Feb_19_6_151.txt
3.91.1.44,10.1037/0022-0663.91.1.44,251,17,Front_Psychol_2015_Feb_20_6_169.txt
3.46.3.331,10.1525/sop.2003.46.3.331,195,16,Front_Psychol_2015_Feb_25_6_194.txt
3.6.2.174,10.1037//0278-7393.6.2.174 7373248,337,18,Front_Psychol_2015_Mar_3_6_231.txt
4.85.2.348,"...l. Soc. Psychol . 85 , 348 –362 . 10.1037/0022-3514.85.2.348 12916575",256,212,Front_Psychol_2015_Mar_11_6_247.txt
4.88.4.686,10.1037/0022-3514.88.4.686,331,17,Front_Psychol_2015_Apr_7_6_357.txt
5.15.3.351,10.1037//0894-4105.15.3.351 11499990,127,18,Front_Psychol_2015_Apr_13_6_405.txt
4.52.3.511,"52 , 511 . 10.1037/0022-3514.52.3.511 3572722",422,28,Front_Psychol_2015_Apr_21_6_464.txt
4.58.2.273,10.1037/0022-3514.58.2.273,241,17,Front_Psychol_2015_Apr_23_6_492.txt
4.85.2.197,"...s. Soc. Psychol . 85 , 197 –216 . 10.1037/0022-3514.85.2.197 12916565",351,199,Front_Psychol_2015_Apr_27_6_415.txt
4.87.5.684,"87 , 684 –697 . 10.1037/0022-3514.87.5.684 15535779",134,33,Front_Psychol_2015_Apr_28_6_502.txt
4.51.6.117,10.1037/0022-3514.51.6.1173 3806354,225,17,Front_Psychol_2015_Apr_30_6_535.txt
4.83.3.616,10.1037/0022-3514.83.3.616 12219858,430,17,Front_Psychol_2015_May_6_6_572.txt
5.40.1.26,10.1027/1864-9335.40.1.26,335,17,Front_Psychol_2015_May_18_6_634.txt
4.68.2.280,"...s. Soc. Psychol . 68 , 280 –291 . 10.1037/0022-3514.68.2.280",197,141,Front_Psychol_2015_May_27_6_649.txt
2.6.3.511,"6 , 511 –516 . 10.1037/1528-3542.6.3.511 16938091",83,32,Front_Psychol_2015_Jun_5_6_706.txt
4.23.1.33,"23 , 33 –38 . 10.1037/0882-7974.23.1.33 18361652",89,31,Front_Psychol_2015_Jun_5_6_706.txt
4.52.4.730,"52 , 730 –738 . 10.1037/0022-3514.52.4.730",195,33,Front_Psychol_2015_Jun_22_6_851.txt
3.9.2.171,"9 , 171 –201 . 10.1037/0097-7403.9.2.171 6842136",159,32,Front_Psychol_2015_Jul_6_6_916.txt
3.23.5.110,10.1037//0278-7393.23.5.1106,331,18,Front_Psychol_2015_Jul_9_6_954.txt
4.20.2.226,226 –240 . 10.1037/0882-7974.20.2.226 16029087,456,28,Front_Psychol_2015_Jul_15_6_999.txt
4.62.6.893,893 –912 . 10.1037/0022-3514.62.6.893 1619549,222,28,Front_Psychol_2015_Jul_17_6_996.txt
3.98.2.265,265 –281 . 10.1037/0022-0663.98.2.265,323,28,Front_Psychol_2015_Jul_23_6_1062.txt
3.25.4.107,1076 –1096 . 10.1037/0096-1523.25.4.1076 10464946,191,30,Front_Psychol_2015_Aug_7_6_1163.txt
4.46.6.131,1313 –1321 . 10.1037/0022-3514.46.6.1313 6737214,336,30,Front_Psychol_2015_Aug_11_6_1133.txt
6.58.1.87,"58 , 87 –90 . 10.2466/pr0.1986.58.1.87 3961085",251,30,Front_Psychol_2015_Aug_14_6_1201.txt
3.17.1.33,"17 , 33 –48 . 10.1037/0278-7393.17.1.33",177,31,Front_Psychol_2015_Aug_18_6_1213.txt
2.19.3.443,"19 , 443 –461 . 10.1525/mp.2002.19.3.443",291,31,Front_Psychol_2015_Aug_20_6_1232.txt
4.70.6.125,1256 –1269 . 10.1037/0022-3514.70.6.1256 8667166,440,30,Front_Psychol_2015_Aug_25_6_1251.txt
3.34.5.121,"34 , 1212 –1228 . 10.1037/0096-1523.34.5.1212 18823206",269,35,Front_Psychol_2015_Aug_25_6_1185.txt
3.92.1.167,167 –173 . 10.2466/pr0.2003.92.1.167 12674278,269,27,Front_Psychol_2015_Sep_1_6_1333.txt
3.13.3.435,"13 , 435 –448 . 10.1037/0096-1523.13.3.435 2958592",244,33,Front_Psychol_2015_Sep_8_6_1366.txt
3.27.2.387,"27 , 387 –394 . 10.1037/0096-1523.27.2.387 11318054",218,33,Front_Psychol_2015_Sep_10_6_1339.txt
4.58.6.104,1040 –1047 . 10.1037/0022-3514.58.6.1040,583,30,Front_Psychol_2015_Sep_15_6_1325.txt
4.71.3.549,549 –570 . 10.1037/0022-3514.71.3.549 8831161,424,28,Front_Psychol_2015_Sep_29_6_1482.txt
4.51.6.117,51 :1173 . 10.1037/0022-3514.51.6.1173 3806354,122,28,Front_Psychol_2015_Oct_13_6_1582.txt
6.1.1.10,"1 , 10 –11 . 10.1162/biot.2006.1.1.10",202,30,Front_Psychol_2015_Oct_13_6_1515.txt
3.34.1.94,94 –105 . 10.1037/0097-7403.34.1.94 18248117,309,27,Front_Psychol_2015_Oct_23_6_1606.txt
4.79.4.602,"79 , 602 –616 . 10.1037//0022-3514.79.4.602 11045741",250,34,Front_Psychol_2015_Nov_20_6_1771.txt
4.37.1.9,9 –18 . 10.1024/0044-3514.37.1.9,378,25,Front_Psychol_2015_Nov_27_6_1752.txt
3.98.2.457,10.1037/0022-0663.98.2.457,233,17,Front_Psychol_2016_Jan_7_6_2023.txt
4.71.1.94,94 –109 . 10.1037/0022-3514.71.1.94,273,27,Front_Psychol_2016_Jan_7_6_1882.txt
3.80.2.210,210 –216 . 10.1037/0022-0663.80.2.210,535,28,Front_Psychol_2016_Jan_8_6_1994.txt
4.52.6.121,1212 –1218 . 10.1037/0022-3514.52.6.1212 3598863,301,30,Front_Psychol_2016_Jan_26_6_2004.txt
3.89.3.420,420 –432 . 10.1037/0022-0663.89.3.420,361,28,Front_Psychol_2016_Feb_15_7_116.txt
4.63.6.903,10.1037/0022-3514.63.6.903,498,17,Front_Psychol_2016_Feb_24_7_189.txt
3.96.1.68,"96 , 68 –84 . 10.1037/0022-0663.96.1.68",81,31,Front_Psychol_2016_Feb_29_7_272.txt
4.57.4.660,"57 , 660 –671 . 10.1037/0022-3514.57.4.660",326,33,Front_Psychol_2016_Mar_9_7_322.txt
3.89.1.41,"89 , 41 –45 . 10.1037/0022-0663.89.1.41",321,31,Front_Psychol_2016_Mar_17_7_356.txt
4.73.6.115,1158 –1176 . 10.1037/0022-3514.73.6.1158,180,30,Front_Psychol_2016_Mar_22_7_395.txt
4.65.1.5,"65 , 5 –17 . 10.1037/0022-3514.65.1.5 8355142",427,30,Front_Psychol_2016_Mar_31_7_483.txt
4.22.24.28,"113 , 365 –376 . 10.2466/04.22.24.28.PMS.113.5.365-376 22185051",151,27,Front_Psychol_2016_Jun_6_7_646.txt
2.2.2.1,2.2.2.1. Quantitative evaluatio,91,1,Front_Psychol_2016_Jun_21_7_906.txt
4.59.4.705,705 –718 . 10.1037/0022-3514.59.4.705,302,28,Front_Psychol_2016_Jun_30_7_1012.txt
4.63.6.913,913 –922 . 10.1037/0022-3514.63.6.913 1460559,317,28,Front_Psychol_2016_Jul_12_7_1063.txt
4.21.1.140,140 –151 . 10.1037/0882-7974.21.1.140 16594799,85,28,Front_Psychol_2016_Aug_9_7_1184.txt
4.61.2.226,226 –244 . 10.1037/0022-3514.61.2.226 1920064,173,28,Front_Psychol_2016_Aug_9_7_1193.txt
4.89.2.205,205 –222 . 10.1037/0022-3514.89.2.205 16162054,227,28,Front_Psychol_2016_Aug_11_7_1153.txt
4.85.1.20,20 –32 . 10.1037/0022-3514.85.1.20 12872882,448,26,Front_Psychol_2016_Aug_23_7_1291.txt
4.12.1.12,12 –21 . 10.1037/0882-7974.12.1.12 9100264,195,26,Front_Psychol_2016_Aug_24_7_1262.txt
4.85.2.197,197 –216 . 10.1037/0022-3514.85.2.197 12916565,225,28,Front_Psychol_2016_Aug_29_7_1301.txt
4.47.3.549,549 –557 . 10.1037/0022-3514.47.3.549 6491869,200,28,Front_Psychol_2016_Aug_29_7_1296.txt
4.70.6.125,1256 –1269 . 10.1037/0022-3514.70.6.1256 8667166,249,30,Front_Psychol_2016_Sep_8_7_1317.txt
3.10.3.340,"10 , 340 –357 . 10.1037/0096-1523.10.3.340 6242411",388,33,Front_Psychol_2016_Sep_15_7_1394.txt
4.52.5.890,890 –898 . 10.1037/0022-3514.52.5.890 3585701,399,28,Front_Psychol_2016_Sep_20_7_1423.txt
4.56.2.267,"56 , 267 –283 . 10.1037/0022-3514.56.2.267 2926629",296,33,Front_Psychol_2016_Sep_21_7_1415.txt
4.65.6.109,1093 –1104 . 10.1037/0022-3514.65.6.1093 8295117,727,30,Front_Psychol_2016_Oct_10_7_1561.txt
1.29.2.195,10.1525/mp.2011.29.2.195,250,15,Front_Psychol_2016_Oct_21_7_1647.txt
4.88.6.969,"88 , 969 –983 . 10.1037/0022-3514.88.6.969 15982116",590,33,Front_Psychol_2016_Nov_4_7_1715.txt
2.2.1.3,2.2.1.3. Recordings transcriptio,177,1,PMC5167744.txt
3.25.6.156,"25 , 1568 –1578 . 10.1037/0096-1523.25.6.1568",367,35,PMC5220188.txt
3.20.3.176,176 –185 . 10.1037/0278-6133.20.3.176 11403215,189,28,PMC5247441.txt
4.83.1.75,83 :75 . 10.1037/0022-3514.83.1.75 12088134,276,26,PMC5258756.txt
4.75.1.219,"75 , 219 –229 . 10.1037/0022-3514.75.1.219 9686460",72,33,PMC5292417.txt
5.22.4.491,491 –507 . 10.1037/0894-4105.22.4.491 18590361,394,28,PMC5292433.txt
1.72.3.995,995 –1006 . 10.2466/pms.1991.72.3.995,432,28,PMC5313490.txt
4.12.3.514,514 –523 . 10.1037/0882-7974.12.3.514 9308098,340,28,PMC5313535.txt
5.64.2.103,103 –114 . 10.1024/1421-0185.64.2.103,440,28,PMC5326803.txt
4.76.2.284,284 –304 . 10.1037/0022-3514.76.2.284 10074710,515,28,PMC5328958.txt
6.18.2.184,184 –198 . 10.1162/jocn.2006.18.2.184 16494680,261,28,PMC5334328.txt
4.51.6.117,...Soc Psychol  (1986 ) 51 :1173 –82 10.1037/0022-3514.51.6.1173 3806354,149,191,Front_Public_Health_2014_May_27_2_56.txt
4.71.5.102,...Soc Psychol  (1996 ) 71 (5 ):1020 10.1037/0022-3514.71.5.1020 8939045,374,182,Front_Public_Health_2016_May_4_4_82.txt
5.23.1.61,10.1525/mp.2005.23.1.61,300,15,Front_Syst_Neurosci_2013_Sep_3_7_48.txt
6.18.8.127,10.1162/jocn.2006.18.8.1277 16859414,232,17,Front_Syst_Neurosci_2013_Nov_13_7_86.txt
4.21.1.49,10.1037/0882-7974.21.1.49 16594791,281,17,Front_Syst_Neurosci_2014_Feb_25_8_21.txt
5.20.2.657,"20 , 657 –665 . 10.2466/pms.1965.20.2.657 14279358",272,32,Front_Syst_Neurosci_2015_May_21_9_77.txt
1.17.1.82,...logy and Motility  2011 17 1 82 87 10.5056/jnm.2011.17.1.82 2-s2.0-79958839484 21369496,52,210,PMC5237729.txt
EC 1.1.1.27,"...zymes EC 5.3.1.9 (glycose-6 phosphate isomerase), EC 1.1.1.27 (lactate dehydrogenase) and EC 4.1.2.1...",70,352,Gene_Regul_Syst_Bio_2007_Nov_29_1_137-149.txt
3.1.6.1,...1-000351	ENZYME Aryl-sulfate sulphohydrolase [EC] 3.1.6.1,382,84,Genes_(Basel)_2012_May_16_3(2)_291-319.txt
6.8.4.353,...ry Pharmacogenomics 2007 8 353 368 10.2217/14622416.8.4.353 17391073,269,167,Genes_(Basel)_2010_May_25_1(1)_38-69.txt
2.25.2.111,...ms J. Fish Pathol. 2012 25 111 116 10.7847/jfp.2012.25.2.111,297,195,PMC5295026.txt
4.3.6.643,...ev Vaccines 2004 3 643 54 15606348 10.1586/14760584.3.6.643,88,195,Genet_Vaccines_Ther_2008_Feb_8_6_5.txt
2.1.1.1,2.1.1.1 Elution buffer 100 m,21,1,Genom_Data_2015_Jun_11_5_218-222.txt
EC 5.4.4.2,"...r salicylate biosynthesis isochorismate synthase (EC 5.4.4.2), isochorismate pyruvate lyase (EC 4.2....",14,1482,Genome_Announc_2013_Apr_4_1(2)_e00138-13.txt
EC 4.2.1.17,"...ation to butyrate, including enoyl-CoA hydratase (EC 4.2.1.17), acetyl-CoA acetyltransferase (EC 2.3...",16,484,Genome_Announc_2013_Mar_28_1(2)_e00128-13.txt
2.15.1.43,15 :43 –53 . 10.1094/MPMI.2002.15.1.43 1184330,120,30,Genome_Announc_2014_Apr_10_2(2)_e00306-14.txt
1.91.11.102,91 :1024 –1029 . 10.1094/PHYTO.2001.91.11.1024 18943436,34,35,Genome_Announc_2014_Sep_25_2(5)_e00944-14.txt
3.4.1.1,"...an iterative mapping of the sequence reads (MIRA v3.4.1.1). Finally, all sequence reads were mapped ...",10,1189,Genome_Announc_2014_Oct_2_2(5)_e00797-14.txt
EC 6.3.4.19,...hock protein 33); tRNA (Ile) lysidine synthetase (EC 6.3.4.19); AbrB family transcriptional regulato...,13,1386,Genome_Announc_2016_Aug_18_4(4)_e00867-16.txt
4.1.99.1,"...me codes for the enzyme tryptophanase (TnaA) (EC: 4.1.99.1), which can transform tryptophan into ind...",14,739,PMC5313623.txt
3.5.4.2,Adenine deaminase	3.5.4.2	1/24	0,181,20,Genome_Biol_2006_Jan_31_7(1)_R8.txt
2.3.1.1,...s-type is a heterodimeric bifunctional enzyme (EC:2.3.1.1/2.3.1.35) whose constituents are proteolyt...,29,1815,Genome_Biol_2008_Jun_9_9(6)_R95.txt
1.2.1.11,"...ysine [22]: EC:2.7.2.8/EC:2.7.2.4, EC:1.2.1.38/EC:1.2.1.11, EC:2.6.1.11/EC:2.6.1.17 and EC:3.5.1.16/...",29,2328,Genome_Biol_2008_Jun_9_9(6)_R95.txt
1.1.1.95,"...two of them, 3-phosphoglycerate dehydrogenase (EC:1.1.1.95) and 3-phosphoserine phosphatase (EC:3.1....",84,203,Genome_Biol_2008_Jun_9_9(6)_R95.txt
5.50.5.168,...e Limnol Oceanogr 2005 14 1687 1696 10.4319/lo.2005.50.5.1687,254,246,Genome_Biol_2013_Nov_28_14(11)_R130.txt
3.36.1.110,...iochem Mol Biol 2003 36 110 119 10.5483/BMBRep.2003.36.1.110 12542981,205,154,Genome_Integr_2012_Aug_22_3_4.txt
3.2.6.631,...e. Future Microbiol 2007 2 631 642 10.2217/17460913.2.6.631 18041904,256,165,Genome_Med_2011_Jul_30_3(7)_50.txt
2.10.1.40,...X2234-0742Korea Genome Organization 10.5808/GI.2012.10.1.40ArticleDecreases in Casz1 mRNA by an siRN...,3,108,Genomics_Inf_2012_Mar_31_10(1)_40-43.txt
3.11.4.211,"...X2234-0742Korea Genome Organization 10.5808/GI.2013.11.4.211Review ArticleCurrent Status, Challenges...",3,114,Genomics_Inform_2013_Dec_31_11(4)_211-217.txt
6.14.3.69,...X2234-0742Korea Genome Organization 10.5808/GI.2016.14.3.69EditorialEditor's Introduction to This Is...,3,114,Genomics_Inform_2016_Sep_30_14(3)_69.txt
2.3.1.167,"...3′-N-debenzoyl-2′-deoxytaxol N-benzoyltransferase	2.3.1.167	1062, 904	446	86	89",290,80,Genomics_Insights_2010_Oct_28_3_29-56.txt
2.3.1.51,"Lysophosphatidic acid acyltransferase	2.3.1.51	564, 561, 565	FM889020	395	54	83	171	48",450,39,Genomics_Insights_2010_Oct_28_3_29-56.txt
EC 6.1.1.20,"...henylalanyl-tRNA by phenylalanyl-tRNA synthetase (EC 6.1.1.20). In the second pathway, it is convert...",31,167,Genomics_Proteomics_Bioinformatics_2007_Feb_8_5(3-4)_166-176.txt
EC 3.1.3.26,"...EC 3.1.4.1, Sigma P4506), and phytase from wheat (EC 3.1.3.26, Sigma P1259). The phytase preparation...",50,888,Geoderma_2016_Dec_15_284_93-102.txt
4.7.2.171,"...y and Aging , 7 , 171 -184 . doi:10.1037//0882-7974.7.2.171 1610505",161,175,PMC5119800.txt
3.92.2.540,...003 92 2 540 544 http://dx.doi.org/10.2466/pr0.2003.92.2.540  12785638,141,238,Glob_J_Health_Sci_2014_Mar_20_6(2)_196-202.txt
6.1.1.1,...1996 1 1 1 36 http://dx.doi.org/10.1902/annals.1996.1.1.1  9118256,118,167,Glob_J_Health_Sci_2016_May_28_8(5)_184-188.txt
2.2.3.1,2.2.3.1 Chemical and mechanical properties,36,1,GMS_Curr_Top_Otorhinolaryngol_Head_Neck_Surg_2011_Mar_10_8_Doc08.txt
2.14.5.508,... Available from: http://dx.doi.org/10.1179/joc.2002.14.5.508  12462431,466,402,PMC5169079.txt
4.2.4.2,4.2.4.2 2nd ste,185,1,GMS_Curr_Top_Otorhinolaryngol_Head_Neck_Surg_2014_Dec_1_13_Doc01.txt
2.5.2.3,2.5.2.3 Medial maxillectom,342,1,GMS_Curr_Top_Otorhinolaryngol_Head_Neck_Surg_2015_Dec_22_14_Doc08.txt
3.3.3.1,3.3.3.1 Closure of rhinobasal defect,282,1,GMS_Curr_Top_Otorhinolaryngol_Head_Neck_Surg_2015_Dec_22_14_Doc06.txt
3.2.3.1,3.2.3.1 Practice essentials of sleep-related breat...,245,1,PMC5169082.txt
3.2.3.4,3.2.3.4 Table and conclusion on the indication of ...,317,1,PMC5169082.txt
4.17.6.4,... Available from: http://dx.doi.org/10.3171/foc.2004.17.6.4  15636574,86,240,GMS_Interdiscip_Plast_Reconstr_Surg_DGPW_2013_Nov_29_2_Doc18.txt
4.16.3.45,...ntation Nurse Res 2009 16 3 45–56 10.7748/nr2009.04.16.3.45.c6945 Available from: http://dx.doi.org/...,135,145,PMC5327661.txt
2.21.1.11,...Z Padagog Psychol 2007 21 1 11 27 10.1024/1010-0652.21.1.11 Available from: http://dx.doi.org/10.102...,117,176,GMS_Z_Med_Ausbild_2013_Nov_15_30(4)_Doc46.txt
3.7.1.66,"...Society of Gastrointestinal Cancer 10.5009/gnl.2013.7.1.66Original ArticleLiver, Pancreas and Biliar...",3,471,Gut_Liver_2013_Jan_14_7(1)_66-73.txt
3.7.3.263,...Society of Gastrointestinal Cancer 10.5009/gnl.2013.7.3.263ReviewIndications for and Technical Aspec...,3,471,Gut_Liver_2013_May_7_7(3)_263-269.txt
4.8.1.109,...Society of Gastrointestinal Cancer 10.5009/gnl.2014.8.1.109Case ReportGemcitabine-Induced Hemolytic ...,3,471,Gut_Liver_2014_Jan_13_8(1)_109-112.txt
2.44.2.113,...1 Cancer Res Treat 2012 44 113 120 10.4143/crt.2012.44.2.113 22802749,243,231,Gut_Liver_2015_Jan_23_9(1)_59-65.txt
2.18.2.109,...B Clin Mol Hepatol 2012 18 109 162 10.3350/cmh.2012.18.2.109 22893865,1038,167,Gut_Liver_2015_May_15_9(3)_267-317.txt
3.7.6.712,... response Gut Liver 2013 7 712 718 10.5009/gnl.2013.7.6.712 24312713,122,185,Gut_Liver_2015_Sep_26_9(5)_657-664.txt
2.10.3.235,... headed? Intest Res 2012 10 235 243 10.5217/ir.2012.10.3.235,196,118,Gut_Liver_2015_Nov_5_9(6)_727-733.txt
2.45.2.138,...ropathy Clin Endosc 2012 45 138 144 10.5946/ce.2012.45.2.138 22866254,197,120,Gut_Liver_2015_Nov_5_9(6)_727-733.txt
2.13.4.124,... J Cancer Prev 2012 13 1247 1251 10.7314/APJCP.2012.13.4.1247 22799313,134,313,Gut_Pathog_2014_Sep_30_6_42.txt
1.60.6.440,...ean J Anesthesiol 2011 60 440 443 10.4097/kjae.2011.60.6.440 21738849,614,193,Gynecol_Surg_2016_Oct_6_13(4)_289-303.txt
3.25.1.91,... Health Psychology 2006 25 91 101 10.1037/0278-6133.25.1.91 16448302,168,259,Harm_Reduct_J_2010_Jun_20_7_13.txt
6.3.5.18,...AIDS Educ Prev 2004 16 Supp A 18 26 10.1521/aeap.16.3.5.18.35533 15262562,40,122,Harm_Reduct_J_2010_Jul_5_7_14.txt
4.19.2.289,...J Korean Med Sci 2004 19 2 289 90 10.3346/jkms.2004.19.2.289 15082905,45,123,Head_Face_Med_2012_Oct_18_8_29.txt
4.43.4.775,...lity Soc.Psychol. 1982 43 775 785 10.1037/0022-3514.43.4.775,538,183,Healthcare_(Basel)_2015_Jun_25_3(3)_478-502.txt
3.18.42.206,...surveillance 2013 18 20609 10.2807/1560-7917.ES2013.18.42.20609 24176581,246,193,Health_Econ_Rev_2016_Jul_12_6_28.txt
1.5.1.40,...ple Research Approaches  5 1 40 51 10.5172/mra.2011.5.1.40,283,259,Health_Psychol_Behav_Med_2014_Jan_1_2(1)_26821-282.txt
3.21.1.3,...ncer Health Psychology  21 1 3 15 10.1037/0278-6133.21.1.3 11846342,224,279,Health_Psychol_Behav_Med_2014_Jan_1_2(1)_28322-295.txt
3.97.3.376,...tional Psychology  97 376 390 doi:10.1037/0022-0663.97.3.376 10.1037/0022-0663.97.3.376,553,299,Health_Psychol_Behav_Med_2014_Jan_1_2(1)_56543-601.txt
4.12.2.147,...surement 2004 12 147 159 16092712 10.1891/jnum.2004.12.2.147,329,217,Health_Qual_Life_Outcomes_2007_May_21_5_26.txt
4.6.4.640,... and Aging 1991 6 640 646 1777153 10.1037/0882-7974.6.4.640,102,197,Health_Qual_Life_Outcomes_2008_Nov_2_6_89.txt
4.67.6.106,...cial Psychology 1994 67 1063 1078 10.1037/0022-3514.67.6.1063 7815302,228,250,Health_Qual_Life_Outcomes_2010_Nov_12_8_130.txt
3.1.23.269,...Clinical Psychology 2004 23 1 23 44 10.1521/jscp.23.1.23.26991,480,206,Health_Qual_Life_Outcomes_2014_May_15_12_71.txt
1.23.4.341,... AIDS Educ Prev 2011 23 4 341 350 10.1521/aeap.2011.23.4.341 21861608,185,187,Health_Qual_Life_Outcomes_2013_Nov_14_11_195.txt
5.18.6.555,...ndocrinol Metab 2005 18 6 555 567 10.1515/JPEM.2005.18.6.555 16042323,365,191,Health_Qual_Life_Outcomes_2014_Aug_13_12_107.txt
4.12.3.433,...rces Psychol Aging 1997 12 433 43 10.1037/0882-7974.12.3.433 9308091,990,138,Health_Qual_Life_Outcomes_2015_May_12_13_54.txt
3.23.1.58,...agement Health Psychol 2004 23 58 10.1037/0278-6133.23.1.58 14756604,393,221,PMC5320673.txt
3.6.2.7,"3.6.2.7 In HBeAg-negative patients, serum HBV DNA ...",856,1,Hepatol_Int_2015_Nov_13_10(1)_1-98.txt
3.13.8.2,3.13.8.2 Because NA therapy cannot completely erad...,1506,1,Hepatol_Int_2015_Nov_13_10(1)_1-98.txt
4.8.1.64,...t failure Gut Liver 2014 8 1 64 69 10.5009/gnl.2014.8.1.64 24516703,205,232,Hepatol_Int_2015_Nov_26_10(2)_302-309.txt
5.27.2.120,...287-32602287-3279Korean Hip Society 10.5371/hp.2015.27.2.120Case ReportSciatic Nerve Palsy Caused by...,3,86,Hip_Pelvis_2015_Jun_30_27(2)_120-124.txt
2.17.11.203,...Bone Miner. Res 2002 17 2038 2047 10.1359/jbmr.2002.17.11.2038 12412812,113,216,HSS_J_2010_Feb_10_6(1)_79-84.txt
3.1.1.1,Network 3.1.1.1 Life Sciences and Engineering Technology S...,361,9,Hum_Genomics_2004_May_1_1(4)_255-273.txt
1.5.4.23,"...temperatures recommended by the Navigator version 1.5.4.23 software (Transgenomics), as previously d...",31,452,Hum_Mutat_2011_Jul_8_32(7)_760-772.txt
4.57.5.792,...Social Psychology 1989 57 792 807 10.1037/0022-3514.57.5.792,378,205,Hum_Nat_2015_Oct_21_26(4)_426-450.txt
3.46.6.300,...ed Public Health 2013 46 300 308 10.3961/jpmph.2013.46.6.300 24349651,297,215,Hum_Resour_Health_2016_Aug_15_14_50.txt
3.46.6.300,...ed Public Health 2013 46 300 308 10.3961/jpmph.2013.46.6.300 24349651,297,215,Hum_Resour_Health_2016_Aug_15_14_50.txt
4.5.6.851,...d Expert Rev Vaccines 2006 5 851 7 10.1586/14760584.5.6.851 17184222,264,165,Hum_Vaccin_Immunother_2012_Jul_1_8(7)_866-872.txt
2.42.2.89,...f Oral and Maxillofacial Radiology 10.5624/isd.2012.42.2.89Original ArticleHow does duration of curi...,3,148,Imaging_Sci_Dent_2012_Jun_25_42(2)_89-93.txt
3.43.1.7,...f Oral and Maxillofacial Radiology 10.5624/isd.2013.43.1.7Original ArticleReference line-pair values...,3,148,Imaging_Sci_Dent_2013_Mar_11_43(1)_7-15.txt
4.44.3.229,...f Oral and Maxillofacial Radiology 10.5624/isd.2014.44.3.229Original ArticleAssessment of bifid and ...,3,148,Imaging_Sci_Dent_2014_Sep_17_44(3)_229-236.txt
4.44.4.257,...f Oral and Maxillofacial Radiology 10.5624/isd.2014.44.4.257Original ArticleAccuracy of linear measu...,3,148,Imaging_Sci_Dent_2014_Dec_25_44(4)_257-262.txt
6.8.12.173,... Pharmacogenomics 2007 8 1735 1745 10.2217/14622416.8.12.1735 18086003,76,177,Immun_Ageing_2010_Jan_17_7_1.txt
3.1.1.189,...n a box AIDS Educ Prev 2001 13 1 28 10.1521/aeap.13.1.1.18926 11252451,253,187,Implement_Sci_2014_Jan_6_9_5.txt
1.11.2.19,...ritique Nurse Res 2003 11 2 19 28 10.7748/nr2004.01.11.2.19.c5919 14708426,397,123,Implement_Sci_2014_Nov_7_9_162.txt
5.47.3.155,...and Korean Society for Chemotherapy 10.3947/ic.2015.47.3.155Review ArticleFebrile Illness with Skin ...,3,169,Infect_Chemother_2015_Sep_30_47(3)_155-166.txt
6.48.3.216,...and Korean Society for Chemotherapy 10.3947/ic.2016.48.3.216Brief CommunicationRisk Factors for Uret...,3,169,Infect_Chemother_2016_Sep_1_48(3)_216-218.txt
5.33.8.64,...somiasis Medicine 2005 33 8 64 67 10.1383/medc.2005.33.8.64,111,68,Infect_Dis_Poverty_2013_Jan_24_2_2.txt
6.9.10.162,...n Pharmacother 2008 9 10 1623 1628 10.1517/14656566.9.10.1623 18570596,230,139,Infect_Dis_Poverty_2013_Mar_27_2_6.txt
6.21.6.301,...Euro Surveill 2016 21 2 5 10.2807/1560-7917.ES.2016.21.6.30131 26889644,98,308,Infection_2016_May_21_44(6)_797-802.txt
2.3.2.1,"....3.1, 2.1.3.3, 2.2.1.1, 2.2.1.1a, 2.2.2, 2.2.2.1, 2.3.2.1, 2.3.4.1, and 2.3.4.3 (Figure1, Table1)",82,1464,Influenza_Other_Respir_Viruses_2015_Sep_4_9(5)_271-276.txt
3.31.2.176,...ew Contemp Nurse 2009 31 2 176 189 10.5172/conu.673.31.2.176 19379119,202,186,Int_Arch_Med_2014_May_3_7_18.txt
4.59.6.121,...cial Psychology 1990 59 1216 1229 10.1037/0022-3514.59.6.1216 2283588,449,168,Integr_Psychol_Behav_Sci_2013_Mar_8_47(1)_1-55.txt
1.41.4.365,...tural Sciences  41 4 2011 365 404 10.1525/hsns.2011.41.4.365 22363966,565,156,Intellect_Hist_Rev_2014_Apr_3_24(2)_2156-238.txt
EC 1.11.2.2,Measurement of myleoperoxidase (MPO; EC 1.11.2.2,104,38,Interdiscip_Toxicol_2012_Dec_5(4)_192-200.txt
4.12.1.74,...or the Study of Intestinal Diseases 10.5217/ir.2014.12.1.74Case ReportSuccessful Treatment of Postop...,3,138,Intestinal_Res_2014_Jan_28_12(1)_74-77.txt
4.12.4.263,...or the Study of Intestinal Diseases 10.5217/ir.2014.12.4.263EditorialCould Early Anti-Tumor Necrosis...,3,138,Intestinal_Res_2014_Oct_27_12(4)_263-265.txt
5.13.3.266,...or the Study of Intestinal Diseases 10.5217/ir.2015.13.3.266Original ArticleEfficacy of Thiopurines ...,3,130,Intest_Res_2015_Jul_9_13(3)_266-273.txt
6.14.1.89,...or the Study of Intestinal Diseases 10.5217/ir.2016.14.1.89Case ReportIschemic enteritis with intest...,3,130,Intest_Res_2016_Jan_26_14(1)_89-95.txt
6.14.1.5,...or the Study of Intestinal Diseases 10.5217/ir.2016.14.1.5ReviewFecal immunochemical test as a bioma...,3,130,Intest_Res_2016_Jan_25_14(1)_5-14.txt
3.12.4.292,...h Psychol 1993 12 292 300 8404803 10.1037/0278-6133.12.4.292,181,207,Int_J_Behav_Nutr_Phys_Act_2007_Oct_2_4_48.txt
4.51.6.117,...chology 1986 51 1173 1182 3806354 10.1037/0022-3514.51.6.1173,226,238,Int_J_Behav_Nutr_Phys_Act_2009_Mar_30_6_19.txt
3.18.6.599,...el Health Psychol 1999 18 599 603 10.1037/0278-6133.18.6.599 10619533,211,173,Int_J_Behav_Nutr_Phys_Act_2011_Mar_30_8_23.txt
3.1.61.269,...d Clinical Psychology 2004 23 61 88 10.1521/jscp.23.1.61.26990,202,252,Int_J_Behav_Nutr_Phys_Act_2012_Mar_2_9_21.txt
3.27.3.379,...ons Health Psychol 2008 27 379 87 10.1037/0278-6133.27.3.379 18624603,239,136,Int_J_Behav_Nutr_Phys_Act_2015_Sep_17_12_118.txt
1.4.3.67,"... was calculated using the software ImageJ version 1.4.3.67 (NIH Image, USA) [19]",27,534,Int_J_Biomater_2012_Nov_13_2012_376321.txt
3.7.3.224,...rch and Practice  2013 7 3 224 232 10.4162/nrp.2013.7.3.224 2-s2.0-84879064497 23766884,239,249,Int_J_Chronic_Dis_2014_Sep_21_2014_548269.txt
2.1.5.980,26 SanPiN 2.1.5.980-00 “Hygienic requirements for surface wa...,380,11,Int_J_Circumpolar_Health_2013_Dec_9_72_10_3402_ijch_v72i0_22646.txt
3.28.1.20,...gy and Metabolism  2013 28 1 20 25 10.3803/EnM.2013.28.1.20 24396646,158,167,Int_J_Endocrinol_2015_Apr_29_2015_410185.txt
3.10.1.121,...ulation Innovation 2008 10 121 131 10.5172/impp.453.10.1.121,122,119,PMC5201359.txt
3.19.5.469,...n Health Psychol. 2000 19 469 478 10.1037/0278-6133.19.5.469 11007155,144,235,Int_J_Environ_Res_Public_Health_2012_Jun_18_9(6)_2241-2251.txt
3.25.5.549,...n Health Psychol. 2006 25 549 557 10.1037/0278-6133.25.5.549 17014271,437,138,Int_J_Environ_Res_Public_Health_2013_Jun_18_10(6)_2471-2499.txt
4.40.2.331,...al. Soc. Psychol. 1981 40 331 345 10.1037/0022-3514.40.2.331,314,257,Int_J_Environ_Res_Public_Health_2013_Jul_3_10(7)_2760-2777.txt
2.91.3.725,...rica Psychol. Rep. 2002 91 725 728 10.2466/pr0.2002.91.3.725 12530714,231,155,Int_J_Environ_Res_Public_Health_2014_Apr_4_11(4)_3803-3821.txt
2.2.16.2,2.2.16.2. The Mobile Telecommunications and Health...,283,1,Int_J_Environ_Res_Public_Health_2014_Sep_10_11(9)_9376-9408.txt
6.1.3.309,...es Pharmacogenomics 2000 1 309 333 10.1517/14622416.1.3.309 11256581,127,140,Int_J_Environ_Res_Public_Health_2015_Mar_19_12(3)_3317-3326.txt
1.56.5.176,...Limnol. Oceanogr. 2011 56 1764 1780 10.4319/lo.2011.56.5.1764,170,211,Int_J_Environ_Res_Public_Health_2015_Apr_1_12(4)_3691-3706.txt
3.41.7.114,...Behav. Perosnal. 2013 41 1141 1152 10.2224/sbp.2013.41.7.1141,195,196,Int_J_Environ_Res_Public_Health_2015_May_15_12(5)_5196-5214.txt
2.32.1.31,...metry Ann. Lab. Med. 2012 32 31 37 10.3343/alm.2012.32.1.31 2225977,141,260,Int_J_Environ_Res_Public_Health_2015_Aug_31_12(8)_9054-9067.txt
5.1.2.175,...rug Metab. Toxicol. 2005 1 175 185 10.1517/17425255.1.2.175 16922635,133,154,Int_J_Environ_Res_Public_Health_2015_Nov_17_12(11)_14610-14625.txt
4.15.5.292,...Ind. Coop. Soc. 2014 15 2923 2929 10.5762/KAIS.2014.15.5.2923,388,212,Int_J_Environ_Res_Public_Health_2015_Dec_8_12(12)_15540-15549.txt
1.22.2.110,...J. Gynecol. Oncol. 2011 22 110 119 10.3802/jgo.2011.22.2.110 21860737,404,241,Int_J_Environ_Res_Public_Health_2016_Feb_2_13(2)_181.txt
1.16.7.132,...one Miner. Res. 2001 16 1329 1336 10.1359/jbmr.2001.16.7.1329 11450709,439,265,Int_J_Environ_Res_Public_Health_2016_Jun_28_13(6)_544.txt
2.45.3.219,... Sociol. Perspect. 2002 45 219 242 10.1525/sop.2002.45.3.219,271,203,Int_J_Environ_Res_Public_Health_2016_Oct_12_13(10)_1005.txt
6.36.4.377,...fe Threat. Behav. 2006 36 377 385 10.1521/suli.2006.36.4.377 16978092,298,195,Int_J_Environ_Res_Public_Health_2016_Nov_1_13(11)_1070.txt
1.54.10.401,...Korean J. Pediatr. 2011 54 401 404 10.3345/kjp.2011.54.10.401 22232621,213,96,PMC5201324.txt
1.44.1.22,... Med Public Health 2011 44 22 31 10.3961/jpmph.2011.44.1.22 21483220,103,256,Int_J_Equity_Health_2014_Jul_25_13_52.txt
EC 2.7.3.2,Creatine kinase (CK) is an enzyme (EC 2.7.3.2,61,36,Int_J_Fertil_Steril_2013_Mar_3_Jan-Mar_6(4)_258-265.txt
EC 3.4.15.1,"... I-converting enzyme (peptidyl carboxy peptidase, EC 3.4.15.1, ACE) belongs to the class of zinc pro...",12,62,Int_J_Food_Sci_2013_May_21_2013_158482.txt
1.14.13.21,...onoid biosynthesis	Flavonoid 3′-monooxygenase [EC:1.14.13.21]	3.49	4.80E − 76	1.03E − 07	0.00068,134,71,Int_J_Genomics_2015_Jul_12_2015_528395.txt
4.50.4.819,... J Pers Soc Psychol 1986 50 4 819 10.1037/0022-3514.50.4.819,577,114,Int_J_Health_Policy_Manag_2016_Aug_17_5(11)_623-630.txt
2.73.10.111,...itis J Periodontol 2002 73 1118 25 10.1902/jop.2002.73.10.1118 12416768,664,195,Int_J_Implant_Dent_2015_Aug_13_1(1)_22.txt
4.44.1.113,... Pers Soc Psychol 1983 44 113 126 10.1037/0022-3514.44.1.113,146,153,Int_J_Med_Educ_2015_Jan_29_6_12-16.txt
2.5.1.113,...teraction. Emotion 2005 5 113 118 10.1037/1528-3542.5.1.113 15755224,113,160,Int_J_Med_Educ_2015_Dec_6_6_179-183.txt
4.93.2.298,... Pers Soc Psychol 2007 93 298 319 10.1037/0022-3514.93.2.298 17645401,388,231,Int_J_Med_Educ_2016_Oct_7_7_324-332.txt
4.4.2.150,... Psychol and Aging 1989 4 150 165 10.1037/0882-7974.4.2.150,309,83,Int_J_Ment_Health_Syst_2007_Sep_4_1_4.txt
4.39.1.114,...Res Pract Train 2002 39 1 114 125 10.1037/0033-3204.39.1.114,247,170,Int_J_Ment_Health_Syst_2015_Jun_23_9_24.txt
6.33.1.33,...cs meet Am Ethnolog 2006 33 1 33 49 10.1525/ae.2006.33.1.33,352,90,Int_J_Ment_Health_Syst_2016_Jun_6_10_46.txt
3.1.52.227,...-Threatening Behavior 2003 33 52 64 10.1521/suli.33.1.52.22784 12710540,201,200,Int_J_Ment_Health_Syst_2014_May_13_8_17.txt
1.10.3.1,...atechol oxidases and/or polyphenol oxidases (E.C. 1.10.3.1). The distinction between polyphenoloxida...,8,347,Int_J_Mol_Sci_2009_Sep_2_10(9)_3811-3823.txt
3.2.3.3,3.2.3.3. Colorimetric Assay using Enzymes Labeled ...,106,1,Int_J_Mol_Sci_2010_Dec_7_11(12)_5077-5094.txt
3.2.1.139,"...feruloyl esterase (EC 3.1.1.73), α-glucuronidase (3.2.1.139), and acetyl- and acetyl-xylan esterases...",35,309,Int_J_Mol_Sci_2011_May_24_12(5)_3381-3393.txt
3.3.1.13,"Memantine (3,5-Dimethyl-tricyclo[3.3.1.13,7]decan-1-amine hydrochloride) and methyl...",45,34,Int_J_Mol_Sci_2012_Feb_17_13(2)_2219-2238.txt
EC 1.6.4.2,"Glutathione reductase (GR, EC 1.6.4.2) activity was assayed by the method of ...",51,28,Int_J_Mol_Sci_2012_Feb_8_13(2)_1790-1803.txt
4.4.2.2,4.4.2.2. Measurement of Antimicrobial Activit,173,1,Int_J_Mol_Sci_2012_Apr_12_13(4)_4673-4695.txt
2.2.2.3,"2.2.2.3. TiO2/(La,Sr)MnO3 Composite Nanowire Array...",61,1,Int_J_Mol_Sci_2012_Jun_15_13(6)_7393-7423.txt
EC 2.4.1.13,"...thase (SPS, EC 2.1.4.14), sucrose synthase (SuSy, EC 2.4.1.13) and neutral invertase (NI, EC 3.2.1.2...",10,791,Int_J_Mol_Sci_2012_Jul_26_13(8)_9460-9477.txt
3.1.2.6,3.1.2.6. 1-(4-Phenylbenzoyl)-4-(4-chlorobenzhydryl...,59,1,Int_J_Mol_Sci_2012_Jun_28_13(7)_8071-8085.txt
1.14.14.1,geraniol 10-hydroxylase (G10H)	1.14.14.1	1	2,98,32,Int_J_Mol_Sci_2012_Oct_23_13(10)_13748-13763.txt
5.3.99.4,...ed as described previously [98]. Human PGIS (E.C. 5.3.99.4) was overexpressed in Spodoptera frugiper...,81,514,Int_J_Mol_Sci_2013_Apr_8_14(4)_7542-7570.txt
6.8.1.21,16.8.1.21	flavonoids. anthocyanins. anthocyanin 5-a...,251,2,Int_J_Mol_Sci_2013_Jun_4_14(6)_11871-11894.txt
6.8.4.1,16.8.4.1	flavonoids. flavonols. flavonol synthase (...,265,2,Int_J_Mol_Sci_2013_Jun_4_14(6)_11871-11894.txt
4.2.1.11,"...t contains a conserved core pattern of Enolase (EC4.2.1.11) between 340 to 353 aa, which is similar ...",20,745,Int_J_Mol_Sci_2013_Apr_24_14(5)_8787-8800.txt
EC 1.3.2.3,... The l-galactono-γ-lactone dehydrogenase (GalLDH; EC 1.3.2.3) activity was measured by the method re...,77,529,Int_J_Mol_Sci_2013_May_2_14(5)_9556-9580.txt
3.1.1.7,"...ewly synthesized acetylcholinesterase (AChE, E.C. 3.1.1.7) reactivators. For newly synthesized compo...",8,347,Int_J_Mol_Sci_2013_Aug_2_14(8)_16076-16086.txt
1.17.1.2,"...xy-3-methylbut-2-enyl-diphosphate reductase (HDR; 1.17.1.2), and isopentenyl-diphosphate delta-isome...",12,1510,Int_J_Mol_Sci_2013_Sep_9_14(9)_18502-18519.txt
1.17.7.1,1.17.7.1	PLHDS	HTIP-2007108	2665,122,1,Int_J_Mol_Sci_2013_Sep_9_14(9)_18502-18519.txt
3.2.1.2,3.2.1.2. 2-(4-propoxybiphen-4′-yl)-5-cyanopyridine...,68,1,Int_J_Mol_Sci_2013_Sep_12_14(9)_18809-18823.txt
3.4.14.5,"..., EC3.4.21.26), dipeptidyl peptidase IV (DPPIV, EC3.4.14.5), oligopeptidase B (OPB, EC3.4.21.83), an...",5,704,Int_J_Mol_Sci_2013_Oct_10_14(10)_20204-20219.txt
3.1.1.1,3.1.1.1. Biochemical Alterations Induced by Differ...,69,1,Int_J_Mol_Sci_2013_Nov_19_14(11)_22753-22781.txt
3.2.2.3,3.2.2.3. 2-[4-(2-Aminobenzamido)phenyl]acetic acid...,47,1,Int_J_Mol_Sci_2014_Mar_21_15(3)_5115-5127.txt
4.2.1.11,"114, 117	22.60	Q96X30	4.2.1.11	47.31/5.39	AFUA_6G06770",153,23,Int_J_Mol_Sci_2014_Aug_20_15(8)_14505-14530.txt
2.13.3.299,...fects J. Vet. Sci. 2012 13 299 310 10.4142/jvs.2012.13.3.299 23000587,372,316,Int_J_Mol_Sci_2014_Jul_31_15(8)_13437-13460.txt
5.76.5.737,...is J. Periodontol. 2005 76 737 739 10.1902/jop.2005.76.5.737 15898934,134,153,Int_J_Mol_Sci_2014_Dec_3_15(12)_22279-22295.txt
2.6.2.188,...crophages Gut Liver 2012 6 188 196 10.5009/gnl.2012.6.2.188 22570747,118,268,Int_J_Mol_Sci_2014_Dec_9_15(12)_22819-22834.txt
4.23.11.521,...rs J. Wound Care 2014 23 521 530 10.12968/jowc.2014.23.11.521 25375400,190,204,Int_J_Mol_Sci_2015_Mar_2_16(3)_4666-4681.txt
3.74.2.175,...ts J. Periodontol. 2003 74 175 180 10.1902/jop.2003.74.2.175 12666705,148,298,Int_J_Mol_Sci_2015_Oct_13_16(10)_24111-24126.txt
2.45.3.183,...Mol. Biol. Rep. 2012 45 183 188 10.5483/BMBRep.2012.45.3.183 22449706,122,204,Int_J_Mol_Sci_2015_Nov_27_16(12)_28242-28254.txt
2.53.2.294,...ats Yonsei Med. J. 2012 53 294 303 10.3349/ymj.2012.53.2.294 22318816,659,284,Int_J_Mol_Sci_2015_Dec_18_16(12)_30269-30308.txt
2.15.2.111,...l. Hepatol. Nutr. 2012 15 111 116 10.5223/pghn.2012.15.2.111,787,214,Int_J_Mol_Sci_2015_Dec_24_17(1)_14.txt
4.24.2.209,...cells J. Life Sci. 2014 24 209 217 10.5352/JLS.2014.24.2.209,147,109,Int_J_Mol_Sci_2016_Mar_3_17(3)_279.txt
EC 3.2.1.132,...ting GlcNAc monomers. Another enzyme chitosanase (EC 3.2.1.132) is also involved in deacetylating ch...,12,1011,Int_J_Mol_Sci_2016_May_26_17(6)_825.txt
EC 2.3.1.-,"2.9. Tabtoxin Resistance Protein Family (TTR, EC 2.3.1.-",85,47,Int_J_Mol_Sci_2016_Jun_28_17(7)_1018.txt
4.26.3.399,...tion Ann. Dermatol. 2014 26 399 400 10.5021/ad.2014.26.3.399 24966644,81,199,Int_J_Mol_Sci_2016_Jul_27_17(8)_1214.txt
4.15.7.333,.... Cancer Prev. 2014 15 3335 3341 10.7314/APJCP.2014.15.7.3335 24815493,421,234,Int_J_Mol_Sci_2016_Sep_8_17(9)_1502.txt
5.4.2.2,"...re 8. Eleven proteins in leaves, gi|168035690 (EC:5.4.2.2), gi|302142655 (EC:2.7.1.1), gi|297735045 ...",45,1368,Int_J_Mol_Sci_2016_Sep_27_17(10)_1607.txt
6.42.7.985,...cancer Drugs Today 2006 42 441 453 10.1358/dot.2006.42.7.985637 16894399,256,140,PMC5187895.txt
1.4.1.14,...phosphosite quantification in Proteome Discoverer 1.4.1.14 suites with Mascot search engine against ...,59,1075,PMC5297695.txt
4.17.11.176,... Investig. Drugs 2008 17 1769 1776 10.1517/13543784.17.11.1769 18922112,244,150,PMC5343939.txt
2.55.2.42,...n Korean J. Pediatr. 2012 55 42 47 10.3345/kjp.2012.55.2.42 22375148,222,120,PMC5343923.txt
EC 6.4.1.1,...e liver in glycerol and aqueous buffer at pH 7.4 (EC 6.4.1.1) was performed in D2O on the 1H NMR sca...,51,133,Int_J_Nanomedicine_2013_Dec_11_8_4707-4720.txt
5.20.10.218,...imal care committee (Muenster: LANUV-NRW 8.87-51.05.20.10.218; Mainz: 23-177-07/G13-1021 and 23-177-...,27,270,Int_J_Neuropsychopharmacol_2015_Aug_1_19(2)_pyv091.txt
3.1.2.1,3.1.2.1 Chemical penetration enhancemen,87,1,Int_J_Pharm_2015_Jun_20_487(1-2)_101-109.txt
1.2.7.6,1.2.7.6	Glyceraldehyde-3-phosphate dehydrogenase	G...,127,1,Int_J_Proteomics_2012_Oct_18_2012_980829.txt
5.4.2.1,5.4.2.1†	Phosphoglycerate mutase	GL50803_8822	551	...,128,1,Int_J_Proteomics_2012_Oct_18_2012_980829.txt
6.9.1.96,...y for Stem Cell Research 2742609110.15283/ijsc.2016.9.1.96ijsc-09-096Original ArticleTherapeutic Pot...,3,153,Int_J_Stem_Cells_2016_May_9(1)_96-106.txt
3.17.2.73,...2093-6931Korean Continence Society 10.5213/inj.2013.17.2.73Original ArticleFree Prostate-Specific An...,3,127,Int_Neurourol_J_2013_Jun_30_17(2)_73-77.txt
3.17.4.162,...2093-6931Korean Continence Society 10.5213/inj.2013.17.4.162Original ArticleAcute Dose-Related Diffe...,3,127,Int_Neurourol_J_2013_Dec_31_17(4)_162-167.txt
4.18.1.42,...2093-6931Korean Continence Society 10.5213/inj.2014.18.1.42Case ReportFemale Urethral Condyloma Caus...,3,127,Int_Neurourol_J_2014_Mar_31_18(1)_42-44.txt
3.32.6.139,...eption & Performance 32 1398 1404 10.1037/0096-1523.32.6.1398 17154780,98,206,Iperception_2010_Dec_20_1(3)_149-158.txt
3.14.2.163,...eption and Performance 14 163 175 10.1037/0096-1523.14.2.163 2967874,180,208,Iperception_2011_Mar_30_2(1)_50-68.txt
3.6.2.174,...an Learning and Memory 6 174 215 10.1037//0278-7393.6.2.174 7373248,248,242,Iperception_2012_Oct_11_3(10)_745-764.txt
4.2.2.3,"...1), the second type is specific toward M block (EC4.2.2.3), and the third type is bifunctional for G...",24,476,PMC5141254.txt
6.67.4.386,...th. J Periodontol. 1996 67 4 386 9 10.1902/jop.1996.67.4.386 8708964,137,194,Iran_Endod_J_2013_Aug_1_Summer_8(3)_94-98.txt
4.57.5.245,... Korean J Pediatr. 2014 57 5 245 9 10.3345/kjp.2014.57.5.245 25045368,51,180,Iran_J_Radiol_2016_Jan_18_13(1)_e29260.txt
4.1.1.3,4.1.1.3. Clinical Knowledge Storage by Student,72,1,Iran_Red_Crescent_Med_J_2014_Oct_5_16(10)_e21835.txt
2.4.4.193,...n & Gynaecologist. 2002 4 4 193 6 10.1576/toag.2002.4.4.193,182,139,Iran_Red_Crescent_Med_J_2016_Jan_13_18(1)_e30493.txt
5.5.1.3,...ia Pac Allergy 2015 515 3 16 10.5415/apallergy.2015.5.1.3,148,158,PMC5282849.txt
1.4.4.2,"...significance. In this calculation, genes encoding 1.4.4.2, 2.3.1.-, 2.7.2.2 and 3.5.1.54 (Supplement...",64,1232,ISME_J_2015_Jan_29_9(1)_166-179.txt
2.18.6.283,...J Palliat Nurs 2012 18 6 283 289 10.12968/ijpn.2012.18.6.283 22885901,197,194,Isr_J_Health_Policy_Res_2016_Jul_20_5_18.txt
1.26.10.138,...6 10 1382 1385 2-s2.0-84856482037 10.3346/jkms.2011.26.10.1382 22022194,61,242,ISRN_Anat_2012_Dec_24_2013_962904.txt
EC 1.1.1.57,"Mannonate oxidoreductase (EC 1.1.1.57) (fructuronate reductase) (gene uxuB),...",97,27,ISRN_Biotechnol_2012_Dec_26_2013_914187.txt
5.23.4.307,...ome J Perinat Med 1995 23 307 314 10.1515/jpme.1995.23.4.307 8537861,125,243,Ital_J_Pediatr_2014_Sep_26_40_76.txt
4.77.4.815,...Social Psychology 1999 77 815 832 10.1037/0022-3514.77.4.815 10531673,166,249,J_Abnorm_Child_Psychol_2010_Jan_8_38(4)_485-495.txt
2.4.3.158,...e Korean Academy of Prosthodontics 10.4047/jap.2012.4.3.158Original ArticleMechanical analysis of co...,3,146,J_Adv_Prosthodont_2012_Aug_28_4(3)_158-161.txt
3.5.3.234,...e Korean Academy of Prosthodontics 10.4047/jap.2013.5.3.234Original ArticleA comparison of retentive...,3,146,J_Adv_Prosthodont_2013_Aug_31_5(3)_234-240.txt
5.7.1.56,...e Korean Academy of Prosthodontics 10.4047/jap.2015.7.1.56Original ArticleInfluence of shape and fin...,3,146,J_Adv_Prosthodont_2015_Feb_17_7(1)_56-61.txt
6.8.4.285,...e Korean Academy of Prosthodontics 10.4047/jap.2016.8.4.285Original ArticleTensile bond strength bet...,3,146,J_Adv_Prosthodont_2016_Aug_18_8(4)_285-289.txt
6.8.6.504,...e Korean Academy of Prosthodontics 10.4047/jap.2016.8.6.504Original ArticleEffect of surface treatme...,3,146,J_Adv_Prosthodont_2016_Dec_15_8(6)_504-510.txt
4.1.1.2,...ting a Median-Joining Network (MJN) using Network 4.1.1.2 [33],39,156,J_Adv_Res_2016_Sep_28_7(5)_615-623.txt
2.2.3.1,2.2.3.1 Mood and Feelings Questionnaire-Short vers...,56,1,J_Affect_Disord_2015_Jan_15_171_60-67.txt
1.1.17.264,...almic Epidemiology  2004 11 1 17 33 10.1076/opep.11.1.17.26437 2-s2.0-1642356680 14977494,139,220,J_Allergy_(Cairo)_2015_Nov_10_2015_245370.txt
1.52.4.22,"... of Apicultural Research , 52 . doi: 10.3896/IBRA.1.52.4.22",703,61,J_Anim_Ecol_2015_May_3_84(3)_615-624.txt
3.4.22.3,"Ficain (ficin; from fig tree)	3.4.22.3	Ala, Asn, Gly, Leu, Lys, Tyr, Val",56,31,PMC5341468.txt
3.7.2.5,ECHA Section 3.7.2.5 Setting of Specific Concentration Limits i...,100,14,J_Appl_Toxicol_2014_Oct_25_34(10)_1068-1072.txt
2.1.2.1,2.1.2.1.,107,1,J_Automat_Chem_1988_10(4)_164-166.txt
2.4.2.1,"2.4.2.1), to form ribose- 1-phosphate and hypoxant...",56,1,J_Automat_Chem_1989_11(4)_164-167.txt
2.5.1.2,"2.5.1.2); ALP, alkaline phosphatase (EC 3.1.3.1); ...",50,1,J_Automat_Chem_1990_12(4)_153-162.txt
4.79.2.260,260–273. 10.1037/0022-3514.79.2.260,569,26,J_Behav_Addict_2015_Mar_18_4(1)_22-26.txt
EC 1.6.2.4,"...me system, NADPH-cytochrome P450 reductase (CPR4; EC 1.6.2.4) plays a central role by catalyzing the...",13,371,J_Biol_Chem_2009_Dec_25_284(52)_36628-36637.txt
3.2.8.1,".... Therefore, recombinant glycoproteins made in Lec3.2.8.1 will have no complex or hybrid N-glycans a...",127,484,J_Biol_Chem_2010_Feb_19_285(8)_5759-5775.txt
3.80.4.446,...Cereal Chemistry 2003 80 446 449 10.1094/CCHEM.2003.80.4.446,125,183,J_Biol_Eng_2007_Dec_28_1_9.txt
5.4.2.2,Phosphoglucomutase	5.4.2.2	WP_007111739	1109	1	+	+	+,85,20,J_Biol_Res_(Thessalon)_2015_Aug_3_22(1)_8.txt
EC 3.1.3.9,"...cy in the enzyme glucose 6-phosphatase-α (G6Pase; EC 3.1.3.9).  Without G6Pase activity, all endogen...",39,184,J_Biomed_Biotechnol_2011_Jan_3_2011_646257.txt
2.13.3.753,...ac J Cancer Prev 2012 13 3 753 9 10.7314/APJCP.2012.13.3.753 22631643,157,249,J_Biomed_Sci_2016_Mar_17_23_35.txt
1.14.3.191,...2-9900Korean Breast Cancer Society 10.4048/jbc.2011.14.3.191Original ArticleThe Impact of Local and ...,3,105,J_Breast_Cancer_2011_Sep_29_14(3)_191-197.txt
2.15.3.337,...2-9900Korean Breast Cancer Society 10.4048/jbc.2012.15.3.337Original ArticleRadiation Pneumonitis in...,3,120,J_Breast_Cancer_2012_Sep_28_15(3)_337-343.txt
4.17.2.129,...2-9900Korean Breast Cancer Society 10.4048/jbc.2014.17.2.129Original ArticleCharacteristics of BRCA1...,3,120,J_Breast_Cancer_2014_Jun_27_17(2)_129-135.txt
6.19.4.358,...2-9900Korean Breast Cancer Society 10.4048/jbc.2016.19.4.358Original ArticleAlkyl Cinnamates Induce ...,3,120,PMC5204042.txt
3.18.2.186,...rean Society of Cancer Prevention 10.15430/JCP.2013.18.2.186jcp-18-186Short CommunicationCurcumin In...,3,128,J_Cancer_Prev_2013_Jun_18(2)_186-191.txt
6.9.11.198,...Opin Pharmacother 2008 9 1981 1986 10.1517/14656566.9.11.1981 18627335,111,146,J_Cancer_Res_Clin_Oncol_2011_Mar_4_137(3)_415-422.txt
3.21.2.96,...Korean Society of Echocardiography 10.4250/jcu.2013.21.2.96Case ReportProsthetic Mitral Valve Leafle...,3,154,J_Cardiovasc_Ultrasound_2013_Jun_26_21(2)_96-99.txt
3.21.3.113,...Korean Society of Echocardiography 10.4250/jcu.2013.21.3.113Editorial CommentVariable Morphology of ...,3,154,J_Cardiovasc_Ultrasound_2013_Sep_30_21(3)_113-115.txt
5.23.3.150,...Korean Society of Echocardiography 10.4250/jcu.2015.23.3.150Original ArticleImpaired Diastolic Recov...,3,154,J_Cardiovasc_Ultrasound_2015_Sep_24_23(3)_150-157.txt
5.23.4.266,...Korean Society of Echocardiography 10.4250/jcu.2015.23.4.266Case ReportA Case of Klippel-Trenaunay S...,3,154,J_Cardiovasc_Ultrasound_2015_Dec_30_23(4)_266-270.txt
1.1.1.37,"malate: NAD oxidoreductase, 1.1.1.37)",201,29,J_Cell_Biol_1968_May_1_37(2)_575-579.txt
1.1.1.8,"1.1.1.8), and a particulate mitochondrial inne",69,1,J_Cell_Biol_1974_Dec_1_63(3)_864-882.txt
EC 4.2.1.1,"tase (EC 6.3.1.2) and carbonic anhydrase (EC 4.2.1.1). These results, togethe",23,43,J_Cell_Biol_1978_Sep_1_78(3)_675-684.txt
EC 3.4.21.14,"3.4.21.4), proteinase K (EC 3.4.21.14), and elastase (EC 3.4.21.11) fro",129,26,J_Cell_Biol_1986_Jul_1_103(1)_241-253.txt
EC 3.4.24.11,"dase (EC 3.4.24.11), also did not affect the enzyme acti...",453,7,J_Cell_Biol_1994_Sep_1_126(5)_1319-1327.txt
EC 3.1.1.7,Acetylcholinesterase (AChE; EC 3.1.1.7) terminates neurotransmission by hydrol...,10,29,J_Cell_Biol_2004_May_24_165(4)_505-515.txt
4.1.1.32,vate carboxykinase (E.C.4.1.1.32) were carried out by the use of glucose,223,25,J_Cell_Biol_1991_Dec_1_115(5)_1397-1408.txt
6.2.1.3,6.2.1.3) (24) were determined by previously descri...,264,1,J_Cell_Biol_1978_Jan_1_76(1)_245-253.txt
5.17.4.301,...Korean Endovascular Neurosurgeons 10.7461/jcen.2015.17.4.301Original ArticleOutcomes of Stent-assist...,3,248,J_Cerebrovasc_Endovasc_Neurosurg_2015_Dec_31_17(4)_301-312.txt
3.16.7.645,... Microbe Interact 2003 16 645 649 10.1094/MPMI.2003.16.7.645 12848430,156,220,J_Chem_Ecol_2014_Sep_28_40(10)_1099-1109.txt
5.4.6.759,...rug Metabol Toxicol 2008 4 759 770 10.1517/17425255.4.6.759,212,131,J_Cheminform_2012_Nov_27_4_31.txt
4.6.7.30,using the pdb2gmx tool from GROMACS 4.6.7.30 Free-energ,164,37,J_Chem_Theory_Comput_2016_Jun_14_12(6)_2790-2798.txt
4.17.1.47,...tr Endocrinol Metab 2004 17 47 54 10.1515/JPEM.2004.17.1.47 14960021,142,206,J_Child_Orthop_2015_Apr_13_9(2)_145-152.txt
3.5.2.88,...y Asthma Immunol Res 2013 5 88 95 10.4168/aair.2013.5.2.88 23450209,257,166,J_Clin_Immunol_2015_Aug_16_35(6)_573-582.txt
3.1.2.1,3.1.2.1. Experimental Dat,141,1,J_Clin_Med_2015_Oct_23_4(10)_1866-1889.txt
4.15.3.511,...y Psychol Aging 2000 15 3 511 526 10.1037/0882-7974.15.3.511 11014714,240,215,J_Clin_Med_Res_2015_Nov_25_7(11)_845-852.txt
4.46.3.261,...Cancer Res Treat 2014 46 3 261 269 10.4143/crt.2014.46.3.261 25038761,84,256,J_Clin_Med_Res_2015_Dec_23_7(12)_1007-1012.txt
5.19.1.11,... Pancreat Surg 2015 19 1 11 16 10.14701/kjhbps.2015.19.1.11 26155271,294,272,PMC5215011.txt
6.2.1.12,...013Korean Neurological Association 10.3988/jcn.2006.2.1.12ReviewTherapeutic Effects of Caloric Stimu...,3,126,J_Clin_Neurol_2006_Mar_20_2(1)_12-28.txt
1.7.2.69,...013Korean Neurological Association 10.3988/jcn.2011.7.2.69Original ArticlePlaque Rupture is a Determ...,3,126,J_Clin_Neurol_2011_Jun_28_7(2)_69-76.txt
5.11.3.283,...n Neurological Association 2574982310.3988/jcn.2015.11.3.283Case ReportAutoantibody-Mediated Sensory...,3,147,J_Clin_Neurol_2015_Jul_1_11(3)_283-286.txt
5.11.4.311,... this article at http://dx.doi.org/10.3988/jcn.2015.11.4.311,78,100,J_Clin_Neurol_2015_Oct_21_11(4)_311-318.txt
4.14.4.511,...pin Investig Drugs 2005 14 511 519 10.1517/13543784.14.4.511,275,152,J_Clin_Transl_Hepatol_2014_Sep_15_2(3)_202-211.txt
2.6.3.511,...wo methodologies Emotion  511 516 10.1037/1528-3542.6.3.511 16938091,148,196,J_Cogn_Psychol_(Hove)_2016_Jul_3_28(5)_6018-610.txt
3.34.4.811,...rception and Performance  811 817 10.1037/0096-1523.34.4.811 18665727,149,222,J_Cogn_Psychol_(Hove)_2016_Jul_3_28(5)_6018-610.txt
5.46.4.471,...Medical Journal  2005 46 4 471 479 10.3349/ymj.2005.46.4.471 2-s2.0-24644482376 16127770,169,196,J_Diabetes_Res_2015_Aug_6_2015_153829.txt
5.89.1.1,... Med 2015 89 1 5 http://dx.doi.org/10.3904/kjm.2015.89.1.1,25,169,J_Educ_Eval_Health_Prof_2016_Jan_11_13_2.txt
2.15.2.28,"...le imputation, in R statistical software, version 2.15.2.2",95,548,J_Epidemiol_2014_Jan_5_24(1)_31-38.txt
1.4.2.35,.... J Womens Med . 2011 ;4 :35 –40 . 10.5468/jwm.2011.4.2.35,250,197,J_Epidemiol_2016_Jul_5_26(7)_371-377.txt
1.2.2.1,... the same habitat (identification scenario 1.1 or 1.2.2.1.2 in the Background chapter),519,958,J_Ethnobiol_Ethnomed_2010_Dec_17_6_36.txt
3.31.2.248,...ayan families Ethos 2003 31 248 73 10.1525/eth.2003.31.2.248,212,116,J_Ethnobiol_Ethnomed_2015_Apr_30_11_33.txt
3.17.4.181,...an Society for Exercise Nutrition 10.5717/jenb.2013.17.4.181jenb-17-4-181Original PaperEffects of ex...,3,171,J_Exerc_Nutrition_Biochem_2013_Dec_23_17(4)_181-188.txt
5.19.1.11,...an Society for Exercise Nutrition 10.5717/jenb.2015.19.1.11jenb-19-1-11Original PaperTreadmill exerc...,3,171,J_Exerc_Nutrition_Biochem_2015_Mar_31_19(1)_11-18.txt
EC 1.6.4.2,"...PX; EC 1.11.1.11), and glutathione reductase (GR; EC 1.6.4.2). For APX, 5 mM ascorbate was included ...",29,645,J_Exp_Bot_2011_Oct_21_62(14)_5037-5050.txt
2.4.1.207,"protein 8; EC=2.4.1.207, Cell wall	38A",159,23,J_Exp_Bot_2012_Jan_20_63(2)_739-755.txt
EC 6.3.4.5,"...ine pathway, encoding argininosuccinate synthase (EC 6.3.4.5) exhibited a high level of expression a...",183,86,J_Exp_Bot_2009_Jan_17_60(1)_153-167.txt
EC 3.1.3.25,"...endent myo-inositol 1-phosphate phosphatase (IMP; EC 3.1.3.25) (Loewus and Loewus, 1983; Loewus,1990...",12,278,J_Exp_Bot_2013_Dec_11_64(18)_5623-5639.txt
EC 4.1.1.31,"...ar plants, phosphoenolpyruvate carboxylase (PEPC; EC 4.1.1.31) belongs to a multigene family, and ea...",33,60,J_Exp_Bot_2014_Jul_9_65(13)_3623-3636.txt
EC 1.11.1.6,Total catalase (CAT) (EC 1.11.1.6) activity was assayed by measuring the...,73,23,J_Exp_Bot_2015_Mar_24_66(5)_1339-1353.txt
4.2.6.791,...stroenterol Hepatol 2008 2 791 802 10.1586/17474124.2.6.791 19090739,150,187,J_Exp_Clin_Cancer_Res_2014_Jul_18_33(1)_57.txt
3.40.4.374,...ion Arch Plast Surg 2013 4 374 379 10.5999/aps.2013.40.4.374 23898434,166,220,J_Exp_Clin_Cancer_Res_2014_Nov_25_33(1)_78.txt
3.2.1.96,F (Endo-F) (E.C. 3.2.1.96) (10 U/ml): 10 mM orthophrenanthro,188,18,J_Exp_Med_1991_Oct_1_174(4)_827-836.txt
2.42.42.32,"V.49 L.C. q- \" Unchanged. 2.42.42.32.4 0.00.13 0X 1.",542,27,J_Exp_Med_1918_Nov_30_28(6)_735-748.txt
6.65.65.8,7.4'3.7[6.65.65.,279,9,J_Exp_Med_1921_Oct_31_34(5)_447-454.txt
1.91.90.7,1.91.90.7 <0.,246,1,J_Exp_Med_1955_May_1_101(5)_461-478.txt
1.2.4.2,1.2.4.2.,496,1,J_Exp_Med_1964_Jun_1_119(6)_869-879.txt
5.6.2.4,"~2b parent, 45.6.2.4 (Table II, line i). These results, like ou...",341,14,J_Exp_Med_1978_Jun_1_147(6)_1535-1550.txt
EC 5.3.1.8,"...1, EC 1.1.1.40);mannose phosphate isomerase (MPI, EC 5.3.1.8);nucleosid",78,66,J_Exp_Med_1978_Aug_1_148(2)_451-465.txt
EC 2.7.4.3,"... (SOD-I, EC 1.1.5.1.1); adenylate kinase-1 (AK-1, EC 2.7.4.3); triose phosphat",123,60,J_Exp_Med_1980_Jul_1_152(1)_219-228.txt
2.7.4.3,(AK-1; EC2.7.4.3) and soluble aconitase (ACON-S; EC4.2.1.3)...,71,10,J_Exp_Med_1982_May_1_155(5)_1480-1490.txt
4.4.4.-,"and the 14.4.4.-H 106-131 interactions, and all sera inhibi...",166,10,J_Exp_Med_1986_May_1_163(5)_1051-1063.txt
3.2.1.88,"...ior Processes , 2 , 88 –96 . doi: 10.1037/0097-7403.2.1.88 1249526",234,208,J_Exp_Psychol_Anim_Behav_Process_2013_Oct_13_39(4)_342-356.txt
3.34.3.419,"...avior Processes , 34 , 419 –422 . 10.1037/0097-7403.34.3.419 18665724",260,212,J_Exp_Psychol_Anim_Learn_Cogn_2016_Jan_16_42(1)_51-66.txt
3.29.2.298,10.1037/0278-7393.29.2.298,475,17,J_Exp_Psychol_Appl_2015_Mar_5_21(1)_15-36.txt
3.18.4.553,...Sports Phys Ther 1993 18 4 553 8 10.2519/jospt.1993.18.4.553 8220414,185,204,J_Foot_Ankle_Res_2016_Jul_26_9_24.txt
1.11.4.239,... Korean Gastric Cancer Association 10.5230/jgc.2011.11.4.239Case ReportTotally Laparoscopic Resectio...,3,116,J_Gastric_Cancer_2011_Dec_29_11(4)_239-242.txt
4.14.4.266,... Korean Gastric Cancer Association 10.5230/jgc.2014.14.4.266Original ArticleThe Result of Conversion...,3,132,J_Gastric_Cancer_2014_Dec_26_14(4)_266-270.txt
6.16.2.98,... Korean Gastric Cancer Association 10.5230/jgc.2016.16.2.98Original ArticleRisk Factors for Gallston...,3,132,J_Gastric_Cancer_2016_Jun_24_16(2)_98-104.txt
6.16.3.191,... Korean Gastric Cancer Association 10.5230/jgc.2016.16.3.191Case ReportHypercalcemia as Initial Pres...,3,132,J_Gastric_Cancer_2016_Sep_30_16(3)_191-194.txt
3.22.6.605,"...nt Health Psychol 2003 22 605 615 10.1037/0278-6133.22.6.605 Ditto PH, Smucker WD, Danks JH, et al. ...",192,158,J_Gen_Intern_Med_2007_Apr_23_22(4)_495-501.txt
4.2.1.1,"carbonic anhydrase (carbonate hydrolyase, E.C. 4.2.1.1., Sigma Chemical Co., St. Louis",156,48,J_Gen_Physiol_1976_Dec_1_68(6)_633-652.txt
EC 3.4.22.-,Ssc.16057.2.S1_a_at	0.650	GANC	Calpain 3 (EC 3.4.22.-) (Calpain L3),194,43,J_Gen_Virol_2008_Oct_89(Pt_10)_2550-2564.txt
1.35.4.487,...an Society of Ginseng grosbr-35-48710.5142/jgr.2011.35.4.487ArticlesCharacterizing a Full Spectrum o...,3,133,J_Ginseng_Res_2011_Nov_35(4)_487-496.txt
EC 1.2.4.1,"..._seq16 (No. 14), encoding pyruvate dehydrogenase (EC 1.2.4.1), were expressed at low levels in SH an...",97,619,PMC5223079.txt
EC 1.2.4.1,ko00020	EC 1.2.4.1	Pyruvate dehydrogenase	XM_002523354.1c	...,187,9,PMC5223079.txt
1.22.3.214,...ynecologic Oncology and Colposcopy 10.3802/jgo.2011.22.3.214CorrespondenceProlonged survival followi...,3,137,J_Gynecol_Oncol_2011_Sep_28_22(3)_214-217.txt
3.24.2.135,...an Society of Gynecologic Oncology 10.3802/jgo.2013.24.2.135Original ArticleOvaryReproductive factor...,3,176,J_Gynecol_Oncol_2013_Apr_5_24(2)_135-140.txt
1.89.1.77,...others Psychol Rep 2001 89 1 77 84 10.2466/pr0.2001.89.1.77 11729556,244,171,J_Headache_Pain_2016_Apr_19_17_39.txt
2.18.2.96,...are Management  2012 18 2 96 102 10.12968/bjhc.2012.18.2.96 2-s2.0-84857855446,177,164,PMC5168447.txt
2.8.5.409,... Opin Ther Targets 2004 8 5 409 22 10.1517/14728222.8.5.409 15469392,127,124,J_Hematol_Oncol_2011_Aug_1_4_31.txt
6.10.3.399,...e Pharmacogenomics 2009 10 399 416 10.2217/14622416.10.3.399 19290790,379,177,J_Hematol_Oncol_2014_Jun_2_7_43.txt
5.45.6.516,...ulation Journal  2015 45 6 516 521 10.4070/kcj.2015.45.6.516 2-s2.0-84958637608 26617655,189,194,J_Immunol_Res_2016_Oct_3_2016_4396368.txt
3.21.34.147,...vity J Psychophys 2007 21 147 163 10.1027/0269-8803.21.34.14,231,94,J_Inherit_Metab_Dis_2011_Aug_4_34(4)_953-962.txt
5.18.4.613,...a Neuropsychology 2004 18 613 620 10.1037/0894-4105.18.4.613 15506828,145,148,J_Inherit_Metab_Dis_2012_Nov_24_35(6)_1001-1009.txt
EC 3.2.1.23,"...ene, the GLB1 gene which encodes β-galactosidase (EC 3.2.1.23)",10,986,J_Inherit_Metab_Dis_2013_Mar_1_36(2)_293-307.txt
2.9.3.2,...uilibrium (LD) were performed by the use of FSTAT 2.9.3.2 (Goudet 2002). Genetic differences between...,88,304,J_Insect_Sci_2010_Sep_10_10_147.txt
6.18.3.259,...on and Prevention 2006 13 259 272 10.1521/aeap.2006.18.3.259 16774467,268,159,J_Int_AIDS_Soc_2010_Nov_15_13_44.txt
4.40.11.872,"..., February 2428, 2002 Abstract 409 10.1358/dot.2004.40.11.872579",256,276,J_Int_AIDS_Soc_2006_May_10_8_36.txt
EC 2.6.1.2,...e less specific markers AST (EC 2.6.1.1) and ALT (EC 2.6.1.2) (Table,78,380,J_Int_Soc_Sports_Nutr_2012_Jun_26_9_30.txt
3.39.2.94,...Oral and Maxillofacial Surgeons 10.5125/jkaoms.2013.39.2.94Case ReportDisplacement of dental implant...,3,239,J_Korean_Assoc_Oral_Maxillofac_Surg_2013_Apr_23_39(2)_94-99.txt
3.39.6.292,...Oral and Maxillofacial Surgeons 10.5125/jkaoms.2013.39.6.292Case ReportVerruciform xanthoma of the p...,3,239,J_Korean_Assoc_Oral_Maxillofac_Surg_2013_Dec_23_39(6)_292-296.txt
3.39.6.292,...Oral and Maxillofacial Surgeons 10.5125/jkaoms.2013.39.6.292Case ReportVerruciform xanthoma of the p...,3,239,J_Korean_Assoc_Oral_Maxillofac_Surg_2013_Dec_23_39(6)_292-296.txt
3.39.6.257,...Oral and Maxillofacial Surgeons 10.5125/jkaoms.2013.39.6.257Original ArticleTibial bone fractures oc...,3,239,J_Korean_Assoc_Oral_Maxillofac_Surg_2013_Dec_23_39(6)_257-262.txt
4.40.2.98,...Oral and Maxillofacial Surgeons 10.5125/jkaoms.2014.40.2.98Letter to the EditorThe current problem w...,3,239,J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Apr_28_40(2)_98-99.txt
4.40.4.195,...Oral and Maxillofacial Surgeons 10.5125/jkaoms.2014.40.4.195Case ReportCavernous sinus thrombosis ca...,3,239,J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Aug_26_40(4)_195-198.txt
5.41.1.52,...Oral and Maxillofacial Surgeons 10.5125/jkaoms.2015.41.1.52Case ReportAn unusual abscess formation i...,3,239,J_Korean_Assoc_Oral_Maxillofac_Surg_2015_Feb_24_41(1)_52-56.txt
5.20.3.373,...orean Academy of Medical Sciences 10.3346/jkms.2005.20.3.37315953855Original ArticleDistribution of ...,3,127,J_Korean_Med_Sci_2005_Jun_30_20(3)_373-378.txt
6.21.2.229,...orean Academy of Medical Sciences 10.3346/jkms.2006.21.2.22916614506Original ArticlePreoperative Con...,3,127,J_Korean_Med_Sci_2006_Apr_20_21(2)_229-235.txt
5.20.6.105,...orean Academy of Medical Sciences 10.3346/jkms.2005.20.6.105316361821Original ArticleNatural Menopau...,3,127,J_Korean_Med_Sci_2005_Dec_31_20(6)_1053-1058.txt
6.21.6.973,...orean Academy of Medical Sciences 10.3346/jkms.2006.21.6.97317179671Original ArticleThree-Year Follo...,3,127,J_Korean_Med_Sci_2006_Dec_31_21(6)_973-978.txt
6.31.8.125,...orean Academy of Medical Sciences 10.3346/jkms.2016.31.8.1254Original ArticlePediatricsCharacteristi...,3,145,J_Korean_Med_Sci_2016_Aug_18_31(8)_1254-1261.txt
5.20.5.740,...orean Academy of Medical Sciences 10.3346/jkms.2005.20.5.74016224145Original ArticlePediatric Radiof...,3,127,J_Korean_Med_Sci_2005_Oct_31_20(5)_740-746.txt
4.19.6.834,...orean Academy of Medical Sciences 10.3346/jkms.2004.19.6.83415608394Original ArticleIn vivo Recombin...,3,127,J_Korean_Med_Sci_2004_Dec_31_19(6)_834-841.txt
4.19.1.321,...orean Academy of Medical Sciences 10.3346/jkms.2004.19.1.3214966338Original ArticleThe Distribution ...,3,127,J_Korean_Med_Sci_2004_Feb_28_19(1)_32-36.txt
1.26.5.654,...orean Academy of Medical Sciences 10.3346/jkms.2011.26.5.654Original ArticleGastroenterology & Hepat...,3,127,J_Korean_Med_Sci_2011_May_21_26(5)_654-658.txt
1.26.6.844,...orean Academy of Medical Sciences 10.3346/jkms.2011.26.6.844Case ReportRehabilitation & Sports Medic...,3,127,J_Korean_Med_Sci_2011_Jun_18_26(6)_844-847.txt
1.26.8.979,"...orean Academy of Medical Sciences 10.3346/jkms.2011.26.8.979Original ArticleInfectious Diseases, Mic...",3,127,J_Korean_Med_Sci_2011_Aug_27_26(8)_979-984.txt
1.26.9.120,...orean Academy of Medical Sciences 10.3346/jkms.2011.26.9.1209Original ArticleRespiratory DiseasesInf...,3,127,J_Korean_Med_Sci_2011_Sep_1_26(9)_1209-1213.txt
1.26.9.124,...orean Academy of Medical Sciences 10.3346/jkms.2011.26.9.1244Case ReportNeuroscienceDopa-responsive ...,3,127,J_Korean_Med_Sci_2011_Sep_1_26(9)_1244-1246.txt
2.27.2.228,...orean Academy of Medical Sciences 10.3346/jkms.2012.27.2.228Brief CommunicationOncology & Hematology...,3,127,J_Korean_Med_Sci_2012_Feb_27_27(2)_228-230.txt
2.27.7.784,...orean Academy of Medical Sciences 10.3346/jkms.2012.27.7.784Original ArticlePediatricsSpot Urine Alb...,3,145,J_Korean_Med_Sci_2012_Jul_29_27(7)_784-787.txt
2.27.9.101,...orean Academy of Medical Sciences 10.3346/jkms.2012.27.9.1014Original ArticleOncology & HematologyPr...,3,145,J_Korean_Med_Sci_2012_Sep_22_27(9)_1014-1018.txt
3.28.4.497,"...orean Academy of Medical Sciences 10.3346/jkms.2013.28.4.497ReviewImmunology, Allergic Disorders & R...",3,145,J_Korean_Med_Sci_2013_Apr_27_28(4)_497-507.txt
3.28.11.159,...orean Academy of Medical Sciences 10.3346/jkms.2013.28.11.1595Original ArticleOncology & HematologyP...,3,145,J_Korean_Med_Sci_2013_Nov_31_28(11)_1595-1602.txt
3.28.12.176,"...orean Academy of Medical Sciences 10.3346/jkms.2013.28.12.1762Original ArticleEndocrinology, Nutriti...",3,145,J_Korean_Med_Sci_2013_Dec_26_28(12)_1762-1767.txt
5.30.5.662,"...orean Academy of Medical Sciences 10.3346/jkms.2015.30.5.662Case ReportInfectious Diseases, Microbio...",3,145,J_Korean_Med_Sci_2015_May_15_30(5)_662-665.txt
5.30.5.591,...orean Academy of Medical Sciences 10.3346/jkms.2015.30.5.591Original ArticleRespiratory DiseasesRadi...,3,145,J_Korean_Med_Sci_2015_May_15_30(5)_591-597.txt
5.30.12.187,...orean Academy of Medical Sciences 10.3346/jkms.2015.30.12.1874Original ArticleEmergency & Critical C...,3,145,J_Korean_Med_Sci_2015_Dec_30_30(12)_1874-1880.txt
6.31.2.315,"...orean Academy of Medical Sciences 10.3346/jkms.2016.31.2.315Brief CommunicationInfectious Diseases, ...",3,145,J_Korean_Med_Sci_2016_Feb_14_31(2)_315-320.txt
6.31.2.159,...orean Academy of Medical Sciences 10.3346/jkms.2016.31.2.159Original ArticleMedicine General & Socia...,3,145,J_Korean_Med_Sci_2016_Feb_26_31(2)_159-163.txt
6.31.3.345,...orean Academy of Medical Sciences 10.3346/jkms.2016.31.3.345Original ArticleMedicine General & Socia...,3,145,J_Korean_Med_Sci_2016_Mar_4_31(3)_345-352.txt
6.31.5.750,...orean Academy of Medical Sciences 10.3346/jkms.2016.31.5.750Original ArticleUrologyDaily Mean Temper...,3,145,J_Korean_Med_Sci_2016_May_18_31(5)_750-756.txt
6.31.6.957,...orean Academy of Medical Sciences 10.3346/jkms.2016.31.6.957Original ArticleUrologyRadical Prostatec...,3,145,J_Korean_Med_Sci_2016_Jun_25_31(6)_957-962.txt
6.31.7.106,...orean Academy of Medical Sciences 10.3346/jkms.2016.31.7.1069Original ArticleRespiratory DiseasesEff...,3,145,J_Korean_Med_Sci_2016_Jul_19_31(7)_1069-1074.txt
6.31.11.172,...ademy of Medical Sciences 2770984910.3346/jkms.2016.31.11.1726Original ArticleOncology & HematologyN...,3,153,J_Korean_Med_Sci_2016_Nov_2_31(11)_1726-1734.txt
2.51.1.62,...6The Korean Neurosurgical Society 10.3340/jkns.2012.51.1.62Case ReportEndovascular Treatment of a La...,3,133,J_Korean_Neurosurg_Soc_2012_Jan_31_51(1)_62-65.txt
2.51.6.367,...6The Korean Neurosurgical Society 10.3340/jkns.2012.51.6.367Case ReportTerson Syndrome Caused by Int...,3,155,J_Korean_Neurosurg_Soc_2012_Jun_30_51(6)_367-369.txt
2.51.6.343,...6The Korean Neurosurgical Society 10.3340/jkns.2012.51.6.343Clinical ArticleNFlex Dynamic Stabilizat...,3,155,J_Korean_Neurosurg_Soc_2012_Jun_30_51(6)_343-349.txt
2.52.2.92,...6The Korean Neurosurgical Society 10.3340/jkns.2012.52.2.92Clinical ArticleTemozolomide during and a...,3,155,J_Korean_Neurosurg_Soc_2012_Aug_31_52(2)_92-97.txt
2.52.2.159,...6The Korean Neurosurgical Society 10.3340/jkns.2012.52.2.159Case ReportCongenital Osseus Bridging of...,3,155,J_Korean_Neurosurg_Soc_2012_Aug_31_52(2)_159-160.txt
2.52.2.120,...6The Korean Neurosurgical Society 10.3340/jkns.2012.52.2.120Clinical ArticlePosterior Atalntoaxial F...,3,155,J_Korean_Neurosurg_Soc_2012_Aug_31_52(2)_120-125.txt
2.52.4.312,...6The Korean Neurosurgical Society 10.3340/jkns.2012.52.4.312Clinical ArticleSeizures after Spontaneo...,3,155,J_Korean_Neurosurg_Soc_2012_Oct_22_52(4)_312-319.txt
2.52.5.435,...6The Korean Neurosurgical Society 10.3340/jkns.2012.52.5.435Laboratory InvestigationEffect of Bone C...,3,155,J_Korean_Neurosurg_Soc_2012_Nov_30_52(5)_435-440.txt
2.52.6.567,...6The Korean Neurosurgical Society 10.3340/jkns.2012.52.6.567Case ReportHemorrhagic Lumbar Synovial C...,3,155,J_Korean_Neurosurg_Soc_2012_Dec_31_52(6)_567-569.txt
3.53.3.155,...6The Korean Neurosurgical Society 10.3340/jkns.2013.53.3.155Clinical ArticleRisk Factors for Develop...,3,155,J_Korean_Neurosurg_Soc_2013_Mar_31_53(3)_155-160.txt
3.54.1.65,...6The Korean Neurosurgical Society 10.3340/jkns.2013.54.1.65Case ReportSymptomatic Epidural Pneumorrh...,3,155,J_Korean_Neurosurg_Soc_2013_Jul_31_54(1)_65-67.txt
4.55.3.152,...6The Korean Neurosurgical Society 10.3340/jkns.2014.55.3.152Case ReportBrainstem Congestion due to D...,3,155,J_Korean_Neurosurg_Soc_2014_Mar_31_55(3)_152-155.txt
4.55.4.212,...6The Korean Neurosurgical Society 10.3340/jkns.2014.55.4.212Case ReportOdontoid Synchondrosis Fractu...,3,155,J_Korean_Neurosurg_Soc_2014_Apr_30_55(4)_212-214.txt
4.56.3.269,...6The Korean Neurosurgical Society 10.3340/jkns.2014.56.3.269Case ReportAcute Spontaneous Spinal Subd...,3,155,J_Korean_Neurosurg_Soc_2014_Sep_30_56(3)_269-271.txt
4.56.4.295,...6The Korean Neurosurgical Society 10.3340/jkns.2014.56.4.295Clinical ArticleAssociation Factors for ...,3,155,J_Korean_Neurosurg_Soc_2014_Oct_31_56(4)_295-302.txt
4.56.5.419,...6The Korean Neurosurgical Society 10.3340/jkns.2014.56.5.419Case ReportProgressive Manifestations of...,3,155,J_Korean_Neurosurg_Soc_2014_Nov_30_56(5)_419-422.txt
5.58.5.471,...6The Korean Neurosurgical Society 10.3340/jkns.2015.58.5.471Case ReportDeep Intracerebral Hemorrhage...,3,155,J_Korean_Neurosurg_Soc_2015_Nov_30_58(5)_471-475.txt
5.58.5.494,...6The Korean Neurosurgical Society 10.3340/jkns.2015.58.5.494Technical NoteSpinous Process-Splitting ...,3,155,J_Korean_Neurosurg_Soc_2015_Nov_30_58(5)_494-498.txt
6.59.2.165,...6The Korean Neurosurgical Society 10.3340/jkns.2016.59.2.165Case ReportCase of Langerhans Cell Histi...,3,155,J_Korean_Neurosurg_Soc_2016_Mar_29_59(2)_165-167.txt
6.59.3.310,...6The Korean Neurosurgical Society 10.3340/jkns.2016.59.3.310Case ReportPosttraumatic Intracranial Tu...,3,155,J_Korean_Neurosurg_Soc_2016_May_10_59(3)_310-313.txt
1.80.4.251,...3-0488The Korean Surgical Society 10.4174/jkss.2011.80.4.251Original ArticleMigrating motor complex ...,3,122,J_Korean_Surg_Soc_2011_Apr_12_80(4)_251-259.txt
5.46.1.173,...penia Yonsei Med J 2005 46 173 176 10.3349/ymj.2005.46.1.173 1574482,45,170,J_Med_Case_Rep_2013_Apr_25_7_113.txt
4.16.6.2,...drome Neurosurg Focus 2004 16 6 e2 10.3171/foc.2004.16.6.2 15202872,121,104,J_Med_Case_Rep_2016_Jun_6_10_165.txt
1.50.5.434,...rean Neurosurg Soc 2011 50 434 40 10.3340/jkns.2011.50.5.434 22259690,175,239,PMC5209804.txt
1.5.1.64,...erature Asian Spine J 2011 5 64 67 10.4184/asj.2011.5.1.64 21386948,69,214,J_Med_Case_Reports_2012_Mar_26_6_89.txt
3.1.50.96,...on Systems Research 2002 13 1 50 69 10.1287/isre.13.1.50.96,311,176,J_Med_Internet_Res_2011_Nov_2_13(4)_e81.txt
4.69.1.176,...sychol 1995 7 69 1 176 90 7643299 10.1037/0022-3514.69.1.176 7643299,259,190,J_Med_Internet_Res_2010_Mar_12_12(1)_e6.txt
3.27.5.557,...Health Psychol 2008 9 27 5 557 66 10.1037/0278-6133.27.5.557 18823182 2008-13168-007 18823182,268,155,J_Med_Internet_Res_2011_Nov_24_13(4)_e100.txt
1.26.1.99,...ng Education 2011 2 26 1 99 131   10.2308/iace.2011.26.1.99,713,246,J_Med_Internet_Res_2013_Nov_25_15(11)_e259.txt
4.1.3.1,4.1.3.1.3 Educators must be aware of human-compute...,2011,2,J_Med_Internet_Res_2013_Oct_8_15(10)_e210.txt
3.19.1.6,...t J Palliat Nurs 2013 1 19 1 6 7 10.12968/ijpn.2013.19.1.6 23354427 23354427,285,127,J_Med_Internet_Res_2015_Apr_2_17(4)_e84.txt
3.25.1.3,...e Health Psychol 2006 1 25 1 3 14 10.1037/0278-6133.25.1.3 16448292 16448292,152,229,J_Med_Internet_Res_2016_Apr_25_18(4)_e88.txt
3.27.3.379,...Health Psychol 2008 5 27 3 379 87 10.1037/0278-6133.27.3.379 18624603 18624603,222,139,J_Med_Internet_Res_2016_Apr_19_18(4)_e86.txt
3.27.3.379,...Health Psychol 2008 5 27 3 379 87 10.1037/0278-6133.27.3.379 18624603 18624603,274,149,J_Med_Internet_Res_2016_Jun_10_18(6)_e147.txt
2.24.2.3,"...ge for parallelizing the code. In addition, MOSIX 2.24.2.3 was installed on the cluster. MOSIX is a ...",35,541,J_Med_Phys_2015_Apr-Jun_40(2)_80-89.txt
5.21.1.24,...761The Korean Society of Menopause 10.6118/jmm.2015.21.1.24Review ArticleNeutral Sphingomyelinase an...,3,131,J_Menopausal_Med_2015_Apr_27_21(1)_24-27.txt
5.21.2.63,...761The Korean Society of Menopause 10.6118/jmm.2015.21.2.63EditorialConsiderations Left behind Middl...,3,131,J_Menopausal_Med_2015_Aug_28_21(2)_63-64.txt
5.21.2.63,...761The Korean Society of Menopause 10.6118/jmm.2015.21.2.63EditorialConsiderations Left behind Middl...,3,131,J_Menopausal_Med_2015_Aug_28_21(2)_63-64.txt
3.27.3.379,...ealth Psychol 2008 5 27 3 379 387 10.1037/0278-6133.27.3.379 18624603 18624603,377,140,JMIR_Mhealth_Uhealth_2015_Mar_25_3(1)_e32.txt
3.28.4.564,...orean Med Sci 2013 4 28 4 564 8   10.3346/jkms.2013.28.4.564 23580444 23580444,300,297,JMIR_Mhealth_Uhealth_2016_Jun_24_4(2)_e57.txt
2.24.1.27,... AIDS Educ Prev 2012 2 24 1 27 40 10.1521/aeap.2012.24.1.27 22339143 22339143,750,216,JMIR_Mhealth_Uhealth_2016_Nov_10_4(4)_e122.txt
1.35.1.50,...abetes Metab J 2011 2 35 1 50 57   10.4093/dmj.2011.35.1.50 21537413 21537413,147,236,JMIR_Res_Protoc_2016_Mar_10_5(1)_e39.txt
2.7.4.10,...s Hum Res Ethics 2012 10 7 4 10 19 10.1525/jer.2012.7.4.10 23086044 23086044,235,274,JMIR_Res_Protoc_2016_Mar_17_5(1)_e48.txt
4.2.5.2,4.2.5.2.  Diamond nanoparticle dispersio,310,1,J_Mod_Opt_2016_Dec_15_63(sup3)_S11-S31.txt
3.2.1.75,...nses Future Microbiol 2007 2 75 84 10.2217/17460913.2.1.75 17661677,112,129,J_Mol_Med_2010_Apr_4_88(4)_371-381.txt
3.9.2.97,...ommon? J Clin Neurol 2013 9 97 102 10.3988/jcn.2013.9.2.97 23626647,183,196,J_Negat_Results_Biomed_2014_May_31_13_10.txt
6.7.14.197,"...Opin Pharmacother 2006 7 1977 1987 10.1517/14656566.7.14.1977 Schwartz TL, Nihalani N (2006) Tiagabi...",214,113,J_Neural_Transm_2009_Jun_8_116(6)_649-657.txt
4.58.1.243,...Percept Mot Skills 1984 58 243 245 10.2466/pms.1984.58.1.243 6718190,322,134,J_Neurodev_Disord_2013_Sep_24_5(1)_26.txt
3.8.5.651,...pt Perform 1982 8 651 663 6218227 10.1037/0096-1523.8.5.651,172,152,J_Neuroeng_Rehabil_2008_Nov_13_5_27.txt
1.17.2.158,...troenterology and Motility 2160299210.5056/jnm.2011.17.2.158Original ArticleYield of Combined Impeda...,3,169,J_Neurogastroenterol_Motil_2011_Apr_27_17(2)_158-163.txt
3.19.1.54,...Neurogastroenterology and Motility 10.5056/jnm.2013.19.1.54Original ArticleComparative Study of 2 Di...,3,187,J_Neurogastroenterol_Motil_2013_Jan_8_19(1)_54-60.txt
3.19.4.485,...astroenterol Motil 2013 19 485 494 10.5056/jnm.2013.19.4.485 24199009,228,236,J_Neurogastroenterol_Motil_2015_Jan_21(1)_69-77.txt
3.19.2.244,...astroenterol Motil 2013 19 244 250 10.5056/jnm.2013.19.2.244 23667756,152,220,J_Neurogastroenterol_Motil_2015_Apr_21(2)_236-246.txt
3.19.1.18,...ogastroenterol Motil 2013 19 18 24 10.5056/jnm.2013.19.1.18 23350043,23,151,J_Neurogastroenterol_Motil_2015_Oct_31_21(4)_455-456.txt
2.18.1.58,...ogastroenterol Motil 2012 18 58 63 10.5056/jnm.2012.18.1.58 22323988,119,265,J_Neurogastroenterol_Motil_2015_Oct_31_21(4)_494-502.txt
1.17.1.14,...ogastroenterol Motil 2011 17 14 27 10.5056/jnm.2011.17.1.14 21369488,115,146,J_Neurogastroenterol_Motil_2016_Jan_30_22(1)_25-30.txt
5.76.3.437,...beta J Periodontol 2005 76 437 442 10.1902/jop.2005.76.3.437 15857079,156,233,J_Neuroinflammation_2013_May_30_10_68.txt
2.8.3.430,...g material Emotion 2008 8 430 434 10.1037/1528-3542.8.3.430 18540760,191,165,J_Nonverbal_Behav_2014_Oct_26_38(1)_145-165.txt
2.1.3.14,"...ich, Switzerland) and (ii) the academic FlowQuant 2.1.3.14,17 Both programs use the same, previously...",57,206,J_Nucl_Cardiol_2016_May_21_23_499-510.txt
3.36.5.499,...ular Biology  2003 36 5 499 504 10.5483/bmbrep.2003.36.5.499 2-s2.0-0242382759 14536034,191,223,J_Obes_2015_Aug_20_2015_687914.txt
3.27.3.167,...f Ophthalmology  2013 27 3 167 171 10.3341/kjo.2013.27.3.167 2-s2.0-84891613343 23730108,120,182,J_Ophthalmol_2016_Feb_16_2016_8150757.txt
2.17.2.200,... Bone Miner Res 2002 17 2 200 209 10.1359/jbmr.2002.17.2.200 11811550,144,187,J_Orthop_Surg_Res_2011_Jun_15_6_30.txt
2.17.2.200,...on J Bone Miner Res 2002 17 200 9 10.1359/jbmr.2002.17.2.200 11811550,215,127,J_Orthop_Surg_Res_2015_Jul_16_10_111.txt
2.24.4.235,...e Surg Relat Res 2012 24 4 235 40 10.5792/ksrr.2012.24.4.235 23269962,229,163,J_Orthop_Surg_Res_2016_Feb_15_11_22.txt
3.40.4.353,...tion Arch Plast Surg 2013 40 353 8 10.5999/aps.2013.40.4.353 23898431,288,149,PMC5351107.txt
1.41.3.117,...Academy of Periodontology 2181168610.5051/jpis.2011.41.3.117Research ArticleEfficacy of electrical n...,3,170,J_Periodontal_Implant_Sci_2011_Jun_30_41(3)_117-122.txt
3.43.4.153,...6Korean Academy of Periodontology 10.5051/jpis.2013.43.4.153Research ArticleWhat is the effect of in...,3,162,J_Periodontal_Implant_Sci_2013_Aug_31_43(4)_153-159.txt
4.44.1.8,...6Korean Academy of Periodontology 10.5051/jpis.2014.44.1.8Research ArticleSurvival of 352 titanium i...,3,162,J_Periodontal_Implant_Sci_2014_Feb_26_44(1)_8-12.txt
6.46.6.396,...6Korean Academy of Periodontology 10.5051/jpis.2016.46.6.396Research ArticleAssociation between dent...,3,162,PMC5200865.txt
6.46.3.197,...6Korean Academy of Periodontology 10.5051/jpis.2016.46.3.197Research ArticleAlterations of papilla d...,3,162,J_Periodontal_Implant_Sci_2016_Jun_29_46(3)_197-206.txt
3.20.1.47,...que Health Psychol. 2001 20 47 63 10.1037/0278-6133.20.1.47 11199066,154,162,J_Pers_Med_2015_Aug_3_5(3)_280-295.txt
1.3.8.979,... Opin Drug Discov 2008 3 8 979 990 10.1517/17460441.3.8.979 23484971,98,156,J_Pharmacopuncture_2013_Dec_16(4)_7-13.txt
3.2.1.14,...n divided into 2 main groups: Endochitinases (E.C 3.2.1.14) and exo-chitinases. The endochitinases r...,12,70,J_Pharm_Bioallied_Sci_2013_Jan-Mar_5(1)_21-29.txt
4.44.1.113,...J Pers Soc Psychol 1983 44 113 26 10.1037/0022-3514.44.1.113,180,152,J_Physiol_Anthropol_2015_Mar_24_34(1)_14.txt
EC 2.4.1.123,...he source are credited.Galactinol synthase (GolS; EC 2.4.1.123) is a member of the glycosyltransfera...,4,256,J_Plant_Res_2014_Nov_5_127(2)_347-358.txt
1.38.4.179,...ctive Medicine  2011 38 4 179 185 10.5653/cerm.2011.38.4.179 2-s2.0-84864581372 22384440,209,172,J_Pregnancy_2016_Apr_28_2016_8689436.txt
4.69.2.237,...Social Psychology 1995 69 237 253 10.1037/0022-3514.69.2.237,179,135,J_Psychopathol_Behav_Assess_2012_Mar_12_34(1)_116-125.txt
5.3.1.4,"l-arabinose isomerase	5.3.1.4	✓	✓	n.a.	n.a.	n.a.	✓	[46,47]",67,23,J_R_Soc_Interface_2012_Jun_7_9(71)_1168-1176.txt
3.19.1.47,10.5056/jnm.2013.19.1.47 23350047,597,16,PMC5137314.txt
4.18.1.1,...oc Magne Res Med 2014 18 1 1 6 10.13104/jksmrm.2014.18.1.1,221,210,J_Ther_Ultrasound_2015_Jun_16_3_9.txt
2.2.1.21,...diovasc Ther 2004 2 21 28 15038410 10.1586/14779072.2.1.21,142,130,J_Transl_Med_2005_May_12_3_21.txt
6.4.4.581,...armacother 2003 4 581 586 12667120 10.1517/14656566.4.4.581,112,256,J_Transl_Med_2009_Mar_26_7_24.txt
6.6.1.27,...ty Pharmacogenomics 2005 6 1 27 36 10.1517/14622416.6.1.27 15723603,219,110,J_Transl_Med_2013_Jul_4_11_163.txt
4.52.2.137,...rean J Parasitol. 2014 52 2 137 42 10.3347/kjp.2014.52.2.137 24850956,154,228,Jundishapur_J_Microbiol_2015_Mar_21_8(3)_e22570.txt
4.34.4.313,...itis. Ann Lab Med. 2014 34 4 313 6 10.3343/alm.2014.34.4.313 24982837,120,272,Jundishapur_J_Microbiol_2015_Dec_26_8(12)_e28395.txt
2.3.2.1,clade 2.3.2.1 (Fig. 1Fig. 1. Phylogenetic trees for the ...,84,7,J_Vet_Med_Sci_2014_Jan_27_76(1)_85-87.txt
6.7.1.43,...iety of Veterinary Science 1643484810.4142/jvs.2006.7.1.43Original ArticlePassive immunization using...,3,124,J_Vet_Sci_2006_Mar_31_7(1)_43-46.txt
1.12.2.165,...iety of Veterinary Science 2158687610.4142/jvs.2011.12.2.165Original ArticleWhite spots on the mucos...,3,124,J_Vet_Sci_2011_Jun_20_12(2)_165-169.txt
6.7.1.63,...iety of Veterinary Science 1643485210.4142/jvs.2006.7.1.63Original ArticleParentage testing of Thoro...,3,124,J_Vet_Sci_2006_Mar_31_7(1)_63-67.txt
6.7.2.143,...iety of Veterinary Science 1664533910.4142/jvs.2006.7.2.143Original ArticleAlteration of nitrergic n...,3,124,J_Vet_Sci_2006_Jun_30_7(2)_143-150.txt
2.13.4.437,...iety of Veterinary Science 2327118810.4142/jvs.2012.13.4.437Case ReportLeft abomasal displacement be...,3,135,J_Vet_Sci_2012_Dec_20_13(4)_437-440.txt
3.14.2.115,...iety of Veterinary Science 2362865810.4142/jvs.2013.14.2.115Original ArticleGenetic diversity of por...,3,135,J_Vet_Sci_2013_Jun_21_14(2)_115-124.txt
4.15.2.297,...iety of Veterinary Science 2437858710.4142/jvs.2014.15.2.297Original ArticleEvaluation of endoscopic...,3,135,J_Vet_Sci_2014_Jun_16_15(2)_297-307.txt
4.15.3.389,...iety of Veterinary Science 2469060410.4142/jvs.2014.15.3.389Original ArticleMolecular characterizati...,3,135,J_Vet_Sci_2014_Sep_16_15(3)_389-398.txt
4.15.4.545,...rean Society of Veterinary Science 10.4142/jvs.2014.15.4.545Original ArticleSensitization rates of c...,3,127,J_Vet_Sci_2014_Dec_15_15(4)_545-550.txt
5.16.3.253,...iety of Veterinary Science 2554922010.4142/jvs.2015.16.3.253Original ArticleComparative proteomic an...,3,135,J_Vet_Sci_2015_Sep_21_16(3)_253-263.txt
5.16.3.289,...iety of Veterinary Science 2579729510.4142/jvs.2015.16.3.289Original ArticleEfficacy of silver ions ...,3,135,J_Vet_Sci_2015_Sep_21_16(3)_289-295.txt
5.16.3.373,...iety of Veterinary Science 2579729310.4142/jvs.2015.16.3.373Original ArticleRapamycin treatment duri...,3,135,J_Vet_Sci_2015_Sep_21_16(3)_373-380.txt
3.35.1.195,doi:http://dx.doi.org/10.1037/0096-1523.35.1.195,845,39,J_Vis_2016_Oct_31_16(13)_6.txt
3.4.6.3,"...d) 1:1,000 in Live Cell Nuclear Staining Solution.3.4.6.3). Add 50 μl of Live Cell Nuclear Staining ...",300,81,J_Vis_Exp_2016_May_10_(111)_53987.txt
1.2.4.3,...id master mix solution that will be split in step 1.2.4.3 to finalize the preparation of 3 different...,61,77,J_Vis_Exp_2016_Aug_1_(114)_54273.txt
3.82.1.33,"...ational Psychology,82, 33–40. doi:10.1037/0022-0663.82.1.33.",195,378,J_Youth_Adolesc_2010_Jan_20_39(1)_36-46.txt
5.3.2.3,5.3.2.3: For anticoagulation during CRRT in patien...,111,1,Kidney_Int_Suppl_(2011)_2012_Mar_29_2(1)_89-115.txt
1.4.2.1,"1.4.2.1: Evaluate the clinical context, including ...",90,1,Kidney_Int_Suppl_(2011)_2013_Jan_28_3(1)_5-14.txt
5.3.1.8,"...1.1.1.37.), MPI, mannose phosphate isomerase (E.C.5.3.1.8); ICD, isocitrate dehydrogenase (E.C.1.1.1...",29,839,Kinetoplastid_Biol_Dis_2002_Nov_20_1_7.txt
3.2.2.1,"... enzyme (ME; E.C.1.1.1.40), nucleotidase (NH, E.C.3.2.2.1), peptidase D (PEP-D, E.C.3.4.13.9), 6-pho...",34,395,Kinetoplastid_Biol_Dis_2003_Oct_28_2_17.txt
3.25.4.233,...62234-2451The Korean Knee Society 10.5792/ksrr.2013.25.4.233Case ReportAdenomyoepithelioma Located O...,3,132,Knee_Surg_Relat_Res_2013_Dec_29_25(4)_233-236.txt
4.26.3.141,...62234-2451The Korean Knee Society 10.5792/ksrr.2014.26.3.141Original ArticleTime-Dependent Clinical ...,3,132,Knee_Surg_Relat_Res_2014_Sep_29_26(3)_141-148.txt
3.25.4.165,...nee Surg Relat Res 2013 25 165 73 10.5792/ksrr.2013.25.4.165 24368993,122,140,Knee_Surg_Relat_Res_2016_Dec_1_28(4)_319-324.txt
6.28.3.207,...62234-2451The Korean Knee Society 10.5792/ksrr.2016.28.3.207Original ArticleProphylaxis for Venous T...,3,132,Knee_Surg_Relat_Res_2016_Sep_25_28(3)_207-212.txt
1.41.3.124,"...55The Korean Society of Cardiology 10.4070/kcj.2011.41.3.124Original ArticleDyslipidemia, Low Left V...",3,109,Korean_Circ_J_2011_Mar_31_41(3)_124-129.txt
1.41.12.754,...55The Korean Society of Cardiology 10.4070/kcj.2011.41.12.754Case ReportVery Late Stent Thrombosis d...,3,109,Korean_Circ_J_2011_Dec_31_41(12)_754-758.txt
5.45.2.161,...55The Korean Society of Cardiology 10.4070/kcj.2015.45.2.161Case ReportA Case of Constrictive Perica...,3,122,Korean_Circ_J_2015_Mar_24_45(2)_161-164.txt
5.45.3.216,http://dx.doi.org/10.4070/kcj.2015.45.3.21,7,34,Korean_Circ_J_2015_Jul_24_45(4)_348.txt
6.46.3.431,...55The Korean Society of Cardiology 10.4070/kcj.2016.46.3.431Letter to the EditorApelin Levels in Pat...,3,122,Korean_Circ_J_2016_May_26_46(3)_431.txt
6.46.5.739,...55The Korean Society of Cardiology 10.4070/kcj.2016.46.5.739Case ReportA Congenital Gerbode Defect a...,3,122,Korean_Circ_J_2016_Sep_16_46(5)_739-742.txt
6.46.5.727,...55The Korean Society of Cardiology 10.4070/kcj.2016.46.5.727Case ReportThrombotic Occlusion of Stent...,3,122,Korean_Circ_J_2016_Sep_16_46(5)_727-729.txt
1.60.3.179,...rean Society of Anesthesiologists 10.4097/kjae.2011.60.3.179Clinical Research ArticleThe optimal vol...,3,131,Korean_J_Anesthesiol_2011_Mar_30_60(3)_179-184.txt
1.60.4.290,...rean Society of Anesthesiologists 10.4097/kjae.2011.60.4.290Case ReportSevere hypotension and water ...,3,131,Korean_J_Anesthesiol_2011_Apr_26_60(4)_290-293.txt
1.60.6.437,...rean Society of Anesthesiologists 10.4097/kjae.2011.60.6.437Case ReportUnexpected difficulty in vent...,3,131,Korean_J_Anesthesiol_2011_Jun_17_60(6)_437-439.txt
1.61.4.281,...rean Society of Anesthesiologists 10.4097/kjae.2011.61.4.281Clinical Research ArticleComparison of t...,3,131,Korean_J_Anesthesiol_2011_Oct_22_61(4)_281-287.txt
1.61.4.327,...rean Society of Anesthesiologists 10.4097/kjae.2011.61.4.327Experimental Research ArticleEffects of ...,3,131,Korean_J_Anesthesiol_2011_Oct_22_61(4)_327-331.txt
2.62.2.175,...rean Society of Anesthesiologists 10.4097/kjae.2012.62.2.175Case ReportAbrupt formation of intracard...,3,131,Korean_J_Anesthesiol_2012_Feb_20_62(2)_175-178.txt
2.62.4.322,...rean Society of Anesthesiologists 10.4097/kjae.2012.62.4.322Clinical Research ArticleComparison of l...,3,151,Korean_J_Anesthesiol_2012_Apr_23_62(4)_322-326.txt
2.62.6.584,...rean Society of Anesthesiologists 10.4097/kjae.2012.62.6.584Letters to the EditorAnesthetic consider...,3,151,Korean_J_Anesthesiol_2012_Jun_19_62(6)_584-585.txt
3.64.1.65,...rean Society of Anesthesiologists 10.4097/kjae.2013.64.1.65Case ReportA detection of unexpected bloo...,3,151,Korean_J_Anesthesiol_2013_Jan_21_64(1)_65-68.txt
3.64.3.251,...rean Society of Anesthesiologists 10.4097/kjae.2013.64.3.251Experimental Research ArticleFalse selec...,3,151,Korean_J_Anesthesiol_2013_Mar_19_64(3)_251-256.txt
3.64.4.388,...rean Society of Anesthesiologists 10.4097/kjae.2013.64.4.388Letter to the EditorSpinal subarachnoid ...,3,151,Korean_J_Anesthesiol_2013_Apr_22_64(4)_388-389.txt
3.64.6.556,...rean Society of Anesthesiologists 10.4097/kjae.2013.64.6.556Letter to the EditorIntravascular migrat...,3,151,Korean_J_Anesthesiol_2013_Jun_24_64(6)_556-557.txt
3.65.1.42,...rean Society of Anesthesiologists 10.4097/kjae.2013.65.1.42Clinical Research ArticleA comparison of ...,3,151,Korean_J_Anesthesiol_2013_Jul_19_65(1)_42-47.txt
3.65.1.89,...rean Society of Anesthesiologists 10.4097/kjae.2013.65.1.89Letter to the EditorMultiple left subclav...,3,151,Korean_J_Anesthesiol_2013_Jul_19_65(1)_89-90.txt
4.66.2.169,...rean Society of Anesthesiologists 10.4097/kjae.2014.66.2.169Case ReportClinical experiences of perfo...,3,151,Korean_J_Anesthesiol_2014_Feb_28_66(2)_169-172.txt
4.67.6.391,...rean Society of Anesthesiologists 10.4097/kjae.2014.67.6.391Clinical Research ArticleComparison of t...,3,151,Korean_J_Anesthesiol_2014_Dec_29_67(6)_391-397.txt
5.68.4.346,...rean Society of Anesthesiologists 10.4097/kjae.2015.68.4.346Clinical Research ArticleUse of triazola...,3,151,Korean_J_Anesthesiol_2015_Aug_28_68(4)_346-351.txt
5.68.6.523,...rean Society of Anesthesiologists 10.4097/kjae.2015.68.6.523EditorialTherapeutic hypothermia for ele...,3,151,Korean_J_Anesthesiol_2015_Dec_25_68(6)_523-524.txt
5.68.6.523,...rean Society of Anesthesiologists 10.4097/kjae.2015.68.6.523EditorialTherapeutic hypothermia for ele...,3,151,Korean_J_Anesthesiol_2015_Dec_25_68(6)_523-524.txt
5.68.6.613,...rean Society of Anesthesiologists 10.4097/kjae.2015.68.6.613Case ReportBronchoconstriction following...,3,151,Korean_J_Anesthesiol_2015_Dec_25_68(6)_613-616.txt
6.69.5.429,...rean Society of Anesthesiologists 10.4097/kjae.2016.69.5.429Review ArticleA first step toward unders...,3,151,Korean_J_Anesthesiol_2016_Oct_25_69(5)_429-434.txt
3.34.4.258,...Korean Academy of Family Medicine 10.4082/kjfm.2013.34.4.258Original ArticleTrends in Cervical Cance...,3,142,Korean_J_Fam_Med_2013_Jul_24_34(4)_258-264.txt
5.36.1.35,...Korean Academy of Family Medicine 10.4082/kjfm.2015.36.1.35Case ReportAnaplastic Lymphoma Kinase-Pos...,3,142,Korean_J_Fam_Med_2015_Jan_31_36(1)_35-41.txt
5.36.2.60,...Korean Academy of Family Medicine 10.4082/kjfm.2015.36.2.60Original ArticleAssociation between Metab...,3,142,Korean_J_Fam_Med_2015_Mar_23_36(2)_60-71.txt
3.4.23.1,"...at -50℃ prior to use (within 2 mon). Pepsin (E.C. 3.4.23.1, from porcine gastric mucosa, 250 units/m...",16,556,Korean_J_Food_Sci_Anim_Resour_2014_Feb_28_34(1)_14-19.txt
4.34.2.151,... of Animal Resources kosfa-34-15110.5851/kosfa.2014.34.2.151ArticleEffects of Concentration and Reac...,3,215,Korean_J_Food_Sci_Anim_Resour_2014_Apr_30_34(2)_151-157.txt
1.31.3.469,... Food Sci. An. (2011) 31 469 476 10.5851/kosfa.2011.31.3.469,141,263,Korean_J_Food_Sci_Anim_Resour_2014_Jun_30_34(3)_372-377.txt
1.11.1.6,GSH-Px (E.C. 1.11.1.6) activity was analyzed with the protocol ...,30,14,Korean_J_Food_Sci_Anim_Resour_2014_Dec_31_34(6)_742-748.txt
1.31.3.405,... Food Sci. An. (2011) 31 405 412 10.5851/kosfa.2011.31.3.405,139,270,Korean_J_Food_Sci_Anim_Resour_2014_Oct_31_34(5)_614-621.txt
2.32.3.308,... Food Sci. An. (2012) 32 308 315 10.5851/kosfa.2012.32.3.308,179,195,Korean_J_Food_Sci_Anim_Resour_2015_Feb_28_35(1)_58-70.txt
4.34.3.297,... Ani. Resour. (2014a) 34 297 306 10.5851/kosfa.2014.34.3.297,208,269,Korean_J_Food_Sci_Anim_Resour_2015_Apr_30_35(2)_179-188.txt
5.35.6.783,... of Animal Resources kosfa-35-78310.5851/kosfa.2015.35.6.783ArticleEffects of Glasswort (Salicornia ...,3,215,Korean_J_Food_Sci_Anim_Resour_2015_Dec_31_35(6)_783-792.txt
6.36.1.14,...e of Animal Resources kosfa-36-1410.5851/kosfa.2016.36.1.14ArticleInduction of Oral Tolerance by Gam...,3,214,Korean_J_Food_Sci_Anim_Resour_2016_Feb_28_36(1)_14-18.txt
3.28.2.204,...n J. Food Culture 2013 28 204 211 10.7318/KJFC/2013.28.2.20,189,177,Korean_J_Food_Sci_Anim_Resour_2016_Aug_30_36(4)_445-451.txt
6.36.6.737,... of Animal Resources kosfa-36-73710.5851/kosfa.2016.36.6.737ArticleEffect of Black Rice Powder Level...,3,215,PMC5243957.txt
3.17.2.75,...ato-Biliary-Pancreatic Surgery 10.14701/kjhbps.2013.17.2.75Case ReportClosure of pancreatoduodenal f...,3,223,Korean_J_Hepatobiliary_Pancreat_Surg_2013_May_31_17(2)_75-78.txt
1.15.4.199,...ato-Biliary-Pancreatic Surgery 10.14701/kjhbps.2011.15.4.199Original ArticleLong-term outcome after ...,3,223,Korean_J_Hepatobiliary_Pancreat_Surg_2011_Nov_15_15(4)_199-205.txt
1.17.1.1,...r the Study of the Liver 2149407110.3350/kjhep.2011.17.1.1ReviewChronic hepatitis B in pregnancy: un...,3,147,Korean_J_Hepatol_2011_Mar_21_17(1)_1-8.txt
1.26.4.474,... Association of Internal Medicine 10.3904/kjim.2011.26.4.474Letter to the EditorTwo Cases of Scrub T...,3,141,Korean_J_Intern_Med_2011_Dec_28_26(4)_474-476.txt
2.27.4.470,... Association of Internal Medicine 10.3904/kjim.2012.27.4.470Letter to the EditorCytomegalovirus Indu...,3,162,Korean_J_Intern_Med_2012_Dec_27_27(4)_470-473.txt
3.28.1.25,... Association of Internal Medicine 10.3904/kjim.2013.28.1.25EditorialAnti-citrullinated protein antib...,3,162,Korean_J_Intern_Med_2013_Jan_28_28(1)_25-28.txt
3.28.2.187,... Association of Internal Medicine 10.3904/kjim.2013.28.2.187Original ArticleClinical characteristics...,3,162,Korean_J_Intern_Med_2013_Mar_27_28(2)_187-196.txt
3.28.5.609,... Association of Internal Medicine 10.3904/kjim.2013.28.5.609Case ReportGestational hyperlipidemia an...,3,162,Korean_J_Intern_Med_2013_Sep_14_28(5)_609-613.txt
6.21.2.116,...tion of Internal Medicine 1691344110.3904/kjim.2006.21.2.116Case ReportConcurrence of Sjögren's Synd...,3,170,Korean_J_Intern_Med_2006_Jun_30_21(2)_116-119.txt
6.21.2.150,...tion of Internal Medicine 1691344910.3904/kjim.2006.21.2.150Case ReportHemorrhagic Fever with Renal ...,3,170,Korean_J_Intern_Med_2006_Jun_30_21(2)_150-153.txt
6.21.4.252,...tion of Internal Medicine 1724950910.3904/kjim.2006.21.4.252Case ReportCapecitabine and Oxaliplatin ...,3,170,Korean_J_Intern_Med_2006_Dec_31_21(4)_252-255.txt
5.20.1.63,...tion of Internal Medicine 1590695510.3904/kjim.2005.20.1.63Case ReportVisualization of Jejunal Bleed...,3,170,Korean_J_Intern_Med_2005_Mar_31_20(1)_63-67.txt
4.29.3.296,... Association of Internal Medicine 10.3904/kjim.2014.29.3.296EditorialA disappearing vertical infecti...,3,162,Korean_J_Intern_Med_2014_May_29_29(3)_296-300.txt
4.29.4.409,"... Association of Internal Medicine 10.3904/kjim.2014.29.4.409ReviewDiet, microbiota, and inflammatory...",3,162,Korean_J_Intern_Med_2014_Jul_27_29(4)_409-415.txt
4.9.1.1,...ation of Internal Medicine 803814110.3904/kjim.1994.9.1.1kjim-9-1-1-1Original ArticleTumor Necrosis ...,3,165,Korean_J_Intern_Med_1994_Jan_9(1)_1-8.txt
4.9.1.1,...ation of Internal Medicine 803814110.3904/kjim.1994.9.1.1kjim-9-1-1-1Original ArticleTumor Necrosis ...,3,165,Korean_J_Intern_Med_1994_Jan_9(1)_1-8.txt
1.6.1.1,...ation of Internal Medicine 174225010.3904/kjim.1991.6.1.1kjim-6-1-1-1Original ArticleComputed Tomogr...,3,165,Korean_J_Intern_Med_1991_Jan_6(1)_1-7.txt
5.30.6.759,...tion of Internal Medicine 2655245110.3904/kjim.2015.30.6.759kjim-30-6-759ReviewRole of dipeptidyl pe...,3,170,Korean_J_Intern_Med_2015_Nov_30_30(6)_759-770.txt
1.24.2.100,...592093-0569The Korean Pain Society 10.3344/kjp.2011.24.2.100Original ArticleMyofascial Pain Syndrome...,3,100,Korean_J_Pain_2011_Jun_3_24(2)_100-104.txt
2.25.4.211,...592093-0569The Korean Pain Society 10.3344/kjp.2012.25.4.211EditorialPulsed Radiofrequency of Non-ne...,3,113,Korean_J_Pain_2012_Oct_4_25(4)_211-212.txt
3.26.4.356,...592093-0569The Korean Pain Society 10.3344/kjp.2013.26.4.356Original ArticleThe Effect of Urinary Tr...,3,113,Korean_J_Pain_2013_Oct_2_26(4)_356-360.txt
5.28.1.39,...592093-0569The Korean Pain Society 10.3344/kjp.2015.28.1.39Original ArticleComparison of Ramosetron ...,3,113,Korean_J_Pain_2015_Jan_2_28(1)_39-44.txt
6.29.1.12,...592093-0569The Korean Pain Society 10.3344/kjp.2016.29.1.12Original ArticleEvaluation of Efficacy of...,3,113,Korean_J_Pain_2016_Jan_4_29(1)_12-17.txt
6.29.4.215,...592093-0569The Korean Pain Society 10.3344/kjp.2016.29.4.215EditorialBig data and pain Leem Jeong Gi...,3,113,Korean_J_Pain_2016_Oct_29_29(4)_215-216.txt
1.31.4.302,...n Society for Laboratory Medicine 10.3343/kjlm.2011.31.4.302Case ReportDiagnostic ImmunologyFalse Ho...,3,130,Korean_J_Lab_Med_2011_Oct_3_31(4)_302-306.txt
5.11.2.195,...Korean Neurotraumatology Society 10.13004/kjnt.2015.11.2.195Case ReportThree Cases of Spine Fracture...,3,141,Korean_J_Neurotrauma_2015_Oct_31_11(2)_195-200.txt
6.12.2.185,...Korean Neurotraumatology Society 10.13004/kjnt.2016.12.2.185Case ReportSpinal Extradural Arachnoid C...,3,141,Korean_J_Neurotrauma_2016_Oct_31_12(2)_185-190.txt
2.26.3.239,...he Korean Ophthalmological Society 10.3341/kjo.2012.26.3.239Letter to the EditorLetter to the Editor...,3,148,Korean_J_Ophthalmol_2012_Jun_22_26(3)_239-240.txt
5.29.4.233,...he Korean Ophthalmological Society 10.3341/kjo.2015.29.4.233Original ArticleIatrogenic Central Retin...,3,148,Korean_J_Ophthalmol_2015_Aug_21_29(4)_233-240.txt
5.29.6.404,...he Korean Ophthalmological Society 10.3341/kjo.2015.29.6.404Original ArticleIntravitreal Anti-vascul...,3,148,Korean_J_Ophthalmol_2015_Dec_25_29(6)_404-410.txt
2.42.6.279,...rean Association of Orthodontists 10.4041/kjod.2012.42.6.279Reader's ForumReader's Forum Kim Jun-Shi...,3,135,Korean_J_Orthod_2012_Dec_28_42(6)_279.txt
4.44.2.54,...rean Association of Orthodontists 10.4041/kjod.2014.44.2.54Original ArticleThree-dimensional evaluat...,3,135,Korean_J_Orthod_2014_Mar_19_44(2)_54-61.txt
5.45.1.38,...rean Association of Orthodontists 10.4041/kjod.2015.45.1.38Original ArticleEarly treatment of anteri...,3,135,Korean_J_Orthod_2015_Jan_26_45(1)_38-46.txt
6.46.5.301,...rean Association of Orthodontists 10.4041/kjod.2016.46.5.301Original ArticleEvaluation of stability ...,3,135,Korean_J_Orthod_2016_Sep_19_46(5)_301-309.txt
3.51.2.259,...Parasitology and Tropical Medicine 10.3347/kjp.2013.51.2.259Brief CommunicationCurrent Status of Hum...,3,166,Korean_J_Parasitol_2013_Apr_25_51(2)_259-263.txt
3.51.5.573,...Parasitology and Tropical Medicine 10.3347/kjp.2013.51.5.573Brief CommunicationDetection of Acute To...,3,166,Korean_J_Parasitol_2013_Oct_31_51(5)_573-577.txt
3.51.6.629,...Parasitology and Tropical Medicine 10.3347/kjp.2013.51.6.629Original ArticleSusceptibility of Labora...,3,166,Korean_J_Parasitol_2013_Dec_31_51(6)_629-632.txt
6.54.1.61,...logy and Tropical Medicine 2695198010.3347/kjp.2016.54.1.61kjp-54-1-61Original ArticleIn Vitro Scoli...,3,174,Korean_J_Parasitol_2016_Feb_26_54(1)_61-66.txt
6.54.1.47,...logy and Tropical Medicine 2695197810.3347/kjp.2016.54.1.47kjp-54-1-47Original ArticleAnimal Models ...,3,174,Korean_J_Parasitol_2016_Feb_26_54(1)_47-53.txt
6.54.2.239,...Parasitology and Tropical Medicine 10.3347/kjp.2016.54.2.239kjp-54-2-239Brief CommunicationWestern B...,3,166,Korean_J_Parasitol_2016_Apr_30_54(2)_239-241.txt
2.46.3.302,...ociety for Cytopathology 10.4132/KoreanJPathol.2012.46.3.302Case ReportCytologic Findings of Thyroid...,3,180,Korean_J_Pathol_2012_Jun_22_46(3)_302-305.txt
4.48.1.54,...ociety for Cytopathology 10.4132/KoreanJPathol.2014.48.1.54Case StudyPrimary Myxoid Leiomyoma of the...,3,180,Korean_J_Pathol_2014_Feb_25_48(1)_54-57.txt
4.48.3.188,...ociety for Cytopathology 10.4132/KoreanJPathol.2014.48.3.188Original ArticleExtrapulmonary Lymphangi...,3,180,Korean_J_Pathol_2014_Jun_26_48(3)_188-192.txt
4.48.4.263,...ociety for Cytopathology 10.4132/KoreanJPathol.2014.48.4.263Original ArticleThe Clinicopathological ...,3,180,Korean_J_Pathol_2014_Aug_26_48(4)_263-269.txt
1.54.8.329,...2-7258The Korean Pediatric Society 10.3345/kjp.2011.54.8.329Original ArticleClinical characteristics...,3,110,Korean_J_Pediatr_2011_Aug_31_54(8)_329-334.txt
2.55.5.181,...2-7258The Korean Pediatric Society 10.3345/kjp.2012.55.5.181Case ReportUrinary bladder rupture durin...,3,126,Korean_J_Pediatr_2012_May_21_55(5)_181-184.txt
2.55.6.212,...2-7258The Korean Pediatric Society 10.3345/kjp.2012.55.6.212Case ReportPulmonary hypertension due to...,3,126,Korean_J_Pediatr_2012_Jun_21_55(6)_212-214.txt
2.55.9.350,...2-7258The Korean Pediatric Society 10.3345/kjp.2012.55.9.350Case ReportA case of Becker muscular dys...,3,126,Korean_J_Pediatr_2012_Sep_14_55(9)_350-353.txt
2.55.10.377,...2-7258The Korean Pediatric Society 10.3345/kjp.2012.55.10.377Original ArticleClinical features and s...,3,126,Korean_J_Pediatr_2012_Oct_29_55(10)_377-382.txt
5.58.3.108,...2-7258The Korean Pediatric Society 10.3345/kjp.2015.58.3.108Case ReportDiGeorge syndrome who develop...,3,126,Korean_J_Pediatr_2015_Mar_20_58(3)_108-111.txt
6.59.1.8,...2-7258The Korean Pediatric Society 10.3345/kjp.2016.59.1.8Original ArticleImpaired angiogenesis in t...,3,126,Korean_J_Pediatr_2016_Jan_22_59(1)_8-15.txt
6.59.2.65,...2-7258The Korean Pediatric Society 10.3345/kjp.2016.59.2.65Original ArticleImpact of lifestyle facto...,3,126,Korean_J_Pediatr_2016_Feb_29_59(2)_65-73.txt
6.59.8.335,...2-7258The Korean Pediatric Society 10.3345/kjp.2016.59.8.335Original ArticleClinical course and prog...,3,126,Korean_J_Pediatr_2016_Aug_24_59(8)_335-340.txt
4.57.8.363,http://dx.doi.org/10.3345/kjp.2014.57.8.36,7,34,Korean_J_Pediatr_2016_Sep_21_59(9)_386.txt
6.59.9.347,...2-7258The Korean Pediatric Society 10.3345/kjp.2016.59.9.347Review ArticleApparent life-threatening ...,3,126,Korean_J_Pediatr_2016_Sep_21_59(9)_347-354.txt
2.16.5.293,...he Korean Society of Pharmacology 10.4196/kjpp.2012.16.5.293Original ArticleEffect of Intensity of U...,3,306,Korean_J_Physiol_Pharmacol_2012_Oct_18_16(5)_293-296.txt
3.17.3.229,...he Korean Society of Pharmacology 10.4196/kjpp.2013.17.3.229Original ArticleElectrophysiological and...,3,306,Korean_J_Physiol_Pharmacol_2013_Jun_11_17(3)_229-235.txt
3.17.6.499,...he Korean Society of Pharmacology 10.4196/kjpp.2013.17.6.499Original ArticleEffects of Ovarian Cycle...,3,306,Korean_J_Physiol_Pharmacol_2013_Dec_16_17(6)_499-503.txt
5.19.4.383,...he Korean Society of Pharmacology 10.4196/kjpp.2015.19.4.383Original ArticleCharacteristics of K+ Ou...,3,306,Korean_J_Physiol_Pharmacol_2015_Jul_30_19(4)_383-388.txt
6.20.6.621,...he Korean Society of Pharmacology 10.4196/kjpp.2016.20.6.621Original ArticleLactobacillus casei stra...,3,297,Korean_J_Physiol_Pharmacol_2016_Nov_28_20(6)_621-628.txt
1.2.1.211,...330The Korean Radiological Society 10.3348/kjr.2001.2.1.2111752965Original ArticleEvaluation by Cont...,3,111,Korean_J_Radiol_2001_Mar_31_Jan-Mar_2(1)_21-27.txt
1.2.4.210,...330The Korean Radiological Society 10.3348/kjr.2001.2.4.21011754328Original ArticleDetection of Mali...,3,111,Korean_J_Radiol_2001_Dec_31_Oct-Dec_2(4)_210-215.txt
2.13.2.210,...330The Korean Society of Radiology 10.3348/kjr.2012.13.2.210Pictorial EssayCT-Guided Percutaneous Bi...,3,111,Korean_J_Radiol_2012_Mar_7_Mar-Apr_13(2)_210-226.txt
2.13.2.240,...330The Korean Society of Radiology 10.3348/kjr.2012.13.2.240Case ReportIntracranial Extramedullary H...,3,111,Korean_J_Radiol_2012_Mar_7_Mar-Apr_13(2)_240-243.txt
3.14.6.951,...330The Korean Society of Radiology 10.3348/kjr.2013.14.6.951Nuclear MedicineOriginal ArticleIs There...,3,126,Korean_J_Radiol_2013_Nov_5_Nov-Dec_14(6)_951-959.txt
4.15.5.578,...330The Korean Society of Radiology 10.3348/kjr.2014.15.5.578Breast ImagingOriginal ArticleThe Effica...,3,126,Korean_J_Radiol_2014_Sep_12_Sep-Oct_15(5)_578-585.txt
5.16.2.391,...330The Korean Society of Radiology 10.3348/kjr.2015.16.2.391Neuroimaging and Head & NeckReview Artic...,3,126,Korean_J_Radiol_2015_Feb_27_Mar-Apr_16(2)_391-401.txt
5.16.4.798,...330The Korean Society of Radiology 10.3348/kjr.2015.16.4.798Experimental and OthersPictorial EssayCo...,3,126,Korean_J_Radiol_2015_Jul_1_Jul-Aug_16(4)_798-809.txt
6.17.3.364,...330The Korean Society of Radiology 10.3348/kjr.2016.17.3.364InterventionOriginal ArticleRetrograde E...,3,126,Korean_J_Radiol_2016_Apr_14_May-Jun_17(3)_364-369.txt
6.17.4.472,...330The Korean Society of Radiology 10.3348/kjr.2016.17.4.472InterventionReview ArticleYttrium-90 Sel...,3,126,Korean_J_Radiol_2016_Jun_27_Jul-Aug_17(4)_472-488.txt
4.11.2.68,...orean Spinal Neurosurgery Society 10.14245/kjs.2014.11.2.68Clinical ArticleDoes Obesity Make an Infl...,3,128,Korean_J_Spine_2014_Jun_30_11(2)_68-73.txt
5.12.3.207,...orean Spinal Neurosurgery Society 10.14245/kjs.2015.12.3.207Case ReportMigration of an Intracranial ...,3,128,Korean_J_Spine_2015_Sep_30_12(3)_207-209.txt
5.12.4.272,...orean Spinal Neurosurgery Society 10.14245/kjs.2015.12.4.272Case ReportCauda Equina Syndrome Caused ...,3,128,Korean_J_Spine_2015_Dec_31_12(4)_272-274.txt
1.44.3.260,...d Cardiovascular Surgery 2226316510.5090/kjtcs.2011.44.3.260Case ReportPostintubation Tracheal Ruptu...,3,223,Korean_J_Thorac_Cardiovasc_Surg_2011_Jun_11_44(3)_260-265.txt
3.46.5.353,...racic and Cardiovascular Surgery 10.5090/kjtcs.2013.46.5.353Case ReportFlorida Sleeve Repair for Aor...,3,215,Korean_J_Thorac_Cardiovasc_Surg_2013_Oct_4_46(5)_353-356.txt
4.47.2.160,...racic and Cardiovascular Surgery 10.5090/kjtcs.2014.47.2.160Case ReportIncidentally Detected Cardiac...,3,215,Korean_J_Thorac_Cardiovasc_Surg_2014_Apr_10_47(2)_160-162.txt
5.48.6.432,...racic and Cardiovascular Surgery 10.5090/kjtcs.2015.48.6.432kjtcvs-48-432Case ReportAnticoagulant Th...,3,214,Korean_J_Thorac_Cardiovasc_Surg_2015_Dec_5_48(6)_432-434.txt
2.53.5.349,...5The Korean Urological Association 10.4111/kju.2012.53.5.349Original ArticleUrolithiasisComparison a...,3,122,Korean_J_Urol_2012_May_18_53(5)_349-354.txt
2.53.7.505,...5The Korean Urological Association 10.4111/kju.2012.53.7.505Case ReportAnterior Urethral Valve and D...,3,122,Korean_J_Urol_2012_Jul_19_53(7)_505-507.txt
1.3.6.3,"...ng WIT was greater (odds ratio [OR], 2.8; 95% CI, 1.3.6.3) when the distance between the tumor margi...",46,429,Korean_J_Urol_2014_Apr_10_55(4)_254-259.txt
4.55.6.405,...5The Korean Urological Association 10.4111/kju.2014.55.6.405Original ArticleVoiding Dysfunction/Fema...,3,122,Korean_J_Urol_2014_Jun_16_55(6)_405-410.txt
4.55.10.670,...5The Korean Urological Association 10.4111/kju.2014.55.10.670Original ArticlePediatric UrologyRole o...,3,122,Korean_J_Urol_2014_Oct_10_55(10)_670-676.txt
5.56.5.393,...5The Korean Urological Association 10.4111/kju.2015.56.5.393Original ArticleGeriatric UrologyEffect ...,3,122,Korean_J_Urol_2015_May_21_56(5)_393-397.txt
5.56.9.624,...5The Korean Urological Association 10.4111/kju.2015.56.9.624Original ArticleUrological OncologyPatho...,3,122,Korean_J_Urol_2015_Sep_2_56(9)_624-629.txt
5.56.9.605,...5The Korean Urological Association 10.4111/kju.2015.56.9.605EditorialGenetic classifiers for prostat...,3,122,Korean_J_Urol_2015_Sep_31_56(9)_605-606.txt
1.27.2.127,...tion for Laboratory Animal Science 10.5625/lar.2011.27.2.127Original ArticleTraumatic and Non-trauma...,3,124,Lab_Anim_Res_2011_Jun_22_27(2)_127-131.txt
5.31.2.69,...tion for Laboratory Animal Science 10.5625/lar.2015.31.2.69Original ArticleProlonged oral administra...,3,136,Lab_Anim_Res_2015_Jun_26_31(2)_69-77.txt
5.31.4.204,"...tion for Laboratory Animal Science 10.5625/lar.2015.31.4.204LetterRadiation-induced eosinophilic, po...",3,136,Lab_Anim_Res_2015_Dec_22_31(4)_204-208.txt
6.32.2.79,...tion for Laboratory Animal Science 10.5625/lar.2016.32.2.79Original ArticleReference values of clini...,3,136,Lab_Anim_Res_2016_Jun_24_32(2)_79-86.txt
3.28.1.163,...eption and Performance  1 163 179 10.1037/0096-1523.28.1.163,232,183,Lang_Cogn_Neurosci_2016_Jul_2_31(6)_7282-740.txt
4.49.5.166,49 : 1667 –1678 . doi:10.4319/lo.2004.49.5.166,1300,37,Limnol_Oceanogr_2015_Jul_20_60(4)_1222-1240.txt
1.74.1.11,...nt J Vitam Nutr Res 2004 74 11 20 10.1024/0300-9831.74.1.11 15060896,118,303,Lipids_Health_Dis_2011_Nov_30_10_222.txt
4.3.1.1,4.3.1.1 Gabbroic cumulate 94T31E,97,1,Lithos_2011_Jul_125(1-2)_434-448.txt
1.1.1.42,Isocitrate dehydrogenase (NADP+);	1.1.1.42	PF13_0242	28	TCA cycle,35,35,Malar_J_2005_Mar_18_4_17.txt
2.7.4.16,... a gene coding for thiamine phosphate kinase (EC: 2.7.4.16) must be resolved and direct biochemical ...,121,1379,Malar_J_2005_Mar_18_4_17.txt
3.1.1.113,...ls Future Microbiol 2006 1 113 125 10.2217/17460913.1.1.113 1766169,120,181,Malar_J_2011_May_10_10_119.txt
2.50.1.15,...n Korean J Parasitol 2012 12 15 21 10.3347/kjp.2012.50.1.15 22451729,215,230,Malar_J_2013_Dec_19_12_454.txt
EC 2.6.1.16,"...mine-fructose-6-phosphate aminotransferase (GFPT)	EC 2.6.1.16	PF3D7_1025100	Pv, Pk, Pc, Pr, Pb, Py, ...",27,60,Malar_J_2015_Oct_31_14_427.txt
3.2.2.10,"3.2.2.10. N-Glycine(methylester)-5,8-dioxo-5,8-dih...",310,1,Mar_Drugs_2013_Sep_9_11(9)_3472-3499.txt
6.9.9.157,...in. Pharmacother. 2008 9 1575 1583 10.1517/14656566.9.9.1575 18518786,178,135,Mar_Drugs_2013_Mar_1_11(3)_623-642.txt
EC 3.2.1.151,"...73), κ-carrageenase (EC 3.2.1.83), xyloglucanase (EC 3.2.1.151), endo-β-1,3-galactanase (EC 3.2.1.18...",21,1768,Mar_Drugs_2014_May_12_12(5)_2731-2747.txt
EC 4.2.3.13,"...ase (EC 4.2.3.7) and (+)-delta-cadinene synthase (EC 4.2.3.13), which are involved in the biosynthes...",41,816,Mar_Drugs_2015_Feb_10_13(2)_879-902.txt
3.1.8.7,3.1.8.7. 3-(4-{1-[(4-Methylphenyl)sulfonyl]-1H-ind...,188,1,Mar_Drugs_2015_Apr_3_13(4)_1901-1924.txt
3.28.2.131,...plications Algae 2013 28 131 147 10.4490/algae.2013.28.2.131,289,148,Mar_Drugs_2015_Aug_14_13(8)_5128-5155.txt
1.1.12.783,.... J. Mar. Sci. 2009 31 113 118 10.2989/AJMS.2009.31.1.12.783,388,245,Mar_Drugs_2015_Nov_26_13(12)_7087-7112.txt
3.2.4.387,...g Future Microbiol. 2007 2 387 395 10.2217/17460913.2.4.387 17683275,168,150,Mar_Drugs_2016_Apr_16_14(4)_80.txt
2.15.9.963,...Microbe Interact. 2002 15 963 970 10.1094/MPMI.2002.15.9.963 12236603,188,189,PMC5334620.txt
4.36.4.154,...c and Reconstructive Surgeons 10.14402/jkamprs.2014.36.4.154mprs-36-154Original ArticleAnchor Plate ...,3,227,Maxillofac_Plast_Reconstr_Surg_2014_Jul_30_36(4)_154-160.txt
4.36.2.84,...c and Reconstructive Surgeons 10.14402/jkamprs.2014.36.2.84mprs-36-084CorrectionCorrigendum: Osteomy...,3,227,Maxillofac_Plast_Reconstr_Surg_2014_Mar_30_36(2)_84.txt
2.1.3.2,"...hicken/North Sumatra/27/09, which belong to clade 2.1.3.2, were antigenically similar. Three other a...",51,195,mBio_2014_Jun_10_5(3)_e01070-14.txt
5.50.5.168,50 :1687 –1696 . doi:10.4319/lo.2005.50.5.1687,164,36,mBio_2015_Feb_10_6(1)_e02083-14.txt
EC 3.2.1.20,...on effort predicted a gene for alpha-glucosidase (EC 3.2.1.20) (see Text S1 and Fig. S4 in the suppl...,100,74,mBio_2015_Feb_10_6(1)_e02445-14.txt
1.56.5.157,56 :1577 –1586 . doi:10.4319/lo.2011.56.5.1577,391,36,mBio_2016_Apr_21_7(2)_e00135-16.txt
2.2.1.3,"...), De causis et signis acutorum morborum 1.7.1-4, 2.2.1.3, Aetius Amidenus (6th century AD)",301,61,Med_Hist_1993_Jan_37(1)_3-36.txt
6.36.1.11,...logy and Virology  2006 36 1 11 20 10.4167/jbv.2006.36.1.11 2-s2.0-44849088063,180,216,Mediators_Inflamm_2015_Mar_4_2015_301716.txt
6.4.6.889,... Pharmacotherapy  2003 4 6 889 901 10.1517/14656566.4.6.889 2-s2.0-0038009151 12783586,129,130,Mediators_Inflamm_2015_Mar_11_2015_293474.txt
3.54.6.130,...dical Journal  2013 54 6 1305 1312 10.3349/ymj.2013.54.6.1305 2-s2.0-84886473216 24142632,279,230,Mediators_Inflamm_2015_Oct_27_2015_635751.txt
5.35.6.570,...ratory Medicine  2015 35 6 570 577 10.3343/alm.2015.35.6.570 2-s2.0-84942241469 26354344,233,164,Mediators_Inflamm_2016_Mar_24_2016_8191254.txt
3.1.9.2,"... was performed using the G∗Power software version 3.1.9.2 (University of Dusseldorf, Dusseldorf, Ger...",48,78,Medicine_(Baltimore)_2016_Apr_8_95(14)_e3340.txt
4.4.4.2,"118 EGE, above, n 11, paras 4.4.4.2 and 4.4.4.3, and Appendix 1",382,29,Med_Law_Rev_2013_Mar_6_21(1)_39-70.txt
4.62.2.189,...Social Psychology 1992 62 189 206 10.1037/0022-3514.62.2.189,434,179,Mem_Cognit_2015_Mar_18_43(6)_879-895.txt
2.7.7.1,"databases, was 2.7.7.1/18, which is consistent with an adenylyltr...",317,16,Mem_Inst_Oswaldo_Cruz_2015_Nov_110(7)_890-897.txt
2.2.2.1,2.2.2.1. Transcriptional Regulatio,45,1,Metabolites_2014_Nov_3_4(4)_977-1006.txt
5.4.6.697,... Drug Metab Toxicol 2008 4 697 720 10.1517/17425255.4.6.697 18611112,753,196,Metabolites_2015_Jan_9_5(1)_3-55.txt
EC 2.6.1.2,"...sferase (EC 2.6.1.44); ALT, Alanine transaminase (EC 2.6.1.2); Glycine cleavage system [glycine dehy...",22,94,Metabolites_2014_Jan_7_4(1)_53-70.txt
6.7.7.108,...harmacogenomics 2006 7 7 1087 1094 10.2217/14622416.7.7.1087 17054418,749,191,Metabolomics_2010_Mar_4_6(1)_3-17.txt
1.3.99.1,"1.3.99.1), glutamate dehydrogenase (GDH EC 1.4.1.2...",61,1,Met_Based_Drugs_1998_5(2)_77-81.txt
EC 1.14.13.22,"... Acinetobacter calcoaceticus NCIMB 9871(CHMO9871; EC 1.14.13.22; Donoghue et al., 1976) are obligate...",10,1364,Microb_Biotechnol_2012_Jul_7_5(4)_549-559.txt
EC 2.4.1.10,...3.2.1.26) Inulosucrase (EC 2.4.1.9) Levansucrase (EC 2.4.1.10)	Fungi (Aspergillus niger; A. japonicu...,21,128,Microb_Biotechnol_2014_Jul_1_7(4)_315-331.txt
EC 3.2.1.20,...) and Pullulanase (EC 3.2.1.41) B) α-Glucosidase (EC 3.2.1.20)	Fungi (Aspergillus sp.; Aureobasidium...,33,117,Microb_Biotechnol_2014_Jul_1_7(4)_315-331.txt
EC 1.2.1.1,"...e (EC 1.11.1.6), FLD: formaldehyde dehydrogenase (EC 1.2.1.1), FGH: S-formylglutathione hydrolase (E...",60,279,Microb_Cell_Fact_2006_Dec_14_5_39.txt
1.1.1.40,ME2	1.1.1.40	malic enzyme (NADP),91,5,Microb_Cell_Fact_2010_Nov_22_9_90.txt
EC 4.2.1.3,EC 4.2.1.3	Aconitate hydratase	acnB,210,1,Microb_Cell_Fact_2011_Mar_31_10_19.txt
EC 3.6.3.10,...ein in GenBank and as copper-transporting ATPase (EC 3.6.3.10) in ERGO database [16],75,84,Microb_Cell_Fact_2011_Jul_21_10_55.txt
EC 2.7.7.23,"...rase; EC 5.4.2.3 Phosphoacetylglucosamine mutase; EC 2.7.7.23, UDP-N-GlcNAc diphosphorylase; EC2.7.1...",23,886,Microb_Cell_Fact_2011_Dec_5_10_102.txt
EC 3.2.1.26,... the activity of endogenous β-fructofuranosidase (EC 3.2.1.26) was analyzed in the supernatant of cu...,47,130,Microb_Cell_Fact_2013_Apr_15_12_34.txt
EC 3.1.1.3,"...ain carboxylic acids (˂10 carbon atoms), lipases (EC 3.1.1.3) prefer long-chain fatty acids (≥10 car...",20,332,Microb_Cell_Fact_2016_Feb_18_15_41.txt
EC 1.1.1.31,... EC 1.1.1.59)/3-hydroxyisobutyrate dehydrogenase (EC 1.1.1.31) or via a bi-functional MCR (EC 1.2.1....,24,356,Microb_Cell_Fact_2016_Mar_15_15_53.txt
EC 2.4.1.-,"...lE: alpha-L-Rha alpha-1,3-l-rhamnosyltransferase (EC 2.4.1.-). c Shows an additional plasmid located...",102,1638,Microb_Cell_Fact_2016_Oct_4_15_170.txt
EC 2.6.1.11,"...ld be paid to N-acetylornithine aminotransferase (EC 2.6.1.11), encoded by gene argD. This gene migh...",120,782,Microbiology_2009_Jun_155(Pt_6)_1758-1775.txt
EC 1.4.3.20,"...flavoproteins such as d-amino acid oxidase (DAAO, EC 1.4.3.20) and sarcosine oxidase (SOX, EC 1.5.3....",107,1157,Microbiologyopen_2013_Aug_22_2(4)_684-694.txt
1.53.1.12,"...tural Research , 53 , 116 –123 . doi:10.3896/IBRA.1.53.1.1",393,212,PMC5300887.txt
EC 2.7.2.2,Carbamate kinase (EC 2.7.2.2)	−0.86	6.86E-03*	24,272,19,Microbiome_2015_Dec_19_3_69.txt
1.23.3.258,...e Psychotherapy 2009 23 3 258 269 10.1891/0889-8391.23.3.258,161,236,Mindfulness_(N_Y)_2015_Oct_27_6(2)_281-289.txt
2.77.4.534,...f Orthopsychiatry 2007 77 534 542 10.1037/0002-9432.77.4.534 18194033,159,213,Mindfulness_(N_Y)_2016_Jul_2_7(5)_1182-1192.txt
3.13.4.721,...esearch  2013 13 4 459 463 10.5829/idosi.mejsr.2013.13.4.7218 2-s2.0-84874993604,482,287,Minim_Invasive_Surg_2016_Jul_21_2016_1967532.txt
4.87.5.698,... Pers Soc Psychol 2004 87 698 706 10.1037/0022-3514.87.5.698 15535780,186,190,Mol_Autism_2016_Jan_19_7_8.txt
EC 6.3.2.12,"...alaria parasites is dihydrofolate synthase (DHFS; EC 6.3.2.12), which adds an l-glutamate residue to...",17,480,Mol_Biochem_Parasitol_2010_Jul_172(1)_41-51.txt
3.2.10.31,...                 authorities (approval number: 9.93.2.10.31.07.247),791,54,Mol_Biol_Cell_2014_Aug_1_25(15)_2260-2271.txt
EC 4.2.1.22,"....5), respectively. Cystathionine β-synthase (CBS, EC 4.2.1.22) is involved in the vitamin B6-depende...",16,1236,Mol_Biol_Rep_2012_Mar_19_39(3)_3123-3130.txt
2.32.1.6,...ood Sci Anim Resour 2012 32 6 12 10.5851/kosfa.2012.32.1.6,243,198,Mol_Biol_Rep_2016_Mar_10_43_381-389.txt
5.7.1.1,...dered J Cogn Neurosci 1995 7 1 24 10.1162/jocn.1995.7.1.1 23961750,189,131,Mol_Brain_2014_Aug_28_7_61.txt
2.21.2.52,...e Brain Exp Neurobiol 2012 21 52 60 10.5607/en.2012.21.2.52 22792025,175,141,Mol_Brain_2016_Feb_9_9_14.txt
3.87.8.890,...d crops Plant Dis 2003 87 890 895 10.1094/PDIS.2003.87.8.890,56,227,Mol_Breed_2015_Jan_20_35(1)_15.txt
2.4.1.14,...Activity of sucrose-phosphate synthase (SPS: E.C. 2.4.1.14) was measured in a reaction mixture conta...,45,1821,Mol_Breed_2015_Mar_15_35(3)_100.txt
EC 1.1.1.49,... by the enzyme glucose-6-phosphate dehydrogenase (EC 1.1.1.49). The pellet obtained (from 15 to 20 m...,50,518,Mol_Breed_2015_Jun_2_35(6)_138.txt
1.27.2.99,...alysis Lab Anim Res 2011 27 99 107 10.5625/lar.2011.27.2.99 21826169,287,200,Mol_Cancer_2012_Aug_24_11_62.txt
1.1.1.36,...e raw files were processed with MaxQuant (version 1.1.1.36) (27) and searched against the NCBI Brach...,48,53,Mol_Cell_Proteomics_2014_Feb_11_13(2)_632-652.txt
1.4.1.2,...A spectra were analyzed with the MaxQuant Version 1.4.1.2 analysis software using default settings w...,40,484,Mol_Cell_Proteomics_2015_May_27_14(5)_1400-1410.txt
EC 2.4.1.18,"...y deficiencies in glycogen branching enzyme (GBE, EC 2.4.1.18), which results in deposition of less-...",21,104,Mol_Genet_Metab_Rep_2016_Oct_4_9_31-33.txt
EC 2.4.1.25,"...ase (EC 2.4.1.1) and glycogen debranching enzyme (EC 2.4.1.25; EC 3.2.1.33). However, a small portio...",23,166,Mol_Genet_Metab_Rep_2016_Oct_4_9_31-33.txt
1.2.1.65,...pert Opin Drug Discov 2007 2 65 85 10.1517/17460441.2.1.65 23496038,121,180,Mol_Imaging_Biol_2013_Aug_26_15(4)_431-440.txt
3.4.14.5,"...ike protein 6 (also named DPPX or DPP6), DPP8 (EC=3.4.14.5), DPP9 (EC=3.4.14.5) and DPP10, and has b...",18,963,Mol_Med_Rep_2015_May_14_11(5)_3203-3211.txt
4.37.2.139,...iochem Mol Biol 37 139 143 2004 10.5483/BMBRep.2004.37.2.139 15469687,151,150,Mol_Med_Rep_2015_Sep_19_12(3)_3315-3322.txt
4.17.3.327,...pin Investig Drugs 17 327 333 2008 10.1517/13543784.17.3.327 18321232,93,126,Mol_Med_Rep_2016_Feb_22_13(2)_1509-1516.txt
4.8.5.544,...diet Nutr Res Pract 8 544 549 2014 10.4162/nrp.2014.8.5.544 25324935,86,181,Mol_Med_Rep_2016_Mar_12_13(3)_2094-2100.txt
4.2.1.1,...Brain Tumor Res Treat 2 1 6 2014 10.14791/btrt.2014.2.1.1 24926466,217,174,Mol_Med_Rep_2015_Dec_13_12(6)_7915-7926.txt
3.46.2.122,...ats Anat Cell Biol 46 122 130 2013 10.5115/acb.2013.46.2.122 23869259,161,203,Mol_Med_Rep_2016_Apr_23_13(4)_3101-3109.txt
1.41.4.167,...ontal Implant Sci 41 167 175 2011 10.5051/jpis.2011.41.4.167 21954421,127,208,Mol_Med_Rep_2016_May_16_13(5)_3747-3754.txt
2.13.5.226,... J Cancer Prev 13 2263 2267 2012 10.7314/APJCP.2012.13.5.2263 22901205,88,199,Mol_Med_Rep_2016_Oct_9_14(4)_2991-2996.txt
5.8.5.781,...xpert Rev Neurother 2008 8 781 797 10.1586/14737175.8.5.781 18457535,353,107,Mol_Pain_2010_May_13_6_27.txt
EC 5.1.3.20,...as inconsistent with the simulation result. GmhD (EC 5.1.3.20) is a critical enzyme involved in the ...,54,1731,Mol_Syst_Biol_2011_Jan_18_7_460.txt
EC 4.2.1.99,"...I). These include 2-methylisocitrate dehydratase (EC 4.2.1.99), the only member of the 2-methylcitra...",34,945,Mol_Syst_Biol_2013_Nov_19_9_708.txt
4.62.3.489,...Social Psychology 1992 62 489 505 10.1037/0022-3514.62.3.489,596,190,Motiv_Emot_2015_Mar_25_39(5)_693-713.txt
2.23.5.169,"...rd, 1958 to 1993 Rangifer 2003 14 169 191 10.7557/2.23.5.1699",402,180,PMC5331706.txt
2.3.4.4,...ammalian IAV strains (20). Our results show clade 2.3.4.4 viruses to have a relatively high HA activ...,147,313,mSphere_2016_Apr_6_1(2)_e00003-16.txt
6.1.3.253,...lin Interv Aging 2006 1 3 253 260 10.2147/ciia.2006.1.3.253 18046878,246,142,PMC5299792.txt
2.40.3.168,...323The Korean Society of Mycology 10.5941/MYCO.2012.40.3.168Research ArticleEffect of Soil Ameliorat...,3,101,Mycobiology_2012_Sep_30_40(3)_168-172.txt
4.42.1.1,...323The Korean Society of Mycology 10.5941/MYCO.2014.42.1.1Mini-ReviewMicrocyle Conidiation in Filame...,3,101,Mycobiology_2014_Mar_31_42(1)_1-5.txt
5.43.3.360,...323The Korean Society of Mycology 10.5941/MYCO.2015.43.3.360Research NoteGenotypes of Clinical and E...,3,101,Mycobiology_2015_Sep_30_43(3)_360-365.txt
3.1.1.1,3.1.1.1. Cathode Material,30,1,PMC5224596.txt
2.1.1.1,"...structures and barrier structures’, 2010/0221/2DP/2.1.1.1.0/10/APIA/VIAA/145 and Latvian Council of ...",81,234,Nanoscale_Res_Lett_2013_Jun_4_8(1)_264.txt
1.2.3.4,...ty specified by the Enzyme Commission (EC) number 1.2.3.4 (Figure 1). The developed approach will su...,19,340,Nat_Chem_Biol_2010_Jan_22_6(1)_34-40.txt
2.7.1.4,2.7.1.4	fructokinase	0.77	41.5	5.3,210,2,Nat_Chem_Biol_2012_Oct_8(10)_848-854.txt
4.2.2.1,"...meroon (4.6.2), LAM (4.3), S-type (4.4.1.1), TUR (4.2.2.1), Uganda (4.6.1), Ural (4.2.1) and X-type ...",20,1413,Nat_Commun_2014_Sep_1_5_4812.txt
EC 2.6.1.2,...nzymatic properties of alanine aminotransferases (EC 2.6.1.2) could account for the comparatively ef...,43,877,Nat_Commun_2015_Apr_10_6_6659.txt
4.1.2.1,...sion numbers for isolates belonging to sublineage 4.1.2.1. The study was funded by a postdoctoral fe...,106,390,Nat_Commun_2015_May_11_6_7119.txt
1.32.71.82,...gle crystal XRD**	Au–SAu–Au (1)Au–Au (2)Au–Au (3)	1.32.71.82.2	2.332.822.983.21	 	 	 	 ,103,56,Nat_Commun_2016_Jan_18_7_10414.txt
EC 2.1.1.71,...hatidyl N-methylethanolamine N-methyltransferase (EC 2.1.1.71)	K00570	1.896	HV	1.842	7.19E-09,135,56,PMC5309854.txt
3.5.1.24,"...d bile salt metaboism [choloyglycine hydrolase (EC3.5.1.24), perhaps reflecting a diet richer in fat...",58,387,Nature_2012_May_9_486(7402)_222-227.txt
3.2.8.118,"... European Collection of Cell Cultures, CHO and Lec3.2.8.118 from P. Stanley, ATG5−/− MEFs33 from N. ...",53,154,Nature_2012_Jan_15_482(7385)_414-418.txt
2.2.2.2,2.2.2.2 The state mode,138,1,Neural_Netw_2008_Nov_21(9)_1247-1260.txt
2.2.2.3,2.2.2.3 The uniform mode,145,1,Neural_Netw_2008_Nov_21(9)_1247-1260.txt
3.3.2.3,3.3.2.3 Genotype-specific effects of ag,153,1,Neurobiol_Aging_2014_Jul_35(7)_1615-1623.txt
2.3.3.2,2.3.3.2 Synaptic terminal,79,1,Neurobiol_Dis_2015_Oct_82_385-396.txt
2.3.2.2,2.3.2.2 Analysis 2: DOR-SIG labeling in spines con...,150,1,Neurobiol_Stress_2016_Nov_10_5_37-53.txt
2.3.2.2,2.3.2.2 Analysis 2: DOR-SIG labeling in spines con...,150,1,Neurobiol_Stress_2016_Nov_10_5_37-53.txt
3.2.1.3,3.2.1.3 Experiment 2 – effect of instructions on a...,153,1,PMC5312784.txt
3.1.1.1,3.1.1.1 AD vs control,528,1,Neuroimage_Clin_2013_Jul_27_3_180-195.txt
3.2.1.2,3.2.1.2 Gray matter increase comparing all CH pati...,53,1,Neuroimage_Clin_2014_Oct_18_6_415-423.txt
2.3.4.2,2.3.4.2 Statistical modelin,76,1,Neuroimage_Clin_2015_Apr_30_8_267-280.txt
2.2.4.1,2.2.4.1 Pre-processin,69,1,Neuroimage_Clin_2015_Sep_6_9_322-337.txt
2.3.1.1,2.3.1.1 Region of interest analyse,81,1,Neuroimage_Clin_2014_Nov_18_7_53-67.txt
6.11.1.55,...Interventional Neuroradiology 10.5469/neuroint.2016.11.1.55Case ReportSuccessful Cross-circulation S...,3,140,Neurointervention_2016_Mar_3_11(1)_55-58.txt
2.2.3.1,2.2.3.1 Behavioural dat,72,1,Neuropsychologia_2015_Apr_70_80-89.txt
2.2.1.2,2.2.1.2 Statistical analyse,57,1,Neuropsychologia_2015_Sep_76_192-207.txt
6.18.8.136,...ve Neuroscience 2006 18 8 1368 79 10.1162/jocn.2006.18.8.1368,376,201,Neuropsychol_Rev_2016_Oct_21_26_73-91.txt
EC 3.1.-.-,"...rt of 1xmx as ‘hydrolases acting on ester bonds’ (EC 3.1.-.-), based on the similarity with the Type...",190,1334,Nucleic_Acids_Res_2007_Apr_16_35(7)_2227-2237.txt
3.1.4.3,"... 3.1.3.n1, 3.1.3.8, 3.1.3.25, 3.1.3.36, 3.1.3.56, 3.1.4.3, 3.1.4.12, 4.2.1.51, 4.2.99.18 and 6.3.5.2...",253,616,Nucleic_Acids_Res_2010_Jan_18_38(3)_720-737.txt
6.3.5.5,"...wn in the top left image and contains the enzymes 6.3.5.5, 2.1.3.2, 3.5.2.3, 1.3.3.1, 2.4.2.10 and 4...",35,396,Nucleic_Acids_Res_2009_Jan_25_37(Database_issue)_D531-D538.txt
6.3.5.3,"...lglycineamide amidotransferase (FGARAT, purL, E.C.6.3.5.3), which is encoded by a separate gene (pur...",15,775,Nucleic_Acids_Res_2010_Nov_14_38(20)_7308-7319.txt
3.40.50.720,"...on (for example, http://beta.cathdb.info/cathnode/3.40.50.720/function)",56,583,Nucleic_Acids_Res_2011_Jan_19_39(Database_issue)_D420-D426.txt
EC 1.1.1.1,"...ction is that catalyzed by alcohol dehydrogenase (EC 1.1.1.1), which is described in the following w...",8,1087,Nucleic_Acids_Res_2012_Jan_30_40(Database_issue)_D754-D760.txt
3.2.1.2,(great-grandmother 14)3.2.1.2. On-the-go lifestyle reduces healthful eat...,140,23,Nutrients_2010_Nov_30_2(12)_1188-1211.txt
2.2.5.3,2.2.5.3. Depression Anxiety and Stress Scale (DASS...,84,1,Nutrients_2014_Oct_30_6(11)_4805-4821.txt
3.42.2.249,.... Food Sci. Nutr. 2013 42 249 254 10.3746/jkfn.2013.42.2.249,129,222,Nutrients_2015_Mar_17_7(3)_1978-1991.txt
3.14.5.285,.... Cancer Prev. 2013 14 2859 2863 10.7314/APJCP.2013.14.5.2859 23803044,174,245,Nutrients_2015_Jun_30_7(7)_5265-5280.txt
3.16.3.272,...n Health Psychol. 1997 16 272 276 10.1037/0278-6133.16.3.272 9152706,395,220,Nutrients_2015_Aug_10_7(8)_6628-6669.txt
1.11.2.311,...Public Policy Law 2005 11 311 319 10.1037/1076-8971.11.2.311,418,128,Nutrients_2015_Dec_2_7(12)_9918-9930.txt
EC 1.11.1.9,"... (GPx, EC 1.11.1.9), glutathione peroxidase (GPx, EC 1.11.1.9), glutathione-S-transferase (GST, EC 2...",32,198,Nutrients_2016_Feb_17_8(2)_38.txt
4.15.22.989,.... Cancer Prev. 2014 15 9899 9903 10.7314/APJCP.2014.15.22.9899 25520125,281,239,Nutrients_2016_Feb_25_8(3)_112.txt
1.77.5.320,...Vitam. Nutr. Res. 2007 77 320 325 10.1024/0300-9831.77.5.320 18453316,122,237,Nutrients_2016_Aug_9_8(8)_485.txt
1.16.11.215,...one Miner. Res. 2001 16 2152 2160 10.1359/jbmr.2001.16.11.2152 11697813,159,336,Nutrients_2016_Oct_21_8(10)_653.txt
4.48.1.107,...al. Soc. Psychol. 1985 48 107 116 10.1037/0022-3514.48.1.107,176,174,PMC5295083.txt
4.49.1.49,...ng storage Blood Res. 2014 49 49 53 10.5045/br.2014.49.1.49 24724067,188,237,PMC5331536.txt
3.18.7.131,... Bone Miner Res 2003 18 1317 1325 10.1359/jbmr.2003.18.7.1317 12854843,433,179,Nutr_J_2011_Apr_30_10_41.txt
2.6.3.343,...ert Rev Cardio Ther 2008 6 343 368 10.1586/14779072.6.3.343,153,266,Nutr_J_2012_Sep_22_11_78.txt
EC 3.2.1.20,... Both α-amylase (E.C. 3.2.1.1) and α-glucosidase (EC 3.2.1.20) belong to the glycoside hydrolase fam...,98,335,Nutr_Metab_(Lond)_2010_Aug_27_7_71.txt
4.75.1.57,...rial J Periodontol 2004 75 1 57 65 10.1902/jop.2004.75.1.57 15025217,372,210,Nutr_Metab_(Lond)_2012_Sep_25_9_88.txt
EC 1.11.1.6,"...ured using pyrogallol (Marklund, 1984). Catalase (EC 1.11.1.6) activity was calculated by spectropho...",30,281,Nutr_Res_Pract_2008_Jun_30_Summer_2(2)_62-67.txt
1.5.3.219,...ean Society of Community Nutrition 10.4162/nrp.2011.5.3.219Original ResearchHigh fat diet-induced ob...,3,157,Nutr_Res_Pract_2011_Jun_21_5(3)_219-223.txt
1.5.5.404,...ean Society of Community Nutrition 10.4162/nrp.2011.5.5.404Original ResearchEffects of freeze-dried ...,3,157,Nutr_Res_Pract_2011_Oct_28_5(5)_404-411.txt
3.7.3.207,...ean Society of Community Nutrition 10.4162/nrp.2013.7.3.207Original ResearchThe prevalence of obesit...,3,171,Nutr_Res_Pract_2013_Jun_3_7(3)_207-215.txt
3.7.2.96,...013;7(2):96-102. http://dx.doi.org/10.4162/nrp.2013.7.2.9,9,342,Nutr_Res_Pract_2013_Jun_3_7(3)_242.txt
5.9.6.613,...ean Society of Community Nutrition 10.4162/nrp.2015.9.6.613Original ResearchEffects of developmental...,3,171,Nutr_Res_Pract_2015_Dec_26_9(6)_613-618.txt
6.10.4.371,...ean Society of Community Nutrition 10.4162/nrp.2016.10.4.371Original ResearchAdenophora remotiflora ...,3,171,Nutr_Res_Pract_2016_Aug_29_10(4)_371-376.txt
4.57.6.464,...ogy; Korean Urogynecologic Society 10.5468/ogs.2014.57.6.464Original ArticleGynecologic OncologyProt...,3,453,Obstet_Gynecol_Sci_2014_Nov_20_57(6)_464-470.txt
5.58.5.423,...ogy; Korean Urogynecologic Society 10.5468/ogs.2015.58.5.423Case ReportGynecologic OncologyAdult gra...,3,453,Obstet_Gynecol_Sci_2015_Sep_22_58(5)_423-426.txt
6.59.6.548,...ogy; Korean Urogynecologic Society 10.5468/ogs.2016.59.6.548Case ReportGynecologic OncologyGiant inv...,3,453,Obstet_Gynecol_Sci_2016_Nov_15_59(6)_548-553.txt
6.59.5.347,...ogy; Korean Urogynecologic Society 10.5468/ogs.2016.59.5.347Original ArticleMaternal-Fetal MedicineM...,3,453,Obstet_Gynecol_Sci_2016_Sep_13_59(5)_347-356.txt
6.59.6.512,...ogy; Korean Urogynecologic Society 10.5468/ogs.2016.59.6.512Original ArticleGeneral GynecologyLaparo...,3,453,Obstet_Gynecol_Sci_2016_Nov_15_59(6)_512-518.txt
5.11.2.185,2005 ;11 :185 –98 . doi:10.1179/oeh.2005.11.2.18515875895,355,40,Occup_Environ_Med_2016_Jul_13_73(7)_452-458.txt
4.7.9.147,...Opin Investig Drugs 1998 7 1475 82 10.1517/13543784.7.9.1475 15992044,361,137,Oncoimmunology_2013_Aug_1_2(8)_e25238.txt
4.7.3.383,... Expert Rev Vaccines 2008 7 383 93 10.1586/14760584.7.3.383 18393608,31,132,Oncoimmunology_2014_Apr_25_3_e28222.txt
4.7.7.101,...019 -30 ; PMID:; http://dx.doi.org/10.1586/14760584.7.7.1019 18767951,734,62,Oncoimmunology_2015_Jan_9_4(4)_e974411.txt
3.16.1.17,... PMID:24010101; http://dx.doi.org/10.5223/pghn.2013.16.1.17 24010101,273,70,Oncoimmunology_2016_Mar_28_5(7)_e1164918.txt
EC 2.1.1.17,"...osphatidylethanolamine N-methyltransferase (PEMT; EC 2.1.1.17), an enzyme responsible for the cataly...",8,310,Oncol_Lett_2014_Jun_4_7(6)_2175-2179.txt
3.7.2.89,... cells Nutr Res Pract 7 89 95 2013 10.4162/nrp.2013.7.2.89 23610600,122,225,Oncol_Lett_2015_Jan_11_9(1)_437-441.txt
6.11.4.351,... J Korean Med Sci 11 351 355 1996 10.3346/jkms.1996.11.4.351 887880,70,243,Oncol_Lett_2015_Feb_24_9(2)_829-832.txt
3.16.1.122,...re J Breast Cancer 16 122 126 2013 10.4048/jbc.2013.16.1.122 23593093,63,228,Oncol_Lett_2015_Apr_6_9(4)_1885-1888.txt
3.47.4.316,...J Pathol 47 316 325 2013 10.4132/KoreanJPathol.2013.47.4.316 24009626,204,309,Oncol_Lett_2016_Feb_2_11(2)_998-1006.txt
2.13.8.380,... J Cancer Prev 13 3809 3813 2012 10.7314/APJCP.2012.13.8.3809 23098475,123,155,Oncol_Lett_2016_Feb_31_11(2)_1406-1412.txt
2.13.12.641,... J Cancer Prev 13 6415 6421 2012 10.7314/APJCP.2012.13.12.6415 23464468,85,249,Oncol_Lett_2016_Oct_11_12(4)_2271-2276.txt
EC 3.4.21.64,"...s were incubated with 3 to 10 μg/ml proteinase K (EC 3.4.21.64) (Sigma, St.Louis, MO) for 10 to 15 m...",258,227,Oncotarget_2015_Mar_12_6(7)_5275-5291.txt
3.6.4.4,...ocol 1998 United Network for Organ Sharing Policy 3.6.4.4,260,300,Oncotarget_2015_Mar_19_6(11)_9551-9563.txt
3.1.1.9,3.1.1.9. Nrf,316,1,Oncotarget_2015_Sep_5_6(27)_23058-23134.txt
2.4.1.5,2.4.1.5 Segmentatio,83,1,Open_Biomed_Eng_J_2012_May_9_6_56-72.txt
1.41.1.23,...Imaging Sci. Dent. 2011 41 1 23 28 10.5624/isd.2011.41.1.23 21977470,138,175,PMC5204061.txt
1.2.2.1,1.2.2.1  Sequencing and Phylogenetic Analysi,69,1,Open_Virol_J_2012_Nov_30_6_122-134.txt
2.1.2.3,2.1.2.3. Experiment,44,1,Pain_2015_Dec_6_156(12)_2449-2457.txt
2.1.2.5,2.1.2.5. Pain Anxiety Symptoms Scale 2,46,1,Pain_2015_Oct_9_156(10)_1978-1990.txt
4.1.2.4,4.1.2.4. Pain Disability Inde,142,1,Pain_2015_Oct_9_156(10)_1978-1990.txt
EC 2.1.1.2,...a. Six GAMT [N-guanidinoacetatemethyltransferase (EC 2.1.1.2)] and 10 X-linked creatine transporter ...,3,5477,Orphanet_J_Rare_Dis_2012_Dec_13_7_96.txt
1.72.7.921,...rowth J Periodontol 2001 72 921 31 10.1902/jop.2001.72.7.921 11495141,272,179,Orphanet_J_Rare_Dis_2016_Jan_27_11_9.txt
3.9.1.61,...ature J Clin Neurol 2013 9 1 61 64 10.3988/jcn.2013.9.1.61 23346163,556,189,Orphanet_J_Rare_Dis_2016_Mar_24_11_29.txt
2.2.4.1,2.2.4.1 Case isolatio,85,1,Osong_Public_Health_Res_Perspect_2011_Jun_12_2(1)_65-71.txt
6.1.2.225,...t Opin Pharmacother 2000 1 225 238 10.1517/14656566.1.2.225 McClung MR (2000) Bisphosphonates in ost...,136,131,Osteoporos_Int_2008_Apr_14_19(4)_511-517.txt
3.18.1.9,...sis J Bone Miner Res 2003 18 9 17 10.1359/jbmr.2003.18.1.9 12510800,125,261,Osteoporos_Int_2014_Oct_10_25(3)_1173-1180.txt
EC 1.6.3.1,"...ein kinase C (PKC, EC 2.7.11.13), NADPH oxidases (EC 1.6.3.1), extracellular-signal-regulated kinase...",35,951,Oxid_Med_Cell_Longev_2011_Nov_24_2011_467180.txt
EC 3.1.3.2,"...phatase (EC 3.6.1.18); (4), FMN phosphohydrolase (EC 3.1.3.2); (5), NAD(H) cleaving enzyme; DH, NAD(...",234,403,Oxid_Med_Cell_Longev_2013_Sep_1_2013_612784.txt
5.7.1.88,...munology Research  2015 7 1 88 91 10.4168/aair.2015.7.1.88 2-s2.0-84919354986,131,217,Oxid_Med_Cell_Longev_2016_Dec_7_2016_4202437.txt
EC 3.4.22.1,"Cathepsin B (CatB; EC 3.4.22.1), a typical cysteine lysosomal proteas...",36,20,Oxid_Med_Cell_Longev_2016_Aug_28_2016_7894247.txt
EC 1.6.4.2,"Glutathione reductase (GSH-R, EC 1.6.4.2) is a flavoprotein that catalyzes the N...",53,31,Oxid_Med_Cell_Longev_2016_Oct_9_2016_9324692.txt
6.10.4.418,...ch and Practice  2016 10 4 418 423 10.4162/nrp.2016.10.4.418 2-s2.0-84982823371 27478549,437,213,PMC5274660.txt
3.28.1.112,... J Intern Med 2013 28 112 115 DOI:10.3904/kjim.2013.28.1.112 23346007,112,231,Pak_J_Med_Sci_2015_Mar-Apr_31(2)_398-402.txt
3.15.16.216,...d Epidemiology Network PAMJ-15-1610.11604/pamj.2013.15.16.2161Case ReportTrans-scaphoid dislocation ...,3,137,Pan_Afr_Med_J_2013_May_8_15_16.txt
3.15.22.210,...d Epidemiology Network PAMJ-15-2210.11604/pamj.2013.15.22.2103PerspectivesLa singularité du patient ...,3,137,Pan_Afr_Med_J_2013_May_13_15_22.txt
4.17.1.301,...gy Network PAMJ-SUPP-17-1-0710.11694/pamj.supp.2014.17.1.3014ResearchAdverse neonatal outcomes in wo...,3,149,Pan_Afr_Med_J_2014_Jan_18_17(Suppl_1)_7.txt
3.16.65.240,...d Epidemiology Network PAMJ-16-6510.11604/pamj.2013.16.65.2403Case ReportPyomyositis in Nodding Synd...,3,137,Pan_Afr_Med_J_2013_Oct_23_16_65.txt
4.17.23.335,...d Epidemiology Network PAMJ-17-2310.11604/pamj.2014.17.23.3358Case ReportCause rare d'une perforatio...,3,137,Pan_Afr_Med_J_2014_Jan_17_17_23.txt
4.17.20.342,...d Epidemiology Network PAMJ-17-2010.11604/pamj.2014.17.20.3424Case SeriesEvolution post-opératoire d...,3,137,Pan_Afr_Med_J_2014_Jan_17_17_20.txt
4.18.1.414,...gy Network PAMJ-SUPP-18-1-0910.11694/pamj.supp.2014.18.1.4149ResearchDeterminants of routine immuniz...,3,149,Pan_Afr_Med_J_2014_Jul_21_18(Suppl_1)_9.txt
4.19.30.518,...d Epidemiology Network PAMJ-19-3010.11604/pamj.2014.19.30.5188Case ReportLe syndrome de Vogt-Koyanag...,3,137,Pan_Afr_Med_J_2014_Sep_12_19_30.txt
4.19.47.491,...d Epidemiology Network PAMJ-19-4710.11604/pamj.2014.19.47.4914Case ReportPemphigoïde gestationis et ...,3,137,Pan_Afr_Med_J_2014_Sep_22_19_47.txt
4.19.63.497,...d Epidemiology Network PAMJ-19-6310.11604/pamj.2014.19.63.4973Images in MedicineAssociation très rar...,3,137,Pan_Afr_Med_J_2014_Sep_23_19_63.txt
4.19.66.527,...d Epidemiology Network PAMJ-19-6610.11604/pamj.2014.19.66.5276Case ReportLiposarcome myxoïde primiti...,3,137,Pan_Afr_Med_J_2014_Sep_24_19_66.txt
4.19.77.402,...d Epidemiology Network PAMJ-19-7710.11604/pamj.2014.19.77.4029Case SeriesDécompression chirurgicale ...,3,137,Pan_Afr_Med_J_2014_Sep_24_19_77.txt
5.20.25.576,...d Epidemiology Network PAMJ-20-2510.11604/pamj.2015.20.25.5769Case ReportLupus érythémateux systémiq...,3,137,Pan_Afr_Med_J_2015_Jan_12_20_25.txt
5.21.26.694,...d Epidemiology Network PAMJ-21-2610.11604/pamj.2015.21.26.6944Images in MedicineTorticolis de l'enfa...,3,137,Pan_Afr_Med_J_2015_May_12_21_26.txt
5.21.41.621,...d Epidemiology Network PAMJ-21-4110.11604/pamj.2015.21.41.6219ResearchPathologies cutanées vues au l...,3,137,Pan_Afr_Med_J_2015_May_21_21_41.txt
5.21.42.604,...d Epidemiology Network PAMJ-21-4210.11604/pamj.2015.21.42.6041ResearchLa place de la thoracoscopie d...,3,137,Pan_Afr_Med_J_2015_May_21_21_42.txt
5.22.78.788,...d Epidemiology Network PAMJ-22-7810.11604/pamj.2015.22.78.7884Case ReportIntranodal palisaded myofib...,3,137,Pan_Afr_Med_J_2015_Oct_1_22_78.txt
6.5.2.263,...t Opin Pharmacother 2004 5 263 285 10.1517/14656566.5.2.263 14996624,263,167,Parasit_Vectors_2014_May_19_7_229.txt
3.5.2.1,"...e (AMOVA), was generated by the software ARLEQUIN 3.5.2.1 [42]. Genetic analysis of population diffe...",88,707,Parasit_Vectors_2014_Dec_16_7_581.txt
3.18.50.206,...uro Surveill 2013 18 20661 10.2807/1560-7917.ES2013.18.50.20661 24342514,308,174,Parasit_Vectors_2016_Feb_3_9_63.txt
3.40.33.10,"...n SCP (SM00198), 27 a pathogenesis-related (G3DSA:3.40.33.10) and 25 a CAP (PF00188) domain (Additio...",39,507,Parasit_Vectors_2016_Jun_24_9_360.txt
4.19.3.136,...unity Nursing  2014 19 3 136 141 10.12968/bjcn.2014.19.3.136 2-s2.0-84901937720 24897835,190,200,PMC5294385.txt
EC 1.1.1.27,"● Lactate dehydrogenase (EC 1.1.1.27; kinetic UV test, 340 nm, 37°C acc. to...",566,26,Part_Fibre_Toxicol_2014_Apr_4_11_16.txt
6.33.1.52,...ablets Vasa 2004 33 52 4 15061050 10.1024/0301-1526.33.1.52,70,143,Patient_Saf_Surg_2008_Dec_9_2_32.txt
3.16.4.261,"...erology, Hepatology and Nutrition 10.5223/pghn.2013.16.4.261Original ArticleClinical Characteristics...",3,232,Pediatr_Gastroenterol_Hepatol_Nutr_2013_Dec_31_16(4)_261-268.txt
4.77.3.600,...Social Psychology 1999 77 600 619 10.1037/0022-3514.77.3.600,397,223,PeerJ_2013_Sep_10_1_e156.txt
1.11.10.43,...d tinamou (Rhynchotus rufescens specimen NHMUK 1851.11.10.43) proximal tibiotarsus in sagittal cross...,75,1071,PeerJ_2014_Dec_23_2_e711.txt
3.84.3.131,... Surgical Society 2013 84 131 139 10.4174/jkss.2013.84.3.131 23486845,265,243,PeerJ_2015_Sep_29_3_e1275.txt
4.17.5.511,...robe Interactions 2004 17 511 520 10.1094/MPMI.2004.17.5.511 15141955,171,306,PeerJ_2015_Dec_1_3_e1469.txt
5.36.3.177,...f Periodontology 1965 36 3 177 187 10.1902/jop.1965.36.3.177 14296927,252,152,PeerJ_2016_Aug_24_4_e2327.txt
6.2.1.12,4CL	K01904	6.2.1.12	4-Coumarate—CoA ligase	15	8	4,137,12,PMC5333554.txt
1.1.1.219,DFR	K13082	1.1.1.219	Dihydroflavonol 4-reductase	27	13	10,142,12,PMC5333554.txt
4.94.11.125,...topathology 2004 94 11 1259 1266 10.1094/phyto.2004.94.11.1259 18944464,196,190,PMC5357341.txt
2.4.7.1,...ents are entitled to material compensation.’ Item 2.4.7.1 titled Obligation of Sponsor to Pay went o...,10,861,Perspect_Clin_Res_2012_Jan-Mar_3(1)_4-7.txt
3.4.2.151,...n Future Microbiol. 2009 4 151 154 10.2217/17460913.4.2.151 19257841,442,149,Pharmaceuticals_(Basel)_2013_Jan_28_6(2)_124-160.txt
2.4.2.2,2.4.2.2 Recognition memory testin,74,1,Pharmacol_Biochem_Behav_2014_Dec_127_42-48.txt
2.6.2.3,2.6.2.3 Role of TRPA1 in visceral hypersensitivit,190,1,Pharmacol_Ther_2011_Jul_131(1)_142-170.txt
2.2.3.273,...7 10.1037/1528-3542.2.3.273  (doi:10.1037/1528-3542.2.3.273)12899360,180,236,Philos_Trans_R_Soc_Lond_B_Biol_Sci_2011_Jun_12_366(1571)_1684-1701.txt
1.1.4.6,   1.1.4.6 Nerves of the lower lim,117,4,Phlebology_2014_Oct_29(9)_587-593.txt
EC 4.2.1.1,The carbonic anhydrase (CA) enzymes (EC 4.2.1.1) are vital for plant and animal metabol...,135,38,Photosynth_Res_2009_Dec_4_102(2-3)_511-522.txt
1.2.1.4,...(http://ipni.org/urn:lsid:ipni.org:names:280343-1:1.2.1.4). Described from: [CHINA] “Y. [Yunnan] In ...,136,102,PhytoKeys_2015_May_13_(50)_9-23.txt
4.84.4.822,...ers Soc Psychol 2003 84 4 822 848 10.1037/0022-3514.84.4.822 12703651,258,162,Pilot_Feasibility_Stud_2016_Aug_5_2_43.txt
3.16.10.945,"... Microbe Interact 2003 10 945 952 10.1094/MPMI.2003.16.10.945 Wietholter N, Graessner B, Mierau M, M...",304,273,Planta_2008_Jun_8_228(1)_61-78.txt
EC 1.15.1.1,"The activity of superoxide dismutase (SOD, EC 1.15.1.1) was measured on the basis of reductio...",33,44,Planta_2016_Jun_22_244(4)_939-960.txt
4.19.1.3,...thodology J Mater Res 2004 19 3 20 10.1557/jmr.2004.19.1.3,181,193,Planta_2015_Aug_26_242(6)_1453-1465.txt
4.2.2.2,Pectate Lyase (4.2.2.2,162,16,Plant_Biotechnol_J_2016_Jun_2_14(6)_1329-1344.txt
3.1.1.73,Feruloyl esterase (3.1.1.73,211,20,Plant_Biotechnol_J_2016_Jun_2_14(6)_1329-1344.txt
3.2.1.21,"1,4‐β‐glucosidase (3.2.1.21",230,20,Plant_Biotechnol_J_2016_Jun_2_14(6)_1329-1344.txt
3.2.1.21,"1,4‐β‐glucosidase (3.2.1.21",230,20,Plant_Biotechnol_J_2016_Jun_2_14(6)_1329-1344.txt
3.1.1.73,Feruloyl esterase (3.1.1.73,284,20,Plant_Biotechnol_J_2016_Jun_2_14(6)_1329-1344.txt
1.1.1.8,...D1; glycerol‐3‐phosphate dehydrogenase (NAD+) [EC:1.1.1.8]	42.68	14.48	−1.56,217,76,PMC5253468.txt
1.2.1.9,At1g12900	1.2.1.9	1.83	0.46	6.30	2.26	11.52	6.24	4.6	GAPA-2	...,93,11,Plant_J_2010_Jun_11_62(6)_1058-1071.txt
4.1.3.24,"...e-CoA ligase (EC:6.2.1.9), or malyl-CoA lyase (EC:4.1.3.24) in the \"serine-isocitrate lyase pathway\"...",46,927,Plant_Methods_2006_Mar_2_2_5.txt
4.17.4.366,...Plant-Microbe Interact 17 366 373 10.1094/MPMI.2004.17.4.366 15077669,143,250,Plant_Pathol_J_2015_Mar_31_31(1)_72-77.txt
EC 3.2.1.67,Exo-polygalacturonase (EC 3.2.1.67,254,24,Plants_(Basel)_2013_Mar_7_2(1)_107-147.txt
EC 2.6.1.44,"... enzyme alanine-glyoxylate aminotransferase (AGT, EC 2.6.1.44) [3]. AGT catalyzes the transamination...",25,513,PLoS_Biol_2012_Apr_17_10(4)_e1001309.txt
1.1.1.37,...malate dehydrogenase (L-MDH) NAD+ (GO:0030060; EC:1.1.1.37) and MDH NADP+ (GO:0046554; EC:1.1.1.83) ...,136,289,PMC1246806.txt
3.50.7.10,Figure S3 Profile Comparison of the 3.50.7.10 Domain Cluster against the Rest of Profi...,283,38,PMC2098864.txt
2.7.1.20,2.7.1.2,252,1,PMC2727484.txt
3.40.50.182,421.0	0.55	3.40.50.1820	c.69.1.30,418,13,PMC2759523.txt
2.5.1.10,2.5.1.1/2.5.1.10	0.52,254,9,PMC2796266.txt
6.1.1.6,6.1.1.12/6.1.1.6,409,10,PMC2796266.txt
3.5.1.25,"Acetylglucosamine phosphate deacetylase	3.5.1.25	B(170), A(6)",288,41,PMC3088654.txt
2.7.1.100,2.7.1.100	2.7.11.1	2pyw	3e7e	At1g49820	BUB1	28.83	...,108,1,PMC3248393.txt
1.1.1.157,"....7.2.7), 3-hydroxybutyryl-CoA dehydrogenase (E.C. 1.1.1.157), acetyl-CoA C-acetyltransferase (E.C. 2...",98,582,PMC3349732.txt
4.74.90.158,"...rostatics (MCCE) [36]–[38], version 2.4 (http://134.74.90.158). The default parameters were used and...",235,107,PMC3585406.txt
2.4.1.184,Galactolipid galactosyltransferase	2.4.1.184	MGA_0001,169,36,PMC3764002.txt
3.40.50.970,"....0098) (which we have already mentioned) and CATH 3.40.50.970 (nd = 0.049), the second largest numbe...",243,158,PLoS_Comput_Biol_2014_May_29_10(5)_e1003642.txt
4.6.5.957,...tation . 1994 ;6 :957 –982 . doi: 10.1162/neco.1994.6.5.957,484,143,PLoS_Comput_Biol_2015_Aug_20_11(8)_e1004439.txt
4.22.1.22,...ogy . 2014 ;22 (1 ):22 –29 . doi: 10.12793/tcp.2014.22.1.22,799,273,PLoS_Comput_Biol_2015_May_15_11(5)_e1004199.txt
2.7.1.26,TGME49_216740	Riboflavin metabolism	2.7.1.26	yes	NA,346,37,PLoS_Comput_Biol_2015_May_22_11(5)_e1004261.txt
EC 2.4.1.147,8	β3Gn-T6	EC 2.4.1.147	acetylgalactosaminyl-O -glycosyl-glyc...,69,11,PLoS_Comput_Biol_2016_Apr_7_12(4)_e1004844.txt
EC 4.1.1.31,"...(EC 2.7.9.2) and phosphoenolpyruvate carboxylase (EC 4.1.1.31; K00720; Figure 3I, Figure S5N), by a ...",191,1593,PLoS_Genet_2012_Nov_15_8(11)_e1003035.txt
1.5.1.62,...rformed using a LightCycler with software version 1.5.1.62 (Roche). The RT qPCR master mix was prepa...,117,91,PLoS_Genet_2016_May_19_12(5)_e1006039.txt
EC 4.2.1.2,"...reaction R01082), catalyzed by a class II enzyme (EC 4.2.1.2B; K01679) in both the host and parasite...",83,1458,PMC5257007.txt
3.2.1.35,... the same class as mammalian hyaluronidases (E.C. 3.2.1.35 according to IUBMB Enzyme Nomenclature) [...,95,339,PLoS_Negl_Trop_Dis_2008_Sep_17_2(9)_e294.txt
2.9.3.2,"...) and tested in each year (2006, 2007) with Fstat 2.9.3.2. The two FST were combined with an unweigh...",52,159,PLoS_Negl_Trop_Dis_2009_Mar_17_3(3)_e392.txt
EC 1.8.1.4,"...aphorases such as dihydrolipoamine dehydrogenase (EC 1.8.1.4,), NAD(P)H:quinone oxidoreductase (EC 1...",143,582,PLoS_Negl_Trop_Dis_2013_Oct_31_7(10)_e2471.txt
6.21.13.301,...ll . 2016 ;21 (13 ). doi: 10.2807/1560-7917.ES.2016.21.13.30181  .27063794,231,205,PLoS_Negl_Trop_Dis_2016_Aug_25_10(8)_e0004877.txt
2.8.4.494,...on . 2008 ;8 (4 ):494 –521 . doi: 10.1037/1528-3542.8.4.494,403,185,PLoS_One_2016_Jun_14_11(6)_e0157444.txt
EC 3.4.24.-,...s0015	ftsH		−9.0	−4.5	Cell division protein ftsH (EC 3.4.24.-),68,53,PLoS_One_2009_Jul_1_4(7)_e6114.txt
EC 2.7.1.11,"...ly, the gene encoding 6-phosphofructokinase (PFK, EC 2.7.1.11), an essential enzyme for the EMP path...",32,579,PLoS_One_2009_Oct_1_4(10)_e7233.txt
EC 1.1.1.35,"...uding (S)-3-hydroxyacyl-CoA: NAD+ oxidoreductase (EC 1.1.1.35), transferases (EC 2.1.1.-), and acyla...",65,564,PLoS_One_2009_Dec_1_4(12)_e8098.txt
EC 1.1.1.49,"... lines. Glucose-6-phosphate dehydrogenase (G6PDH, EC 1.1.1.49), fructose-1,6-bisphosphate aldolase (...",175,225,PLoS_One_2010_Apr_1_5(4)_e9991.txt
2.2.1.2,"...he Mascot Distiller Quantitation Toolbox (version 2.2.1.2, Matrix Science) and was based on calculat...",59,89,PLoS_One_2010_Jul_22_5(7)_e11708.txt
EC 1.11.1.9,"...aled a putative glutathione peroxidase (Krad1247; EC 1.11.1.9), a glutathione S-transferase (Krad036...",80,235,PLoS_One_2010_Aug_26_5(8)_e12427.txt
EC 3.1.3.12,...ARI_05410) and trehalose-6-phosphate phosphatase (EC 3.1.3.12; AARI_05400). The environmental strain...,121,524,PLoS_One_2010_Nov_24_5(11)_e15489.txt
2.3.4.3,"...nt from Europe to North America. Similarly, in H6g2.3.4.3, some strains from North American birds fr...",248,1042,PLoS_One_2010_Dec_29_5(12)_e14454.txt
EC 1.2.1.12,... glyceraldehyde-3-phosphate dehydrogenase (GAPDH; EC 1.2.1.12) [6] and creatine kinase (CK; EC 2.7.3...,17,605,PLoS_One_2011_Jul_8_6(7)_e22154.txt
3.30.6.119,jep∶lmc	10.1037/0278–7393.30.6.1196	1196–1210	37	0.004050	0.00000	1	1	0,64,25,PLoS_One_2011_Nov_2_6(11)_e26828.txt
4.87.5.631,jpsp	10.1037/0022–3514.87.5.631	631–648	6	0.008074	0.00385	0	0	0,78,22,PLoS_One_2011_Nov_2_6(11)_e26828.txt
3.2.8.1,CHO Lec3.2.8.1 cell clones with stable genome integration...,23,8,PLoS_One_2011_Dec_9_6(12)_e27829.txt
EC 2.6.1.9,Histidinol-phosphate aminotransferase (EC 2.6.1.9)	OKIT_1689,131,41,PLoS_One_2012_Jan_3_7(1)_e29626.txt
EC 4.1.3.6,Citrate lyase alpha chain (EC 4.1.3.6)	YP_810047.1a,146,29,PLoS_One_2012_Jan_3_7(1)_e29626.txt
EC 1.14.-.-,"...ochrome P450 alkane hydroxylase (CYP153) protein (EC 1.14.-.-; Q2MHE2 and A9CMS7), protocatechuate 3...",39,610,PLoS_One_2012_Jan_11_7(1)_e30058.txt
EC 3.1.4.1,NPP1 (EC 3.1.4.1) is a plasma membrane glycoprotein that...,14,7,PLoS_One_2012_Feb_16_7(2)_e32177.txt
1.2.3.4,428	1.2.3.4f.7	0.8	-,43,6,PLoS_One_2012_Feb_17_7(2)_e30574.txt
3.5.1.49,"Formamidase	1	212	IPR002469, IPR004304	3.5.1.49: Formamidase	N",177,40,PLoS_One_2012_Apr_9_7(4)_e32990.txt
2.4.2.3,Uridine phosphorylase	Upp1/2.4.2.3,84,28,PLoS_One_2012_Apr_13_7(4)_e35445.txt
2.3.1.39,"...talyzed by malonyl-CoA ACP transacylase (MAT, EC: 2.3.1.39). All elongation reactions of the pathway...",141,1190,PLoS_One_2012_Apr_20_7(4)_e35142.txt
2.5.1.32,Phytoene synthase	PSY	2.5.1.32	1	NM	55(XP_002178776.1)	NM,191,23,PLoS_One_2012_Apr_20_7(4)_e35142.txt
1.14.13.-,Beta-carotene hydroxylase	CrtZ	1.14.13.-	1	NM	NM	NM,196,32,PLoS_One_2012_Apr_20_7(4)_e35142.txt
2.7.7.60,"...osphocytidyl-2-C-methyl-D-erythritol synthase (EC:2.7.7.60); IspE, 4-diphosphocytidyl-2-C-methyl-D-e...",264,306,PLoS_One_2012_Apr_20_7(4)_e35142.txt
EC 2.3.1.85,...pids (or lipogenesis). Fatty acid synthase (FASN; EC 2.3.1.85) and acetyl-CoA carboxylase (ACC; EC 6...,18,300,PLoS_One_2012_May_30_7(5)_e33233.txt
3.5.1.2,... π respectively) [22] were calculated in Arlequin 3.5.1.2 [23]. Pairwise Φst values were calculated ...,27,150,PLoS_One_2012_Jun_6_7(6)_e38042.txt
EC 1.6.99.2,"NAD(P)H:quinone oxidoreductase (NQO1, EC 1.6.99.2) is a cytosolic flavoenzyme that catal...",14,39,PLoS_One_2012_Jul_27_7(7)_e42138.txt
2.7.7.-,2.7.7.-	Transferases. Transfering P groups. Nucleo...,39,2,PLoS_One_2012_Sep_10_7(9)_e39912.txt
6.78.10.2,...hol Other (Description)	61.416.839.98.322.624.87.06.78.10.2	64.114.735.911.621.926.79.68.811.20.0	59...,101,180,PLoS_One_2012_Oct_25_7(10)_e48056.txt
3.7.1.1,"...ed for ambiguities with CodonCode Aligner version 3.7.1.1, and were submitted to Genbank (accession ...",61,482,PLoS_One_2012_Nov_29_7(11)_e50254.txt
EC 3.2.1.73,"...1,3-β glucosidades (EC 3.2.1.58) and licheninase (EC 3.2.1.73) activities, were identified in the se...",67,537,PLoS_One_2012_Dec_5_7(12)_e50571.txt
2.7.2.1,"...62	1.03	C	COG0282	ackA	K00925, acetate kinase [EC:2.7.2.1]",321,75,PLoS_One_2012_Dec_7_7(12)_e50777.txt
1.17.4.1,1.17.4.1	Ribonucleotide reductase	CCM_05761	169.9	...,115,1,PLoS_One_2012_Dec_14_7(12)_e51853.txt
2.7.4.3,2.7.4.3	Adenylate kinase	CCM_07479	90.15	47.03	0.9...,122,1,PLoS_One_2012_Dec_14_7(12)_e51853.txt
EC 4.1.1.39,"...(ribulose-1,5-bisphosphate carboxylase/oxygenase, EC 4.1.1.39) serves as the main gateway for inorga...",19,59,PLoS_One_2012_Dec_20_7(12)_e52974.txt
EC 3.6.3.14,"FoF1-ATP synthase (Complex V, EC 3.6.3.14) activity was determined on freshly is...",47,31,PLoS_One_2013_Jan_4_8(1)_e52328.txt
2.3.2.1,".... A tri-clade DNA vaccine encoding HA of clade 0, 2.3.2.1 and 7.2 elicits broadly neutralizing antib...",14,807,PLoS_One_2013_Jan_8_8(1)_e53568.txt
3.5.1.3,"...and ITS haplotypes were performed using Arlequin v3.5.1.3 [42], with haplotypes (including indel cha...",113,738,PLoS_One_2013_Jan_14_8(1)_e53134.txt
EC 3.4.21.34,...rinolysis and/or inhibition of plasma kallikrein (EC 3.4.21.34) limiting activation of inflammatory ...,14,722,PLoS_One_2013_Jan_15_8(1)_e54104.txt
2.9.3.2,...ere calculated with microsatellite data in FSTAT v2.9.3.2 [36] and GENETIX v4.05 [37]. Departures fr...,40,306,PLoS_One_2013_Jan_18_8(1)_e54428.txt
EC 3.2.1.37,"....1.8), β xylosidase (1,4 β-D-xylan xylohydrolase; EC 3.2.1.37) α-glucuronidase, α-L-arabinofuranosid...",19,720,PLoS_One_2013_Jan_31_8(1)_e52459.txt
1.14.14.1,"...oduced from T by the enzyme aromatase (CYP19A1, EC1.14.14.1), which interestingly is increased in th...",19,640,PLoS_One_2013_Feb_6_8(2)_e55905.txt
2.4.1.41,...lypeptide N-acetylgalactosaminyltransferase	GALNT	2.4.1.41	24,122,53,PLoS_One_2013_Feb_20_8(2)_e56998.txt
2.1.2.10,"... (EC.1.4.4.2, GLDC) and aminomethytransferase (EC.2.1.2.10, AMT). The expression profiles determined...",112,288,PLoS_One_2013_Mar_12_8(3)_e58563.txt
3.4.1.10,"...Tec SARAMIS database version 4.07, system version 3.4.1.10, including 45,894 spectra and 3,382 super...",88,790,PLoS_One_2013_Apr_30_8(4)_e63222.txt
EC 2.7.11.1,... to a family of serine/threonine protein kinases (EC 2.7.11.1) that are encoded by the pim proto-onc...,12,71,PLoS_One_2013_Jun_5_8(6)_e64824.txt
2.9.3.2,... the present study using PowerMarker V3.25. FSTAT 2.9.3.2 [40] was used to evaluate population relat...,175,173,PLoS_One_2013_Jun_10_8(6)_e65942.txt
EC 3.5.4.4,"...eir activities are expected: adenosine deaminase, EC 3.5.4.4; acetylxylan esterase, EC 3.1.1.72; pho...",153,412,PLoS_One_2013_Jun_18_8(6)_e66605.txt
3.2.8.1,...er cell line from the glycosylation mutant CHO Lec3.2.8.1 cell line containing an RMCE cassette was ...,35,57,PLoS_One_2013_Jul_17_8(7)_e68674.txt
EC 3.4.11.2,....4.14.11) and the general aminopeptidase N (PepN; EC 3.4.11.2) is important to achieve a high degree...,12,1075,PLoS_One_2013_Jul_19_8(7)_e70055.txt
5.2.2.231,...n Drug Metab Toxicol 2 : 231 -240 .10.1517/17425255.2.2.231 PubMed: 1686660916866609,194,134,PLoS_One_2013_Jul_23_8(7)_e69513.txt
1.1.1.195,Cinnamyl alcohol dehydrogenase	K00083	1.1.1.195	6,125,39,PLoS_One_2013_Jul_29_8(7)_e70781.txt
EC 3.5.3.3,"..., CCGE 1001, CCGE 1002 and CCGE 1003. Creatinase (EC 3.5.3.3) enzyme is also absent in all compared ...",72,729,PLoS_One_2013_Aug_5_8(8)_e70624.txt
1.14.13.132,squalene monooxygenase [EC:1.14.13.132]	Unigene11783_All,77,28,PLoS_One_2013_Aug_14_8(8)_e71350.txt
3.5.1.3,...gosities (α = 0.05) was determined using Arlequin 3.5.1.3 after a sequential Bonferonni correction c...,75,622,PLoS_One_2013_Sep_2_8(9)_e72997.txt
4.17.10.143,...in Investig Drugs 17 : 1435 -1463 .10.1517/13543784.17.10.1435 PubMed: 1880830,164,234,PLoS_One_2013_Sep_9_8(9)_e73706.txt
2.3.1.15,...erol-3-phosphate acyltransferase (chloroplast)	EC:2.3.1.15	3,128,60,PLoS_One_2013_Sep_11_8(9)_e74441.txt
2.3.1.15,GPAT5	glycerol-3-phosphate acyltransferase 5	EC:2.3.1.15	1,129,49,PLoS_One_2013_Sep_11_8(9)_e74441.txt
1.56.6.220,... . Limnol Oceanogr 56 : 2200 -2210 .10.4319/lo.2011.56.6.220,346,230,PLoS_One_2013_Sep_30_8(9)_e75798.txt
3.6.3.14,...161	-1.50 	-1.61 	F-type ATPase subunit alpha [EC:3.6.3.14] (K02111)	Photosynthesis (ko00195),165,60,PLoS_One_2013_Oct_10_8(10)_e77217.txt
1.13.11.12,Unigene71221	-1.70 	-2.87	Lipoxygenase [EC:1.13.11.12] (K00454)	alpha-Linolenic acid metaboli...,226,44,PLoS_One_2013_Oct_10_8(10)_e77217.txt
EC 3.1.8.1,"... EC 3.1.8.1) [12], the PhosphoTriEsterases (PTEs; EC 3.1.8.1) and the Phosphotriesterase-Like Lacton...",24,498,PLoS_One_2013_Nov_4_8(11)_e77995.txt
5.19.3.65,...ylem . Holzforschung 19 : 65 –69 .10.1515/hfsg.1965.19.3.6,214,121,PLoS_One_2013_Nov_12_8(11)_e75857.txt
1.2.1.277,"...evelopment, Ministry of Health, Indonesia (KS.02.01.2.1.2776, KS.02.01.2.1.3461 and KS.02.01.2.1.233...",20,275,PLoS_One_2013_Nov_19_8(11)_e80891.txt
1.1.1.37,"....9), Malate deshydrogenase-1 and -2 (Mdh 1 and 2, 1.1.1.37), and Hexokinase-1 (Hk, 2.7.1.1). Alleles...",78,267,PLoS_One_2013_Dec_2_8(12)_e81555.txt
2.45.4.247,... cells . BMB Rep 45 : 247 -252 .10.5483/BMBRep.2012.45.4.247 PubMed: 2253113622531136,134,219,PLoS_One_2013_Dec_5_8(12)_e82436.txt
EC 3.5.1.42,...zyme nicotinamide mononucleotide (NMN) deamidase (EC 3.5.1.42) catalyzes the conversion of NMN to ni...,12,57,PLoS_One_2013_Dec_5_8(12)_e82705.txt
6.18.3.311,... . J Cogn Neurosci 18 : 311 –319 .10.1162/jocn.2006.18.3.311 PubMed: 1660219316602193,97,191,PLoS_One_2013_Nov_7_8(11)_e80270.txt
3.1.2.15,"...specific peptidase 5/isopeptidase T (USP5/IsoT, EC3.1.2.15), as a target molecule of vialinin A in R...",19,390,PLoS_One_2013_Dec_4_8(12)_e80931.txt
2.24.28.79,"Completed further or higher education	25.51(22.24.28.79)	41.35(37.65,45.05)	33.14(29.60,36.67)	...",168,46,PLoS_One_2013_Dec_11_8(12)_e75679.txt
1.5.1.10,1.5.1.10_Glycine_,87,1,PLoS_One_2013_Dec_23_8(12)_e84027.txt
2.11.11.147,...Opin Ther Targets 11 : 1473 -1491 .10.1517/14728222.11.11.1473 PubMed: 1802801118028011,253,191,PLoS_One_2013_Dec_27_8(12)_e85143.txt
EC 3.2.1.21,...s genomes are predicted to encode β–glucosidases (EC 3.2.1.21) that are required for the conversion ...,152,802,PLoS_One_2013_Dec_30_8(12)_e83418.txt
2.4.2.1,56	F	deoD	2.4.2.1	Purine-nucleoside phosphorylase	Purine nuc...,141,11,PLoS_One_2014_Jan_15_9(1)_e85195.txt
2.4.1.-2,59	B	ugtP	2.4.1.-2.4.1.157	Glucosyldiacylglycerol 6-beta-glu...,146,11,PLoS_One_2014_Jan_15_9(1)_e85195.txt
3.5.2.6,Bacteria harboring β-lactamase enzymes [E.C. 3.5.2.6] pose a significant threat to public healt...,12,46,PLoS_One_2014_Jan_16_9(1)_e85892.txt
EC 3.1.3.16,"gi|346323	phosphoprotein phosphatase (EC 3.1.3.16) X catalytic chain	35,1	6	26,1",138,39,PLoS_One_2014_Jan_27_9(1)_e87215.txt
EC 3.2.1.4,"...ellobiohydrolase); endo-1,4-β-glucanases, such as EC 3.2.1.4; and β-glucosidases, such as EC 3.2.1.2...",16,553,PLoS_One_2014_Feb_18_9(2)_e88689.txt
2.3.1.199,...of very long chain fatty acids protein AAEL008004	2.3.1.199	1095	Tribolium castaneum	XP_968784	2.73E...,168,73,PLoS_One_2014_Feb_19_9(2)_e88589.txt
2.3.1.199,...of very long chain fatty acids protein AAEL008004	2.3.1.199	820	Tribolium castaneum	XP_968784	3.46E-...,171,73,PLoS_One_2014_Feb_19_9(2)_e88589.txt
3.1.-.-,"... In these cases (Table 3, common sources 2.3.1.-, 3.1.-.-, 3.2.1.18, 4.2.2.- and 6.-.-.-), if the cl...",214,678,PLoS_One_2014_Feb_19_9(2)_e89162.txt
2.1.5.1,All statistical analyses were performed in R v. 2.1.5.1. Non-parametric statistics (Kruskal-Wallis...,88,49,PLoS_One_2014_Feb_27_9(2)_e89808.txt
EC 6.4.1.2,...3.4.14) (Acetyl-CoA carboxylase subunit A) (ACC) (EC 6.4.1.2),114,116,PLoS_One_2014_Mar_11_9(3)_e91814.txt
4.64.1.83,... Pers Soc Psychol 64 : 83 –93 doi:10.1037/0022-3514.64.1.83 8421253,167,163,PLoS_One_2014_Mar_26_9(3)_e90876.txt
EC 2.7.3.-,...D	Osmosensitive K+ channel histidine kinase KdpD (EC 2.7.3.-)	Potassium homeostasis	0	0	0	41	28	7	6	...,154,60,PLoS_One_2014_Mar_27_9(3)_e92798.txt
2.4.3.3,...les in mgf format using Mascot Distiller (version 2.4.3.3). The parameters for data processing were:...,42,100,PLoS_One_2014_Apr_10_9(4)_e94646.txt
EC 2.3.2.5,"...catalyzed by the enzyme glutaminyl cyclases (QCs, EC 2.3.2.5) [11], [12]",12,1241,PLoS_One_2014_Apr_14_9(4)_e94812.txt
1.10.1.368,"...ia cornigera (Pourtalès, 1867) n. comb., NHMUK 1911.10.1.368, Barbados. G–H, Aspiscellaria frondis (...",267,299,PLoS_One_2014_Apr_18_9(4)_e95296.txt
2.4.1.21,Starch synthase	SSS	2.4.1.21	Soluble starch synthase	21	18,158,21,PLoS_One_2014_Apr_23_9(4)_e95428.txt
3.2.8.1,...todomain LFA-1 protein was expressed from CHO Lec 3.2.8.1 cells stably transfected with LFA-1 plasmi...,54,329,PLoS_One_2014_May_6_9(5)_e96649.txt
3.2.8.1,...todomain LFA-1 protein was expressed from CHO Lec 3.2.8.1 cells stably transfected with LFA-1 plasmi...,54,329,PLoS_One_2014_May_6_9(5)_e96649.txt
2.1.3.2,"...Ab bound to clade 1 and 2.2 HAs, but not to clade 2.1.3.2 or 2.3.4 HAs. OM-b and AY-2C2 mAbs bound t...",67,472,PLoS_One_2014_Jun_19_9(6)_e99201.txt
EC 1.2.1.27,"...sed of methylmalonyl semialdehyde dehydrogenases (EC 1.2.1.27). Thus far, the function of these gene...",100,81,PLoS_One_2014_Jul_2_9(7)_e101136.txt
EC 3.1.2.6,"...ly glyoxalase I (GLO1, EC 4.4.1.5) and –II (GLO2, EC 3.1.2.6) also called hydroxyacyl glutathione hy...",16,583,PLoS_One_2014_Jul_1_9(7)_e101473.txt
3.23.5.108,...earn Mem Cogn 23 : 1083 –1105 doi:10.1037/0278-7393.23.5.1083 9293623,189,169,PLoS_One_2014_Aug_11_9(8)_e104645.txt
EC 1.3.5.5,"...sequential catalysis of phytoene desaturase (PDS, EC 1.3.5.5), ζ-carotene isomerase (ZISO, EC 5.2.1....",158,174,PLoS_One_2014_Sep_25_9(9)_e108488.txt
1.14.13.129,"...droxylated by β-carotene 3-hydroxylase (CrtZ, EC: 1.14.13.129) and LUT5 to form zeaxanthin through β...",159,590,PLoS_One_2014_Sep_25_9(9)_e108488.txt
EC 3.1.1.1,"...d for enzymes of the XIII.2 are carboxylesterase (EC 3.1.1.1), esterase/lipase (EC 3.1.1.3) and mono...",35,322,PLoS_One_2015_Aug_25_10(8)_e0136940.txt
EC 1.1.1.133,"...(RmlA), EC 4.2.1.46 (RmlB), EC 5.1.3.13 (RmlC) or EC 1.1.1.133 (RmlD). In this manner, 69 genomes we...",108,530,PLoS_One_2014_May_15_9(5)_e97441.txt
4.68.1.83,68 : 83 –96 . doi: 10.1037/0022-3514.68.1.83,222,36,PLoS_One_2015_Sep_25_10(9)_e0138886.txt
2.5.1.47,... L-3-cyanoalanine synthase/ cysteine synthase	[EC:2.5.1.47 4.4.1.9]	00270 Cysteine and methionine me...,169,84,PLoS_One_2015_Oct_20_10(10)_e0140507.txt
5.3.4.6,"... of all paratypes same as for holotype): NHMUK 2015.3.4.6, one colony on coral, mounted on stub and ...",342,82,PLoS_One_2015_Oct_21_10(10)_e0139084.txt
4.1.1.4,"12 Joinpoint Regression Program, Version 4.1.1.4—February 2015 ; Statistical Methodology an...",214,42,PLoS_One_2015_Oct_29_10(10)_e0141685.txt
EC 2.3.1.74,"...f enzymes are as follows: CHS, chalcone synthase (EC 2.3.1.74); CHI, chalcone isomerase (EC 5.5.1.6)...",16,298,PLoS_One_2015_Sep_14_10(9)_e0137925.txt
1.13.11.51,...o putative 9-cis-epoxycarotenoid dioxygenase [EC: 1.13.11.51] genes may provide previously unknown g...,188,379,PLoS_One_2015_Sep_14_10(9)_e0137213.txt
2.6.2.172,...Liver . 2012 ; 6 : 172 –187 . doi: 10.5009/gnl.2012.6.2.172,279,148,PLoS_One_2015_Sep_11_10(9)_e0137660.txt
4.15.3.313,2014 ;15 :313 –21 . doi: 10.3348/kjr.2014.15.3.313,330,41,PLoS_One_2015_Sep_3_10(9)_e0136667.txt
4.90.4.529,...ol . 2006 ;90 (4 ):529 –42 . doi: 10.1037/0022-3514.90.4.529  .16649853,182,172,PLoS_One_2015_Aug_27_10(8)_e0136521.txt
4.80.6.101,.... 2001 ;80 (6 ):1011 –1027 . doi: 10.1037/0022-3514.80.6.1011,277,215,PLoS_One_2015_Aug_27_10(8)_e0135740.txt
4.54.6.106,....nlm.nih.gov/pubmed/3397865. doi: 10.1037/0022-3514.54.6.1063,284,107,PLoS_One_2015_Aug_27_10(8)_e0135740.txt
4.17.1.8,...(1 ):8 –17 . Epub 2014/04/20. doi: 10.4048/jbc.2014.17.1.8  ; PubMed Central PMCID: PMCPMC3988347.24...,248,191,PLoS_One_2015_Aug_25_10(8)_e0136374.txt
2.20.1.25,...(1 ):25 –9 . Epub 2012/04/18. doi: 10.4250/jcu.2012.20.1.25  ; PubMed Central PMCID: PMC3324724.2250...,379,341,PLoS_One_2015_Aug_20_10(8)_e0135778.txt
3.2.1.50,"...iciency in N-acetyl-α-glucosaminidase (Naglu, EC: 3.2.1.50) activity, which leads to lysosomal accum...",21,508,PLoS_One_2015_Aug_19_10(8)_e0135873.txt
EC 3.2.1.75,"...-1,3-glucanase (EC 3.2.1.58), endo-1,6-glucanase (EC 3.2.1.75), β-mannanase (EC 3.2.1.78), and endog...",212,674,PLoS_One_2015_Aug_11_10(8)_e0135239.txt
3.97.2.170,...170 –183 . doi: http://dx.doi.org/10.1037/0022-0663.97.2.170,355,220,PLoS_One_2015_Aug_6_10(8)_e0134660.txt
EC 3.4.14.5,...ion of native human CD26/dipeptidyl peptidase IV (EC 3.4.14.5) . J Immunol Methods . 1996 ;189 : 99 ...,242,181,PLoS_One_2015_Nov_6_10(11)_e0141408.txt
4.2.1.79,"..._05260 encoding a 2-methylcitrate dehydratase (EC:4.2.1.79), an important enzyme involved in the met...",269,673,PLoS_One_2015_Apr_13_10(4)_e0124360.txt
3.30.6.132,.../11/04. 2004-19815-014 [pii] doi: 10.1037/0278-7393.30.6.1322  .15521807,259,272,PLoS_One_2015_Apr_7_10(4)_e0121904.txt
4.83.1.160,"...Psychology , 83 , 160 –184 . doi: 10.1037/0022-3514.83.1.160",325,227,PLoS_One_2015_Mar_24_10(3)_e0122245.txt
5.1.20.2,"...n using a Sectra-PACS workstation (IDS7, Version 15.1.20.2, Sectra AB, Linköping, Sweden). ADC value...",81,235,PLoS_One_2015_Mar_30_10(3)_e0122516.txt
3.1.3.16,PAAG_02594.2	Phosphoprotein phosphatase 2C	3.1.3.16	+2,205,44,PLoS_One_2015_Jun_26_10(6)_e0130703.txt
EC 1.15.1.1,"....4). The activities of superoxide dismutase (SOD, EC 1.15.1.1), catalase (CAT, EC 1.11.1.6), and per...",52,323,PLoS_One_2015_Mar_20_10(3)_e0120627.txt
3.96.4.723,96 : 723 –730 . doi: 10.1037/0022-0663.96.4.723,290,38,PLoS_One_2015_Mar_24_10(3)_e0119638.txt
3.11.3.149,...tics . 2013 ;11 (3 ):149 –54 . doi: 10.5808/GI.2013.11.3.149  ; PubMed Central PMCID: PMC3794088.241...,402,137,PLoS_One_2015_Nov_16_10(11)_e0142130.txt
EC 1.11.1.7,...cient of 6.93×10−3 mM−1cm−1. Guaiacol peroxidase (EC 1.11.1.7) was determined by the method as given...,132,635,PLoS_One_2014_Nov_12_9(11)_e112614.txt
2.3.1.74,Flavonoidbiosynthesis	K00660	2.3.1.74	Unigene56280_All	−1.9	D	chalcone synthase...,136,30,PLoS_One_2014_Nov_17_9(11)_e112966.txt
3.2.1.21,"...ncode cellulose-degrading activities (EC 3.2.1.4, 3.2.1.21, EC 3.2.1.91 and EC 3.2.1.176 and LPMOs),...",210,93,PLoS_One_2014_Dec_2_9(12)_e114138.txt
3.2.1.59,"...3.2.1.37, 3.2.1.151, 3.2.1.8, 3.2.1.55, 3.2.1.23, 3.2.1.59, 3.2.1.131, 3.2.1.177, 3.2.1.78, 3.2.1.67...",210,233,PLoS_One_2014_Dec_2_9(12)_e114138.txt
EC 1.4.7.1,"...eaction: it exist as a ferredoxin (Fd) dependent (EC 1.4.7.1), and a NADH dependent (EC 1.4.1.14) fo...",24,266,PLoS_One_2014_Aug_6_9(8)_e103869.txt
5.20.2.193,doi: 10.1037/0894-4105.20.2.193 16594780,290,22,PLoS_One_2014_Aug_21_9(8)_e105623.txt
EC 3.2.1.14,"...EC 1.2.1.59), stress-related EP3 chitinase (−4.7; EC 3.2.1.14), thaumatin (pathogenesis-related prot...",141,968,PLoS_One_2014_Sep_5_9(9)_e106886.txt
EC 3.2.1.54,...anotransferase (EC 2.4.1.19) and cyclodextrinase (EC 3.2.1.54) are known to exhibit different substr...,15,279,PLoS_One_2014_Sep_15_9(9)_e106481.txt
2.45.12.242,45 : 686 –692 . doi: 10.5483/BMBRep.2012.45.12.242,333,40,PLoS_One_2015_Jan_14_10(1)_e0116484.txt
6.6.2.157,6 : 157 –164 . doi: 10.1517/14656566.6.2.157,108,36,PLoS_One_2015_Jan_15_10(1)_e0116939.txt
EC 2.4.1.5,"...transucrases, also known as glucosyltransferases (EC 2.4.1.5), which catalyse the hydrolysis of sucr...",13,562,PLoS_One_2015_Jan_20_10(1)_e0116418.txt
6.18.3.259,...DS Educ Prev 18 : 259 –272 . doi: 10.1521/aeap.2006.18.3.259,461,169,PLoS_One_2015_Jan_27_10(1)_e0115290.txt
1.16.3.497,16 : 497 –500 . doi: 10.1359/jbmr.2001.16.3.497,270,38,PLoS_One_2015_Feb_2_10(2)_e0116833.txt
2.1.1.183,"...sing DP Controller software (Olympus Corporation, 2.1.1.183)",39,787,PLoS_One_2015_Feb_6_10(2)_e0114813.txt
1.14.13.11,CYP73A;trans-cinnamate 4-monooxygenase	1.14.13.11	comp10963_c0	51.93,203,40,PLoS_One_2015_May_4_10(5)_e0125722.txt
2.2.4.-2,"... multicenter DISCHARGE trial (603266-2, HEALTH-2012.2.4.-2), the European Regional Development Fund ...",3,1178,PLoS_One_2015_May_6_10(5)_e0125943.txt
3.1.2.-,"...ntrol of acyl-ACP thioesterase (FAT, EC: 3.1.2.14 3.1.2.-) and palmitoyl-CoA hydrolase (PCH, EC: 3.1...",105,2582,PLoS_One_2015_May_12_10(5)_e0126250.txt
2.3.1.51,"...1.15); LPAT, lysophosphatidyl acyltransferase (EC:2.3.1.51); PP, phosphatidate phosphatase (EC:3.1.3...",108,809,PLoS_One_2015_May_12_10(5)_e0126250.txt
3.1.3.4,"...s catalyzed by phosphatidate phosphatase (PP, EC: 3.1.3.4), a key regulator of lipid homeostasis, to...",155,1322,PLoS_One_2015_May_12_10(5)_e0126250.txt
2.3.1.20,"...e was diacylglycerol O-acyltransferase (DGAT, EC: 2.3.1.20), encoded by five unigenes (two for DGAT1...",155,1708,PLoS_One_2015_May_12_10(5)_e0126250.txt
2.3.1.51,...acyl-sn-glycerol-3-phosphate acyltransferase 5	EC:2.3.1.51	1	1up,173,59,PLoS_One_2015_May_12_10(5)_e0126250.txt
4.2.1.17,"...ratase/3-hydroxyacyl-CoA dehydrogenase (MFP2, EC: 4.2.1.17 1.1.1.35 1.1.1.211) and acetyl-CoA acyltr...",215,1188,PLoS_One_2015_May_12_10(5)_e0126250.txt
2.24.3.243,...rmatol . 2012 ;24 : 243 –252 . doi: 10.5021/ad.2012.24.3.243,301,130,PLoS_One_2015_May_22_10(5)_e0127852.txt
1.2.1.41,Glutamylphosphate reductase	1.2.1.41	Unitig_69676	-	94.4,122,31,PLoS_One_2015_May_22_10(5)_e0126751.txt
3.7.1.2,3.7.1.2	Fumarylacetoacetase	1	2,62,1,PLoS_One_2015_May_22_10(5)_e0127789.txt
1.1.1.35,1.1.1.35	3-hydroxyacyl-CoA dehydrogenase	3	1,94,1,PLoS_One_2015_May_22_10(5)_e0127789.txt
4.94.7.751,...ogy . 2004 ;94 : 751 –758 . doi: 10.1094/PHYTO.2004.94.7.751,284,210,PLoS_One_2015_May_26_10(5)_e0127916.txt
3.28.12.170,...:1703 –10 . Epub 2013/12/18. doi: 10.3346/jkms.2013.28.12.1703  ; PubMed Central PMCID: PMC3857363.2...,217,162,PLoS_One_2015_Jun_5_10(6)_e0128537.txt
3.93.1.23,...chology . 2001 ;93 :23 –34 . doi: 10.1037/0022-0663.93.1.23,256,238,PLoS_One_2015_Jun_8_10(6)_e0129630.txt
2.16.1.2,...rourol J . 2012 ;16 : 2 –12 . doi: 10.5213/inj.2012.16.1.2,206,179,PLoS_One_2015_Jun_8_10(6)_e0129095.txt
1.15.1.1,...Biochem . 2011 ;15 : 1 –10 . doi: 10.5717/jenb.2011.15.1.1,200,174,PLoS_One_2015_Jun_10_10(6)_e0128720.txt
1.1.96.878,...p://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.96.8783&rep=rep1&type=pdf. Accessed 14 April 2...,335,99,PLoS_One_2015_Jun_18_10(6)_e0127470.txt
EC 1.4.7.1,"...etase (GS, EC 6.3.1.2)/glutamate synthase (GOGAT, EC 1.4.7.1 and 1.4.1.14) cycle. In addition to pri...",13,989,PLoS_One_2015_Jun_19_10(6)_e0130438.txt
4.76.2.320,...hol . 1999 ;76 : 320 –338 . doi: 10.1037//0022-3514.76.2.320,345,201,PLoS_One_2015_Jun_26_10(6)_e0130100.txt
4.67.6.106,...ion; 1994 ;67 : 1063 –1078 . doi: 10.1037/0022-3514.67.6.1063,373,287,PLoS_One_2015_Jun_26_10(6)_e0130100.txt
1.36.6.107,36 6  (1991 ): 1071 –1077 . doi: 10.4319/lo.1991.36.6.1071,324,48,PLoS_One_2015_Nov_23_10(11)_e0143299.txt
2.3.1.180,beta-ketoacyl-ACP Synthase III	KAS III/FabH	2.3.1.180	P49243,35,45,PLoS_One_2016_Jan_4_11(1)_e0146158.txt
4.28.2.130,doi: 10.3341/kjo.2014.28.2.130,194,21,PLoS_One_2016_Jan_8_11(1)_e0146676.txt
1.1.1.37,...1.1.1.1.1.1.1.35 306	1.1.1.1.1.1.1.36 4.3	1.1.1.1.1.1.1.37 3.4	1.1.1.1.1.1.1.38 191,68,67,PLoS_One_2016_Jan_26_11(1)_e0146101.txt
1.1.1.1,...New	1.1.1.1.1.1.1.44 0.082	1.1.1.1.1.1.1.45 0.336	1.1.1.1.1.1.1.46 2,310,75,PLoS_One_2016_Jan_26_11(1)_e0146101.txt
2.2.12.67,...faces . 2002 ;32 (2 ):12 –22 . doi: 10.1287/inte.32.2.12.67,341,153,PLoS_One_2016_Feb_5_11(2)_e0148377.txt
4.38.5.375,... ):375 –87 . Epub 2014/10/29. doi: 10.4093/dmj.2014.38.5.375  ; PubMed Central PMCID: PMCPMC4209352....,221,237,PLoS_One_2016_Feb_18_11(2)_e0149321.txt
2.3.2.1,"...1.1 (A/chicken/Cambodia/TCL1/2009-like) and clade 2.3.2.1c (A/HongKong/6841/2010-like), respectively...",55,398,PLoS_One_2016_Feb_22_11(2)_e0149608.txt
2.3.2.1,"...rsubtype reassortment events between virus clades 2.3.2.1c, 2.3.2.1b, and 2.3.2.1a. The HA gene clus...",117,793,PLoS_One_2016_Feb_22_11(2)_e0149608.txt
1.14.99.45,23	Carotene epsilon-monooxygenase (LUT1) [EC:1.14.99.45]		Locus_11363_Transcript_1/1,171,46,PLoS_One_2016_Mar_4_11(3)_e0150273.txt
EC 1.14.11.9,"...avanones to flavones and flavanone 3-hydroxylase (EC 1.14.11.9, 1 unigene) can convert these flavano...",203,749,PLoS_One_2016_Mar_4_11(3)_e0150273.txt
4.94.4.396,94 : 396 –401 . doi: 10.1094/PHYTO.2004.94.4.396,208,39,PLoS_One_2016_Mar_8_11(3)_e0144573.txt
1.91.12.118,...thology . 91 : 1189 –1196 . doi: 10.1094/PHYTO.2001.91.12.1189,228,221,PLoS_One_2016_Mar_8_11(3)_e0144573.txt
1.15.1.1,Superoxide dismutase	Sod	1.15.1.1	2	ATP,78,26,PLoS_One_2016_Mar_9_11(3)_e0149556.txt
4.26.5.471,...:471 –483 . Epub 2014/10/10. doi: 10.1521/aeap.2014.26.5.471  .25299810,387,243,PLoS_One_2016_Mar_16_11(3)_e0151078.txt
5.45.1.9,...irc J . 2015 ;45 (1 ):9 –19 . doi: 10.4070/kcj.2015.45.1.9  ; PubMed Central PMCID: PMC4310986.25653...,175,215,PLoS_One_2016_Mar_17_11(3)_e0151485.txt
4.29.4.427,...ism . 2014 ;29 (4 ):427 –34 . doi: 10.3803/EnM.2014.29.4.427  ; PubMed Central PMCID: PMC4285032.255...,162,186,PLoS_One_2016_Mar_22_11(3)_e0149394.txt
3.25.1.184,...form . 1999 ;25 : 184 –197 . doi: 10.1037/0096-1523.25.1.184,304,203,PLoS_One_2016_Mar_22_11(3)_e0151374.txt
3.25.6.164,doi: 10.1037/0096-1523.25.6.1641,134,22,PLoS_One_2016_Mar_24_11(3)_e0151906.txt
3.15.2.67,... Stroke . 2013 ;15 : 67 –77 . doi: 10.5853/jos.2013.15.2.67,199,210,PLoS_One_2016_Mar_25_11(3)_e0152433.txt
2.63.4.321,2012 ;63 (4 ):321 –6 . doi: 10.4097/kjae.2012.63.4.321,224,45,PLoS_One_2016_Mar_31_11(3)_e0152605.txt
EC 1.20.4.1,"...al resistance protein (Acr3), arsenate reductase (EC 1.20.4.1), arsenic efflux pump protein, and ars...",83,753,PLoS_One_2016_Apr_1_11(4)_e0150413.txt
1.16.8.153,...):1532 –9 . Epub 2001/08/14. doi: 10.1359/jbmr.2001.16.8.1532  .11499876,278,351,PLoS_One_2016_Apr_7_11(4)_e0153120.txt
EC 1.11.1.9,"... (APX, EC 1.11.1.1), glutathione peroxidase (GPX, EC 1.11.1.9), catalase (CAT, EC 1.11.1.6) and supe...",13,1559,PLoS_One_2016_Apr_20_11(4)_e0154042.txt
3.16.11.103,...t . 2003 ;16 (11 ):1030 –8 . doi: 10.1094/mpmi.2003.16.11.1030,329,157,PLoS_One_2016_May_19_11(5)_e0154793.txt
1.1.58.685,...tp://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.58.6852. doi: 10.1145/1015330.1015414,339,176,PLoS_One_2016_May_20_11(5)_e0153384.txt
1.41.4.568,... Nurs . 2011 ;41 : 568 –79 . doi: 10.4040/jkan.2011.41.4.568,256,207,PLoS_One_2016_Jun_2_11(6)_e0156305.txt
4.16.3.400,9 ;16 (3 ):400 –13 . doi: 10.1037/0882-7974.16.3.400,298,43,PLoS_One_2016_Jun_23_11(6)_e0157649.txt
EC 3.4.21.4,"... (2–6 ng/mL). To obtain activated toxin, trypsin (EC 3.4.21.4) was added to a trypsin-to-toxin mass ...",24,913,PLoS_One_2016_Jun_24_11(6)_e0158356.txt
1.41.5.652,.... 2011 ; 41 (5 ): 652 –662 . doi: 10.4040/jkan.2011.41.5.652,264,175,PLoS_One_2016_Jul_8_11(7)_e0156348.txt
4.84.3.608,...logy . 2003 ;84 : 608 –618 . doi: 10.1037/0022-3514.84.3.608,230,173,PLoS_One_2016_Jul_11_11(7)_e0159103.txt
4.68.2.199,...chol . 1995 ;68 : 199 –214 . doi: 10.1037/0022-3514.68.2.199,778,169,PLoS_One_2016_Jul_14_11(7)_e0159193.txt
2.10.15.1,6	Listeria	monocytogenes	12.10.15.1–1	1/2b (I)	River water,72,27,PLoS_One_2016_Jul_21_11(7)_e0159730.txt
3.33.5.360,...medicine . 2013 ;33 :360 –3 . doi: 10.3343/alm.2013.33.5.360,115,208,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
EC 2.8.1.7,...as been found to be a novel cysteine desulfurase (EC 2.8.1.7) which has cysteine sulfoxide lyase (EC...,76,126,PLoS_One_2016_Aug_8_11(8)_e0160336.txt
5.2.1.12,Z-ISO; zeta-carotene isomerase [EC:5.2.1.12]	/	/	/	/	/	/,53,36,PLoS_One_2015_Oct_20_10(10)_e0140609.txt
5.2.1.13,"crtISO, crtH; prolycopene isomerase [EC:5.2.1.13]	/	/	/	/	/	/",61,41,PLoS_One_2015_Oct_20_10(10)_e0140609.txt
4.94.8.805,94 : 805 –812 . doi: 10.1094/PHYTO.2004.94.8.805,233,39,PLoS_One_2016_Aug_11_11(8)_e0120054.txt
5.18.3.564,...y . 2004 ; 18 (3 ):564 –71 . doi: 10.1037/0894-4105.18.3.564  .1529173,362,218,PLoS_One_2016_Sep_9_11(9)_e0162383.txt
3.24.5.517,...chol . 2005 ;24 : 517 –525 . doi: 10.1037/0278-6133.24.5.517,255,202,PLoS_One_2016_Sep_15_11(9)_e0162993.txt
4.63.5.797,...l . 1992 ;63 (5 ):797 –805 . doi: 10.1037/0022-3514.63.5.797,227,166,PLoS_One_2016_Sep_22_11(9)_e0163117.txt
2.4.1.2,...47720	Chicken breast	New Mexico (USA)	2013	152	15	2.4.1.2,145,56,PLoS_One_2016_Oct_3_11(10)_e0161225.txt
3.29.1.121,...form . 2003 ;29 : 121 –138 . doi: 10.1037/0096-1523.29.1.121,356,160,PLoS_One_2016_Oct_3_11(10)_e0163141.txt
4.29.2.172,... . 2014 ;29 (2 ): 172 –175 . doi: 10.3346/jkms.2014.29.2.172,150,170,PLoS_One_2016_Oct_5_11(10)_e0163588.txt
5.7.1.62,doi: 10.1037//0894-4105.7.1.62,285,23,PLoS_One_2016_Oct_6_11(10)_e0163772.txt
3.19.6.129,... . 1993 ;19 (6 ):1292 –312 . doi: 10.1037/0096-1523.19.6.1292,256,217,PLoS_One_2016_Oct_10_11(10)_e0164373.txt
3.31.6.143,...Cogn . 2005 ;31 : 1433 –58 . doi: 10.1037/0278-7393.31.6.1433,277,173,PLoS_One_2016_Oct_20_11(10)_e0165260.txt
4.14.1.32,14 : 32 –38 . doi: 10.5230/jgc.2014.14.1.32,272,35,PLoS_One_2016_Oct_26_11(10)_e0165179.txt
1.7.1.1,3 ;7 (1 ):1 –9 . doi: 10.3988/jcn.2011.7.1.1,355,38,PLoS_One_2016_Nov_8_11(11)_e0166261.txt
3.16.1.17,...tr . 2013 ;16 (1 ): 17 –21 . doi: 10.5223/pghn.2013.16.1.17,377,142,PLoS_One_2016_Nov_8_11(11)_e0165782.txt
3.5.2.2,...(HWE) was performed by Arlequin software (version 3.5.2.2; Computational and Molecular Population Ge...,89,96,PLoS_One_2016_Nov_10_11(11)_e0166544.txt
6.12.3.340,2016 ;12 :340 –344 . doi: 10.3988/jcn.2016.12.3.340,214,42,PLoS_One_2016_Nov_11_11(11)_e0165933.txt
4.4.29.208,"... of London, 1876 “1875”: 571–572. Lectotype. NHM 74.4.29.208 (ex BMNH 1947.2.27.72), designated by D...",143,233,PLoS_One_2016_Nov_16_11(11)_e0166326.txt
1.29.1.652,... Hum Neurosci . 2016 ;10 : 1 . doi: 10.1525/mp.2011.29.1.6526858619,269,161,PLoS_One_2016_Nov_23_11(11)_e0166880.txt
EC 2.1.2.1,...EC 2.1.1.2: guanidinoacetate N-methyltransferase; EC 2.1.2.1: glycine hydroxymethyltransferase (alt....,162,494,PLoS_One_2016_Dec_1_11(12)_e0167309.txt
3.5.2.2,...polymorphic sites per population using ARLEQUIN v.3.5.2.2 [27]. We conducted an AMOVA and pairwise F...,114,89,PLoS_One_2016_Dec_9_11(12)_e0167723.txt
2.6.1.12,"...or enzymes 2.3.1.117 and 2.6.1.17, Esim(2.6.1.18, 2.6.1.12) = 0.75. The input compounds of u and v a...",126,757,PLoS_One_2016_Dec_9_11(12)_e0168044.txt
1.11.1.7,"AT5G67400	14.606	5.960	-1.293	EC-1.11.1.7	RHS19; peroxidase activity, heme binding",183,34,PMC5231383.txt
4.16.58.129,...onf. 2014; 3025–3034. Available: internal-pdf://224.16.58.129/DoesGamificationWork.pd,216,206,PMC5242502.txt
EC 3.1.3.75,...anolamine/phosphocholine phosphatase (KEGG enzyme EC 3.1.3.75) in the presence of H2O. Up-regulation...,137,590,PMC5268493.txt
2.7.4.2,...52938.1 (L. corymbifera)	Phosphomevalonate kinase	2.7.4.2,105,130,PMC5289490.txt
1.3.1.21,..._013924762 (P. acanthamoebae)	Δ7 sterol reductase	1.3.1.21,156,134,PMC5289490.txt
5.20.2.133,doi: 10.1037/0894-4105.20.2.133,147,22,PMC5293243.txt
EC 1.1.1.85,...2-oxopentanoate 	3-Isopropylmalate dehydrogenase (EC 1.1.1.85),132,165,PMC5302809.txt
4.19.2.265,... Res . 2004 ;19 : 265 –269 . doi: 10.1359/jbmr.2004.19.2.265,452,223,PMC5310904.txt
4.55.6.149,...d J . 2014 ;55 : 1498 –1506 . doi: 10.3349/ymj.2014.55.6.1498,246,271,PMC5325284.txt
4.29.1.31,29 : 31 –39 . doi: 10.3904/kjim.2014.29.1.31,249,36,PMC5325306.txt
3.2.1.20,α-Glucosidase	αG	4-MUB-α-D-glucoside	3.2.1.20,77,38,PMC5338777.txt
4.79.4.656,...ology . 2000 ;79 :656 –669 . doi: 10.1037/0022-3514.79.4.656,365,209,PMC5333865.txt
1.3.1.44,"... Fig 2. ST736 is a single locus variant of ST750 (1.3.1.44.1.1.1), while ST18 is a triple locus vari...",80,528,PMC5340350.txt
1.7.1.4,"...nt assimilatory nitrite reductase (NAD[P]H-NIR, EC1.7.1.4). The latter two proteins are required for...",8,479,PLoS_ONE_2007_Oct_31_2(10)_e1097.txt
4.1.3.27,"1	3	368	R00986	4.1.3.27	Anthranilate synthase	Phenylalanine, tyro...",172,16,PLoS_ONE_2007_Sep_12_2(9)_e881.txt
EC 3.4.24.18,"Meprin (EC 3.4.24.18), an astacin-like metalloprotease, is...",6,9,PLoS_ONE_2008_May_14_3(5)_e2153.txt
EC 3.2.1.143,"...s is degraded by poly(ADP-ribose) glycohydrolase (EC 3.2.1.143; PARG), for which there is only one i...",23,101,PLoS_ONE_2009_Mar_25_4(3)_e4896.txt
1.5.1.3,...ner and analyzed by Illumina's BeadStudio version 1.5.1.3. Data were normalized with the Illumina Be...,122,590,PLoS_ONE_2009_May_14_4(5)_e5542.txt
2.7.1.149,"...n D. melanogaster (EC: 1.8.4.2, 2.4.2.8, 5.3.2.1, 2.7.1.149, 3.6.1.14)",82,1052,PLoS_Pathog_2013_Aug_1_9(8)_e1003505.txt
1.14.17.1,4	DB00988 (Dopamine)	6	1.14.17.1	Comm Nem	Dopamine	−	−,108,24,PLoS_Pathog_2013_Aug_1_9(8)_e1003505.txt
EC 1.5.1.12,...o glutamic acid by a P5C dehydrogenase (TbP5CDH) [EC 1.5.1.12] with a concomitant reduction of NAD(P...,49,1332,PMC5289646.txt
2.3.2.2,2.3.2.2 Dietary intak,45,1,Prev_Med_Rep_2016_Oct_26_4_591-596.txt
2.17.2.136,...Food Science and Nutrition 2447107510.3746/pnf.2012.17.2.136e1fsa3_2012_v17n2_136ArticlesBioactivity...,3,182,Prev_Nutr_Food_Sci_2012_Jun_17(2)_136-140.txt
2.17.4.274,...Food Science and Nutrition 2447109610.3746/pnf.2012.17.4.274e1fsa3_2012_v17n4_274ArticlesEstablishme...,3,182,Prev_Nutr_Food_Sci_2012_Dec_17(4)_274-279.txt
4.19.4.299,...iety of Food Science and Nutrition 10.3746/pnf.2014.19.4.299pnfs-19-299ArticlesHesperetin Inhibits V...,3,156,Prev_Nutr_Food_Sci_2014_Dec_31_19(4)_299-306.txt
4.46.2.148,...an J Food Sci Technol 46 148 152 10.9721/KJFST.2014.46.2.14,123,229,Prev_Nutr_Food_Sci_2016_Mar_31_21(1)_52-56.txt
6.21.2.160,...iety of Food Science and Nutrition 10.3746/pnf.2016.21.2.160pnfs-21-160Research NoteInfluence of Sul...,3,156,Prev_Nutr_Food_Sci_2016_Jun_30_21(2)_160-164.txt
6.21.3.202,...iety of Food Science and Nutrition 10.3746/pnf.2016.21.3.202pnfs-21-202ArticlesOily Fish Consumption...,3,156,Prev_Nutr_Food_Sci_2016_Sep_30_21(3)_202-207.txt
EC 1.14.13.55,...ydrosanguinarine by protopine 6-hydroxylase (P6H; EC 1.14.13.55).34) Although the cDNA of MSH was no...,37,758,Proc_Jpn_Acad_Ser_B_Phys_Biol_Sci_2013_May_10_89(5)_165-182.txt
3.1.1.1,3.1.1.1 CGI-58: gene and protein structur,65,1,Prog_Lipid_Res_2011_Jan_50(1-4)_14-27.txt
1.4.1.1,"29. MaxQuant, version 1.4.1.1 Max Planck Institute of Biochemistry Marti...",124,23,PMC5217376.txt
EC 3.1.3.48,...ut by phosphotyrosyl protein phosphatases (PTPs) (EC 3.1.3.48) acting as a negative control of recep...,105,459,Proteome_Sci_2004_Jun_11_2_2.txt
EC 2.2.1.1,"...1.39, spots 8, 14, 22, 26 and 32), transketolase (EC 2.2.1.1, spots 2, 3, 4, 5 and 6), ferredoxin--N...",317,730,Proteome_Sci_2015_May_2_13_15.txt
1.8.1.1,...Korean Neuropsychiatric Association 10.4306/pi.2011.8.1.1Original ArticleThe Clinical Research Cente...,3,114,Psychiatry_Investig_2011_Mar_7_8(1)_1-8.txt
1.8.4.297,...Korean Neuropsychiatric Association 10.4306/pi.2011.8.4.297Original ArticleTrauma in PsychiatryPost-...,3,114,Psychiatry_Investig_2011_Dec_8_8(4)_297-304.txt
3.10.2.108,...Korean Neuropsychiatric Association 10.4306/pi.2013.10.2.108Original ArticleMediating Effect of Exec...,3,133,Psychiatry_Investig_2013_Jun_30_10(2)_108-114.txt
3.10.3.286,...Korean Neuropsychiatric Association 10.4306/pi.2013.10.3.286Original ArticleCYP2D6 P34S Polymorphism...,3,133,Psychiatry_Investig_2013_Sep_16_10(3)_286-293.txt
6.13.1.157,...h this article at http://dx.doi.org/10.4306/pi.2016.13.1.157,41,99,Psychiatry_Investig_2016_Jan_20_13(1)_157-160.txt
6.13.1.161,...Korean Neuropsychiatric Association 10.4306/pi.2016.13.1.161Case ReportDesensitization of Triggers a...,3,133,Psychiatry_Investig_2016_Jan_20_13(1)_161-163.txt
6.13.4.413,...Korean Neuropsychiatric Association 10.4306/pi.2016.13.4.413Original ArticleAssociation between Medi...,3,133,Psychiatry_Investig_2016_Jul_25_13(4)_413-419.txt
3.32.2.413,"...Performance , 32 , 413 –422 . doi:10.1037/0096-1523.32.2.41316634679",342,287,Psychol_Rev_2012_Apr_27_119(2)_388-407.txt
4.83.5.117,...J Pers Soc Psychol 2002 83 5 1178 10.1037/0022-3514.83.5.1178 12416921,366,184,Psychol_Well_Being_2016_Jun_15_6_5.txt
2.3.4.344,"...r analyses Emotion 2003 3 344 360 10.1037/1528-3542.3.4.344 Ferrer, E., & Nesselroade, J.R. (2003). ...",173,145,Psychometrika_2006_Sep_23_71(3)_425-440.txt
5.11.11.200,"...5 ;11 (11 ):562, 564 –571 . doi: 10.12968/ijpn.2005.11.11.20096",1068,54,PMC5324630.txt
5.8.8.118,...ert Rev Neurother 2008 8 1189 1191 10.1586/14737175.8.8.1189 18671662,259,118,Psychopharmacology_(Berl)_2010_Jul_20_210(4)_533-545.txt
4.85.2.197,... Pers Soc Psychol 2003 85 197 216 10.1037/0022-3514.85.2.197 12916565,134,173,Psychopharmacology_(Berl)_2010_Jul_30_211(1)_79-86.txt
3.14.4.301,...ts Health Psychol 1995 14 301 309 10.1037/0278-6133.14.4.301 7556033,309,184,Psychopharmacology_(Berl)_2016_Jun_8_233_2857-2868.txt
3.14.2.101,... Health Psychol 1995 14 2 101 108 10.1037/0278-6133.14.2.101 Available from: http://dx.doi.org/10.10...,237,181,Psychosoc_Med_2011_Sep_1_8_Doc05.txt
4.39.2.186,...ers Soc Psychol 1980 39 2 186 200 10.1037/0022-3514.39.2.186 Available from: http://dx.doi.org/10.10...,120,178,Psychosoc_Med_2013_Dec_16_10_Doc08.txt
4.12.3.479,"...t Opin Emerg Drugs 2007 12 479 492 10.1517/14728214.12.3.479 Gao Z-G, Jacobson KA (2007) Emerging ad...",317,118,Purinergic_Signal_2008_Dec_29_4(4)_287-303.txt
4.74.3.774,...cial Psychology 1998 74 3 774 789 10.1037/0022-3514.74.3.774 9523419,218,181,Qual_Life_Res_2012_Dec_23_21(10)_1745-1753.txt
4.51.1.149,...al. Soc. Psychol. 1986 51 149 160 10.1037/0022-3514.51.1.149,599,150,Qual_Quant_2016_Aug_6_50_1871-1905.txt
2.30.2.53,...ean Society for Radiation Oncology 10.3857/roj.2012.30.2.53Original ArticleClinical InvestigationCli...,3,139,Radiation_Oncol_J_2012_Jun_30_30(2)_53-61.txt
3.31.4.206,...rapy Radiat Oncol J 2013 31 206 15 10.3857/roj.2013.31.4.206 24501708,325,238,Radiat_Oncol_2015_Jan_13_10_18.txt
3.31.1.48,...ean Society for Radiation Oncology 10.3857/roj.2013.31.1.48Case ReportCases report of unicentric Cas...,3,133,Radiat_Oncol_J_2013_Mar_31_31(1)_48-54.txt
4.32.3.116,...ean Society for Radiation Oncology 10.3857/roj.2014.32.3.116Original ArticleClinical InvestigationsF...,3,133,Radiat_Oncol_J_2014_Sep_30_32(3)_116-124.txt
5.33.2.89,...ean Society for Radiation Oncology 10.3857/roj.2015.33.2.89Original ArticleClinical InvestigationCli...,3,133,Radiat_Oncol_J_2015_Jun_30_33(2)_89-97.txt
5.33.3.207,...ean Society for Radiation Oncology 10.3857/roj.2015.33.3.207Original ArticleClinical InvestigationSt...,3,133,Radiat_Oncol_J_2015_Sep_30_33(3)_207-216.txt
3.95.3.482,...tional Psychology 2003 95 482 494 10.1037/0022-0663.95.3.482,215,178,Read_Writ_2012_Feb_3_25(2)_465-482.txt
1.11.1.6,Glutathione peroxidase (GSH-Px – EC.1.11.1.6) activity was assessed spectrophotometric...,55,37,Redox_Biol_2016_Aug_20_9_210-219.txt
EC 1.6.2.4,...y encoding for a NADPH-cytochrome P450 reductase (EC 1.6.2.4) was also located in cluster 1. The aro...,217,415,Reprod_Biol_Endocrinol_2006_Jul_27_4_39.txt
2.18.7.331,...t J Palliat Nurs 2012 18 331 337 10.12968/ijpn.2012.18.7.331 22885965,162,183,Respir_Res_2015_Jul_3_16(1)_83.txt
6.83.3.779,"...Motor Skills , 83 , 779 –787 . doi:10.2466/pms.1996.83.3.779",663,164,Rev_Educ_Res_2015_Dec_85(4)_698-739.txt
4.1.3.27,1	LOC_Os03g15780.1	4.1.3.27	anthranilate synthase,67,20,Rice_(N_Y)_2013_May_29_6_15.txt
4.77.6.112,"77 , 1121  (doi:10.1037/0022-3514.77.6.1121)10626367",247,33,R_Soc_Open_Sci_2015_Dec_23_2(12)_150222.txt
4.37.6.822,"37 , 822 –832 . (doi:10.1037/0022-3514.37.6.822",279,38,R_Soc_Open_Sci_2016_Apr_6_3(4)_160007.txt
2.1.1.2,2.1.1.2. Monthly data. Monthly data spanned 11 yea...,67,1,R_Soc_Open_Sci_2016_Sep_7_3(9)_160197.txt
3.1.3.3,3.1.3.3. Serotonin-LI,64,1,R_Soc_Open_Sci_2016_Oct_26_3(10)_160289.txt
1.7.99.4,K00371 narH: nitrate reductase beta subunit (EC: 1.7.99.4),16,51,PMC5319346.txt
1.2.2.135,...ety and Health Research Institute 10.5491/SHAW.2011.2.2.135Original ArticleCancer Mortality and Inci...,3,144,Saf_Health_Work_2011_Jun_30_2(2)_135-147.txt
2.3.4.257,...ety and Health Research Institute 10.5491/SHAW.2012.3.4.257ReviewOccupational Neurotoxic Diseases in...,3,144,Saf_Health_Work_2012_Dec_30_3(4)_257-267.txt
2.3.4.4,"ProMED . Global, H5 evolution, new clade 2.3.4.4, WHO/OIE/FAO , 2015 , http://www.promedmai...",122,42,SAGE_Open_Med_Case_Rep_2015_Aug_4_3_2050313X15596484.txt
3.5.3.1,Arginase [E.C 3.5.3.1] catalyzes synthesis of ornithine and urea...,10,15,Scientifica_(Cairo)_2016_May_16_2016_3675283.txt
EC 1.10.3.2,Laccases (EC 1.10.3.2) are multicopper oxidases mainly invol...,11,11,ScientificWorldJournal_2012_Apr_1_2012_398725.txt
5.36.4.174,...amily Medicine  2015 36 4 174 179 10.4082/kjfm.2015.36.4.174 2-s2.0-84938258325 26217481,212,281,PMC5244027.txt
1.3.99.3,...c defect of fatty acid oxidation. MCAD (MCAD E.C. 1.3.99.3) is a mitochondrial flavoprotein which ca...,48,133,ScientificWorldJournal_2013_Oct_31_2013_625824.txt
1.51.51.51,"...xp⁡−∑j=0nxij−μij22σij2, where  (10) σ=1.51.51.51.51.51.51.51.51.51.5222222222211111111112222222222,μ...",100,977,ScientificWorldJournal_2015_Mar_24_2015_704587.txt
3.4.8.1,...offline from saved text files generated by Chart v3.4.8.1® by an in-house software programme (the “M...,64,1546,Sci_Pharm_2015_Apr_13_Apr-Jun_83(2)_339-352.txt
1.2.1.3,...-dependent aldehyde dehydrogenase (Sama2648; E.C. 1.2.1.3) that can shunt to succinyl-CoA as well as...,22,1432,Sci_Rep_2011_Jun_29_1_25.txt
EC 4.2.2.1,"...es (Supplementary Fig. S1)13: hyaluronate lyases (EC 4.2.2.1, Streptococcus hyaluronate lyase), hyal...",7,279,Sci_Rep_2014_Mar_26_4_4471.txt
EC 4.2.1.3,"...). We further examined the activity of aconitase (EC 4.2.1.3.), which catalyzes the conversion of ci...",16,1283,Sci_Rep_2014_Aug_5_4_5952.txt
EC 1.15.1.1,"Superoxide dismutases (SODs, EC 1.15.1.1) are metalloenzymes that are widely ex...",7,30,Sci_Rep_2014_Dec_2_4_7284.txt
2.3.4.612,"...another with both belonging to the proposed clade 2.3.4.612. More recently, after reviewing the avai...",5,1502,Sci_Rep_2015_Mar_25_5_9484.txt
EC 2.3.1.137,...roxisomal carnitine O-octanoyltransferase (CrOT) (EC 2.3.1.137) responsible for the transfer of medi...,59,404,Sci_Rep_2015_Sep_1_5_13610.txt
3.4.2.1,"...nzene (100:0 to 0:100) and yield 3 fractions (Fr. 3.4.2.1-3.4.2.3). Fr. 3.4.2.2 (830 mg, 2:1) was pu...",62,1755,Sci_Rep_2015_Sep_9_5_13914.txt
3.4.2.2,...lution (100:0 to 0:100) to yield 2 fractions (Fr. 3.4.2.2.1–3.4.2.2.2). Fr. 3.4.2.2.1 was further pu...,62,1964,Sci_Rep_2015_Sep_9_5_13914.txt
2.6.1.1,"...-116), AT5G19550 (1E-112), AT1G62800 (1E-107)	EC: 2.6.1.1	aspartate transaminase",120,75,Sci_Rep_2015_Aug_11_5_12952.txt
3.1.3.11,"...9E-102), AT3G54050 (3E-77), AT5G64380 (1E-51)	EC: 3.1.3.11	fructose-bisphosphatase",131,74,Sci_Rep_2015_Aug_11_5_12952.txt
1.1.1.40,"...106), AT2G19900 (9E-106), AT5G11670 (2E-103),	EC: 1.1.1.40	malate dehydrogenase (oxaloacetate- decar...",137,97,Sci_Rep_2015_Aug_11_5_12952.txt
EC 1.1.5.9,... (FAD)-dependent glucose dehydrogenases (FADGDHs; EC 1.1.5.9) comprise oxidoreductases that catalyze...,5,82,Sci_Rep_2015_Aug_27_5_13498.txt
2.2.1.2,K00616	[EC:2.2.1.2]	Biosynthesis of antibiotics	9.16E-03	0.07...,154,12,Sci_Rep_2015_Nov_27_5_17084.txt
4.7.2.108,"7 , 108 –117 , doi: 10.15283/ijsc.2014.7.2.108  (2014 ).25473448",202,38,Sci_Rep_2015_Dec_7_5_17898.txt
1.1.18.1,...ty and Cell Count Assay (NucleoView software ver. 1.1.18.1) according to the manufacturer’s instruct...,36,206,Sci_Rep_2015_Dec_11_5_18016.txt
3.2.1.99,"EC:3.2.1.99	Arabinan endo-1,5-alpha-L-arabinosidase.	...",89,4,Sci_Rep_2016_Jan_4_6_18408.txt
3.2.1.14,"...sidase, MUF-N-acetyl-β-D-glucosaminide dehydrate (3.2.1.14) for N-acetylglucosaminidase, and 4-MUF-p...",82,203,Sci_Rep_2016_Feb_29_6_22240.txt
4.1.3.3,"... EC(5.4.2.10), EC(2.3.1.157), EC(2.7.7.23) and EC(4.1.3.3). Meanwhile, EC(3.5.2.10) was associated w...",70,337,Sci_Rep_2016_Mar_2_6_22525.txt
EC 4.1.1.1,"...ate kinase (EC 2.7.1.40), pyruvate decarboxylase (EC 4.1.1.1) and alcohol dehydrogenase (EC 1.1.1.1)...",22,3471,Sci_Rep_2016_Mar_3_6_22583.txt
2.3.4.4,...chicken/BC/FAV-002/2015 (H5N1) belonging to clade 2.3.4.4 that was isolated from backyard chickens i...,3,1755,Sci_Rep_2016_Mar_18_6_23380.txt
2.3.4.4,"... number of different species using Eurasian clade 2.3.4.4 H5N8 viruses672021, little was known about...",11,403,Sci_Rep_2016_Mar_18_6_23380.txt
4.19.3.467,"19 , 467 –481 , doi: 10.1037/0882-7974.19.3.467  (2004 ).15382997",130,38,Sci_Rep_2016_Apr_13_6_24194.txt
2.3.2.1,...nd M) from H9N2 virus and belongs to the subclade 2.3.2.1c,3,2227,Sci_Rep_2016_May_10_6_25845.txt
1.3.5.4,"...ntary Fig. S3 and Dataset S4). Genes (lp_3491, EC:1.3.5.4; lp_1425, EC:1.3.5.4; CitE, EC:4.1.3.34; a...",23,619,Sci_Rep_2016_Jun_7_6_27392.txt
2.3.4.4,Despite the widespread detection of Clade 2.3.4.4 H5 viruses in wild birds sampled during th...,39,43,Sci_Rep_2016_Jul_6_6_28980.txt
2.3.-.-,"...ted to two enzymes, polyketide synthase (PKS, EC: 2.3.-.-) and cytochrome P450 (P450, EC: 1.14.-.-),...",24,1310,Sci_Rep_2016_Aug_1_6_30760.txt
2.9.3.258,... of allelic frequency57) using the software FSTAT 2.9.3.258. We also estimated contemporary effectiv...,59,441,Sci_Rep_2016_Aug_18_6_31957.txt
1.51.1.14,"51 , 115 –124 , 10.3896/IBRA.1.51.1.14  (2012 )",128,30,Sci_Rep_2016_Aug_24_6_32023.txt
5.9.3.242,"9 , 242 –248 , doi: 10.4162/nrp.2015.9.3.242  (2015 ).26060535",259,36,Sci_Rep_2016_Aug_25_6_31775.txt
3.46.1.24,"46 , 24 –29 , doi: 10.5946/ce.2013.46.1.24  (2013 ).23422955",179,34,Sci_Rep_2016_Sep_30_6_33234.txt
1.4.1.3,...ng and Perseus used to organize the data (version 1.4.1.3),129,1134,Sci_Rep_2016_Oct_17_6_35306.txt
1.6.1.2, Pnta; [EC:1.6.1.2]	K00324	0.023	0.013	0.016	0.003	0.060	0.02...,332,12,Sci_Rep_2016_Nov_23_6_34668.txt
EC 4.2.1.79,"...e (EC 4.2.1.3; Acn), 2-methylcitrate dehydratase (EC 4.2.1.79; AcnD), homoaconitase (EC 4.2.1.114; H...",9,131,Sci_Rep_2016_Dec_8_6_38720.txt
EC 2.7.1.1,EC 2.7.1.1	evm.model.unitig_1.1360	hexokinase	0.79...,192,1,PMC5247736.txt
EC 4.3.1.5,"...re catalyzed by phenylalanine ammonia-lyase (PAL; EC 4.3.1.5), cinnamate 4-hydroxylase (C4H; EC 1.14...",7,386,PMC5259741.txt
2.5.1.18,"...enes encoding glutathione S-transferase (GST) [EC:2.5.1.18], one was up-regulated while the other wa...",24,1702,PMC5278365.txt
2.1.1.104,"....11.1.7] and caffeoyl-CoA O-methyltransferase [EC:2.1.1.104] were both up-regulated, which indicated...",51,389,PMC5278365.txt
1.1.1.34,HMGR1	hydroxymethylglutaryl-CoA reductase	1.1.1.34	K00021	SmTc_1585,167,43,PMC5320516.txt
1.17.7.1,...4-hydroxy-3-methylbut-2-enyl-diphosphate synthase	1.17.7.1	K03526	SmTc_845,183,60,PMC5320516.txt
EC 1.15.1.1,"...(POD, EC 1.11.1.7) and superoxide dismutase (SOD, EC 1.15.1.1). SOD activity was assayed by monitori...",89,437,PMC5324167.txt
2.1.3.1,2.1.3.1. Liquid crystalline propertie,41,1,Sci_Technol_Adv_Mater_2014_Aug_21_15(4)_044203.txt
2.2.1.8,2.2.1.8. Yield measuremen,61,1,Sci_Technol_Adv_Mater_2015_May_5_16(3)_034602.txt
2.4.1.6,"2.4.1.6.  CellSizeX, CellSizeY, CellSize",453,1,Sci_Technol_Adv_Mater_2016_Jul_29_17(1)_41045-430.txt
1.1.3.17,"...8) from Equine serum, choline oxidase (ChOx) (E.C.1.1.3.17) from Alkaligenes species, peroxidase (HR...",20,84,Sensors_(Basel)_2010_Dec_9_10(12)_11274-11286.txt
3.5.1.5,"...were purchased from Sigma, including urease (E.C. 3.5.1.5, type IX, at activity 20 kU), glutaraldehy...",21,89,Sensors_(Basel)_2011_Apr_27_11(5)_4562-4571.txt
1.2.2.1,9.1.2.2.1. Dedicated Common Control Channe,286,3,Sensors_(Basel)_2013_Sep_26_13(10)_13005-13038.txt
EC 1.1.3.4,"Glucose	Glucose oxidase (GOD), EC 1.1.3.4, from a microorganism",109,32,Sensors_(Basel)_2008_Feb_21_8(2)_1111-1127.txt
EC 1.11.1.7,"...s purchased from Reanal (Budapest, Hungary), HRP (EC 1.11.1.7), specific activity 250 U mg-1 solid, ...",23,155,Sensors_(Basel)_2005_Nov_14_5(6)_364-376.txt
EC 1.1.3.2,"...tate oxidase	Pediococcus sp. Aerococcus viridians EC 1.1.3.2	l-Lactate	[28,36,37,38]",208,54,Sensors_(Basel)_2016_May_30_16(6)_780.txt
1.1.1.790,"...ID>/set_water_pump, where <deviceID>, e.g., 0.2.481.1.1.790.0001 is plugged in. Note that the single...",168,1008,Sensors_(Basel)_2016_Oct_6_16(10)_1645.txt
2.2.53.585,...e sensors Tech. Mess. 2005 72 53 76 10.1524/teme.72.2.53.58572,200,165,PMC5190965.txt
4.35.8.587,...Social Psychology 1977 35 587 596 10.1037/0022-3514.35.8.587 915695,246,182,Sex_Roles_2010_Jan_22_62(1-2)_77-88.txt
3.97.4.673,...tional Psychology 2005 97 673 686 10.1037/0022-0663.97.4.673,180,190,Sex_Roles_2010_Dec_11_63(11-12)_860-870.txt
4.57.1.55,...d Social Psychology 1989 57 55 66 10.1037/0022-3514.57.1.55 2754604,197,219,Sex_Roles_2011_Jan_9_64(1-2)_70-80.txt
4.75.3.729,...Social Psychology 1998 75 729 750 10.1037/0022-3514.75.3.729 9781409,167,230,Soc_Indic_Res_2015_May_16_121(2)_455-470.txt
5.11.1.21,... Int J Stress Manag 2004 11 21 40 10.1037/1072-5245.11.1.21,256,249,Soc_Psychiatry_Psychiatr_Epidemiol_2014_Feb_20_49(8)_1209-1218.txt
1.41.6.742,...i.org/10.4040/jkan.2011.41.6.742  10.4040/jkan.2011.41.6.742 22310858,276,216,South_Med_Rev_2012_Dec_27_5(2)_26-33.txt
3.2.1.21,....C. 3.2.1.4) and cellobiase or β-glucosidase (E.C.3.2.1.21),9,549,Springerplus_2013_Jan_12_2_10.txt
2.19.64.221,172.19.64.221	0,206,3,Springerplus_2016_Jul_8_5(1)_1032.txt
6.21.4.749,... J Korean Med Sci 2006 21 749 751 10.3346/jkms.2006.21.4.749 16891825,112,152,Springerplus_2016_Aug_30_5(1)_1443.txt
5.16.4.677,...e Cogn Linguist 2005 16 4 677 731 10.1515/cogl.2005.16.4.677,229,124,Springerplus_2016_Oct_12_5(1)_1773.txt
3.7.3.236,...vum Asian Spine J 2013 7 3 236 241 10.4184/asj.2013.7.3.236 24066222,84,176,Springerplus_2016_Nov_7_5(1)_1927.txt
EC 1.15.1.1,"...otations, such as manganese superoxide dismutase (EC 1.15.1.1), superoxide dismutase [Cu-Zn] precurs...",128,729,Stand_Genomic_Sci_2013_Jul_30_8(3)_491-499.txt
1.1.1.35,"...encoding for 3-hydroxyacyl-CoA dehydrogenase ([EC:1.1.1.35], A3ECDRAFT_1916), three fadA genes encod...",189,454,Stand_Genomic_Sci_2015_Aug_5_10_50.txt
EC 5.3.1.5,"...merase, esterase, and aldolase. Xylose isomerase (EC 5.3.1.5) catalyzes the isomerization of xylose ...",235,181,Stand_Genomic_Sci_2015_Sep_26_10_70.txt
EC 4.2.1.12,"...osphogluconate by 6-phosphogluconate dehydratase (EC 4.2.1.12). Alternatively, gluconate could be fi...",213,632,PMC5322786.txt
2.73.4.409,...ects J Periodontol 2002 73 409 417 10.1902/jop.2002.73.4.409 11990442,133,282,Stem_Cell_Res_Ther_2014_Apr_16_5(2)_52.txt
2.17.9.161,... Bone Miner Res 2002 17 1613 1620 10.1359/jbmr.2002.17.9.1613 12211431,74,199,Stem_Cell_Res_Ther_2013_Jan_31_4(1)_10.txt
3.54.5.129,...apy Yonsei Med J 2013 54 1293 1296 10.3349/ymj.2013.54.5.1293 23918585,153,208,Stem_Cell_Res_Ther_2015_Feb_9_6(1)_33.txt
5.8.2.200,... of Stem Cells  2015 8 2 200 208 10.15283/ijsc.2015.8.2.200 26634068,32,228,Stem_Cells_Int_2016_Jan_17_2016_4801953.txt
3.14.10.578,...Prevention  2013 14 10 5789 5795 10.7314/APJCP.2013.14.10.5789 2-s2.0-84890526582 24289579,70,249,Stem_Cells_Int_2016_Jul_14_2016_4829106.txt
4.23.1.77,...ental Neurobiology  2014 23 1 77 85 10.5607/en.2014.23.1.77 24737942,316,289,Stem_Cells_Int_2016_Sep_6_2016_4617983.txt
4.7.45.238,...DS Educ Prev 2002 14 45 52 12413192 10.1521/aeap.14.7.45.23867,56,202,Subst_Abuse_Treat_Prev_Policy_2006_Dec_4_1_34.txt
4.73.5.109,...chology 1997 73 1092 1106 9364763 10.1037/0022-3514.73.5.1092,231,178,Subst_Abuse_Treat_Prev_Policy_2006_Nov_2_1_32.txt
2.74.3.365,... J Orthopsychiatry 2004 74 365 75 10.1037/0002-9432.74.3.365 15291712,162,181,Subst_Abuse_Treat_Prev_Policy_2015_Jan_17_10_2.txt
2.7.4.14,2.7.4.14	Cytidylate kinase	PA3163	1.37	1.59	50169	...,101,1,Summit_on_Translat_Bioinforma_2009_Mar_1_2009_100-104.txt
4.29.10.134,...Korean Med Sci 2014 29 10 1341 52 10.3346/jkms.2014.29.10.1341 25368486,151,204,PMC5237475.txt
1.3.2.1,...1) and transferred using EpiData Manager (version 1.3.2.1.) to a statistical package (R version. 3.1...,81,186,Telemed_J_E_Health_2016_Jul_1_22(7)_553-563.txt
4.6.1.1,"...k analysis using DNA Alignment v1.3.1.1, Network v4.6.1.1 and Network Publisher v1.3.0.0 software (F...",43,848,PMC5263206.txt
3.51.1.61,...OS Korean J Parasitol 2013 51 61 8 10.3347/kjp.2013.51.1.61 23467460,445,196,Tissue_Barriers_2013_Dec_1_1(5)_e26938.txt
3.14.6.348,... J Cancer Prev 2013 14 3483 3489 10.7314/APJCP.2013.14.6.3483 23886133,354,221,Tob_Induc_Dis_2016_Aug_15_14_28.txt
EC 3.6.1.3,...ed according to Weiser[14] and Ca2+- Mg2+-ATPase (EC 3.6.1.3.) as described by Hidalgo et al.[15] En...,29,316,Toxicol_Int_2012_Jan-Apr_19(1)_25-30.txt
2.28.2.123,... Society of Toxicology toxicr-28-12310.5487/TR.2012.28.2.123ArticlesDiagnostic Assay of Toxic Zinc i...,3,118,Toxicol_Res_2012_Jun_28(2)_123-127.txt
EC 3.1.1.8,"...hE, EC 3.1.1.7) and butyrylcholinesterase (BuChE, EC 3.1.1.8), although some require metabolism to a...",13,111,Toxicol_Sci_2013_Dec_19_136(2)_274-283.txt
4.2.2.1,4.2.2.1. Bacillus cereus cereulid,231,1,Toxins_(Basel)_2010_Apr_15_2(4)_683-737.txt
3.1.2.2,3.1.2.2. Polypeptide Toxic Metabolite,143,1,Toxins_(Basel)_2011_Dec_20_3(12)_1569-1605.txt
4.30.3.132,...s Ann. Coloproctol. 2014 30 132 134 10.3393/ac.2014.30.3.132 24999464,534,151,Toxins_(Basel)_2015_May_29_7(6)_1882-1916.txt
2.13.6.262,.... Cancer Prev. 2012 13 2625 2628 10.7314/APJCP.2012.13.6.2625 22938431,154,305,Toxins_(Basel)_2015_Aug_20_7(8)_3267-3296.txt
1.5.2.6,"Results were processed in the Perseus (V. 1.5.2.6, Max Planck Institute of Biochemistry, Mar...",92,43,Toxins_(Basel)_2016_Apr_12_8(4)_105.txt
2.19.9.31,...ster? Emerg Nurse. 2012 19 9 31 7 10.7748/en2012.02.19.9.31.c8943 22489365,158,108,Trauma_Mon_2015_Nov_23_20(4)_e29033.txt
3.-.-.-,PNKD	1	25953; 3.-.-.-; 2q35	I 1: ME; I 2: C (http://www.uniprot....,134,15,Trends_Biochem_Sci_2016_Apr_41(4)_338-355.txt
4.50.4.171,...tudie Diagnostica 2004 50 171 181 10.1026/0012-1924.50.4.171,169,209,Trials_2013_Oct_14_14_334.txt
4.54.6.106,...ers Soc Psychol 1988 54 1063 1070 10.1037/0022-3514.54.6.1063 3397865,295,186,Trials_2014_Oct_27_15_411.txt
4.45.4.194,...EE) Diagnostica. 1999 45 194 204 10.1026//0012-1924.45.4.194,240,183,Trials_2015_May_27_16_230.txt
2.45.2.78,... Med Public Health 2012 45 78 89 10.3961/jpmph.2012.45.2.78 22509448,193,197,Trials_2015_Jul_14_16_301.txt
5.33.10.58,... vaginosis Medicine 2005 33 58 61 10.1383/medc.2005.33.10.58,144,72,Trials_2015_Jul_26_16_315.txt
3.27.3.379,...ions Health Psychol 2008 27 3 379 10.1037/0278-6133.27.3.379 18624603,212,135,Trials_2015_Aug_17_16_353.txt
2.8.3.364,...l response Emotion. 2008 8 364 78 10.1037/1528-3542.8.3.364 18540752,259,215,Trials_2016_Jan_4_17_1.txt
2.73.1.38,...erculosis and Respiratory Diseases 10.4046/trd.2012.73.1.38Original ArticleRisk Factors Related with...,3,184,Tuberc_Respir_Dis_(Seoul)_2012_Jul_31_73(1)_38-47.txt
2.73.6.303,...erculosis and Respiratory Diseases 10.4046/trd.2012.73.6.303Original ArticleGefitinib in Selected Pa...,3,184,Tuberc_Respir_Dis_(Seoul)_2012_Dec_28_73(6)_303-311.txt
1.10.5.34,"...s ratio [OR], 2.42, 95% confidence interval [CI], 1.10.5.34) were independently associated with incr...",56,547,Tuberc_Respir_Dis_(Seoul)_2013_Jul_31_75(1)_18-24.txt
3.75.2.47,...erculosis and Respiratory Diseases 10.4046/trd.2013.75.2.47ReviewInterstitial Lung Diseases: Respira...,3,184,Tuberc_Respir_Dis_(Seoul)_2013_Aug_30_75(2)_47-51.txt
3.75.6.238,...erculosis and Respiratory Diseases 10.4046/trd.2013.75.6.238Original ArticleCauses and Predictive Fa...,3,184,Tuberc_Respir_Dis_(Seoul)_2013_Dec_24_75(6)_238-243.txt
5.78.2.72,...erculosis and Respiratory Diseases 10.4046/trd.2015.78.2.72Original ArticlePrevalence of Benign Dise...,3,184,Tuberc_Respir_Dis_(Seoul)_2015_Apr_2_78(2)_72-77.txt
5.78.4.380,...erculosis and Respiratory Diseases 10.4046/trd.2015.78.4.380Case ReportAberrant Bronchial Artery to ...,3,184,Tuberc_Respir_Dis_(Seoul)_2015_Oct_1_78(4)_380-384.txt
4.3.2.2,4.3.2.2.	Concurrent cisplatin at 100 mg/m2 at day ...,92,1,Urol_Ann_2011_Mar_3(Suppl)_S6-S9.txt
3.2.1.5,3.2.1.5.3.	Treatment is usually stopped only if th...,142,1,Urol_Ann_2011_Mar_3(Suppl)_S10-S16.txt
3.2.2.2,3.2.2.2.1.	In patients on monotherapy with LHRH ag...,147,1,Urol_Ann_2011_Mar_3(Suppl)_S10-S16.txt
3.2.1.1,... will depend on the pathological stage as in item 3.2.1.1.3,105,166,Urol_Ann_2011_Mar_3(Suppl)_S17-S20.txt
3.1.1.1,3.1.1.1. If the patient is asymptomatic with life ...,134,1,Urol_Ann_2014_Oct-Dec_6(4)_278-285.txt
3.1.1.1,3.1.1.1. If the patient is asymptomatic with life ...,134,1,Urol_Ann_2014_Oct-Dec_6(4)_278-285.txt
3.2.1.7,3.2.1.7.1. LHRH antagonist or CAB (antiandrogen an...,229,1,Urol_Ann_2014_Oct-Dec_6(4)_278-285.txt
4.8.3.1,4.8.3.1. Recurrent disease postprimary nephrectomy...,156,1,Urol_Ann_2014_Oct-Dec_6(4)_286-289.txt
5.3.1.6,5.3.1.6. Urothelial histology,226,1,Urol_Ann_2014_Oct-Dec_6(4)_273-277.txt
4.1.2.3,4.1.2.3. Genetic Stability of MTBVA,161,1,Vaccines_(Basel)_2014_Jun_16_2(2)_463-499.txt
3.3.1.3,3.3.1.3. Advantages of long-lasting persistence in...,87,1,Vet_Res_2009_Apr_21_Mar-Apr_40(2)_37.txt
1.52.1.14,...ema research J Apic Res 2013 52 1 28 10.3896/IBRA.1.52.1.14,244,242,Vet_Res_2016_Apr_26_47_51.txt
4.4.1.77,...? Expert Rev Vaccines 2005 4 77 88 10.1586/14760584.4.1.77 15757475,148,162,Vet_Res_2016_Nov_28_47_119.txt
2.3.4.4,"[18]	2.3.4.4	α-2,3+α-2,6",152,7,PMC5294818.txt
4.94.5.490,...o Phytopathology 2004 94 490 496 10.1094/PHYTO.2004.94.5.490,256,202,Virol_J_2007_Oct_26_4_111.txt
4.17.1.97,...Opin Investig Drugs 2008 17 97 103 10.1517/13543784.17.1.97 18095922,206,163,Virol_J_2011_Mar_31_8_149.txt
3.16.8.681,... Microbe Interact 2003 16 681 688 10.1094/MPMI.2003.16.8.681 12906112,219,174,Virol_J_2012_May_29_9_101.txt
4.19.23.208,...Euro Surveill 2014 19 23 1 10.2807/1560-7917.ES2014.19.23.20828,261,276,Virol_J_2015_Dec_22_12_222.txt
2.2.1.2,"...hese produced by the homologous viruses in clades 2.2.1.2, 2.2 and clade 1 and 32 fold lower than th...",60,647,PMC5343302.txt
2.53.4.217,... ; PMID:6951991; http://dx.doi.org/10.1902/jop.1982.53.4.217 6951991,228,73,Virulence_2015_Feb_5_6(3)_2086-215.txt
4.88.5.436,...eonpea Plant Dis. 2004 88 436 445 10.1094/PDIS.2004.88.5.436,218,185,Viruses_2012_Sep_12_4(9)_1515-1536.txt
2.86.5.528,... virus Plant Dis. 2002 86 528 534 10.1094/PDIS.2002.86.5.528,444,169,Viruses_2012_Sep_24_4(9)_1753-1791.txt
4.3.5.481,...abies Future Virol. 2008 3 481 490 10.2217/17460794.3.5.481 19578477,159,134,Viruses_2013_Feb_15_5(2)_732-752.txt
2.3.2.1,... be phylogenetically closely related to the clade 2.3.2.1 viruses that were isolated in 2009–2011 fr...,24,130,Viruses_2013_Apr_23_5(4)_1153-1174.txt
2.3.2.1,...y (100% mortality) of genotypically related clade 2.3.2.1 Mongolian virus (A/whooper swan/Mongolia/6...,167,655,Viruses_2013_Apr_23_5(4)_1153-1174.txt
4.3.1.71,...estions Future Virol. 2008 3 71 81 10.2217/17460794.3.1.71,134,150,Viruses_2013_Jun_19_5(6)_1536-1552.txt
4.19.42.209,...ro Surveill. 2014 19 art 1 10.2807/1560-7917.ES2014.19.42.20935,171,197,Viruses_2015_Aug_10_7(8)_4529-4562.txt
4.15.6.271,.... Cancer Prev. 2014 15 2719 2725 10.7314/APJCP.2014.15.6.2719 24761891,279,271,Viruses_2015_Aug_19_7(8)_4734-4755.txt
4.19.42.209,...Eur. Surveill. 2014 19 1 6 10.2807/1560-7917.ES2014.19.42.20935,84,196,Viruses_2015_Nov_24_7(11)_6043-6050.txt
3.28.1.120,... Korean Med. Sci. 2013 28 120 127 10.3346/jkms.2013.28.1.120 23341722,112,268,Viruses_2015_Nov_17_7(11)_5919-5932.txt
6.1.1.111,...se Expert Rev. Hematol. 2008 1 111 10.1586/17474086.1.1.111 20151032,373,148,Viruses_2016_Mar_22_8(3)_85.txt
5.20.4.573,...s J Korean Med Sci 2005 1 573 578 10.3346/jkms.2005.20.4.573 16100446,92,150,World_Allergy_Organ_J_2008_Jul_15_1(7)_129-133.txt
4.32.2.76,"...for Sexual Medicine and Andrology 10.5534/wjmh.2014.32.2.76Original ArticleA Milk Protein, Casein, a...",3,159,World_J_Mens_Health_2014_Aug_26_32(2)_76-82.txt
2.5.3.107,...c liver Swiss Surg 1999 5 107 110 10.1024/1023-9332.5.3.107 10414180,168,122,World_J_Surg_2012_Oct_15_36(10)_2420-2427.txt
4.3.3.263,...ture Oncol 2007 3 263 271 17547520 10.2217/14796694.3.3.263,184,128,World_J_Surg_Oncol_2008_Jun_20_6_65.txt
1.22.3.161,...rs J Gynecol Oncol 2011 11 161 167 10.3802/jgo.2011.22.3.161 21998758,216,144,World_J_Surg_Oncol_2013_Dec_27_11_314.txt
6.9.11.169,... Pharmacogenomics 2008 9 1695 1709 10.2217/14622416.9.11.1695 19018724,183,155,World_J_Surg_Oncol_2014_May_24_12_164.txt
3.47.4.378,... Pathol 2013 47 4 378 82 10.4132/KoreanJPathol.2013.47.4.378 24009634,122,128,World_J_Surg_Oncol_2015_Mar_24_13_118.txt
2.11.1.69,... Opin Ther Targets 2007 11 1 69 79 10.1517/14728222.11.1.69 17150035,122,96,World_J_Surg_Oncol_2010_Apr_20_8_31.txt
2.53.3.524,...ersity College of Medicine 2247699510.3349/ymj.2012.53.3.524Original ArticleCardiac & Cardiovascular...,3,130,Yonsei_Med_J_2012_May_1_53(3)_524-529.txt
2.53.1.43,...ersity College of Medicine 2218723110.3349/ymj.2012.53.1.43Original ArticleNeurology & Neurosciences...,3,117,Yonsei_Med_J_2012_Jan_1_53(1)_43-52.txt
2.53.2.427,...ersity College of Medicine 2231883410.3349/ymj.2012.53.2.427Original ArticleAnesthesiologyBeneficial...,3,117,Yonsei_Med_J_2012_Mar_1_53(2)_427-432.txt
2.53.2.262,...ersity College of Medicine 2231881210.3349/ymj.2012.53.2.262Review ArticleKawasaki Disease: Laborato...,3,117,Yonsei_Med_J_2012_Mar_1_53(2)_262-275.txt
2.53.3.477,...ersity College of Medicine 2247698910.3349/ymj.2012.53.3.477Original ArticleNeurology & Neuroscience...,3,130,Yonsei_Med_J_2012_May_1_53(3)_477-485.txt
2.53.6.112,...ersity College of Medicine 2307411110.3349/ymj.2012.53.6.1120Original ArticleOncologyHigh Dose Invol...,3,130,Yonsei_Med_J_2012_Nov_1_53(6)_1120-1127.txt
3.54.1.108,...ersity College of Medicine 2322580610.3349/ymj.2013.54.1.108Original ArticleOncologyLong-Term Outcom...,3,130,Yonsei_Med_J_2013_Jan_1_54(1)_108-115.txt
5.56.2.535,...sei University College of Medicine 10.3349/ymj.2015.56.2.535Original ArticleAnesthesiologySelective ...,3,122,Yonsei_Med_J_2015_Mar_1_56(2)_535-542.txt
5.56.2.503,"...sei University College of Medicine 10.3349/ymj.2015.56.2.503Original ArticleRadiology, Nuclear Medic...",3,122,Yonsei_Med_J_2015_Mar_1_56(2)_503-509.txt
5.56.2.519,"...sei University College of Medicine 10.3349/ymj.2015.56.2.519Original ArticleRadiology, Nuclear Medic...",3,122,Yonsei_Med_J_2015_Mar_1_56(2)_519-528.txt
5.56.4.112,...ersity College of Medicine 2606913810.3349/ymj.2015.56.4.1122Original ArticleAnesthesiologyHead Elev...,3,130,Yonsei_Med_J_2015_Jul_1_56(4)_1122-1127.txt
5.56.5.128,...ersity College of Medicine 2625697110.3349/ymj.2015.56.5.1288Original ArticleGastroenterology & Hepa...,3,130,Yonsei_Med_J_2015_Sep_1_56(5)_1288-1295.txt
6.57.2.496,...sei University College of Medicine 10.3349/ymj.2016.57.2.496Original ArticleRehabilitationBotulinum ...,3,122,Yonsei_Med_J_2016_Mar_1_57(2)_496-504.txt
6.57.2.306,...sei University College of Medicine 10.3349/ymj.2016.57.2.306Original ArticleCardiac & Cardiovascular...,3,122,Yonsei_Med_J_2016_Mar_1_57(2)_306-312.txt
6.57.3.549,...sei University College of Medicine 10.3349/ymj.2016.57.3.549Original ArticleOncologyApolipoproteins ...,3,122,Yonsei_Med_J_2016_May_1_57(3)_549-556.txt
6.57.4.963,...ersity College of Medicine 2718929210.3349/ymj.2016.57.4.963Original ArticleTransplantationCompariso...,3,130,Yonsei_Med_J_2016_Jul_1_57(4)_963-967.txt
6.57.5.128,...ersity College of Medicine 2740166410.3349/ymj.2016.57.5.1286Case ReportHematologyBone Marrow Suppre...,3,130,Yonsei_Med_J_2016_Sep_1_57(5)_1286-1289.txt
6.57.6.137,...sei University College of Medicine 10.3349/ymj.2016.57.6.1370Original ArticleGastroenterology & Hepa...,3,122,Yonsei_Med_J_2016_Nov_1_57(6)_1370-1375.txt
4.2.2.5,"...Methodological Standards in Pharmacoepidemiology, 4.2.2.5. Unmeasured confounding [Mar 10]. London, ...",372,138,PMC5330542.txt
1.7.1.1,...83. Comment: family-group name unavailable (Art. 11.7.1.1): not based on an available genus name at ...,7189,148,Zookeys_2011_Apr_4_(88)_1-972.txt
1.7.1.1,...me proposed as a new taxon but unavailable (Art. 11.7.1.1) because it was based on a type genus whic...,18806,202,Zookeys_2011_Apr_4_(88)_1-972.txt
1.3.3.99,"...types of Ilyphagus coronatus Monro, 1939 (NHML-1941.3.3.99–100), off Princess Elizabeth Land, Stat. ...",164,77,Zookeys_2012_May_4_(190)_1-19.txt
2.7.23.1,"...6.7 mm, H=20.1 mm, W=4½), paralectotypes NHMUK 1892.7.23.1-2 (2 shells: 1 adult and 1 juvenile; Fig....",311,108,Zookeys_2014_May_23_(411)_1-56.txt
3.2.26.6,"...e NHMUK 1893.2.26.5, and C paralectotype NHMUK 1893.2.26.6-7 D,",1162,92,Zookeys_2014_May_23_(411)_1-56.txt
1.3.17.356,"..., NHMUK 20150129/5; India, Hengdan Peak, NHMUK 1891.3.17.356–357/2; India, NHMUK 1874.4.26.2/2; Khas...",802,291,Zookeys_2015_Oct_26_(529)_1-70.txt
6.2.-3.3,"...mibia: “Kavango, Popa Falls 18°07'S-21°35'E, lux 26.2.-3.3. 1992 Uhlig leg.” (10 exs. ZMHB, 2 exx. M...",3639,1161,Zookeys_2015_Dec_7_(542)_1-379.txt
6.33.2.322,... Natural History 33: 322–343. doi: 10.3366/anh.2006.33.2.32,22125,235,Zookeys_2016_Apr_25_(583)_1-776.txt
2.3.20.2,2012.3.20.2	Paratyp,685,4,Zootaxa_2013_Sep_6_3709(4)_301-329.txt
